id	sid	tid	token	lemma	pos
work_vvlzsj54cvf5de6ji6py6krqlm	1	1	Management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1	3	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1	4	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1	5	Non	Non	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	6	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1	7	Vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1	8	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1	9	Antagonist	Antagonist	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	10	Oral	Oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	11	Anticoagulants	Anticoagulants	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1	12	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1	13	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1	14	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	15	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1	17	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	18	Setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1	19	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1	20	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1	21	Scientific	scientific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1	22	Statement	statement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1	23	From	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1	25	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	26	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	27	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	28	e604	e604	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	29	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	30	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1	32	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1	33	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	2	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	2	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	2	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	2	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	3	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	3	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	3	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	3	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	3	5	CIR.0000000000000477	cir.0000000000000477	NN
work_vvlzsj54cvf5de6ji6py6krqlm	3	6	ABSTRACT	ABSTRACT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	3	7	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	3	8	Non	non	UH
work_vvlzsj54cvf5de6ji6py6krqlm	3	9	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	3	10	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	3	11	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	3	12	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	3	13	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	3	14	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	3	15	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	3	16	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	3	17	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	3	18	now	now	RB
work_vvlzsj54cvf5de6ji6py6krqlm	3	19	widely	widely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	3	20	used	use	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	3	21	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	3	22	alternatives	alternative	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	3	23	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	3	24	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	3	25	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	3	26	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	3	27	prevention	prevention	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	3	28	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	3	29	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	3	30	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	3	31	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	3	32	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	3	33	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	3	34	venous	venous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	3	35	thromboembolism	thromboembolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	3	36	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	4	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	4	2	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	4	3	practice	practice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	4	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	4	5	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	4	6	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	4	7	still	still	RB
work_vvlzsj54cvf5de6ji6py6krqlm	4	8	widespread	widespread	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	4	9	uncertainty	uncertainty	NN
work_vvlzsj54cvf5de6ji6py6krqlm	4	10	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	4	11	how	how	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	4	12	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	4	13	manage	manage	VB
work_vvlzsj54cvf5de6ji6py6krqlm	4	14	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	4	15	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	4	16	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	4	17	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	4	18	bleed	blee	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	4	19	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	4	20	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	4	21	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	4	22	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	4	23	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	4	24	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	4	25	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	4	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	5	1	Clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	5	2	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	5	3	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	5	4	related	relate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	5	5	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	5	6	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	5	7	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	5	8	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	5	9	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	5	10	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	5	11	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	5	12	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	5	13	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	5	14	sparse	sparse	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	5	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	5	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	5	17	recommendations	recommendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	5	18	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	5	19	largely	largely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	5	20	derived	derive	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	5	21	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	5	22	expert	expert	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	5	23	opinion	opinion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	5	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	6	1	Knowledge	knowledge	NN
work_vvlzsj54cvf5de6ji6py6krqlm	6	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	6	3	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	6	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	6	5	last	last	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	6	6	ingestion	ingestion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	6	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	6	8	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	6	9	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	6	10	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	6	11	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	6	12	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	6	13	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	6	14	critical	critical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	6	15	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	6	16	managing	manage	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	6	17	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	6	18	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	6	19	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	6	20	that	that	DT
work_vvlzsj54cvf5de6ji6py6krqlm	6	21	laboratory	laboratory	NN
work_vvlzsj54cvf5de6ji6py6krqlm	6	22	measurement	measurement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	6	23	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	6	24	challenging	challenging	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	6	25	because	because	IN
work_vvlzsj54cvf5de6ji6py6krqlm	6	26	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	6	27	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	6	28	lack	lack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	6	29	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	6	30	commercially	commercially	RB
work_vvlzsj54cvf5de6ji6py6krqlm	6	31	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	6	32	assays	assay	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	6	33	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	6	34	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	6	35	United	United	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	6	36	States	States	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	6	37	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	7	1	Idarucizumab	Idarucizumab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	7	2	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	7	3	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	7	4	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	7	5	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	7	6	antidote	antidote	NN
work_vvlzsj54cvf5de6ji6py6krqlm	7	7	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	7	8	rapidly	rapidly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	7	9	reverse	reverse	VB
work_vvlzsj54cvf5de6ji6py6krqlm	7	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	7	11	effects	effect	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	7	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	7	13	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	7	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	8	1	At	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	8	2	present	present	NN
work_vvlzsj54cvf5de6ji6py6krqlm	8	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	8	4	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	8	5	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	8	6	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	8	7	specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	8	8	antidote	antidote	NN
work_vvlzsj54cvf5de6ji6py6krqlm	8	9	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	8	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	8	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	8	12	United	United	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	8	13	States	States	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	8	14	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	8	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	8	16	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	8	17	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	8	18	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	8	19	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	8	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	9	1	Prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	9	2	concentrate	concentrate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	9	3	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	9	4	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	9	5	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	9	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	9	7	life	life	NN
work_vvlzsj54cvf5de6ji6py6krqlm	9	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	9	9	threatening	threaten	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	9	10	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	9	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	10	1	Healthcare	Healthcare	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	10	2	institutions	institution	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	10	3	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	10	4	adopt	adopt	VB
work_vvlzsj54cvf5de6ji6py6krqlm	10	5	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	10	6	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	10	7	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	10	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	10	9	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	10	10	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	10	11	protocol	protocol	NN
work_vvlzsj54cvf5de6ji6py6krqlm	10	12	developed	develop	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	10	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	10	14	multidisciplinary	multidisciplinary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	10	15	input	input	NN
work_vvlzsj54cvf5de6ji6py6krqlm	10	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	11	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	11	2	s	s	NN
work_vvlzsj54cvf5de6ji6py6krqlm	11	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	11	4	US	US	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	11	5	population	population	NN
work_vvlzsj54cvf5de6ji6py6krqlm	11	6	ages	age	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	11	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	11	8	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	11	9	burden	burden	NN
work_vvlzsj54cvf5de6ji6py6krqlm	11	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	11	11	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	11	12	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	11	13	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	11	14	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	11	15	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	11	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	11	17	venous	venous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	11	18	throm-	throm-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	11	19	boembolic	boembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	11	20	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	11	21	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	11	22	expected	expect	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	11	23	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	11	24	increase	increase	VB
work_vvlzsj54cvf5de6ji6py6krqlm	11	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	11	26	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	11	27	prescriptions	prescription	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	11	28	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	11	29	long	long	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	11	30	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	11	31	term	term	NN
work_vvlzsj54cvf5de6ji6py6krqlm	11	32	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	11	33	will	will	MD
work_vvlzsj54cvf5de6ji6py6krqlm	11	34	climb	climb	VB
work_vvlzsj54cvf5de6ji6py6krqlm	11	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	12	1	Anticoagulated	anticoagulated	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	12	2	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	12	3	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	12	4	vulnerable	vulnerable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	12	5	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	12	6	spontane-	spontane-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	12	7	ous	ous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	12	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	12	9	traumatic	traumatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	12	10	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	12	11	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	12	12	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	12	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	13	1	Warfarin	Warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	13	2	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	13	3	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	13	4	vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	13	5	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	13	6	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	13	7	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	13	8	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	13	9	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	13	10	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	13	11	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	13	12	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	13	13	used	use	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	13	14	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	13	15	decades	decade	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	13	16	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	13	17	prevent	prevent	VB
work_vvlzsj54cvf5de6ji6py6krqlm	13	18	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	13	19	treat	treat	VB
work_vvlzsj54cvf5de6ji6py6krqlm	13	20	arterial	arterial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	13	21	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	13	22	venous	venous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	13	23	thromboem-	thromboem-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	13	24	bolism	bolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	13	25	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	13	26	VTE	VTE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	13	27	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	13	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	14	1	More	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	14	2	recently	recently	RB
work_vvlzsj54cvf5de6ji6py6krqlm	14	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	14	4	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	14	5	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	14	6	–	–	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	14	7	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	14	8	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	14	9	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	14	10	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	14	11	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	14	12	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	14	13	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	14	14	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	14	15	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	14	16	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	14	17	approved	approve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	14	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	14	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	14	20	United	United	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	14	21	States	States	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	14	22	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	14	23	alternatives	alternative	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	14	24	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	14	25	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	14	26	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	14	27	prevention	prevention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	14	28	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	14	29	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	14	30	resulting	result	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	14	31	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	14	32	nonvalvular	nonvalvular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	14	33	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	14	34	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	14	35	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	14	36	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	14	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	14	38	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	14	39	prevention	prevention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	14	40	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	14	41	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	14	42	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	14	43	VTE	VTE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	14	44	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	15	1	These	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	15	2	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	15	3	dabigatran	dabigatran	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	15	4	etexilate	etexilate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	15	5	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	15	6	Pradaxa	Pradaxa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	8	Boehringer	Boehringer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	9	Ingelheim	Ingelheim	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	11	Germany	Germany	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	12	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	15	13	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	15	14	rivaroxa-	rivaroxa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	15	15	ban	ban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	15	16	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	15	17	Xarelto	Xarelto	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	19	Bayer	Bayer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	20	HealthCare	HealthCare	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	21	AG	AG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	23	Leverkusen	Leverkusen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	25	Germany	Germany	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	26	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	15	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	28	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	29	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	15	30	Eliquis	Eliquis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	32	Pfizer	Pfizer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	33	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	15	34	Bristol	Bristol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	35	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	15	36	Myers	Myers	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	37	Squibb	Squibb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	39	New	New	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	40	York	York	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	42	NY	NY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	43	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	15	44	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	15	45	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	15	46	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	15	47	Savaysa	Savaysa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	49	Daiichi	Daiichi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	50	Sankyo	Sankyo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	52	Tokyo	Tokyo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	15	54	Japan	Japan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	15	55	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	15	56	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	16	1	Direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	2	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	3	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	16	4	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	16	5	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	16	6	proposed	propose	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	16	7	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	16	8	alternative	alternative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	9	nomen-	nomen-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	10	clature	clature	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	11	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	16	12	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	16	13	class	class	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	16	15	agents.1	agents.1	DT
work_vvlzsj54cvf5de6ji6py6krqlm	16	16	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	16	17	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	16	18	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	16	19	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	16	20	comparable	comparable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	21	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	16	22	lower	low	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	16	23	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	24	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	16	25	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	16	27	systemic	systemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	28	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	16	30	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	31	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	16	33	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	16	34	death	death	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	35	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	16	36	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	16	37	warfa-	warfa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	38	rin	rin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	39	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	16	40	NVAF.2–5	NVAF.2–5	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	16	41	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	16	42	contrast	contrast	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	43	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	16	44	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	16	46	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	16	47	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	16	48	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	16	49	more	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	16	50	predictable	predictable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	51	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	52	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	16	54	do	do	VB
work_vvlzsj54cvf5de6ji6py6krqlm	16	55	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	16	56	require	require	VB
work_vvlzsj54cvf5de6ji6py6krqlm	16	57	routine	routine	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	58	monitoring	monitoring	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	59	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	16	60	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	16	61	fewer	few	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	16	62	potential	potential	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	63	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	64	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	16	65	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	66	interactions	interaction	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	16	67	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	16	68	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	16	69	restriction	restriction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	70	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	16	71	dietary	dietary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	16	72	consumption	consumption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	73	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	16	74	vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	75	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	76	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	16	77	containing	contain	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	16	78	food	food	NN
work_vvlzsj54cvf5de6ji6py6krqlm	16	79	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	17	1	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	17	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	17	3	universal	universal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	17	4	adoption	adoption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	17	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	17	6	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	17	7	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	17	8	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	17	9	stunted	stunt	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	17	10	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	17	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	17	12	lack	lack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	17	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	17	14	specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	17	15	antidotes	antidote	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	17	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	17	17	measurement	measurement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	17	18	assays	assay	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	17	19	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	18	1	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	18	2	scientific	scientific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	18	3	statement	statement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	18	4	reviews	review	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	18	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	18	6	literature	literature	NN
work_vvlzsj54cvf5de6ji6py6krqlm	18	7	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	18	8	offers	offer	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	18	9	practical	practical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	18	10	suggestions	suggestion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	18	11	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	18	12	providers	provider	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	18	13	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	18	14	manage	manage	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	18	15	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	18	16	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	18	17	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	18	18	actively	actively	RB
work_vvlzsj54cvf5de6ji6py6krqlm	18	19	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	18	20	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	18	21	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	18	22	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	18	23	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	18	24	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	18	25	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	18	26	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	18	27	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	18	28	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	18	29	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	18	30	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	18	31	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	18	32	periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	18	33	setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	18	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	19	1	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	19	2	statement	statement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	3	focuses	focus	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	19	4	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	5	interpreting	interpret	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	19	6	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	19	7	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	19	8	rather	rather	RB
work_vvlzsj54cvf5de6ji6py6krqlm	19	9	than	than	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	10	providing	provide	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	19	11	specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	19	12	man-	man-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	13	Amish	amish	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	19	14	N.	N.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	15	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	17	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	19	FAHA	FAHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	21	Chair	Chair	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	22	Joaquin	Joaquin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	23	E.	E.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	24	Cigarroa	Cigarroa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	26	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	27	Mina	Mina	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	28	K.	K.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	29	Chung	Chung	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	31	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	33	FAHA	FAHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	34	Larry	Larry	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	35	J.	J.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	36	Diaz	Diaz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	37	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	19	38	Sandoval	Sandoval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	40	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	42	FAHA	FAHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	43	Deborah	Deborah	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	44	Diercks	Diercks	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	46	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	47	Jonathan	Jonathan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	48	P.	P.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	49	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	51	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	53	MHS	MHS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	55	FAHA	FAHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	56	Hee	Hee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	57	Soo	Soo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	58	Jung	Jung	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	59	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	60	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	61	Jeffrey	Jeffrey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	62	B.	B.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	63	Washam	Washam	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	65	PharmD	PharmD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	66	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	67	FAHA	FAHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	68	Babu	Babu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	69	G.	G.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	70	Welch	Welch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	71	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	72	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	73	Allyson	Allyson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	74	R.	R.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	75	Zazulia	Zazulia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	76	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	77	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	78	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	79	FAHA	FAHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	80	Sean	Sean	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	81	P.	P.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	82	Collins	Collins	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	83	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	84	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	85	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	86	MSc	MSc	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	19	87	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	88	FAHA	FAHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	89	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	90	Co	co	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	91	-	-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	92	Chair	Chair	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	93	On	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	94	behalf	behalf	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	95	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	96	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	19	97	Ameri-	Ameri-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	98	can	can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	19	99	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	100	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	101	Clinical	Clinical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	102	Pharmacology	Pharmacology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	103	Subcommittee	Subcommittee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	104	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	105	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	19	106	Acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	19	107	Cardiac	Cardiac	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	108	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	109	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	19	110	General	General	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	111	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	112	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	113	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	114	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	19	115	Coun-	Coun-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	116	cil	cil	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	117	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	118	Clinical	Clinical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	119	Cardiol-	Cardiol-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	120	ogy	ogy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	121	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	19	122	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	123	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	124	Car-	Car-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	125	diovascular	diovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	19	126	Disease	Disease	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	127	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	128	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	19	129	Young	Young	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	130	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	19	131	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	19	132	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	133	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	134	Quality	Quality	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	135	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	136	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	137	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	19	138	Outcomes	Outcomes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	139	Research	Research	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	140	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	141	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	142	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	19	143	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	144	Non	Non	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	145	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	19	146	Vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	147	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	148	Antagonist	Antagonist	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	149	Oral	Oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	150	Anticoagulants	Anticoagulants	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	19	151	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	152	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	19	153	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	154	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	155	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	19	156	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	157	Setting	set	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	19	158	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	19	159	Scientific	scientific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	19	160	Statement	statement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	161	From	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	162	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	19	163	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	164	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	165	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	166	©	©	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	167	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	19	168	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	169	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	170	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	171	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	172	Inc.	Inc.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	173	Key	key	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	19	174	Words	word	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	19	175	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	19	176	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	177	Scientific	Scientific	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	178	Statements	statement	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	19	179	◼	◼	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	19	180	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	19	181	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	182	◼	◼	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	183	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	19	184	◼	◼	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	185	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	19	186	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	19	187	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	19	188	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	189	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	190	◼	◼	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	191	periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	19	192	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	193	SCIENTIFIC	SCIENTIFIC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	194	STATEMENT	statement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	195	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	196	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	197	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	19	198	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	199	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	200	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	19	201	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	202	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	19	203	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	19	204	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	19	205	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	19	206	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	19	207	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	208	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	209	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	19	210	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	211	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	19	212	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	19	213	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	19	214	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	215	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	216	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	19	217	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	218	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	219	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	19	220	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	20	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	20	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	20	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	20	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	21	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	21	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	21	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	21	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	21	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	21	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	21	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	21	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	21	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	21	10	e605	e605	NN
work_vvlzsj54cvf5de6ji6py6krqlm	21	11	CLINICAL	clinical	NN
work_vvlzsj54cvf5de6ji6py6krqlm	21	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	21	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	21	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	21	15	GUIDELINES	GUIDELINES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	21	16	agement	agement	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	21	17	recommendations	recommendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	21	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	21	19	under	under	RB
work_vvlzsj54cvf5de6ji6py6krqlm	21	20	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	21	21	studied	study	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	21	22	populations	population	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	21	23	such	such	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	21	24	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	21	25	oncology	oncology	NN
work_vvlzsj54cvf5de6ji6py6krqlm	21	26	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	21	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	22	1	Members	member	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	22	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	22	3	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	22	4	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	22	5	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	22	6	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	22	7	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	22	8	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	22	9	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	22	10	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	22	11	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	22	12	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	22	13	selected	select	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	22	14	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	22	15	their	-PRON-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	22	16	diverse	diverse	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	22	17	expertise	expertise	NN
work_vvlzsj54cvf5de6ji6py6krqlm	22	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	22	19	cardiovascular	cardiovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	22	20	medicine	medicine	NN
work_vvlzsj54cvf5de6ji6py6krqlm	22	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	22	22	emergency	emergency	NN
work_vvlzsj54cvf5de6ji6py6krqlm	22	23	medicine	medicine	NN
work_vvlzsj54cvf5de6ji6py6krqlm	22	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	22	25	critical	critical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	22	26	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	22	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	22	28	neurology	neurology	NN
work_vvlzsj54cvf5de6ji6py6krqlm	22	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	22	30	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	22	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	22	32	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	22	33	pharmacology	pharmacology	NN
work_vvlzsj54cvf5de6ji6py6krqlm	22	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	23	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	23	2	system-	system-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	23	3	atic	atic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	23	4	search	search	NN
work_vvlzsj54cvf5de6ji6py6krqlm	23	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	23	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	23	7	literature	literature	NN
work_vvlzsj54cvf5de6ji6py6krqlm	23	8	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	23	9	each	each	DT
work_vvlzsj54cvf5de6ji6py6krqlm	23	10	subtopic	subtopic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	23	11	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	23	12	per-	per-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	23	13	formed	form	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	23	14	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	23	15	PubMed	PubMed	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	23	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	23	17	Ovid	Ovid	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	23	18	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	23	19	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	23	20	supplemented	supplement	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	23	21	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	23	22	review	review	NN
work_vvlzsj54cvf5de6ji6py6krqlm	23	23	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	23	24	bibliographies	bibliography	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	23	25	as	as	RB
work_vvlzsj54cvf5de6ji6py6krqlm	23	26	well	well	RB
work_vvlzsj54cvf5de6ji6py6krqlm	23	27	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	23	28	manual	manual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	23	29	searches	search	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	23	30	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	23	31	key	key	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	23	32	articles	article	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	23	33	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	24	1	Each	each	DT
work_vvlzsj54cvf5de6ji6py6krqlm	24	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	24	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	24	4	following	follow	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	24	5	search	search	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	6	terms	term	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	24	7	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	24	8	in-	in-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	24	9	cluded	clude	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	24	10	individually	individually	RB
work_vvlzsj54cvf5de6ji6py6krqlm	24	11	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	24	12	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	24	13	combination	combination	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	14	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	24	15	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	24	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	17	apix-	apix-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	24	18	aban	aban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	24	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	20	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	22	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	24	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	26	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	28	antidote	antidote	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	30	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	24	31	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	33	venous	venous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	24	34	thromboembolism	thromboembolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	36	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	38	intracranial	intracranial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	24	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	40	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	42	catheterization	catheterization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	44	cardiac	cardiac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	24	45	implantable	implantable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	24	46	devices	device	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	24	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	48	kidney	kidney	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	49	injury	injury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	51	transition	transition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	53	switching	switching	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	55	pharmacology	pharmacology	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	57	andexanet	andexanet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	24	58	alfa	alfa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	24	59	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	60	idarucizumab	idarucizumab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	24	61	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	62	ciraparantag	ciraparantag	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	24	63	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	64	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	24	65	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	66	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	67	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	68	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	69	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	70	percu-	percu-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	24	71	taneous	taneous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	24	72	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	24	73	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	24	74	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	75	neuraxial	neuraxial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	24	76	anesthesia	anesthesia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	24	77	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	78	stroke	stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	24	79	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	24	80	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	24	81	overdose	overdose	VB
work_vvlzsj54cvf5de6ji6py6krqlm	24	82	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	25	1	Writing	write	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	25	2	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	25	3	members	member	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	25	4	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	25	5	instructed	instruct	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	25	6	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	25	7	write	write	VB
work_vvlzsj54cvf5de6ji6py6krqlm	25	8	subtopic	subtopic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	25	9	sections	section	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	25	10	aligned	align	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	25	11	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	25	12	their	-PRON-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	25	13	experience	experience	NN
work_vvlzsj54cvf5de6ji6py6krqlm	25	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	26	1	Members	member	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	26	2	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	26	3	instructed	instruct	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	26	4	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	26	5	cite	cite	VB
work_vvlzsj54cvf5de6ji6py6krqlm	26	6	contempo-	contempo-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	26	7	rary	rary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	26	8	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	26	9	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	26	10	scientific	scientific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	26	11	statements	statement	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	26	12	where	where	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	26	13	appropri-	appropri-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	26	14	ate	eat	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	26	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	27	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	27	2	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	27	3	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	27	4	did	do	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	27	5	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	27	6	assign	assign	VB
work_vvlzsj54cvf5de6ji6py6krqlm	27	7	formal	formal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	27	8	classes	class	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	27	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	27	10	recommendation	recommendation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	27	11	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	27	12	level	level	NN
work_vvlzsj54cvf5de6ji6py6krqlm	27	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	27	14	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	27	15	per	per	IN
work_vvlzsj54cvf5de6ji6py6krqlm	27	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	27	17	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	27	18	Scien-	Scien-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	27	19	tific	tific	NN
work_vvlzsj54cvf5de6ji6py6krqlm	27	20	Document	Document	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	27	21	Development	Development	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	27	22	Process	Process	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	27	23	recommendation	recommendation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	27	24	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	27	25	went	go	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	27	26	into	into	IN
work_vvlzsj54cvf5de6ji6py6krqlm	27	27	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	27	28	September	September	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	27	29	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	27	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	27	31	2015	2015	CD
work_vvlzsj54cvf5de6ji6py6krqlm	27	32	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	28	1	Sections	section	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	28	2	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	28	3	then	then	RB
work_vvlzsj54cvf5de6ji6py6krqlm	28	4	reviewed	review	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	28	5	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	28	6	another	another	DT
work_vvlzsj54cvf5de6ji6py6krqlm	28	7	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	28	8	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	28	9	member	member	NN
work_vvlzsj54cvf5de6ji6py6krqlm	28	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	29	1	Sec-	Sec-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	29	2	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	29	3	drafts	draft	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	29	4	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	29	5	submitted	submit	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	29	6	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	29	7	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	29	8	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	29	9	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	29	10	chair	chair	NN
work_vvlzsj54cvf5de6ji6py6krqlm	29	11	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	29	12	co	co	NN
work_vvlzsj54cvf5de6ji6py6krqlm	29	13	-	-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	29	14	chair	chair	NN
work_vvlzsj54cvf5de6ji6py6krqlm	29	15	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	29	16	compiled	compile	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	29	17	into	into	IN
work_vvlzsj54cvf5de6ji6py6krqlm	29	18	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	29	19	single	single	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	29	20	document	document	NN
work_vvlzsj54cvf5de6ji6py6krqlm	29	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	30	1	Web	web	NN
work_vvlzsj54cvf5de6ji6py6krqlm	30	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	30	3	teleconferences	teleconference	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	30	4	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	30	5	convened	convene	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	30	6	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	30	7	review	review	VB
work_vvlzsj54cvf5de6ji6py6krqlm	30	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	30	9	edit	edit	VB
work_vvlzsj54cvf5de6ji6py6krqlm	30	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	30	11	full	full	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	30	12	draft	draft	NN
work_vvlzsj54cvf5de6ji6py6krqlm	30	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	31	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	31	2	final	final	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	31	3	document	document	NN
work_vvlzsj54cvf5de6ji6py6krqlm	31	4	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	31	5	submitted	submit	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	31	6	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	31	7	indepen-	indepen-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	31	8	dent	dent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	31	9	peer	peer	NN
work_vvlzsj54cvf5de6ji6py6krqlm	31	10	review	review	NN
work_vvlzsj54cvf5de6ji6py6krqlm	31	11	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	31	12	approved	approve	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	31	13	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	31	14	publication	publication	NN
work_vvlzsj54cvf5de6ji6py6krqlm	31	15	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	31	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	31	17	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	31	18	Manuscript	Manuscript	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	31	19	Oversight	Oversight	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	31	20	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	31	21	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	31	22	April	April	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	31	23	29	29	CD
work_vvlzsj54cvf5de6ji6py6krqlm	31	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	31	25	2016	2016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	31	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	32	1	PHARMACOLOGY	PHARMACOLOGY	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	32	2	OF	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	32	3	NOACS	NOACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	32	4	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	32	5	act	act	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	32	6	through	through	IN
work_vvlzsj54cvf5de6ji6py6krqlm	32	7	direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	32	8	inhibition	inhibition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	32	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	32	10	thrombin	thrombin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	32	11	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	32	12	inhi-	inhi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	32	13	bition	bition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	32	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	32	15	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	32	16	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	32	17	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	32	18	Figure	Figure	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	32	19	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	32	20	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	32	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	33	1	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	33	2	etexilate	etexilate	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	33	3	me-	me-	CD
work_vvlzsj54cvf5de6ji6py6krqlm	33	4	sylate	sylate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	33	5	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	33	6	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	33	7	competitive	competitive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	33	8	direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	33	9	thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	33	10	inhibitor	inhibitor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	33	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	34	1	Rivar-	Rivar-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	34	2	oxaban	oxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	34	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	34	4	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	34	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	34	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	34	7	edoxaban	edoxaban	VB
work_vvlzsj54cvf5de6ji6py6krqlm	34	8	inhibit	inhibit	NN
work_vvlzsj54cvf5de6ji6py6krqlm	34	9	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	34	10	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	34	11	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	34	12	prothrombinase	prothrombinase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	34	13	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	34	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	34	15	thus	thus	RB
work_vvlzsj54cvf5de6ji6py6krqlm	34	16	inhibiting	inhibit	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	34	17	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	34	18	conversion	conversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	34	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	34	20	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	34	21	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	34	22	thrombin	thrombin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	34	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	35	1	Thrombin	Thrombin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	35	2	catalyzes	catalyze	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	35	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	35	4	con-	con-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	35	5	version	version	NN
work_vvlzsj54cvf5de6ji6py6krqlm	35	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	35	7	fibrinogen	fibrinogen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	35	8	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	35	9	fibrin	fibrin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	35	10	;	;	,
work_vvlzsj54cvf5de6ji6py6krqlm	35	11	activates	activate	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	35	12	factors	factor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	35	13	V	v	NN
work_vvlzsj54cvf5de6ji6py6krqlm	35	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	35	15	VIII	VIII	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	35	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	35	17	XI	XI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	35	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	35	19	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	35	20	XIII	XIII	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	35	21	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	35	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	35	23	activates	activate	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	35	24	platelets	platelet	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	35	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	36	1	Therefore	therefore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	36	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	36	3	inhibiting	inhibit	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	36	4	thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	36	5	decreases	decrease	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	36	6	thrombus	thrombus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	36	7	formation	formation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	36	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	37	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	37	2	contrast	contrast	NN
work_vvlzsj54cvf5de6ji6py6krqlm	37	3	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	37	4	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	37	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	37	6	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	37	7	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	37	8	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	37	9	rapid	rapid	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	37	10	onset	onset	NN
work_vvlzsj54cvf5de6ji6py6krqlm	37	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	37	12	action	action	NN
work_vvlzsj54cvf5de6ji6py6krqlm	37	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	37	14	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	37	15	shorter	short	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	37	16	half	half	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	37	17	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	37	18	life	life	NN
work_vvlzsj54cvf5de6ji6py6krqlm	37	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	37	20	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	37	21	more	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	37	22	predictable	predictable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	37	23	pharmacokinet-	pharmacokinet-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	37	24	ics	ics	NN
work_vvlzsj54cvf5de6ji6py6krqlm	37	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	38	1	Routine	routine	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	38	2	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	38	3	monitoring	monitoring	NN
work_vvlzsj54cvf5de6ji6py6krqlm	38	4	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	38	5	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	38	6	done	do	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	38	7	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	38	8	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	38	9	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	38	10	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	38	11	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	38	12	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	38	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	38	14	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	38	15	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	38	16	present	present	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	38	17	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	38	18	recom-	recom-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	38	19	mended	mend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	38	20	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	38	21	usual	usual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	38	22	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	38	23	practice	practice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	38	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	39	1	Information	information	NN
work_vvlzsj54cvf5de6ji6py6krqlm	39	2	pertaining	pertain	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	39	3	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	39	4	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	39	5	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	39	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	39	7	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	39	8	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	39	9	peak	peak	VB
work_vvlzsj54cvf5de6ji6py6krqlm	39	10	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	39	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	39	12	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	39	13	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	39	14	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	39	15	offset	offset	VB
work_vvlzsj54cvf5de6ji6py6krqlm	39	16	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	39	17	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	39	18	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	39	19	outlined	outline	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	39	20	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	39	21	Table	Table	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	39	22	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	39	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	40	1	NOACs	noac	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	40	2	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	40	3	substrates	substrate	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	40	4	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	40	5	P	p	NN
work_vvlzsj54cvf5de6ji6py6krqlm	40	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	40	7	glycoprotein	glycoprotein	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	40	8	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	40	9	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	40	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	40	11	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	40	12	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	40	13	trans-	trans-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	40	14	port	port	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	40	15	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	40	16	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	40	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	40	18	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	40	19	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	40	20	substrates	substrate	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	40	21	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	40	22	CYP	CYP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	40	23	3A4	3a4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	40	24	metabolism	metabolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	40	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	41	1	Therefore	therefore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	41	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	41	3	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	41	4	medica-	medica-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	41	5	tions	tion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	41	6	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	41	7	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	41	8	inducers	inducer	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	41	9	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	41	10	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	41	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	41	12	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	41	13	pathways	pathway	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	41	14	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	41	15	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	41	16	evaluated	evaluate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	41	17	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	41	18	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	41	19	potential	potential	NN
work_vvlzsj54cvf5de6ji6py6krqlm	41	20	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	41	21	interact	interact	VB
work_vvlzsj54cvf5de6ji6py6krqlm	41	22	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	41	23	Table	table	NN
work_vvlzsj54cvf5de6ji6py6krqlm	41	24	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	41	25	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	41	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	42	1	Macrolides	macrolide	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	42	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	42	3	nondihydropyridine	nondihydropyridine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	4	calcium	calcium	NN
work_vvlzsj54cvf5de6ji6py6krqlm	42	5	channel	channel	NN
work_vvlzsj54cvf5de6ji6py6krqlm	42	6	blockers	blocker	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	42	7	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	42	8	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	42	9	commonly	commonly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	42	10	prescribed	prescribe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	42	11	classes	class	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	42	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	13	medica-	medica-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	42	14	tions	tion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	42	15	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	42	16	impact	impact	NN
work_vvlzsj54cvf5de6ji6py6krqlm	42	17	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	42	18	levels	level	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	42	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	20	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	42	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	42	22	although	although	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	23	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	42	24	post	post	FW
work_vvlzsj54cvf5de6ji6py6krqlm	42	25	hoc	hoc	FW
work_vvlzsj54cvf5de6ji6py6krqlm	42	26	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	42	27	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	28	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	29	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	30	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	42	31	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	32	Once	once	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	33	Daily	Daily	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	34	Oral	Oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	35	Direct	Direct	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	36	Factor	Factor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	37	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	38	Inhibition	Inhibition	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	39	Compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	42	40	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	41	Vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	42	42	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	43	Antagonism	Antagonism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	44	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	45	Prevention	Prevention	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	46	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	47	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	48	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	42	49	Embolism	Embolism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	50	Trial	Trial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	51	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	52	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	53	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	54	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	42	55	showed	show	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	42	56	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	42	57	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	42	58	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	59	differential	differential	NN
work_vvlzsj54cvf5de6ji6py6krqlm	42	60	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	42	61	between	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	62	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	42	63	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	42	64	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	42	65	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	66	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	42	67	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	42	68	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	69	≥1	≥1	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	42	70	combined	combine	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	42	71	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	72	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	42	73	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	74	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	42	75	CYP	CYP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	76	3A4	3A4	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	77	inhibitors.6	inhibitors.6	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	78	Edoxaban	Edoxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	42	79	exists	exist	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	42	80	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	42	81	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	42	82	predominantly	predominantly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	42	83	unchanged	unchanged	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	42	84	form	form	NN
work_vvlzsj54cvf5de6ji6py6krqlm	42	85	Figure	figure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	42	86	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	42	87	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	43	1	Clotting	clot	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	43	2	cascade	cascade	NN
work_vvlzsj54cvf5de6ji6py6krqlm	43	3	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	43	4	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	43	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	44	1	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	44	2	indicates	indicate	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	44	3	vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	44	4	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	44	5	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	44	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	45	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	45	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	45	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	45	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	45	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	45	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	45	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	45	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	45	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	45	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	45	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	45	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	45	13	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	45	14	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	45	15	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	45	16	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	45	17	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	45	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	45	19	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	45	20	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	45	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	46	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	46	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	46	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	46	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	47	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	47	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	47	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	47	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	47	5	CIR.0000000000000477e606	CIR.0000000000000477e606	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	47	6	Table	Table	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	47	7	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	47	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	48	1	Comparison	Comparison	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	2	Among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	48	3	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	48	4	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	5	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	6	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	7	Edoxaban	Edoxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	8	Approved	approve	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	48	9	indications	indication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	48	10	Nonvalular	Nonvalular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	11	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	12	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	13	Risk	Risk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	48	15	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	48	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	48	17	systemic	systemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	48	18	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	48	19	Nonvalular	Nonvalular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	20	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	21	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	22	Risk	Risk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	23	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	48	24	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	48	25	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	48	26	systemic	systemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	48	27	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	48	28	Nonvalular	Nonvalular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	29	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	30	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	31	Risk	Risk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	32	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	48	33	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	48	34	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	48	35	systemic	systemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	48	36	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	48	37	Nonvalular	Nonvalular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	38	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	39	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	40	Risk	Risk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	48	41	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	48	42	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	48	43	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	48	44	systemic	systemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	48	45	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	48	46	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	49	1	Limitation	limitation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	3	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	49	4	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	49	5	use	use	VB
work_vvlzsj54cvf5de6ji6py6krqlm	49	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	7	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	49	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	9	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	10	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	49	11	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	12	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	13	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	49	14	min	min	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	15	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	16	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	49	17	result	result	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	19	↑	↑	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	20	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	22	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	23	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	24	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	49	25	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	26	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	27	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	28	60	60	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	29	mg	mg	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	30	DVT	DVT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	32	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	33	Treatment	Treatment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	34	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	35	5–10	5–10	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	36	d	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	37	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	38	AC	AC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	39	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	40	Recurrence	Recurrence	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	41	Prophylaxis	Prophylaxis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	42	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	43	hip	hip	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	44	replacement	replacement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	45	DVT	DVT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	47	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	48	Treatment	Treatment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	49	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	50	Recurrence	Recurrence	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	51	Prophylaxis	Prophylaxis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	52	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	53	hip	hip	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	54	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	49	55	knee	knee	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	56	replacement	replacement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	57	DVT	DVT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	58	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	59	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	60	Treatment	Treatment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	61	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	62	Recurrence	Recurrence	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	63	Prophylaxis	Prophylaxis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	64	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	65	hip	hip	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	66	replacement	replacement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	67	DVT	DVT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	68	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	69	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	70	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	71	Recurrence	Recurrence	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	72	Treatment	Treatment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	73	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	74	5–10	5–10	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	75	d	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	76	initial	initial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	77	parenteral	parenteral	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	78	AC	AC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	79	Mechanism	Mechanism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	80	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	81	action	action	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	82	Direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	83	thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	84	inhibitor	inhibitor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	85	Factor	Factor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	86	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	87	inhibitor	inhibitor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	88	Factor	Factor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	89	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	90	inhibitor	inhibitor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	91	Factor	Factor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	92	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	93	inhibitor	inhibitor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	94	Time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	95	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	49	96	peak	peak	VB
work_vvlzsj54cvf5de6ji6py6krqlm	49	97	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	98	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	99	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	100	delayed	delay	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	49	101	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	102	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	103	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	104	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	105	food	food	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	106	2–4	2–4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	107	h	h	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	108	3–4	3–4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	109	h	h	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	110	1–2	1–2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	111	h	h	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	112	Bioavailability	Bioavailability	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	113	3%–7	3%–7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	114	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	115	10-mg	10-mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	116	dose	dose	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	49	117	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	118	80%–100	80%–100	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	119	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	120	~50	~50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	121	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	122	62	62	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	123	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	124	20-mg	20-mg	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	125	dose	dose	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	49	126	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	127	66	66	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	128	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	129	↑	↑	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	130	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	131	food	food	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	132	Plasma	Plasma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	133	protein	protein	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	134	binding	bind	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	49	135	35	35	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	136	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	137	92%–95	92%–95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	138	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	139	~87	~87	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	140	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	141	55	55	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	142	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	143	Volume	volume	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	144	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	145	distribution	distribution	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	146	50–70	50–70	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	147	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	148	50	50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	149	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	150	21	21	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	151	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	152	107	107	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	153	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	154	Plasma	Plasma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	155	t	t	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	156	1/2	1/2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	157	12–17	12–17	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	158	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	159	5–9	5–9	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	160	h	h	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	161	~12	~12	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	49	162	h	h	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	163	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	164	8–15	8–15	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	165	h	h	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	166	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	167	10–14	10–14	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	49	168	h	h	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	169	Elderly	Elderly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	170	14–17	14–17	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	171	h	h	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	49	172	Elderly	elderly	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	173	11–13	11–13	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	174	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	175	Mild	Mild	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	176	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	49	177	moderate	moderate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	178	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	179	impairment	impairment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	180	15–18	15–18	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	181	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	182	Severe	severe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	183	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	184	impairment	impairment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	185	28	28	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	186	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	187	Metabolism	Metabolism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	188	Hepatic	Hepatic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	189	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	49	190	plasma	plasma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	191	hydrolysis	hydrolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	192	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	193	active	active	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	194	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	195	Hepatic	Hepatic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	196	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	197	oxidation	oxidation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	198	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	199	CYP3A4/5	CYP3A4/5	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	200	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	201	CYP2J2	cyp2j2	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	49	202	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	203	hydrolysis	hydrolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	204	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	205	inactive	inactive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	206	metabolites	metabolite	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	49	207	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	208	51	51	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	209	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	210	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	211	Hepatic	hepatic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	212	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	213	25	25	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	214	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	215	mainly	mainly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	49	216	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	217	CYP3A4/5	CYP3A4/5	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	49	218	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	219	lesser	less	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	49	220	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	221	CYP1A2	CYP1A2	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	222	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	223	CYP2C8	CYP2C8	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	224	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	225	CYP2C9	CYP2C9	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	226	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	227	CYP2C19	CYP2C19	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	228	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	229	CYP2J2	cyp2j2	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	49	230	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	231	O	o	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	232	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	49	233	demethylation	demethylation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	234	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	49	235	hydroxylation	hydroxylation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	236	Minimal	Minimal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	237	CYP3A4	CYP3A4	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	238	hydrolysis	hydrolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	239	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	240	conjugation	conjugation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	241	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	242	oxidation	oxidation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	243	Hepatic	hepatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	244	glucuronidation	glucuronidation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	245	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	246	active	active	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	247	metabolites	metabolite	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	49	248	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	249	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	49	250	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	251	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	252	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	253	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	254	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	49	255	gp	gp	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	256	substrate	substrate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	257	No	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	49	258	active	active	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	259	circulating	circulate	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	49	260	metabolites	metabolite	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	49	261	Active	active	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	262	metabolite	metabolite	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	263	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	264	M-4	M-4	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	265	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	266	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	49	267	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	268	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	269	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	270	parent	parent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	271	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	272	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	273	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	49	274	gp	gp	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	275	substrate	substrate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	276	No	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	49	277	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	278	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	49	279	active	active	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	280	circulating	circulate	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	49	281	metabolites	metabolite	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	49	282	Substrate	Substrate	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	283	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	284	CYP3A4	CYP3A4	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	285	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	286	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	287	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	49	288	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	289	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	290	BCRP	BCRP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	291	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	292	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	49	293	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	294	substrate	substrate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	295	Substrate	Substrate	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	296	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	297	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	298	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	49	299	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	300	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	49	301	ABCG2	abcg2	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	302	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	303	BCRP	BCRP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	304	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	305	Excretion	Excretion	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	306	Renal	Renal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	307	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	308	~80	~80	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	49	309	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	310	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	311	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	312	IV	IV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	313	administration	administration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	314	Renal	Renal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	315	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	316	66	66	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	317	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	318	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	319	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	320	36	36	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	321	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	322	active	active	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	323	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	324	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	325	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	326	inactive	inactive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	327	metabolites	metabolite	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	49	328	Renal	Renal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	329	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	330	27	27	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	331	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	332	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	333	Renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	334	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	335	~50	~50	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	49	336	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	337	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	338	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	339	primarily	primarily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	49	340	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	341	unchanged	unchanged	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	342	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	343	After	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	344	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	345	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	346	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	347	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	348	recovered	recover	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	49	349	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	350	urine	urine	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	351	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	352	86	86	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	353	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	354	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	355	feces	fece	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	49	356	Feces	Feces	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	357	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	358	28	28	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	359	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	360	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	361	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	49	362	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	363	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	364	active	active	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	365	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	366	21	21	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	367	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	368	inactive	inactive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	369	metabolites	metabolite	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	49	370	Biliary	Biliary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	371	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	49	372	direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	373	intestinal	intestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	374	excretion	excretion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	375	Metabolism	Metabolism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	376	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	49	377	biliary/	biliary/	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	378	intestinal	intestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	379	excretion	excretion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	380	accounts	account	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	49	381	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	382	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	49	383	rest	rest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	384	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	385	Continued	continued	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	49	386	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	49	387	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	388	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	389	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	49	390	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	391	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	392	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	49	393	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	394	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	49	395	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	49	396	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	397	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	49	398	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	49	399	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	400	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	401	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	49	402	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	403	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	49	404	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	49	405	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	49	406	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	407	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	408	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	49	409	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	410	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	411	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	49	412	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	50	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	50	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	50	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	50	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	51	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	51	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	10	e607	e607	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	11	CLINICAL	clinical	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	15	GUIDELINES	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	16	Dosing	dose	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	51	17	Nonvalvular	nonvalvular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	18	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	19	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	20	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	21	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	22	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	23	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	24	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	25	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	26	150	150	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	27	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	28	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	29	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	30	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	31	50	50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	32	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	33	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	34	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	35	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	36	20	20	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	37	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	38	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	39	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	40	evening	evening	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	41	meal	meal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	42	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	43	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	44	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	45	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	46	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	47	50	50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	48	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	49	≤95	≤95	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	50	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	51	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	52	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	53	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	54	60	60	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	55	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	56	daily	daily	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	57	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	58	15–30	15–30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	59	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	60	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	61	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	62	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	63	75	75	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	64	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	65	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	66	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	67	15–50	15–50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	68	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	69	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	70	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	71	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	72	15	15	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	73	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	74	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	75	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	76	evening	evening	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	77	meal	meal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	78	2.5	2.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	79	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	80	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	81	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	51	82	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	83	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	84	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	85	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	86	characteristics	characteristic	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	87	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	88	Cr	Cr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	89	≥1.5	≥1.5	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	51	90	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	91	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	92	dL	dL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	93	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	51	94	age	age	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	95	≥80	≥80	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	96	y	y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	97	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	51	98	weight	weight	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	99	≤60	≤60	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	100	kg	kg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	101	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	102	15–50	15–50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	103	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	104	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	105	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	106	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	107	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	108	mg	mg	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	109	daily	daily	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	110	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	111	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	112	15	15	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	113	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	114	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	115	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	116	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	117	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	118	dialysis	dialysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	119	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	120	Not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	121	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	122	Not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	123	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	124	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	125	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	126	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	127	15	15	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	128	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	129	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	130	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	131	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	132	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	133	dialysis	dialysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	134	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	135	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	136	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	137	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	138	NOT	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	139	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	140	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	141	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	142	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	143	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	144	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	145	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	146	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	147	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	148	30–50	30–50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	149	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	150	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	151	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	152	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	153	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	154	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	155	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	51	156	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	157	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	158	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	159	75	75	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	160	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	161	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	162	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	163	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	164	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	165	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	166	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	167	min	min	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	168	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	169	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	170	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	171	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	51	172	gp	gp	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	173	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	174	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	175	Avoid	avoid	VB
work_vvlzsj54cvf5de6ji6py6krqlm	51	176	coadministration	coadministration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	177	DVT	DVT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	178	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	179	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	180	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	181	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	182	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	183	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	184	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	185	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	186	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	187	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	188	150	150	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	189	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	190	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	191	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	192	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	193	-	-	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	194	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	195	d	d	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	196	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	197	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	198	15	15	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	199	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	200	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	201	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	202	food	food	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	203	first	first	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	204	21	21	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	205	d	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	206	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	207	initial	initial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	208	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	209	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	51	210	then	then	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	211	20	20	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	212	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	213	once	once	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	214	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	215	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	216	food	food	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	217	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	218	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	219	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	220	x	x	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	221	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	222	d	d	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	223	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	51	224	then	then	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	225	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	226	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	227	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	228	60	60	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	229	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	230	once	once	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	231	daily	daily	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	232	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	233	≤30	≤30	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	51	234	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	235	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	236	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	237	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	238	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	239	dialysis	dialysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	240	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	241	Not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	242	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	243	Not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	244	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	245	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	246	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	247	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	248	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	249	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	250	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	251	min	min	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	252	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	253	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	254	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	255	DVT	DVT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	256	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	257	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	258	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	259	15–50	15–50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	260	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	261	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	262	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	263	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	264	weight	weight	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	265	≤60	≤60	DT
work_vvlzsj54cvf5de6ji6py6krqlm	51	266	kg	kg	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	267	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	268	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	269	certain	certain	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	270	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	271	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	51	272	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	273	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	274	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	275	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	276	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	277	once	once	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	278	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	279	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	280	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	281	recurrent	recurrent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	282	DVT	DVT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	283	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	284	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	285	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	286	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	287	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	288	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	289	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	290	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	291	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	292	150	150	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	293	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	294	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	295	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	296	5–10	5–10	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	297	d	d	DT
work_vvlzsj54cvf5de6ji6py6krqlm	51	298	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	299	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	300	20	20	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	301	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	302	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	303	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	304	food	food	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	305	2.5	2.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	306	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	307	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	308	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	309	≤30	≤30	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	51	310	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	311	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	312	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	313	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	314	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	315	dialysis	dialysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	316	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	317	Not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	318	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	319	DVT	DVT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	320	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	51	321	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	322	prophylaxis	prophylaxis	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	323	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	324	hip	hip	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	325	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	326	knee	knee	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	327	replacement	replacement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	328	After	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	329	hip	hip	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	330	replacement	replacement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	331	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	332	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	333	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	334	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	335	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	336	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	337	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	338	min	min	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	339	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	340	achievement	achievement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	341	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	342	hemostasis	hemostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	343	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	344	If	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	345	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	346	day	day	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	347	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	348	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	349	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	51	350	110	110	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	351	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	352	1–4	1–4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	353	h	h	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	354	postop	postop	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	355	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	356	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	357	day	day	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	358	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	359	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	360	220	220	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	361	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	362	once	once	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	363	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	364	x	x	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	365	28–35	28–35	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	366	d	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	367	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	368	≤30	≤30	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	51	369	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	370	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	371	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	372	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	373	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	374	dialysis	dialysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	375	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	376	Not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	377	recommended	recommend	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	51	378	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	379	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	380	50	50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	381	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	382	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	383	min	min	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	384	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	385	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	386	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	387	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	51	388	gp	gp	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	389	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	390	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	391	Avoid	avoid	VB
work_vvlzsj54cvf5de6ji6py6krqlm	51	392	coadministration	coadministration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	393	Initial	Initial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	394	dose	dose	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	51	395	6–10	6–10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	396	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	397	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	398	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	399	provided	provide	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	400	hemostasis	hemostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	401	established	establish	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	51	402	2.5	2.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	403	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	404	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	405	x	x	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	406	35	35	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	407	d	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	408	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	409	hip	hip	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	410	replacement	replacement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	411	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	412	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	413	x	x	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	414	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	415	d	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	416	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	417	knee	knee	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	418	replacement	replacement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	419	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	420	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	421	mg	mg	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	422	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	423	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	424	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	425	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	426	food	food	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	427	x	x	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	428	35	35	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	429	d	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	430	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	431	hip	hip	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	432	replacement	replacement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	433	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	51	434	x	x	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	435	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	436	d	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	437	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	438	knee	knee	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	439	replacement	replacement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	440	Additional	additional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	441	dosing	dosing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	442	comments	comment	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	443	Avoid	avoid	VB
work_vvlzsj54cvf5de6ji6py6krqlm	51	444	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	445	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	446	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	447	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	448	moderate	moderate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	449	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	51	450	severe	severe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	451	hepatic	hepatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	452	impairment	impairment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	453	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	51	454	Child-	Child-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	455	Pugh	Pugh	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	456	class	class	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	457	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	458	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	459	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	460	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	51	461	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	462	hepatic	hepatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	463	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	464	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	465	coagulopathy	coagulopathy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	466	Not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	467	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	468	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	469	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	470	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	471	severe	severe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	472	hepatic	hepatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	473	impairment	impairment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	474	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	51	475	Child	child	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	476	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	51	477	Pugh	pugh	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	478	class	class	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	479	C	c	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	480	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	51	481	Not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	482	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	483	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	484	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	485	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	51	486	15	15	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	487	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	488	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	489	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	490	15	15	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	491	-	-	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	492	20	20	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	493	mg	mg	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	494	taken	take	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	495	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	496	food	food	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	497	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	51	498	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	499	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	500	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	501	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	51	502	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	503	food	food	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	504	Not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	51	505	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	51	506	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	507	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	51	508	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	51	509	moderate	moderate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	510	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	51	511	severe	severe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	512	hepatic	hepatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	51	513	impairment	impairment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	514	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	51	515	Child	child	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	516	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	51	517	Pugh	pugh	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	518	class	class	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	519	B	b	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	520	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	51	521	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	51	522	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	51	523	Table	table	NN
work_vvlzsj54cvf5de6ji6py6krqlm	51	524	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	51	525	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	52	1	Continued	Continued	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	2	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	3	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	4	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	5	Edoxaban	Edoxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	6	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	52	7	Continued	Continued	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	8	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	52	9	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	52	10	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	52	11	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	52	12	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	52	13	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	14	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	52	15	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	52	16	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	52	17	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	52	18	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	52	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	52	20	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	52	21	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	22	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	23	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	24	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	25	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	52	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	52	27	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	52	28	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	52	29	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	53	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	53	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	53	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	53	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	54	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	54	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	54	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	54	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	54	5	CIR.0000000000000477e608	CIR.0000000000000477e608	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	54	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	54	7	plasma	plasma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	54	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	54	9	minimal	minimal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	54	10	metabolism	metabolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	54	11	through	through	IN
work_vvlzsj54cvf5de6ji6py6krqlm	54	12	hydrolysis	hydrolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	54	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	54	14	conjugation	conjugation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	54	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	54	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	54	17	oxidation	oxidation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	54	18	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	54	19	CYP	CYP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	54	20	3A4	3a4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	54	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	55	1	LABORATORY	LABORATORY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	55	2	MEASUREMENT	MEASUREMENT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	55	3	OF	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	55	4	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	55	5	EFFECT	EFFECT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	55	6	One	one	CD
work_vvlzsj54cvf5de6ji6py6krqlm	55	7	advantage	advantage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	55	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	55	9	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	55	10	over	over	IN
work_vvlzsj54cvf5de6ji6py6krqlm	55	11	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	55	12	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	55	13	more	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	55	14	rapid	rapid	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	55	15	on-	on-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	55	16	set	set	NN
work_vvlzsj54cvf5de6ji6py6krqlm	55	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	55	18	offset	offset	NN
work_vvlzsj54cvf5de6ji6py6krqlm	55	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	55	20	action	action	NN
work_vvlzsj54cvf5de6ji6py6krqlm	55	21	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	55	22	predictable	predictable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	55	23	pharmacokinet-	pharmacokinet-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	55	24	ics	ics	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	55	25	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	55	26	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	55	27	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	55	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	56	1	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	56	2	eliminates	eliminate	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	56	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	56	4	necessi-	necessi-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	5	ty	ty	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	6	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	56	7	routine	routine	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	8	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	9	monitoring	monitoring	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	10	except	except	IN
work_vvlzsj54cvf5de6ji6py6krqlm	56	11	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	56	12	periodic	periodic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	13	assessment	assessment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	56	15	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	16	function.7	function.7	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	56	17	Laboratory	Laboratory	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	56	18	measurement	measurement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	56	20	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	21	level	level	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	22	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	56	23	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	24	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	56	25	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	56	26	necessary	necessary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	27	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	56	28	certain	certain	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	29	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	30	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	31	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	56	32	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	33	settings	setting	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	56	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	56	35	particularly	particularly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	56	36	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	56	37	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	56	38	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	56	39	uncertainty	uncertainty	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	40	about	about	IN
work_vvlzsj54cvf5de6ji6py6krqlm	56	41	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	56	42	timing	timing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	43	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	56	44	last	last	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	45	ingestion	ingestion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	56	47	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	48	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	49	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	56	50	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	56	51	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	56	52	absorption	absorption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	56	53	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	57	1	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	57	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	57	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	57	4	lack	lack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	57	6	US	US	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	57	7	Food	Food	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	57	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	57	9	Drug	Drug	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	57	10	Administration	Administration	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	57	11	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	57	12	approved	approve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	57	13	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	57	14	laboratory	laboratory	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	15	assays	assays	RB
work_vvlzsj54cvf5de6ji6py6krqlm	57	16	complicates	complicate	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	57	17	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	57	18	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	57	20	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	57	21	overdose	overdose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	57	23	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	57	24	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	57	25	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	57	26	life	life	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	27	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	57	28	threatening	threaten	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	57	29	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	57	31	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	57	32	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	57	33	scheduling	scheduling	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	34	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	57	35	urgent	urgent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	57	36	surgical	surgical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	57	37	proce-	proce-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	38	dures.8	dures.8	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	57	39	All	all	DT
work_vvlzsj54cvf5de6ji6py6krqlm	57	40	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	57	41	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	57	42	affect	affect	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	57	43	routine	routine	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	57	44	coagulation	coagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	45	tests	test	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	57	46	but	but	CC
work_vvlzsj54cvf5de6ji6py6krqlm	57	47	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	57	48	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	57	49	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	57	50	manner	manner	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	51	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	57	52	allows	allow	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	57	53	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	57	54	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	57	55	predictable	predictable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	57	56	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	57	57	quantitative	quantitative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	57	58	measurement	measurement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	59	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	57	60	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	61	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	57	62	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	58	1	Spe-	spe-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	58	2	cific	cific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	58	3	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	58	4	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	58	5	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	58	6	subsequently	subsequently	RB
work_vvlzsj54cvf5de6ji6py6krqlm	58	7	discussed	discuss	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	58	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	59	1	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	59	2	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	59	3	agent	agent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	59	4	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	59	5	known	know	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	59	6	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	59	7	prolong	prolong	VB
work_vvlzsj54cvf5de6ji6py6krqlm	59	8	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	59	9	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	59	10	partial	partial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	59	11	thromboplastin	thromboplastin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	59	12	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	59	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	59	14	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	59	15	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	59	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	59	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	59	18	thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	59	19	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	59	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	60	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	60	2	package	package	NN
work_vvlzsj54cvf5de6ji6py6krqlm	60	3	insert	insert	NN
work_vvlzsj54cvf5de6ji6py6krqlm	60	4	recommends	recommend	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	60	5	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	60	6	partial	partial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	60	7	thromboplastin	thromboplastin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	60	8	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	60	9	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	60	10	measurement	measurement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	60	11	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	60	12	however	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	60	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	60	14	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	60	15	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	60	16	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	60	17	defined	define	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	60	18	partial	partial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	60	19	thromboplastin	thromboplastin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	60	20	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	60	21	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	60	22	range	range	NN
work_vvlzsj54cvf5de6ji6py6krqlm	60	23	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	60	24	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	60	25	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	60	26	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	60	27	assay	assay	NN
work_vvlzsj54cvf5de6ji6py6krqlm	60	28	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	60	29	relatively	relatively	RB
work_vvlzsj54cvf5de6ji6py6krqlm	60	30	insensitive	insensitive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	60	31	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	60	32	different	different	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	60	33	plasma	plasma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	60	34	concentrations	concentration	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	60	35	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	60	36	direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	60	37	thrombin	thrombin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	60	38	inhibi-	inhibi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	60	39	tors	tor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	60	40	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	61	1	Furthermore	furthermore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	61	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	61	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	61	4	partial	partial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	61	5	thromboplastin	thromboplastin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	61	6	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	61	7	can-	can-	:
work_vvlzsj54cvf5de6ji6py6krqlm	61	8	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	61	9	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	61	10	used	use	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	61	11	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	61	12	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	61	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	61	14	lupus	lupus	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	61	15	anticoagulant	anticoagulant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	61	16	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	61	17	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	61	18	intrinsic	intrinsic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	61	19	clotting	clotting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	61	20	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	61	21	deficiency	deficiency	NN
work_vvlzsj54cvf5de6ji6py6krqlm	61	22	because	because	IN
work_vvlzsj54cvf5de6ji6py6krqlm	61	23	its	-PRON-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	61	24	prolonga-	prolonga-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	61	25	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	61	26	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	61	27	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	61	28	conditions	condition	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	61	29	would	would	MD
work_vvlzsj54cvf5de6ji6py6krqlm	61	30	mask	mask	VB
work_vvlzsj54cvf5de6ji6py6krqlm	61	31	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	61	32	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	61	33	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	61	34	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	61	35	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	61	36	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	62	1	Thrombin	Thrombin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	62	2	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	62	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	62	4	far	far	RB
work_vvlzsj54cvf5de6ji6py6krqlm	62	5	more	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	62	6	sensi-	sensi-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	62	7	tive	tive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	62	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	62	9	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	62	10	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	62	11	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	62	12	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	62	13	less	less	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	62	14	sensitive	sensitive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	62	15	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	62	16	dabigatran	dabigatran	VB
work_vvlzsj54cvf5de6ji6py6krqlm	62	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	63	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	63	2	normal	normal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	63	3	partial	partial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	63	4	thromboplastin	thromboplastin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	63	5	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	63	6	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	63	7	thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	63	8	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	63	9	most	most	RBS
work_vvlzsj54cvf5de6ji6py6krqlm	63	10	likely	likely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	63	11	excludes	exclude	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	63	12	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	63	13	levels	level	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	63	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	63	15	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	63	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	63	17	whereas	whereas	IN
work_vvlzsj54cvf5de6ji6py6krqlm	63	18	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	63	19	normal	normal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	63	20	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	63	21	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	63	22	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	63	23	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	63	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	64	1	Quantita-	quantita-	VB
work_vvlzsj54cvf5de6ji6py6krqlm	64	2	tive	tive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	64	3	assessments	assessment	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	64	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	64	5	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	64	6	levels	level	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	64	7	can	can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	64	8	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	64	9	obtained	obtain	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	64	10	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	64	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	64	12	dilute	dilute	NN
work_vvlzsj54cvf5de6ji6py6krqlm	64	13	thrombin	thrombin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	64	14	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	64	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	64	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	64	17	ecarin	ecarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	64	18	clotting	clotting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	64	19	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	64	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	64	21	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	64	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	64	23	ecarin	ecarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	64	24	chromogenic	chromogenic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	64	25	assay	assay	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	64	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	65	1	Thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	65	2	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	65	3	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	65	4	ecarin-	ecarin-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	65	5	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	65	6	assays	assays	RB
work_vvlzsj54cvf5de6ji6py6krqlm	65	7	show	show	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	65	8	excellent	excellent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	65	9	linearity	linearity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	65	10	across	across	IN
work_vvlzsj54cvf5de6ji6py6krqlm	65	11	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	65	12	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	65	13	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	65	14	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	65	15	concentrations	concentration	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	65	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	65	17	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	65	18	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	65	19	used	use	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	65	20	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	65	21	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	65	22	quantifica-	quantifica-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	65	23	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	65	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	66	1	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	66	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	66	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	66	4	US	US	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	5	Food	Food	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	66	7	Drug	Drug	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	8	Administration	Administration	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	9	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	66	10	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	66	11	approved	approve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	66	12	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	66	13	latter	latter	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	66	14	assays	assay	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	66	15	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	66	16	measuring	measure	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	66	17	levels	level	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	66	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	66	19	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	20	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	66	21	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	66	22	direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	66	23	thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	66	24	inhibitors.8	inhibitors.8	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	25	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	66	27	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	66	29	Edoxaban	Edoxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	30	At	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	66	31	present	present	NN
work_vvlzsj54cvf5de6ji6py6krqlm	66	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	66	33	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	66	34	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	66	35	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	66	36	US	US	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	37	Food	Food	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	38	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	66	39	Drug	Drug	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	40	Administra-	Administra-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	41	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	66	42	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	66	43	approved	approve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	66	44	assays	assay	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	66	45	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	66	46	calibration	calibration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	66	47	reagents	reagent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	66	48	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	66	49	measure	measure	VB
work_vvlzsj54cvf5de6ji6py6krqlm	66	50	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	66	51	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	66	52	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	66	53	direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	66	54	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	66	55	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	66	56	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	66	57	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	66	58	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	67	1	Rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	67	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	67	3	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	67	4	affect	affect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	67	5	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	67	6	clotting	clotting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	67	7	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	67	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	67	9	chro-	chro-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	67	10	mogenic	mogenic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	67	11	anti	anti	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	67	12	–	–	NN
work_vvlzsj54cvf5de6ji6py6krqlm	67	13	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	67	14	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	67	15	assay	assay	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	67	16	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	67	17	however	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	67	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	67	19	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	67	20	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	67	21	range	range	NN
work_vvlzsj54cvf5de6ji6py6krqlm	67	22	exists	exist	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	67	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	68	1	Prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	68	2	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	68	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	68	4	less	less	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	68	5	sensitive	sensitive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	68	6	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	68	7	espe-	espe-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	68	8	cially	cially	RB
work_vvlzsj54cvf5de6ji6py6krqlm	68	9	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	68	10	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	68	11	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	68	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	68	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	68	14	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	68	15	normal	normal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	68	16	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	68	17	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	68	18	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	68	19	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	68	20	exclude	exclude	VB
work_vvlzsj54cvf5de6ji6py6krqlm	68	21	clinically	clinically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	68	22	relevant	relevant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	68	23	levels	level	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	68	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	69	1	Partial	partial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	2	thromboplas-	thromboplas-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	3	tin	tin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	4	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	5	demonstrates	demonstrate	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	69	6	insufficient	insufficient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	7	sensitivity	sensitivity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	69	9	linearity	linearity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	10	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	69	11	quantification.9	quantification.9	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	69	12	Studies	Studies	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	69	13	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	69	14	spiked	spike	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	69	15	plasma	plasma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	16	samples	sample	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	69	17	suggest	suggest	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	69	18	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	69	19	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	20	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	21	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	69	22	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	69	23	qualitative	qualitative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	24	assess-	assess-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	25	ment	ment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	26	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	69	27	direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	28	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	29	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	30	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	69	31	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	69	32	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	69	33	chromogenic	chromogenic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	34	anti	anti	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	35	–	–	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	36	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	37	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	69	38	assay	assay	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	69	39	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	69	40	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	69	41	quantitative	quantitative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	42	assessment	assessment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	43	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	69	44	direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	45	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	46	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	47	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	69	48	inhibitors.8–10	inhibitors.8–10	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	69	49	Anti	Anti	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	69	50	-	-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	69	51	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	69	52	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	53	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	69	54	linear	linear	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	55	over	over	IN
work_vvlzsj54cvf5de6ji6py6krqlm	69	56	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	69	57	wide	wide	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	69	58	range	range	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	59	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	69	60	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	61	levels	level	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	69	62	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	69	63	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	69	64	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	69	65	used	use	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	69	66	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	69	67	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	68	quantification	quantification	NN
work_vvlzsj54cvf5de6ji6py6krqlm	69	69	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	70	1	Undetectable	undetectable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	70	2	anti	anti	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	70	3	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	70	4	Xa	xa	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	70	5	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	70	6	likely	likely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	70	7	excludes	exclude	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	70	8	clinically	clinically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	70	9	relevant	relevant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	70	10	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	70	11	concentrations	concentration	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	70	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	71	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	71	2	summary	summary	NN
work_vvlzsj54cvf5de6ji6py6krqlm	71	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	71	4	although	although	IN
work_vvlzsj54cvf5de6ji6py6krqlm	71	5	routine	routine	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	71	6	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	71	7	monitoring	monitoring	NN
work_vvlzsj54cvf5de6ji6py6krqlm	71	8	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	71	9	unnecessary	unnecessary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	71	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	71	11	measurement	measurement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	71	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	71	13	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	71	14	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	71	15	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	71	16	assist	assist	VB
work_vvlzsj54cvf5de6ji6py6krqlm	71	17	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	71	18	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	71	19	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	71	20	certain	certain	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	71	21	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	71	22	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	71	23	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	71	24	peripro-	peripro-	VB
work_vvlzsj54cvf5de6ji6py6krqlm	71	25	cedural	cedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	71	26	settings	setting	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	71	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	72	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	72	2	most	most	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	72	3	situations	situation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	72	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	72	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	72	6	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	72	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	72	8	last	last	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	72	9	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	72	10	ingestion	ingestion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	72	11	combined	combine	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	72	12	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	72	13	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	72	14	recent	recent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	72	15	assessment	assessment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	72	16	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	72	17	creati-	creati-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	72	18	nine	nine	CD
work_vvlzsj54cvf5de6ji6py6krqlm	72	19	clearance	clearance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	72	20	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	72	21	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	72	22	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	72	23	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	72	24	enable	enable	VB
work_vvlzsj54cvf5de6ji6py6krqlm	72	25	appropriate	appropriate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	72	26	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	72	27	decision	decision	NN
work_vvlzsj54cvf5de6ji6py6krqlm	72	28	making	making	NN
work_vvlzsj54cvf5de6ji6py6krqlm	72	29	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	73	1	Therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	2	measurement	measurement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	3	Routine	Routine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	4	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	5	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	73	6	Routine	Routine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	7	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	8	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	73	9	Routine	Routine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	10	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	11	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	73	12	Routine	Routine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	13	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	14	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	73	15	To	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	73	16	detect	detect	VB
work_vvlzsj54cvf5de6ji6py6krqlm	73	17	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	18	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	19	aPTT	aptt	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	21	ECT	ECT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	22	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	73	23	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	73	24	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	25	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	73	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	27	TT	TT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	28	To	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	73	29	detect	detect	VB
work_vvlzsj54cvf5de6ji6py6krqlm	73	30	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	31	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	32	PT	PT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	34	aPTT	aptt	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	36	antifactor	antifactor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	37	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	38	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	39	To	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	73	40	detect	detect	VB
work_vvlzsj54cvf5de6ji6py6krqlm	73	41	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	42	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	43	PT	PT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	45	aPTT	aptt	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	47	antifactor	antifactor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	48	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	49	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	50	Prolongs	Prolongs	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	51	PT	PT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	53	aPTT	aptt	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	55	antifactor	antifactor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	56	Xa	xa	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	57	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	58	aPTT	aptt	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	59	>	>	CD
work_vvlzsj54cvf5de6ji6py6krqlm	73	60	2.5	2.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	73	61	times	time	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	73	62	control	control	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	63	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	73	64	indicate	indicate	VB
work_vvlzsj54cvf5de6ji6py6krqlm	73	65	overanticoagulation	overanticoagulation	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	66	Renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	67	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	68	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	69	CBC	CBC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	70	periodically	periodically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	71	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	72	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	73	73	least	least	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	73	74	annually	annually	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	75	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	76	hepatic	hepatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	77	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	78	Renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	79	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	80	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	81	CBC	CBC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	82	periodically	periodically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	83	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	84	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	73	85	least	least	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	73	86	annually	annually	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	87	Renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	88	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	89	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	90	CBC	CBC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	91	periodically	periodically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	92	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	93	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	73	94	least	least	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	73	95	annually	annually	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	96	Renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	97	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	98	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	99	CBC	CBC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	100	periodically	periodically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	101	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	102	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	73	103	least	least	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	73	104	annually	annually	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	105	AC	AC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	106	indicates	indicate	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	73	107	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	108	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	109	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	110	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	111	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	112	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	113	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	114	aPTT	aPTT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	115	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	116	activated	activate	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	73	117	partial	partial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	118	thromboplastin	thromboplastin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	119	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	120	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	121	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	122	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	123	twice	twice	RB
work_vvlzsj54cvf5de6ji6py6krqlm	73	124	daily	daily	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	125	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	126	CBC	CBC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	127	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	128	complete	complete	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	129	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	130	count	count	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	131	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	132	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	133	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	134	creatinine	creatinine	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	135	clearance	clearance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	136	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	137	DVT	DVT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	138	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	139	deep	deep	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	140	vein	vein	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	141	thrombosis	thrombosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	142	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	143	ECT	ECT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	144	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	145	ecarin	ecarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	146	clotting	clotting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	147	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	148	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	149	IV	IV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	150	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	151	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	152	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	153	NOACs	noacs	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	73	154	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	155	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	156	–	–	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	157	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	158	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	159	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	160	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	161	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	73	162	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	163	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	164	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	165	pulmonary	pulmonary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	73	166	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	167	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	168	P	p	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	169	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	73	170	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	171	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	172	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	173	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	73	174	glycoprotein	glycoprotein	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	175	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	176	PT	PT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	177	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	178	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	179	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	180	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	73	181	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	73	182	TT	TT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	73	183	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	73	184	thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	185	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	73	186	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	74	1	Table	table	NN
work_vvlzsj54cvf5de6ji6py6krqlm	74	2	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	74	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	75	1	Continued	Continued	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	2	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	3	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	4	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	5	Edoxaban	Edoxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	6	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	7	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	75	8	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	75	9	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	75	10	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	11	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	75	12	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	75	13	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	75	14	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	75	15	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	75	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	75	17	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	75	18	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	75	20	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	75	21	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	75	22	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	75	23	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	75	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	75	25	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	26	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	27	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	75	28	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	29	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	30	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	75	31	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	76	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	76	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	76	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	76	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	77	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	77	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	77	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	77	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	77	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	77	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	77	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	77	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	77	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	77	10	e609	e609	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	77	11	CLINICAL	CLINICAL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	77	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	77	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	77	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	77	15	GUIDELINES	GUIDELINES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	77	16	Table	Table	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	77	17	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	77	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	78	1	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	2	Drug	Drug	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	3	Interactions	Interactions	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	78	4	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	5	Interacting	Interacting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	6	Medications	Medications	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	78	7	Effect	Effect	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	8	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	78	9	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	10	Labeled	Labeled	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	11	Guidance	Guidance	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	12	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	78	13	Comments	Comments	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	14	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	15	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	16	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	78	17	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	18	inducer	inducer	NN
work_vvlzsj54cvf5de6ji6py6krqlm	78	19	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	78	20	rifampin	rifampin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	78	21	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	22	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	78	23	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	78	24	Concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	78	25	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	78	26	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	78	27	generally	generally	RB
work_vvlzsj54cvf5de6ji6py6krqlm	78	28	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	78	29	avoided	avoid	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	78	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	79	1	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	3	gp	gp	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	4	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	5	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	6	ketoconazole	ketoconazole	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	8	dronedarone	dronedarone	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	9	↑	↑	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	10	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	11	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	12	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	13	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	14	moderate	moderate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	15	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	16	impairment	impairment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	17	If	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	18	moderate	moderate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	19	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	20	impairment	impairment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	21	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	79	22	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	23	30–50	30–50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	79	24	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	25	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	79	26	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	27	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	79	28	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	29	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	30	75	75	CD
work_vvlzsj54cvf5de6ji6py6krqlm	79	31	mg	mg	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	32	BID	bid	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	33	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	34	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	35	use	use	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	36	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	37	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	38	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	39	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	40	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	41	ketoconazole	ketoconazole	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	43	dronedarone	dronedarone	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	45	verapamil	verapamil	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	47	amiodarone	amiodarone	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	49	quinidine	quinidine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	51	clarithromycin	clarithromycin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	53	ticagrelor	ticagrelor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	54	↑	↑	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	55	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	56	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	57	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	58	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	59	severe	severe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	60	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	61	impairment	impairment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	62	If	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	63	severe	severe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	64	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	65	impairment	impairment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	66	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	79	67	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	68	15–30	15–30	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	79	69	mL/	mL/	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	79	70	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	71	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	79	72	avoid	avoid	VB
work_vvlzsj54cvf5de6ji6py6krqlm	79	73	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	74	use	use	VB
work_vvlzsj54cvf5de6ji6py6krqlm	79	75	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	76	Strong	strong	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	77	dual	dual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	78	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	79	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	80	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	81	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	82	CYP3A4	CYP3A4	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	83	inducers	inducer	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	84	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	85	rifampin	rifampin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	86	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	87	carbamazepine	carbamazepine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	88	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	89	phenytoin	phenytoin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	90	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	91	St.	St.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	92	John	John	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	93	’s	’s	POS
work_vvlzsj54cvf5de6ji6py6krqlm	79	94	wort	wort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	95	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	96	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	97	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	98	Avoid	avoid	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	99	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	100	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	101	Strong	strong	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	102	dual	dual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	103	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	104	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	105	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	106	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	107	CYP3A4	CYP3A4	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	108	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	109	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	110	ketoconazole	ketoconazole	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	111	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	112	itraconazole	itraconazole	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	113	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	114	ritonavir	ritonavir	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	115	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	116	clarithromycin	clarithromycin	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	117	↑	↑	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	79	118	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	119	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	120	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	121	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	122	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	123	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	79	124	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	125	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	126	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	79	127	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	128	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	129	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	130	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	131	dose	dose	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	79	132	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	133	50	50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	79	134	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	135	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	79	136	coadministered	coadministere	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	79	137	Avoid	Avoid	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	138	coadministration	coadministration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	139	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	140	2.5	2.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	79	141	mg	mg	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	142	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	143	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	144	Combined	Combined	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	145	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	146	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	147	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	148	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	149	strong	strong	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	150	CYP3A4	CYP3A4	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	151	inducers	inducer	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	152	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	153	rifampin	rifampin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	154	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	155	carbamazepine	carbamazepine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	156	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	157	phenytoin	phenytoin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	158	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	159	St.	St.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	160	John	John	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	161	’s	’s	POS
work_vvlzsj54cvf5de6ji6py6krqlm	79	162	wort	wort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	163	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	164	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	165	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	166	Avoid	Avoid	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	167	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	168	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	169	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	170	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	79	171	decrease	decrease	VB
work_vvlzsj54cvf5de6ji6py6krqlm	79	172	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	173	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	174	Combined	Combined	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	175	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	176	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	177	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	178	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	179	strong	strong	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	180	CYP3A4	CYP3A4	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	181	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	182	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	183	ketoconazole	ketoconazole	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	184	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	185	itraconazole	itraconazole	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	186	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	187	HIV	HIV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	188	protease	protease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	189	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	190	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	79	191	ritonavir	ritonavir	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	192	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	193	lopinavir/	lopinavir/	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	194	ritonavir	ritonavir	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	195	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	196	indinavir	indinavir	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	197	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	79	198	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	199	conivaptan	conivaptan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	200	↑	↑	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	201	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	202	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	203	Avoid	avoid	VB
work_vvlzsj54cvf5de6ji6py6krqlm	79	204	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	205	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	206	Combined	Combined	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	207	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	208	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	209	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	210	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	211	moderate	moderate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	212	CYP3A4	CYP3A4	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	213	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	214	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	215	diltiazem	diltiazem	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	216	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	217	verapamil	verapamil	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	218	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	219	amiodarone	amiodarone	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	220	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	221	dronedarone	dronedarone	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	222	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	223	erythromycin	erythromycin	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	79	224	↑	↑	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	225	Rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	226	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	227	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	228	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	229	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	230	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	231	impairment	impairment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	232	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	233	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	234	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	235	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	236	15	15	CD
work_vvlzsj54cvf5de6ji6py6krqlm	79	237	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	238	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	79	239	80	80	CD
work_vvlzsj54cvf5de6ji6py6krqlm	79	240	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	241	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	79	242	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	243	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	244	rivaroxaban	rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	245	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	79	246	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	79	247	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	79	248	used	use	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	79	249	concomitantly	concomitantly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	79	250	unless	unless	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	251	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	79	252	potential	potential	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	253	benefit	benefit	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	254	justifies	justify	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	79	255	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	79	256	potential	potential	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	257	risks	risk	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	79	258	No	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	79	259	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	260	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	261	interaction	interaction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	262	observed	observe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	79	263	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	264	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	265	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	266	between	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	267	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	268	assignment	assignment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	269	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	270	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	271	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	272	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	273	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	79	274	≥1	≥1	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	79	275	combined	combine	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	79	276	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	277	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	278	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	279	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	280	moderate	moderate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	281	3A4	3a4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	79	282	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	283	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	79	284	including	include	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	79	285	amiodarone	amiodarone	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	286	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	287	diltiazem	diltiazem	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	288	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	289	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	290	verapamil)6	verapamil)6	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	291	Edoxaban	Edoxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	292	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	293	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	294	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	295	inducer	inducer	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	296	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	297	rifampin	rifampin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	79	298	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	299	Edoxaban	Edoxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	300	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	301	Avoid	avoid	VB
work_vvlzsj54cvf5de6ji6py6krqlm	79	302	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	303	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	304	Strong	Strong	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	305	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	306	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	307	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	308	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	309	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	310	ritonavir	ritonavir	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	311	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	312	nelfinavir	nelfinavir	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	313	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	314	saquinavir	saquinavir	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	315	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	316	indinavir	indinavir	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	317	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	318	cyclosporine	cyclosporine	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	319	↑	↑	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	320	Edoxaban	Edoxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	321	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	322	Avoid	Avoid	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	323	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	324	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	325	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	326	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	327	taking	take	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	79	328	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	329	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	330	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	331	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	332	VTE	VTE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	333	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	334	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	335	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	336	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	337	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	338	verapamil	verapamil	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	339	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	340	quinidine	quinidine	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	341	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	342	azithromycin	azithromycin	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	343	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	344	clarithromycin	clarithromycin	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	79	345	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	346	itraconazole	itraconazole	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	347	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	348	ketoconazole	ketoconazole	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	349	↑	↑	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	350	Edoxaban	Edoxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	351	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	352	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	353	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	354	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	79	355	mg	mg	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	356	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	79	357	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	358	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	359	administration	administration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	360	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	361	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	362	taking	take	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	79	363	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	364	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	365	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	79	366	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	367	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	368	VTE	VTE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	369	Dose	Dose	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	370	reduction	reduction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	371	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	79	372	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	79	373	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	79	374	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	375	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	376	indications	indication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	79	377	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	378	ENGAGE	ENGAGE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	379	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	380	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	381	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	79	382	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	383	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	384	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	385	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	386	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	387	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	79	388	result	result	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	389	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	390	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	391	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	392	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	393	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	394	inhibitor	inhibitor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	395	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	396	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	79	397	verapamil	verapamil	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	398	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	399	quinidine	quinidine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	400	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	401	dronedarone	dronedarone	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	402	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	79	403	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	79	404	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	79	405	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	406	↓	↓	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	407	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	408	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	409	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	410	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	79	411	relative	relative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	412	↑	↑	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	413	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	414	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	415	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	416	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	417	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	418	systemic	systemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	419	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	420	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	421	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	422	relative	relative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	423	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	424	warfarin176	warfarin176	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	425	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	426	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	427	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	428	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	429	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	430	BID	BID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	431	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	432	twice	twice	RB
work_vvlzsj54cvf5de6ji6py6krqlm	79	433	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	79	434	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	435	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	436	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	437	creatinine	creatinine	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	438	clearance	clearance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	439	;	;	.
work_vvlzsj54cvf5de6ji6py6krqlm	79	440	ENGAGE	engage	VB
work_vvlzsj54cvf5de6ji6py6krqlm	79	441	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	442	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	443	Effective	Effective	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	444	Anticoagulation	Anticoagulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	445	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	446	Factor	Factor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	447	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	448	Next	Next	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	449	Generation	Generation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	450	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	451	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	452	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	453	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	454	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	455	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	456	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	457	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	458	–	–	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	459	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	460	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	461	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	462	oral	oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	463	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	464	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	465	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	466	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	467	gp	gp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	468	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	469	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	470	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	79	471	glycoprotein	glycoprotein	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	472	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	473	ROCKET	rocket	VB
work_vvlzsj54cvf5de6ji6py6krqlm	79	474	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	475	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	476	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	477	Once	once	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	478	Daily	Daily	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	479	Oral	Oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	480	Direct	Direct	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	481	Factor	Factor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	482	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	483	Inhibition	Inhibition	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	484	Compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	79	485	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	486	Vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	487	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	488	Antagonism	Antagonism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	489	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	490	Prevention	Prevention	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	491	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	492	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	493	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	494	Embolism	Embolism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	495	Trial	Trial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	496	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	79	497	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	498	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	79	499	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	79	500	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	79	501	VTE	vte	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	502	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	79	503	venous	venous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	79	504	thromboembolism	thromboembolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	79	505	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	80	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	80	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	80	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	80	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	80	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	80	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	80	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	80	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	80	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	80	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	80	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	80	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	80	13	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	80	14	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	80	15	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	80	16	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	80	17	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	80	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	80	19	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	80	20	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	80	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	81	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	81	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	81	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	81	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	82	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	82	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	82	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	82	5	CIR.0000000000000477e610	CIR.0000000000000477e610	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	82	6	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	82	7	REVERSAL	REVERSAL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	82	8	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	82	9	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	82	10	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	11	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	12	suggests	suggest	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	82	13	hospital	hospital	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	14	systems	system	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	82	15	adopt	adopt	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	82	16	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	17	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	18	protocols	protocol	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	82	19	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	82	20	multidisciplinary	multidisciplinary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	82	21	representation	representation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	22	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	82	23	emergency	emergency	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	24	medicine	medicine	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	26	critical	critical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	82	27	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	29	cardiology	cardiology	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	31	hematology	hematology	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	33	gastroenterology	gastroenterology	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	35	neurology	neurology	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	37	neurosurgery	neurosurgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	39	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	41	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	82	42	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	43	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	45	cardiotho-	cardiotho-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	82	46	racic	racic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	82	47	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	49	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	82	50	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	52	pharmacy	pharmacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	82	54	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	82	55	nursing	nursing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	82	56	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	83	1	An	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	83	2	example	example	NN
work_vvlzsj54cvf5de6ji6py6krqlm	83	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	83	4	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	83	5	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	83	6	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	83	7	protocol	protocol	NN
work_vvlzsj54cvf5de6ji6py6krqlm	83	8	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	83	9	shown	show	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	83	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	83	11	Figure	Figure	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	83	12	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	83	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	84	1	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	84	2	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	84	3	minor	minor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	84	4	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	84	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	84	6	supportive	supportive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	84	7	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	84	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	84	9	careful	careful	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	84	10	obser-	obser-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	84	11	vation	vation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	84	12	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	84	13	suggested	suggest	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	84	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	85	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	85	2	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	85	3	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	85	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	85	5	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	85	6	idarucizumab	idarucizumab	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	85	7	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	85	8	Praxbind	Praxbind	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	85	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	85	10	Boehringer	Boehringer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	85	11	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	85	12	Ingelheim	Ingelheim	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	85	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	85	14	Germa-	Germa-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	85	15	ny	ny	NN
work_vvlzsj54cvf5de6ji6py6krqlm	85	16	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	85	17	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	85	18	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	85	19	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	85	20	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	85	21	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	85	22	grams	gram	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	85	23	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	85	24	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	85	25	consecutive	consecutive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	85	26	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	85	27	infu-	infu-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	85	28	sions	sion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	85	29	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	85	30	2.5	2.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	85	31	g	g	NN
work_vvlzsj54cvf5de6ji6py6krqlm	85	32	each	each	DT
work_vvlzsj54cvf5de6ji6py6krqlm	85	33	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	85	34	will	will	MD
work_vvlzsj54cvf5de6ji6py6krqlm	85	35	reverse	reverse	VB
work_vvlzsj54cvf5de6ji6py6krqlm	85	36	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	85	37	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	85	38	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	85	39	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	85	40	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	85	41	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	85	42	minutes.11	minutes.11	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	85	43	Idarucizumab	Idarucizumab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	85	44	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	85	45	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	85	46	mono-	mono-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	85	47	clonal	clonal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	85	48	antibody	antibody	NN
work_vvlzsj54cvf5de6ji6py6krqlm	85	49	fragment	fragment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	85	50	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	85	51	binds	bind	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	85	52	dabigatran	dabigatran	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	85	53	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	85	54	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	85	55	affinity	affinity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	85	56	350	350	CD
work_vvlzsj54cvf5de6ji6py6krqlm	85	57	times	time	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	85	58	that	that	DT
work_vvlzsj54cvf5de6ji6py6krqlm	85	59	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	85	60	thrombin	thrombin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	85	61	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	86	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	86	2	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	86	3	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	86	4	VERSE	verse	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	5	AD	ad	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	6	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	86	7	Reversal	Reversal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	86	8	Effects	Effects	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	86	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	86	10	Idarucizumab	Idarucizumab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	86	11	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	86	12	Active	Active	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	86	13	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	86	14	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	86	15	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	86	16	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	86	17	prospective	prospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	86	18	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	19	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	20	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	86	21	showed	show	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	86	22	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	86	23	ida-	ida-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	86	24	rucizumab	rucizumab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	86	25	administration	administration	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	86	26	reversed	reverse	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	86	27	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	28	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	86	29	evidenced	evidence	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	86	30	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	86	31	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	86	32	normalization	normalization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	33	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	86	34	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	86	35	dilute	dilute	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	36	thrombin	thrombin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	86	37	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	38	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	86	39	ecarin	ecarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	40	clotting	clotting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	41	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	42	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	86	43	minutes	minute	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	86	44	among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	86	45	sub-	sub-	DT
work_vvlzsj54cvf5de6ji6py6krqlm	86	46	jects	ject	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	86	47	suffering	suffer	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	86	48	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	86	49	serious	serious	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	86	50	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	51	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	86	52	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	86	53	required	require	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	86	54	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	86	55	urgent	urgent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	86	56	procedure.11	procedure.11	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	86	57	Early	early	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	86	58	hemostasis	hemostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	59	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	86	60	achieved	achieve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	86	61	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	86	62	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	86	63	subjects	subject	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	86	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	86	65	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	86	66	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	86	67	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	86	68	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	69	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	86	70	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	86	71	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	86	72	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	86	73	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	86	74	observed	observe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	86	75	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	86	76	subjects	subject	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	86	77	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	86	78	urgent	urgent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	86	79	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	86	80	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	87	1	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	87	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	87	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	87	4	strength	strength	NN
work_vvlzsj54cvf5de6ji6py6krqlm	87	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	87	6	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	87	7	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	87	8	observations	observation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	87	9	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	87	10	limited	limit	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	87	11	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	87	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	87	13	nonrandomized	nonrandomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	87	14	nature	nature	NN
work_vvlzsj54cvf5de6ji6py6krqlm	87	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	87	16	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	87	17	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	87	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	88	1	Several	several	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	88	2	studies	study	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	88	3	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	88	4	investigated	investigate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	88	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	88	6	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	88	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	88	8	pro-	pro-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	88	9	thrombin	thrombin	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	88	10	complex	complex	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	88	11	concentrates	concentrate	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	88	12	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	88	13	PCCs	PCCs	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	88	14	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	88	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	88	16	recombinant	recombinant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	88	17	fac-	fac-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	88	18	tor	tor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	88	19	VII	vii	NN
work_vvlzsj54cvf5de6ji6py6krqlm	88	20	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	88	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	88	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	88	23	fresh	fresh	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	88	24	frozen	frozen	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	88	25	plasma	plasma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	88	26	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	88	27	FFP	FFP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	88	28	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	88	29	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	88	30	animal	animal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	88	31	models	model	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	88	32	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	88	33	however	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	88	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	88	35	human	human	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	88	36	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	88	37	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	88	38	mixed	mixed	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	88	39	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	89	1	One	one	CD
work_vvlzsj54cvf5de6ji6py6krqlm	89	2	random-	random-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	3	ized	ize	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	89	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	89	5	placebo	placebo	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	89	7	controlled	control	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	89	8	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	10	healthy	healthy	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	89	11	men	man	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	89	12	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	89	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	14	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	15	showed	show	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	89	16	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	17	4-factor	4-factor	CD
work_vvlzsj54cvf5de6ji6py6krqlm	89	18	PCC	PCC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	19	did	do	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	89	20	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	89	21	reverse	reverse	VB
work_vvlzsj54cvf5de6ji6py6krqlm	89	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	89	23	dabigatran	dabigatran	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	89	24	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	25	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	26	partial	partial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	89	27	thromboplastin	thromboplastin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	28	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	89	30	endoge-	endoge-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	89	31	nous	nous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	89	32	thrombin	thrombin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	33	potential	potential	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	34	lag	lag	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	35	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	89	37	thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	38	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	89	40	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	89	41	ecarin	ecarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	42	clotting	clot	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	89	43	time.12	time.12	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	44	Case	Case	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	45	reports	report	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	89	46	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	47	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	89	48	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	49	life	life	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	50	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	89	51	threat-	threat-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	52	ening	ene	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	89	53	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	89	54	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	89	55	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	56	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	57	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	58	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	89	59	demonstrated	demonstrate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	89	60	mixed	mixed	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	89	61	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	89	62	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	63	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	89	64	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	65	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	66	FFP	FFP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	67	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	89	68	recombi-	recombi-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	89	69	nant	nant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	89	70	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	71	VII	VII	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	72	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	89	73	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	89	74	PCCs	pcc	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	89	75	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	89	76	fibrinogen	fibrinogen	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	77	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	89	78	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	89	79	platelets.8	platelets.8	DT
work_vvlzsj54cvf5de6ji6py6krqlm	89	80	Hemodialysis	hemodialysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	81	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	89	82	remove	remove	VB
work_vvlzsj54cvf5de6ji6py6krqlm	89	83	49	49	CD
work_vvlzsj54cvf5de6ji6py6krqlm	89	84	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	85	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	86	57	57	CD
work_vvlzsj54cvf5de6ji6py6krqlm	89	87	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	88	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	89	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	90	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	91	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	89	92	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	89	93	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	89	94	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	95	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	89	96	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	97	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	89	98	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	89	99	35	35	CD
work_vvlzsj54cvf5de6ji6py6krqlm	89	100	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	101	bound	bind	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	89	102	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	103	plasma	plasma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	104	proteins.13,14	proteins.13,14	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	105	Hemodialysis	Hemodialysis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	106	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	89	107	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	89	108	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	89	109	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	110	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	89	111	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	112	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	89	113	chronically	chronically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	89	114	below	below	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	115	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	89	116	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	117	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	89	118	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	89	119	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	89	120	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	89	121	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	89	122	kidney	kidney	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	123	injury	injury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	89	124	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	90	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	90	2	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	90	3	ingestion	ingestion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	90	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	90	5	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	90	6	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	90	7	some	some	DT
work_vvlzsj54cvf5de6ji6py6krqlm	90	8	evi-	evi-	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	90	9	dence	dence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	90	10	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	90	11	support	support	VB
work_vvlzsj54cvf5de6ji6py6krqlm	90	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	90	13	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	90	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	90	15	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	90	16	charcoal	charcoal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	90	17	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	90	18	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	90	19	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	90	20	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	90	21	consumed	consume	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	90	22	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	90	23	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	90	24	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	90	25	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	90	26	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	90	27	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	90	28	however	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	90	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	90	30	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	90	31	must	must	MD
work_vvlzsj54cvf5de6ji6py6krqlm	90	32	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	90	33	taken	take	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	90	34	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	90	35	prevent	prevent	VB
work_vvlzsj54cvf5de6ji6py6krqlm	90	36	aspiration	aspiration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	90	37	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	90	38	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	90	39	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	90	40	decreased	decreased	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	90	41	level	level	NN
work_vvlzsj54cvf5de6ji6py6krqlm	90	42	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	90	43	consciousness.7,8	consciousness.7,8	.
work_vvlzsj54cvf5de6ji6py6krqlm	90	44	Furthermore	furthermore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	90	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	90	46	acti-	acti-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	90	47	vated	vated	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	90	48	charcoal	charcoal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	90	49	induced	induce	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	90	50	vomiting	vomiting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	90	51	could	could	MD
work_vvlzsj54cvf5de6ji6py6krqlm	90	52	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	90	53	deleterious	deleterious	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	90	54	effects	effect	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	90	55	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	90	56	increasing	increase	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	90	57	intracranial	intracranial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	90	58	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	90	59	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	90	60	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	90	61	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	90	62	intracranial	intracranial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	90	63	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	90	64	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	90	65	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	90	66	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	90	67	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	91	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	91	2	summary	summary	NN
work_vvlzsj54cvf5de6ji6py6krqlm	91	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	91	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	91	5	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	91	6	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	91	7	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	91	8	suggests	suggest	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	91	9	com-	com-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	91	10	pression	pression	NN
work_vvlzsj54cvf5de6ji6py6krqlm	91	11	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	91	12	possible	possible	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	91	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	91	14	supportive	supportive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	91	15	measures	measure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	91	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	91	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	91	18	up-	up-	CD
work_vvlzsj54cvf5de6ji6py6krqlm	91	19	front	front	NN
work_vvlzsj54cvf5de6ji6py6krqlm	91	20	idarucizumab	idarucizumab	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	91	21	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	91	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	91	23	event	event	NN
work_vvlzsj54cvf5de6ji6py6krqlm	91	24	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	91	25	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	91	26	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	91	27	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	91	28	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	91	29	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	91	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	92	1	Rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	92	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	92	3	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	92	4	Similar	Similar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	92	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	92	6	dabigatran	dabigatran	VB
work_vvlzsj54cvf5de6ji6py6krqlm	92	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	92	8	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	92	9	charcoal	charcoal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	92	10	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	92	11	prevent	prevent	VB
work_vvlzsj54cvf5de6ji6py6krqlm	92	12	absorption	absorption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	92	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	92	14	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	92	15	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	92	16	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	92	17	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	92	18	administered	administer	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	92	19	Figure	Figure	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	92	20	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	92	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	93	1	Example	example	NN
work_vvlzsj54cvf5de6ji6py6krqlm	93	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	93	3	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	93	4	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	93	5	Serious	serious	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	93	6	Bleeding	Bleeding	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	93	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	93	8	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	93	9	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	93	10	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	93	11	protocol	protocol	NN
work_vvlzsj54cvf5de6ji6py6krqlm	93	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	94	1	BUN	BUN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	94	2	indicates	indicate	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	94	3	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	4	urea	urea	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	94	5	nitrogen	nitrogen	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	6	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	94	7	CBC	CBC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	94	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	94	9	complete	complete	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	94	10	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	11	count	count	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	12	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	94	13	IU	IU	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	94	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	94	15	international	international	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	94	16	units	unit	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	94	17	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	94	18	IV	IV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	94	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	94	20	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	94	21	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	94	22	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	94	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	94	24	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	94	25	–	–	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	94	26	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	94	27	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	28	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	29	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	94	30	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	94	31	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	94	32	PCC	PCC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	94	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	94	34	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	35	complex	complex	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	94	36	concentrate	concentrate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	37	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	94	38	PRBC	PRBC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	94	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	94	40	packed	pack	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	94	41	red	red	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	94	42	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	43	cells	cell	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	94	44	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	94	45	PTT	PTT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	94	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	94	47	partial	partial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	94	48	thrombo-	thrombo-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	49	plastin	plastin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	94	50	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	51	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	94	52	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	94	53	TT	TT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	94	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	94	55	thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	56	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	94	57	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	95	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	95	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	95	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	95	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	95	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	95	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	95	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	95	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	95	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	95	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	95	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	95	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	95	13	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	95	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	95	15	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	95	16	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	95	17	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	95	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	95	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	95	20	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	95	21	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	95	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	95	23	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	95	24	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	95	25	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	95	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	96	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	96	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	96	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	96	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	97	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	97	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	97	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	97	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	97	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	97	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	97	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	97	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	97	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	97	10	e611	e611	NN
work_vvlzsj54cvf5de6ji6py6krqlm	97	11	CLINICAL	clinical	NN
work_vvlzsj54cvf5de6ji6py6krqlm	97	12	STATEM	statem	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	97	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	97	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	97	15	GUIDELINES	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	97	16	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	97	17	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	97	18	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	97	19	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	97	20	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	97	21	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	97	22	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	97	23	ingestion	ingestion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	97	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	98	1	Rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	98	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	98	3	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	98	4	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	98	5	highly	highly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	98	6	bound	bind	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	98	7	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	98	8	plasma	plasma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	98	9	proteins	protein	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	98	10	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	98	11	therefore	therefore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	98	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	98	13	dialysis	dialysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	98	14	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	98	15	ineffective	ineffective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	98	16	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	98	17	clearing	clear	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	98	18	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	98	19	drugs	drug	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	98	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	99	1	Andexanet	andexanet	VB
work_vvlzsj54cvf5de6ji6py6krqlm	99	2	alfa	alfa	NN
work_vvlzsj54cvf5de6ji6py6krqlm	99	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	99	4	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	99	5	recombinant	recombinant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	99	6	modified	modify	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	99	7	human	human	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	99	8	fac-	fac-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	99	9	tor	tor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	99	10	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	99	11	decoy	decoy	VB
work_vvlzsj54cvf5de6ji6py6krqlm	99	12	protein	protein	NN
work_vvlzsj54cvf5de6ji6py6krqlm	99	13	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	99	14	serves	serve	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	99	15	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	99	16	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	99	17	specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	99	18	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	99	19	agent	agent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	99	20	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	99	21	neutralize	neutralize	VB
work_vvlzsj54cvf5de6ji6py6krqlm	99	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	99	23	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	99	24	effects	effect	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	99	25	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	99	26	direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	99	27	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	99	28	indirect	indirect	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	99	29	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	99	30	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	99	31	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	99	32	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	100	1	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	100	2	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	100	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	100	4	admin-	admin-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	100	5	istered	istere	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	100	6	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	100	7	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	100	8	initial	initial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	100	9	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	100	10	bolus	bolus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	100	11	followed	follow	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	100	12	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	100	13	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	100	14	infusion	infusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	100	15	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	100	16	up	up	IN
work_vvlzsj54cvf5de6ji6py6krqlm	100	17	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	100	18	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	100	19	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	100	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	101	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	101	2	recent	recent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	3	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	4	revealed	reveal	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	101	5	that	that	DT
work_vvlzsj54cvf5de6ji6py6krqlm	101	6	andexanet	andexanet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	7	alpha	alpha	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	8	reversed	reverse	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	101	9	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	101	10	laboratory	laboratory	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	11	assessed	assess	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	101	12	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	13	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	15	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	101	17	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	19	older	old	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	101	20	healthy	healthy	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	21	individuals	individual	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	101	22	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	23	minutes	minute	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	101	24	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	25	administra-	administra-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	26	tion.15	tion.15	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	101	27	At	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	28	present	present	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	101	30	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	101	31	single	single	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	32	arm	arm	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	101	34	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	35	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	101	36	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	37	ANNEXA-4	ANNEXA-4	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	101	38	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	101	39	Andexanet	andexanet	VB
work_vvlzsj54cvf5de6ji6py6krqlm	101	40	Alfa	Alfa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	101	41	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	42	Acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	43	Major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	44	Bleeding	Bleeding	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	101	45	Associated	Associated	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	101	46	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	47	Factor	Factor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	101	48	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	101	49	Inhibitors	Inhibitors	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	101	50	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	101	51	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	52	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	101	53	under	under	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	54	way	way	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	55	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	101	56	confirm	confirm	VB
work_vvlzsj54cvf5de6ji6py6krqlm	101	57	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	101	58	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	59	benefit	benefit	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	60	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	61	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	101	62	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	63	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	64	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	101	65	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	66	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	67	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	101	68	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	69	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	101	70	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	71	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	101	72	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	101	73	enoxaparin	enoxaparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	101	74	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	101	75	present	present	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	101	76	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	101	77	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	101	78	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	79	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	101	80	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	101	81	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	102	1	An	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	102	2	interim	interim	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	102	3	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	102	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	102	5	67	67	CD
work_vvlzsj54cvf5de6ji6py6krqlm	102	6	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	102	7	revealed	reveal	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	102	8	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	102	9	89	89	CD
work_vvlzsj54cvf5de6ji6py6krqlm	102	10	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	102	11	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	102	12	93	93	CD
work_vvlzsj54cvf5de6ji6py6krqlm	102	13	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	102	14	reduction	reduction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	102	15	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	102	16	anti	anti	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	102	17	–	–	NN
work_vvlzsj54cvf5de6ji6py6krqlm	102	18	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	102	19	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	102	20	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	102	21	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	102	22	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	102	23	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	102	24	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	102	25	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	102	26	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	102	27	respectively.16	respectively.16	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	102	28	Of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	102	29	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	102	30	entire	entire	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	102	31	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	102	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	102	33	47	47	CD
work_vvlzsj54cvf5de6ji6py6krqlm	102	34	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	102	35	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	102	36	followed	follow	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	102	37	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	102	38	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	102	39	hemostasis	hemostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	102	40	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	103	1	Of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	103	2	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	103	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	103	4	37	37	CD
work_vvlzsj54cvf5de6ji6py6krqlm	103	5	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	103	6	79	79	CD
work_vvlzsj54cvf5de6ji6py6krqlm	103	7	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	103	8	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	103	9	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	103	10	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	103	11	confidence	confidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	103	12	interval	interval	NN
work_vvlzsj54cvf5de6ji6py6krqlm	103	13	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	103	14	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	103	15	]	]	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	103	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	103	17	64–89	64–89	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	103	18	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	103	19	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	103	20	adjudicated	adjudicate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	103	21	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	103	22	having	have	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	103	23	excellent	excellent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	103	24	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	103	25	good	good	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	103	26	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	103	27	hemostasis	hemostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	103	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	104	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	104	2	dosing	dose	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	104	3	protocol	protocol	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	104	5	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	104	6	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	7	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	104	8	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	104	9	follows	follow	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	104	10	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	104	11	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	104	12	1	1	LS
work_vvlzsj54cvf5de6ji6py6krqlm	104	13	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	104	14	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	104	15	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	104	16	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	104	17	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	104	18	taken	take	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	104	19	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	104	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	104	21	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	104	22	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	104	23	>	>	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	24	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	104	25	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	104	26	prior	prior	RB
work_vvlzsj54cvf5de6ji6py6krqlm	104	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	104	28	andexanet	andexanet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	29	alfa	alfa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	104	30	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	104	31	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	104	32	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	104	33	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	104	34	bolus	bolus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	35	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	36	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	104	37	400	400	CD
work_vvlzsj54cvf5de6ji6py6krqlm	104	38	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	104	39	followed	follow	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	104	40	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	104	41	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	104	42	infusion	infusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	43	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	104	44	480	480	CD
work_vvlzsj54cvf5de6ji6py6krqlm	104	45	mg	mg	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	46	over	over	IN
work_vvlzsj54cvf5de6ji6py6krqlm	104	47	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	104	48	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	104	49	;	;	,
work_vvlzsj54cvf5de6ji6py6krqlm	104	50	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	104	51	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	104	52	2	2	LS
work_vvlzsj54cvf5de6ji6py6krqlm	104	53	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	104	54	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	104	55	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	104	56	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	104	57	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	104	58	enoxaparin	enoxaparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	104	59	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	104	60	edoxa-	edoxa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	104	61	ban	ban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	62	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	104	63	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	104	64	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	65	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	104	66	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	104	67	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	104	68	prior	prior	RB
work_vvlzsj54cvf5de6ji6py6krqlm	104	69	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	104	70	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	104	71	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	104	72	unknown	unknown	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	104	73	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	74	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	104	75	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	104	76	bolus	bolus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	77	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	78	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	104	79	infusion	infusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	80	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	81	amount	amount	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	82	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	104	83	doubled	double	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	104	84	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	104	85	800-mg	800-mg	CD
work_vvlzsj54cvf5de6ji6py6krqlm	104	86	bolus	bolus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	87	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	104	88	960-mg	960-mg	CD
work_vvlzsj54cvf5de6ji6py6krqlm	104	89	infusion	infusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	104	90	over	over	IN
work_vvlzsj54cvf5de6ji6py6krqlm	104	91	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	104	92	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	104	93	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	104	94	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	105	1	At	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	105	2	present	present	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	105	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	105	4	andexanet	andexanet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	105	5	alfa	alfa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	105	6	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	105	7	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	105	8	approved	approve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	105	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	105	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	105	11	United	United	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	105	12	States	States	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	105	13	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	105	14	elsewhere	elsewhere	RB
work_vvlzsj54cvf5de6ji6py6krqlm	105	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	106	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	106	2	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	3	placebo	placebo	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	4	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	106	5	controlled	control	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	106	6	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	8	young	young	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	106	10	healthy	healthy	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	11	volunteers	volunteer	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	106	12	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	106	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	14	20	20	CD
work_vvlzsj54cvf5de6ji6py6krqlm	106	15	mg	mg	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	106	16	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	17	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	18	dosed	dose	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	106	19	twice	twice	RB
work_vvlzsj54cvf5de6ji6py6krqlm	106	20	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	106	21	found	find	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	106	22	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	23	administration	administration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	24	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	25	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	106	26	4-factor	4-factor	CD
work_vvlzsj54cvf5de6ji6py6krqlm	106	27	PCC	PCC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	28	led	lead	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	106	29	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	30	normalization	normalization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	31	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	32	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	106	33	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	34	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	35	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	106	36	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	106	37	endogenous	endogenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	38	thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	39	potential.12	potential.12	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	40	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	41	contrast	contrast	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	106	43	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	106	44	in	in	FW
work_vvlzsj54cvf5de6ji6py6krqlm	106	45	vitro	vitro	FW
work_vvlzsj54cvf5de6ji6py6krqlm	106	46	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	47	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	106	48	human	human	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	49	plasma	plasma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	50	obtained	obtain	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	106	51	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	52	healthy	healthy	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	53	donors	donor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	106	54	found	find	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	106	55	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	56	recombinant	recombinant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	57	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	58	VII	VII	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	59	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	106	60	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	106	61	superior	superior	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	62	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	63	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	106	64	4-factor	4-factor	CD
work_vvlzsj54cvf5de6ji6py6krqlm	106	65	PCC	PCC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	66	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	67	normalizing	normalizing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	68	laboratory	laboratory	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	69	co-	co-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	106	70	agulation	agulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	71	studies.17	studies.17	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	72	Case	Case	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	73	reports	report	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	106	74	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	75	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	106	76	FFP	FFP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	77	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	106	78	PCC	PCC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	79	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	106	80	treat	treat	VB
work_vvlzsj54cvf5de6ji6py6krqlm	106	81	excess	excess	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	82	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	83	ingestion	ingestion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	84	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	106	85	shown	show	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	106	86	mod-	mod-	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	106	87	est	est	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	88	success	success	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	89	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	90	improving	improve	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	106	91	laboratory	laboratory	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	92	coagulation	coagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	93	param-	param-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	94	eters.18–20	eters.18–20	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	95	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	106	96	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	106	97	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	106	98	correction	correction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	99	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	100	coagulation	coagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	101	tests	test	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	106	102	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	103	PCC	PCC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	104	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	106	105	FFP	FFP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	106	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	106	107	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	106	108	recombinant	recombinant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	109	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	110	VII	VII	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	106	111	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	106	112	does	do	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	106	113	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	106	114	imply	imply	VB
work_vvlzsj54cvf5de6ji6py6krqlm	106	115	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	106	116	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	117	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	118	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	106	119	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	106	120	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	121	ef-	ef-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	106	122	fect	fect	RB
work_vvlzsj54cvf5de6ji6py6krqlm	106	123	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	106	124	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	106	125	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	106	126	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	107	1	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	107	2	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	107	3	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	107	4	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	107	5	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	107	6	FFP	FFP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	107	7	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	107	8	PCC	PCC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	107	9	controls	control	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	107	10	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	107	11	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	107	12	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	107	13	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	107	14	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	107	15	humans	human	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	107	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	108	1	Edoxaban	Edoxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	108	2	Four	four	CD
work_vvlzsj54cvf5de6ji6py6krqlm	108	3	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	108	4	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	5	PCC	PCC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	108	6	showed	show	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	108	7	dose	dose	VB
work_vvlzsj54cvf5de6ji6py6krqlm	108	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	108	9	dependent	dependent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	108	10	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	108	12	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	13	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	14	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	108	15	complete	complete	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	108	16	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	17	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	108	18	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	108	19	duration	duration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	20	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	108	21	skin	skin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	22	punch	punch	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	23	biopsy	biopsy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	24	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	108	25	volunteers	volunteer	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	108	26	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	108	27	par-	par-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	108	28	tial	tial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	108	29	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	30	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	108	31	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	32	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	33	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	108	34	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	108	35	50-IU	50-IU	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	108	36	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	108	37	kg	kg	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	108	38	dose	dose	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	108	39	administration.21	administration.21	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	108	40	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	108	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	108	42	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	108	43	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	108	44	relevance	relevance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	45	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	108	46	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	108	47	finding	finding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	108	48	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	108	49	uncertain	uncertain	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	108	50	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	109	1	Ciraparantag	Ciraparantag	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	109	2	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	109	3	PER977	PER977	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	109	4	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	109	5	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	109	6	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	109	7	small	small	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	109	8	synthetic	synthetic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	109	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	109	10	water-	water-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	109	11	soluble	soluble	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	109	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	109	13	cationic	cationic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	109	14	molecule	molecule	NN
work_vvlzsj54cvf5de6ji6py6krqlm	109	15	designed	design	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	109	16	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	109	17	specifically	specifically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	109	18	bind	bind	VB
work_vvlzsj54cvf5de6ji6py6krqlm	109	19	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	109	20	unfractionated	unfractionated	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	109	21	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	109	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	109	23	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	109	24	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	109	25	molecular	molecular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	109	26	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	109	27	weight	weight	NN
work_vvlzsj54cvf5de6ji6py6krqlm	109	28	hep-	hep-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	109	29	arin	arin	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	109	30	through	through	IN
work_vvlzsj54cvf5de6ji6py6krqlm	109	31	noncovalent	noncovalent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	109	32	hydrogen	hydrogen	NN
work_vvlzsj54cvf5de6ji6py6krqlm	109	33	bonding	bonding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	109	34	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	109	35	charge-	charge-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	109	36	charge	charge	NN
work_vvlzsj54cvf5de6ji6py6krqlm	109	37	interactions	interaction	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	109	38	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	110	1	It	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	110	2	also	also	RB
work_vvlzsj54cvf5de6ji6py6krqlm	110	3	binds	bind	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	110	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	110	5	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	110	6	similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	110	7	way	way	NN
work_vvlzsj54cvf5de6ji6py6krqlm	110	8	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	110	9	di-	di-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	110	10	rect	rect	VB
work_vvlzsj54cvf5de6ji6py6krqlm	110	11	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	110	12	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	110	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	110	14	direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	110	15	thrombin	thrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	110	16	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	110	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	111	1	It	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	111	2	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	111	3	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	111	4	shown	show	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	111	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	111	6	normalize	normalize	VB
work_vvlzsj54cvf5de6ji6py6krqlm	111	7	whole	whole	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	111	8	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	111	9	clot	clot	NN
work_vvlzsj54cvf5de6ji6py6krqlm	111	10	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	111	11	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	111	12	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	111	13	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	111	14	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	111	15	minutes	minute	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	111	16	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	111	17	administration.22,23	administration.22,23	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	111	18	Ciraparantag	Ciraparantag	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	111	19	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	111	20	still	still	RB
work_vvlzsj54cvf5de6ji6py6krqlm	111	21	being	be	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	111	22	investigated	investigate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	111	23	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	111	24	early	early	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	111	25	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	111	26	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	111	27	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	111	28	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	111	29	antidote	antidote	NN
work_vvlzsj54cvf5de6ji6py6krqlm	111	30	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	111	31	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	111	32	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	111	33	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	111	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	112	1	It	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	112	2	remains	remain	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	112	3	unknown	unknown	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	112	4	whether	whether	IN
work_vvlzsj54cvf5de6ji6py6krqlm	112	5	andexanet	andexanet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	112	6	alfa	alfa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	112	7	will	will	MD
work_vvlzsj54cvf5de6ji6py6krqlm	112	8	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	112	9	greater	great	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	112	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	112	11	equal	equal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	112	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	112	13	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	112	14	less-	less-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	112	15	er	er	UH
work_vvlzsj54cvf5de6ji6py6krqlm	112	16	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	112	17	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	112	18	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	112	19	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	112	20	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	112	21	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	112	22	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	112	23	ciraparantag	ciraparantag	NN
work_vvlzsj54cvf5de6ji6py6krqlm	112	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	113	1	MANAGEMENT	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	113	2	OF	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	113	3	LIFE	LIFE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	113	4	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	113	5	THREATENING	threatening	NN
work_vvlzsj54cvf5de6ji6py6krqlm	113	6	BLEEDING	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	113	7	All	all	DT
work_vvlzsj54cvf5de6ji6py6krqlm	113	8	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	113	9	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	113	10	life	life	NN
work_vvlzsj54cvf5de6ji6py6krqlm	113	11	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	113	12	threatening	threaten	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	113	13	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	113	14	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	113	15	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	113	16	man-	man-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	113	17	aged	age	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	113	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	113	19	similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	113	20	basic	basic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	113	21	resuscitation	resuscitation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	113	22	principals	principal	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	113	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	113	24	irrespec-	irrespec-	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	113	25	tive	tive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	113	26	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	113	27	what	what	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	113	28	type	type	NN
work_vvlzsj54cvf5de6ji6py6krqlm	113	29	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	113	30	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	113	31	they	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	113	32	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	113	33	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	113	34	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	113	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	114	1	Imme-	Imme-	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	114	2	diate	diate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	114	3	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	114	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	114	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	114	6	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	114	7	’s	’s	POS
work_vvlzsj54cvf5de6ji6py6krqlm	114	8	airway	airway	NN
work_vvlzsj54cvf5de6ji6py6krqlm	114	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	114	10	breathing	breathing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	114	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	114	12	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	114	13	circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	114	14	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	114	15	attempts	attempt	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	114	16	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	114	17	control	control	VB
work_vvlzsj54cvf5de6ji6py6krqlm	114	18	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	114	19	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	114	20	vital	vital	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	114	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	115	1	When	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	115	2	life	life	NN
work_vvlzsj54cvf5de6ji6py6krqlm	115	3	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	115	4	threatening	threaten	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	115	5	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	115	6	occurs	occur	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	115	7	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	115	8	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	115	9	compressible	compressible	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	115	10	area	area	NN
work_vvlzsj54cvf5de6ji6py6krqlm	115	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	115	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	115	13	body	body	NN
work_vvlzsj54cvf5de6ji6py6krqlm	115	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	115	15	direct	direct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	115	16	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	115	17	along	along	IN
work_vvlzsj54cvf5de6ji6py6krqlm	115	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	115	19	selective	selective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	115	20	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	115	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	115	22	tourniquets	tourniquet	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	115	23	can	can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	115	24	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	115	25	life	life	NN
work_vvlzsj54cvf5de6ji6py6krqlm	115	26	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	115	27	saving	save	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	115	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	116	1	Similarly	similarly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	116	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	116	3	immedi-	immedi-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	116	4	ate	eat	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	116	5	resuscitation	resuscitation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	116	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	116	7	stabilization	stabilization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	116	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	116	9	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	116	10	flu-	flu-	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	116	11	ids	ids	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	116	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	116	13	packed	pack	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	116	14	red	red	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	116	15	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	116	16	cells	cell	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	116	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	116	18	plasma	plasma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	116	19	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	116	20	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	116	21	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	116	22	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	116	23	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	116	24	unstable	unstable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	116	25	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	116	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	117	1	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	117	2	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	117	3	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	117	4	indicated	indicate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	117	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	117	6	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	117	7	Reversal	Reversal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	117	8	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	117	9	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	117	10	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	117	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	118	1	These	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	118	2	concepts	concept	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	118	3	apply	apply	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	118	4	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	118	5	blunt	blunt	NN
work_vvlzsj54cvf5de6ji6py6krqlm	118	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	118	7	penetrating	penetrate	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	118	8	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	118	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	118	10	massive	massive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	118	11	gastro-	gastro-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	118	12	intestinal	intestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	118	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	118	14	retroperitoneal	retroperitoneal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	118	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	118	16	pericardial	pericardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	118	17	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	118	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	118	19	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	118	20	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	118	21	forms	form	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	118	22	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	118	23	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	118	24	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	118	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	119	1	Specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	119	2	Scenario	scenario	NN
work_vvlzsj54cvf5de6ji6py6krqlm	119	3	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	119	4	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	119	5	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	119	6	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	119	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	119	8	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	119	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	119	10	studies	study	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	119	11	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	119	12	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	119	13	tested	test	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	119	14	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	119	15	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	119	16	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	119	17	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	119	18	prevention	prevention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	119	19	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	119	20	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	119	21	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	119	22	estimated	estimate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	119	23	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	119	24	pooled	pool	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	119	25	incidence	incidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	119	26	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	119	27	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	119	28	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	119	29	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	119	30	0.4%.2–5,24	0.4%.2–5,24	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	119	31	Overall	Overall	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	119	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	119	33	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	119	34	represents	represent	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	119	35	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	119	36	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	119	37	50	50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	119	38	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	119	39	relative	relative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	119	40	reduction	reduction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	119	41	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	119	42	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	119	43	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	119	44	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	119	45	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	119	46	0.9	0.9	CD
work_vvlzsj54cvf5de6ji6py6krqlm	119	47	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	119	48	observed	observe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	119	49	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	119	50	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	119	51	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	120	1	Past	past	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	120	2	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	120	3	studies	study	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	120	4	suggest	suggest	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	120	5	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	120	6	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	120	7	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	120	8	11	11	CD
work_vvlzsj54cvf5de6ji6py6krqlm	120	9	times	time	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	120	10	more	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	120	11	likely	likely	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	120	12	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	120	13	result	result	VB
work_vvlzsj54cvf5de6ji6py6krqlm	120	14	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	120	15	mortality	mortality	NN
work_vvlzsj54cvf5de6ji6py6krqlm	120	16	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	120	17	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	120	18	extracranial	extracranial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	120	19	hemorrhage.25	hemorrhage.25	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	120	20	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	120	21	reduction	reduction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	120	22	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	120	23	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	120	24	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	120	25	coupled	couple	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	120	26	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	120	27	consistent	consistent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	120	28	non-	non-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	120	29	inferiority	inferiority	NN
work_vvlzsj54cvf5de6ji6py6krqlm	120	30	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	120	31	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	120	32	VKAs	vka	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	120	33	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	120	34	preventing	prevent	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	120	35	thrombotic	thrombotic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	120	36	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	120	37	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	120	38	produced	produce	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	120	39	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	120	40	steady	steady	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	120	41	increase	increase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	120	42	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	120	43	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	120	44	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	120	45	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	120	46	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	120	47	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	120	48	prevent	prevent	VB
work_vvlzsj54cvf5de6ji6py6krqlm	120	49	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	120	50	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	120	51	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	120	52	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	120	53	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	120	54	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	121	1	Uniform	uniform	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	121	2	recommendations	recommendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	121	3	do	do	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	121	4	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	121	5	exist	exist	VB
work_vvlzsj54cvf5de6ji6py6krqlm	121	6	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	121	7	man-	man-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	121	8	agement	agement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	121	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	121	10	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	121	11	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	121	12	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	121	13	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	121	14	suffer	suffer	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	121	15	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	121	16	primarily	primarily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	121	17	because	because	IN
work_vvlzsj54cvf5de6ji6py6krqlm	121	18	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	121	19	consistent	consistent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	121	20	approach	approach	NN
work_vvlzsj54cvf5de6ji6py6krqlm	121	21	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	121	22	their	-PRON-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	121	23	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	121	24	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	121	25	undertaken	undertake	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	121	26	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	121	27	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	121	28	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	121	29	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	121	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	122	1	Factors	factor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	122	2	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	122	3	consider	consider	VB
work_vvlzsj54cvf5de6ji6py6krqlm	122	4	include	include	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	122	5	availability	availability	NN
work_vvlzsj54cvf5de6ji6py6krqlm	122	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	122	7	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	122	8	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	122	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	122	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	122	11	timing	timing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	122	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	122	13	urgent	urgent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	122	14	neurosur-	neurosur-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	122	15	gery	gery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	122	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	122	17	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	122	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	122	19	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	122	20	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	122	21	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	122	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	122	23	period	period	NN
work_vvlzsj54cvf5de6ji6py6krqlm	122	24	off	off	RB
work_vvlzsj54cvf5de6ji6py6krqlm	122	25	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	122	26	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	122	27	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	122	28	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	122	29	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	122	30	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	122	31	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	122	32	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	122	33	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	122	34	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	122	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	122	36	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	122	37	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	122	38	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	122	39	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	122	40	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	122	41	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	122	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	122	43	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	122	44	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	122	45	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	123	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	123	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	123	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	123	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	124	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	124	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	124	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	124	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	124	5	CIR.0000000000000477e612	CIR.0000000000000477e612	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	124	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	124	7	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	124	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	124	9	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	124	10	reinstitution	reinstitution	NN
work_vvlzsj54cvf5de6ji6py6krqlm	124	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	124	12	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	124	13	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	124	14	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	124	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	124	16	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	124	17	event	event	NN
work_vvlzsj54cvf5de6ji6py6krqlm	124	18	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	124	19	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	124	20	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	124	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	125	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	125	2	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	125	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	125	4	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	125	5	creates	create	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	125	6	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	125	7	unique	unique	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	125	8	circumstance	circumstance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	125	9	because	because	IN
work_vvlzsj54cvf5de6ji6py6krqlm	125	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	125	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	125	12	noncom-	noncom-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	125	13	pressible	pressible	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	125	14	location	location	NN
work_vvlzsj54cvf5de6ji6py6krqlm	125	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	125	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	125	17	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	125	18	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	125	19	poor	poor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	125	20	tolerance	tolerance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	125	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	125	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	125	23	brain	brain	NN
work_vvlzsj54cvf5de6ji6py6krqlm	125	24	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	125	25	continued	continue	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	125	26	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	125	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	126	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	126	2	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	126	3	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	126	4	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	126	5	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	126	6	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	126	7	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	126	8	Guidelines	Guidelines	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	126	9	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	126	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	126	11	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	126	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	126	13	Spontane-	Spontane-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	126	14	ous	ous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	126	15	Intracerebral	Intracerebral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	126	16	Hemorrhage	Hemorrhage	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	126	17	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	126	18	recommends	recommend	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	126	19	prompt	prompt	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	126	20	cre-	cre-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	126	21	ation	ation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	126	22	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	126	23	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	126	24	hemostatic	hemostatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	126	25	environment	environment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	126	26	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	126	27	limit	limit	VB
work_vvlzsj54cvf5de6ji6py6krqlm	126	28	extension	extension	NN
work_vvlzsj54cvf5de6ji6py6krqlm	126	29	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	126	30	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	126	31	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	126	32	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	126	33	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	126	34	surgical	surgical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	126	35	treatment.26	treatment.26	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	126	36	Any	any	DT
work_vvlzsj54cvf5de6ji6py6krqlm	126	37	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	126	38	neurological	neurological	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	126	39	change	change	NN
work_vvlzsj54cvf5de6ji6py6krqlm	126	40	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	126	41	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	126	42	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	126	43	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	126	44	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	126	45	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	126	46	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	126	47	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	126	48	presumed	presume	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	126	49	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	126	50	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	126	51	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	126	52	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	126	53	origin	origin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	126	54	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	127	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	127	2	baseline	baseline	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	127	3	severity	severity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	127	4	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	127	5	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	127	6	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	127	7	performed	perform	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	127	8	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	127	9	part	part	NN
work_vvlzsj54cvf5de6ji6py6krqlm	127	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	127	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	127	12	initial	initial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	127	13	evaluation.26,27	evaluation.26,27	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	127	14	Computed	compute	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	127	15	tomography	tomography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	127	16	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	127	17	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	127	18	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	127	19	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	127	20	widely	widely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	127	21	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	127	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	127	23	detects	detect	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	127	24	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	127	25	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	127	26	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	127	27	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	127	28	sensitivity	sensitivity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	127	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	127	30	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	127	31	defines	define	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	127	32	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	127	33	extent	extent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	127	34	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	127	35	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	127	36	injury	injury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	127	37	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	127	38	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	127	39	sur-	sur-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	127	40	rounding	round	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	127	41	parenchyma	parenchyma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	127	42	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	128	1	Contrast	contrast	NN
work_vvlzsj54cvf5de6ji6py6krqlm	128	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	128	3	enhanced	enhance	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	128	4	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	128	5	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	128	6	iden-	iden-	VB
work_vvlzsj54cvf5de6ji6py6krqlm	128	7	tify	tify	VB
work_vvlzsj54cvf5de6ji6py6krqlm	128	8	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	128	9	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	128	10	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	128	11	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	128	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	128	13	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	128	14	expansion	expansion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	128	15	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	128	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	128	17	basis	basis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	128	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	128	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	128	20	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	128	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	128	22	contrast	contrast	NN
work_vvlzsj54cvf5de6ji6py6krqlm	128	23	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	128	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	128	25	hematoma	hematoma	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	128	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	128	27	also	also	RB
work_vvlzsj54cvf5de6ji6py6krqlm	128	28	known	know	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	128	29	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	128	30	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	128	31	spot	spot	NN
work_vvlzsj54cvf5de6ji6py6krqlm	128	32	sign.28,29	sign.28,29	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	128	33	Detailed	detailed	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	128	34	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	128	35	imaging	imaging	NN
work_vvlzsj54cvf5de6ji6py6krqlm	128	36	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	128	37	identify	identify	VB
work_vvlzsj54cvf5de6ji6py6krqlm	128	38	predisposing	predispose	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	128	39	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	128	40	lesions	lesion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	128	41	such	such	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	128	42	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	128	43	an-	an-	DT
work_vvlzsj54cvf5de6ji6py6krqlm	128	44	eurysm	eurysm	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	128	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	128	46	arteriovenous	arteriovenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	128	47	malformation	malformation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	128	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	128	49	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	128	50	dural	dural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	128	51	fistula	fistula	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	128	52	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	129	1	Concurrent	concurrent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	129	2	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	129	3	reversing	reverse	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	129	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	129	5	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	129	6	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	129	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	129	8	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	129	9	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	129	10	needs	need	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	129	11	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	129	12	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	129	13	intensively	intensively	RB
work_vvlzsj54cvf5de6ji6py6krqlm	129	14	managed	manage	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	129	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	130	1	Many	many	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	130	2	studies	study	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	130	3	associate	associate	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	130	4	elevated	elevated	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	130	5	systolic	systolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	130	6	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	7	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	9	greater	great	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	130	10	hematoma	hematoma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	11	expansion	expansion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	130	13	neurological	neurological	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	130	14	deterioration	deterioration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	130	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	130	17	death	death	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	18	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	130	19	dependency	dependency	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	20	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	21	ICH.30,31	ICH.30,31	.
work_vvlzsj54cvf5de6ji6py6krqlm	130	22	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	130	23	INTERACT2	INTERACT2	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	24	tri-	tri-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	25	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	26	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	130	27	Intensive	Intensive	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	28	Blood	Blood	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	29	Pressure	Pressure	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	30	Reduction	Reduction	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	31	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	32	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	33	Cerebral	Cerebral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	34	Hemorrhage	Hemorrhage	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	35	Trial	Trial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	36	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	130	37	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	130	38	showed	show	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	130	39	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	40	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	130	41	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	42	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	43	reduction	reduction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	44	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	45	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	130	46	140	140	CD
work_vvlzsj54cvf5de6ji6py6krqlm	130	47	mm	mm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	48	Hg	Hg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	49	systolic	systolic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	50	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	130	51	safe	safe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	130	52	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	130	53	resulted	result	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	130	54	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	55	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	130	56	trend	trend	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	57	toward	toward	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	58	improvement	improvement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	59	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	60	functional	functional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	130	61	recovery	recovery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	62	de-	de-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	63	spite	spite	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	130	64	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	130	65	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	130	66	reduction	reduction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	67	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	68	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	130	69	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	70	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	71	hematoma	hematoma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	72	growth.32	growth.32	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	73	No	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	130	74	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	130	75	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	76	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	130	77	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	78	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	130	79	included	include	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	130	80	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	130	81	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	130	82	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	130	83	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	131	1	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	131	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	131	3	recent	recent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	131	4	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	131	5	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	131	6	ATACH-2	ATACH-2	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	131	7	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	131	8	Antihy-	Antihy-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	131	9	pertensive	pertensive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	131	10	Treatment	Treatment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	131	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	131	12	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	131	13	Cerebral	Cerebral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	131	14	Hemorrhage	Hemorrhage	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	131	15	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	131	16	II	II	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	131	17	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	131	18	suggest	suggest	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	131	19	aggressive	aggressive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	131	20	lowering	lowering	NN
work_vvlzsj54cvf5de6ji6py6krqlm	131	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	131	22	systolic	systolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	131	23	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	131	24	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	131	25	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	131	26	110	110	CD
work_vvlzsj54cvf5de6ji6py6krqlm	131	27	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	131	28	139	139	CD
work_vvlzsj54cvf5de6ji6py6krqlm	131	29	mm	mm	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	131	30	Hg	hg	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	131	31	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	131	32	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	131	33	confer	confer	VB
work_vvlzsj54cvf5de6ji6py6krqlm	131	34	benefit.32a	benefit.32a	.
work_vvlzsj54cvf5de6ji6py6krqlm	131	35	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	131	36	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	131	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	131	38	resuming	resume	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	131	39	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	131	40	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	131	41	regimen	regimen	NN
work_vvlzsj54cvf5de6ji6py6krqlm	131	42	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	131	43	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	131	44	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	131	45	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	131	46	common	common	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	131	47	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	131	48	dilemma	dilemma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	131	49	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	132	1	Decisions	decision	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	132	2	about	about	IN
work_vvlzsj54cvf5de6ji6py6krqlm	132	3	whether	whether	IN
work_vvlzsj54cvf5de6ji6py6krqlm	132	4	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	132	5	resume	resume	VB
work_vvlzsj54cvf5de6ji6py6krqlm	132	6	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	132	7	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	132	8	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	132	9	must	must	MD
work_vvlzsj54cvf5de6ji6py6krqlm	132	10	take	take	VB
work_vvlzsj54cvf5de6ji6py6krqlm	132	11	into	into	IN
work_vvlzsj54cvf5de6ji6py6krqlm	132	12	account	account	NN
work_vvlzsj54cvf5de6ji6py6krqlm	132	13	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	132	14	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	132	15	’s	’s	POS
work_vvlzsj54cvf5de6ji6py6krqlm	132	16	underlying	underlie	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	132	17	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	132	18	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	132	19	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	132	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	132	21	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	132	22	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	132	23	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	132	24	recurrence	recurrence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	132	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	133	1	Embolic	embolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	2	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	3	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	4	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	133	5	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	133	6	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	7	stratification	stratification	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	8	schemes	scheme	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	133	9	such	such	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	10	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	133	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	133	12	CHA	CHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	133	13	2DS2-VASc	2ds2-vasc	CD
work_vvlzsj54cvf5de6ji6py6krqlm	133	14	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	133	15	HAS	HAS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	133	16	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	133	17	BLED	BLED	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	133	18	scores	score	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	133	19	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	133	20	help	help	VB
work_vvlzsj54cvf5de6ji6py6krqlm	133	21	guide	guide	VB
work_vvlzsj54cvf5de6ji6py6krqlm	133	22	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	23	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	133	24	ICH.30,31	ICH.30,31	.
work_vvlzsj54cvf5de6ji6py6krqlm	133	25	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	133	26	HAS	HAS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	133	27	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	133	28	BLED	BLED	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	133	29	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	30	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	133	31	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	133	32	validated	validate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	133	33	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	133	34	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	133	35	wide	wide	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	36	range	range	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	133	38	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	133	39	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	133	40	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	133	41	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	133	42	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	43	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	44	AF	af	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	133	46	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	133	47	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	133	48	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	49	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	50	VKA	vka	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	51	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	133	52	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	133	53	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	133	54	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	133	55	only	only	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	56	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	133	57	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	58	scheme	scheme	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	59	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	133	60	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	133	61	predictive	predictive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	62	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	133	63	ICH.33	ICH.33	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	133	64	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	133	65	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	133	66	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	133	67	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	68	HAS	HAS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	133	69	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	133	70	BLED	BLED	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	133	71	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	72	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	133	73	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	133	74	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	133	75	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	133	76	sole	sole	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	77	consideration	consideration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	78	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	133	79	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	133	80	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	133	81	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	134	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	134	2	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	134	4	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	134	5	recent	recent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	134	6	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	134	7	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	134	8	prompt	prompt	VB
work_vvlzsj54cvf5de6ji6py6krqlm	134	9	closer	close	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	134	10	evalua-	evalua-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	134	11	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	134	13	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	134	14	factors	factor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	134	15	related	relate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	134	16	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	134	17	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	134	18	reoccurrence.24,34,35	reoccurrence.24,34,35	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	19	Factors	factor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	134	20	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	134	21	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	134	22	suggested	suggest	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	134	23	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	134	24	increase	increase	VB
work_vvlzsj54cvf5de6ji6py6krqlm	134	25	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	134	26	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	27	include	include	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	134	28	older	old	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	134	29	age	age	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	134	31	poor	poor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	134	32	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	33	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	34	control	control	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	134	36	lobar	lobar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	134	37	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	134	38	loca-	loca-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	134	39	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	134	41	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	42	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	134	43	microbleeds	microbleed	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	134	44	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	134	45	gradient	gradient	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	134	46	echo	echo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	134	47	magnetic	magnetic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	134	48	resonance	resonance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	49	imaging	imaging	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	134	51	concurrent	concurrent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	134	52	aspirin	aspirin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	53	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	134	55	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	134	56	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	134	57	pres-	pres-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	58	ence	ence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	59	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	134	60	apolipoprotein	apolipoprotein	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	134	61	E	e	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	62	ε2	ε2	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	63	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	134	64	ε4	ε4	NN
work_vvlzsj54cvf5de6ji6py6krqlm	134	65	alleles	allele	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	134	66	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	135	1	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	135	2	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	135	3	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	135	4	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	135	5	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	135	6	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	135	7	provide	provide	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	135	8	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	135	9	class	class	NN
work_vvlzsj54cvf5de6ji6py6krqlm	135	10	IIb	iib	NN
work_vvlzsj54cvf5de6ji6py6krqlm	135	11	recom-	recom-	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	135	12	mendation	mendation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	135	13	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	135	14	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	135	15	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	135	16	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	135	17	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	135	18	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	135	19	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	135	20	nonlobar	nonlobar	NN
work_vvlzsj54cvf5de6ji6py6krqlm	135	21	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	135	22	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	135	23	however	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	135	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	135	25	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	135	26	recommendation	recommendation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	135	27	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	135	28	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	135	29	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	135	30	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	135	31	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	135	32	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	135	33	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	135	34	data.34	data.34	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	135	35	Whether	whether	IN
work_vvlzsj54cvf5de6ji6py6krqlm	135	36	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	135	37	can	can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	135	38	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	135	39	safely	safely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	135	40	administered	administer	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	135	41	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	135	42	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	135	43	population	population	NN
work_vvlzsj54cvf5de6ji6py6krqlm	135	44	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	135	45	still	still	RB
work_vvlzsj54cvf5de6ji6py6krqlm	135	46	unknown	unknown	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	135	47	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	136	1	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	136	2	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	136	3	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	136	4	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	136	5	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	136	6	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	136	7	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	136	8	guide	guide	VB
work_vvlzsj54cvf5de6ji6py6krqlm	136	9	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	136	10	man-	man-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	136	11	agement	agement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	136	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	136	13	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	136	14	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	136	15	traumatic	traumatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	136	16	brain	brain	NN
work_vvlzsj54cvf5de6ji6py6krqlm	136	17	injury	injury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	136	18	while	while	IN
work_vvlzsj54cvf5de6ji6py6krqlm	136	19	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	136	20	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	136	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	137	1	An	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	137	2	initial	initial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	137	3	head	head	NN
work_vvlzsj54cvf5de6ji6py6krqlm	137	4	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	137	5	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	137	6	typical	typical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	137	7	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	137	8	however	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	137	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	137	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	137	11	role	role	NN
work_vvlzsj54cvf5de6ji6py6krqlm	137	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	137	13	repeated	repeat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	137	14	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	137	15	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	137	16	inpatient	inpatient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	137	17	observation	observation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	137	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	137	19	neuro-	neuro-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	137	20	logical	logical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	137	21	assessment	assessment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	137	22	remains	remain	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	137	23	controversial	controversial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	137	24	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	137	25	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	137	26	initial	initial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	137	27	head	head	NN
work_vvlzsj54cvf5de6ji6py6krqlm	137	28	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	137	29	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	137	30	negative	negative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	137	31	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	138	1	Until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	138	2	further	further	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	138	3	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	138	4	become	become	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	138	5	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	138	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	138	7	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	138	8	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	138	9	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	138	10	traumatic	traumatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	138	11	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	138	12	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	138	13	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	138	14	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	138	15	similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	138	16	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	138	17	nontraumatic	nontraumatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	138	18	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	138	19	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	139	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	139	2	summary	summary	NN
work_vvlzsj54cvf5de6ji6py6krqlm	139	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	139	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	139	5	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	139	6	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	139	7	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	139	8	suggests	suggest	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	139	9	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	139	10	trau-	trau-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	139	11	matic	matic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	139	12	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	139	13	nontraumatic	nontraumatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	139	14	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	139	15	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	139	16	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	139	17	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	139	18	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	139	19	re-	re-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	139	20	quire	quire	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	139	21	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	139	22	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	139	23	receive	receive	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	139	24	idarucizumab	idarucizumab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	139	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	140	1	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	140	2	patients	patient	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	140	3	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	140	4	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	140	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	140	6	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	140	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	140	8	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	140	9	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	140	10	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	140	11	receive	receive	VB
work_vvlzsj54cvf5de6ji6py6krqlm	140	12	PCC	PCC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	140	13	until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	140	14	more	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	140	15	specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	140	16	antidotes	antidote	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	140	17	become	become	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	140	18	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	140	19	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	141	1	Specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	141	2	Scenario	scenario	NN
work_vvlzsj54cvf5de6ji6py6krqlm	141	3	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	141	4	Trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	141	5	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	141	6	prevalence	prevalence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	141	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	141	8	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	141	9	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	141	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	141	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	141	12	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	141	13	population	population	NN
work_vvlzsj54cvf5de6ji6py6krqlm	141	14	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	141	15	unknown	unknown	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	141	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	142	1	To	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	142	2	compare	compare	VB
work_vvlzsj54cvf5de6ji6py6krqlm	142	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	142	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	142	5	prevalence	prevalence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	142	7	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	8	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	142	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	142	11	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	12	population	population	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	142	14	2006	2006	CD
work_vvlzsj54cvf5de6ji6py6krqlm	142	15	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	142	16	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	142	17	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	142	19	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	142	20	1.7	1.7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	142	21	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	22	absolute	absolute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	142	23	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	24	increase	increase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	25	over	over	IN
work_vvlzsj54cvf5de6ji6py6krqlm	142	26	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	142	27	previous	previous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	142	28	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	142	29	years.36	years.36	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	142	30	Pa-	Pa-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	142	31	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	142	32	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	142	33	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	142	34	encouraged	encourage	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	142	35	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	142	36	carry	carry	VB
work_vvlzsj54cvf5de6ji6py6krqlm	142	37	information	information	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	38	cards	card	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	142	39	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	142	40	bracelets	bracelet	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	142	41	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	142	42	would	would	MD
work_vvlzsj54cvf5de6ji6py6krqlm	142	43	alert	alert	VB
work_vvlzsj54cvf5de6ji6py6krqlm	142	44	emergency	emergency	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	45	medical	medical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	142	46	provid-	provid-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	47	ers	ers	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	142	48	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	142	49	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	142	50	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	51	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	142	52	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	143	1	Apart	apart	RB
work_vvlzsj54cvf5de6ji6py6krqlm	143	2	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	143	3	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	143	4	few	few	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	143	5	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	143	6	reports	report	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	143	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	143	8	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	143	9	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	143	10	limited	limit	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	143	11	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	143	12	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	143	13	guide	guide	VB
work_vvlzsj54cvf5de6ji6py6krqlm	143	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	143	15	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	143	16	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	143	17	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	143	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	143	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	143	20	setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	143	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	143	22	trauma.37–42	trauma.37–42	NN
work_vvlzsj54cvf5de6ji6py6krqlm	143	23	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	143	24	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	143	25	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	143	26	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	143	27	Surgeons	Surgeons	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	143	28	Advance	Advance	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	143	29	Trauma	Trauma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	143	30	Life	Life	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	143	31	Support	Support	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	143	32	course43	course43	NN
work_vvlzsj54cvf5de6ji6py6krqlm	143	33	recommends	recommend	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	143	34	obtaining	obtain	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	143	35	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	143	36	brief	brief	NN
work_vvlzsj54cvf5de6ji6py6krqlm	143	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	143	38	focused	focus	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	143	39	history	history	NN
work_vvlzsj54cvf5de6ji6py6krqlm	143	40	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	143	41	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	143	42	initial	initial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	143	43	evaluation	evaluation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	143	44	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	143	45	traumatically	traumatically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	143	46	injured	injured	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	143	47	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	143	48	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	144	1	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	144	2	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	144	3	include	include	VB
work_vvlzsj54cvf5de6ji6py6krqlm	144	4	iden-	iden-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	144	5	tifying	tifye	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	144	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	144	7	specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	144	8	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	144	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	144	10	timing	timing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	144	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	144	12	last	last	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	144	13	ingestion	ingestion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	144	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	144	15	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	144	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	144	17	underlying	underlying	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	144	18	reason	reason	NN
work_vvlzsj54cvf5de6ji6py6krqlm	144	19	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	144	20	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	144	21	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	144	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	145	1	Laboratory	laboratory	NN
work_vvlzsj54cvf5de6ji6py6krqlm	145	2	testing	testing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	145	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	145	4	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	145	5	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	145	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	145	7	coagulation	coagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	145	8	parameters	parameter	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	145	9	described	describe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	145	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	145	11	Laboratory	Laboratory	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	145	12	Measurement	Measurement	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	145	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	145	14	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	145	15	Effect	Effect	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	145	16	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	145	17	help	help	VB
work_vvlzsj54cvf5de6ji6py6krqlm	145	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	145	19	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	145	20	decisions	decision	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	145	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	146	1	Thromboelastography	thromboelastography	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	146	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	146	3	rotational	rotational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	146	4	thromboelastometry	thromboelastometry	NN
work_vvlzsj54cvf5de6ji6py6krqlm	146	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	146	6	detect	detect	VB
work_vvlzsj54cvf5de6ji6py6krqlm	146	7	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	146	8	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	146	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	146	10	isolated	isolate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	146	11	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	146	12	cases	case	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	146	13	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	146	14	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	146	15	reported	report	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	146	16	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	146	17	however	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	146	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	146	19	routine	routine	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	146	20	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	146	21	can	can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	146	22	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	146	23	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	146	24	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	146	25	until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	146	26	further	further	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	146	27	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	146	28	becomes	become	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	146	29	available.44,45	available.44,45	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	146	30	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	146	31	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	146	32	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	146	33	held	hold	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	146	34	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	146	35	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	146	36	period	period	NN
work_vvlzsj54cvf5de6ji6py6krqlm	146	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	146	38	clinic	clinic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	146	39	as-	as-	CC
work_vvlzsj54cvf5de6ji6py6krqlm	146	40	sessment	sessment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	146	41	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	146	42	until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	146	43	hemostasis	hemostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	146	44	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	146	45	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	146	46	achieved	achieve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	146	47	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	146	48	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	146	49	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	146	50	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	146	51	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	146	52	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	146	53	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	146	54	mild	mild	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	146	55	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	146	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	146	57	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	146	58	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	146	59	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	146	60	easily	easily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	146	61	controllable	controllable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	146	62	foci	foci	NN
work_vvlzsj54cvf5de6ji6py6krqlm	146	63	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	147	1	Maintaining	maintain	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	147	2	ade-	ade-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	147	3	quate	quate	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	147	4	urine	urine	NN
work_vvlzsj54cvf5de6ji6py6krqlm	147	5	output	output	NN
work_vvlzsj54cvf5de6ji6py6krqlm	147	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	147	7	specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	147	8	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	147	9	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	147	10	strategies	strategy	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	147	11	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	147	12	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	147	13	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	147	14	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	147	15	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	147	16	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	147	17	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	147	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	147	19	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	147	20	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	147	21	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	147	22	moderate	moderate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	147	23	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	147	24	severe	severe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	147	25	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	147	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	147	27	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	147	28	suspected	suspect	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	147	29	bleed-	bleed-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	147	30	ing	ing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	147	31	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	147	32	requires	require	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	147	33	further	further	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	147	34	evaluation	evaluation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	147	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	148	1	Specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	148	2	Scenario	scenario	NN
work_vvlzsj54cvf5de6ji6py6krqlm	148	3	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	148	4	Gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	148	5	Bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	148	6	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	148	7	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	148	8	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	148	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	148	10	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	148	11	150	150	CD
work_vvlzsj54cvf5de6ji6py6krqlm	148	12	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	148	13	twice	twice	RB
work_vvlzsj54cvf5de6ji6py6krqlm	148	14	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	148	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	148	16	rivaroxa-	rivaroxa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	148	17	ban	ban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	148	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	148	19	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	148	20	edoxaban	edoxaban	VB
work_vvlzsj54cvf5de6ji6py6krqlm	148	21	60	60	CD
work_vvlzsj54cvf5de6ji6py6krqlm	148	22	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	148	23	once	once	RB
work_vvlzsj54cvf5de6ji6py6krqlm	148	24	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	148	25	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	148	26	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	148	27	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	148	28	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	148	29	1.5-fold	1.5-fold	CD
work_vvlzsj54cvf5de6ji6py6krqlm	148	30	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	148	31	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	148	32	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	148	33	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	148	34	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	148	35	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	148	36	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	148	37	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	148	38	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	148	39	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	148	40	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	148	41	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	148	42	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	148	43	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	148	44	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	148	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	148	46	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	148	47	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	148	48	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	148	49	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	148	50	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	148	51	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	148	52	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	148	53	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	148	54	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	148	55	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	148	56	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	148	57	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	148	58	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	148	59	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	148	60	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	149	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	149	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	149	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	149	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	150	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	150	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	150	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	150	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	150	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	150	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	150	10	e613	e613	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	11	CLINICAL	clinical	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	150	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	150	15	GUIDELINES	GUIDELINES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	16	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	150	17	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	150	18	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	19	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	150	20	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	21	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	150	22	dabigatran	dabigatran	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	150	23	110	110	CD
work_vvlzsj54cvf5de6ji6py6krqlm	150	24	mg	mg	RB
work_vvlzsj54cvf5de6ji6py6krqlm	150	25	twice	twice	RB
work_vvlzsj54cvf5de6ji6py6krqlm	150	26	daily	daily	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	27	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	150	28	similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	29	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	30	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	31	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	32	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	150	33	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	150	34	edoxaban	edoxaban	VB
work_vvlzsj54cvf5de6ji6py6krqlm	150	35	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	150	36	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	37	once	once	RB
work_vvlzsj54cvf5de6ji6py6krqlm	150	38	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	150	39	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	150	40	significantly	significantly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	150	41	lower	low	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	150	42	risk.2,3,5	risk.2,3,5	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	150	43	Factors	factor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	150	44	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	150	45	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	150	46	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	47	bleed-	bleed-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	48	ing	ing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	49	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	150	50	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	51	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	52	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	150	53	anemia	anemia	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	150	55	previous	previous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	56	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	57	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	58	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	150	59	long	long	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	60	term	term	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	61	aspirin	aspirin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	62	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	63	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	150	64	baseline	baseline	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	65	nonaspirin	nonaspirin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	66	antiplatelet	antiplatelet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	67	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	68	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	150	69	age	age	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	70	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	150	71	diastolic	diastolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	72	hypertension	hypertension	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	73	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	150	74	smoking	smoking	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	75	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	150	76	sleep	sleep	VB
work_vvlzsj54cvf5de6ji6py6krqlm	150	77	apnea	apnea	RB
work_vvlzsj54cvf5de6ji6py6krqlm	150	78	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	150	79	chronic	chronic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	80	obstructive	obstructive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	81	pulmonary	pulmonary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	82	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	83	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	150	84	pre-	pre-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	85	vious	vious	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	86	proton	proton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	87	pump	pump	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	88	inhibitor	inhibitor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	89	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	90	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	150	91	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	92	dysfunction	dysfunction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	93	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	150	94	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	150	95	male	male	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	96	sex.46	sex.46	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	150	97	Although	although	IN
work_vvlzsj54cvf5de6ji6py6krqlm	150	98	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	99	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	100	accounts	account	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	150	101	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	150	102	nearly	nearly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	150	103	90	90	CD
work_vvlzsj54cvf5de6ji6py6krqlm	150	104	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	105	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	150	106	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	107	extracranial	extracranial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	108	hemorrhages	hemorrhage	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	150	109	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	150	110	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	111	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	150	112	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	150	113	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	114	anticoagulation,47	anticoagulation,47	CD
work_vvlzsj54cvf5de6ji6py6krqlm	150	115	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	150	116	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	150	117	specifically	specifically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	150	118	pertaining	pertain	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	150	119	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	150	120	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	150	121	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	150	122	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	150	123	lacking	lack	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	150	124	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	151	1	Of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	151	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	151	3	3.3	3.3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	151	4	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	151	6	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	151	7	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	151	8	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	151	9	Dresden	Dresden	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	151	10	registry	registry	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	11	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	151	12	expe-	expe-	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	151	13	rienced	rience	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	151	14	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	151	15	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	16	while	while	IN
work_vvlzsj54cvf5de6ji6py6krqlm	151	17	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	151	18	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	151	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	151	21	majority	majority	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	22	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	151	23	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	151	24	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	151	25	managed	manage	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	151	26	conservatively	conservatively	RB
work_vvlzsj54cvf5de6ji6py6krqlm	151	27	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	151	28	requir-	requir-	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	151	29	ing	e	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	151	30	surgery.48	surgery.48	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	151	31	As	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	151	32	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	151	33	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	151	34	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	35	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	151	36	trauma	trauma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	151	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	151	38	general	general	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	151	39	resuscita-	resuscita-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	151	40	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	41	principles	principle	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	151	42	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	151	43	airway	airway	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	151	45	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	151	46	fluid	fluid	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	151	48	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	49	transfu-	transfu-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	50	sion	sion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	151	52	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	151	53	maintaining	maintain	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	151	54	adequate	adequate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	151	55	urine	urine	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	56	output	output	NN
work_vvlzsj54cvf5de6ji6py6krqlm	151	57	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	151	58	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	151	59	applied	apply	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	151	60	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	152	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	152	2	Blakemore	Blakemore	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	152	3	tube	tube	NN
work_vvlzsj54cvf5de6ji6py6krqlm	152	4	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	152	5	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	152	6	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	152	7	esophageal	esophageal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	152	8	varices	varix	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	152	9	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	152	10	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	152	11	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	152	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	153	1	Immediate	immediate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	153	2	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	153	3	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	153	4	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	153	5	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	153	6	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	153	7	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	153	8	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	153	9	unstable	unstable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	153	10	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	153	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	154	1	Reinitiating	reinitiate	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	154	2	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	154	3	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	154	4	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	154	5	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	154	6	bleed-	bleed-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	154	7	ing	ing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	154	8	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	154	9	take	take	VB
work_vvlzsj54cvf5de6ji6py6krqlm	154	10	into	into	IN
work_vvlzsj54cvf5de6ji6py6krqlm	154	11	account	account	NN
work_vvlzsj54cvf5de6ji6py6krqlm	154	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	154	13	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	154	14	’s	’s	POS
work_vvlzsj54cvf5de6ji6py6krqlm	154	15	underlying	underlying	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	154	16	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	154	17	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	154	18	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	154	19	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	154	20	thrombosis	thrombosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	154	21	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	154	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	155	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	155	2	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	155	3	retrospective	retrospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	155	4	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	155	6	>	>	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	7	4600	4600	CD
work_vvlzsj54cvf5de6ji6py6krqlm	155	8	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	155	9	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	155	10	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	155	11	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	155	12	suffered	suffer	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	155	13	gastrointes-	gastrointes-	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	155	14	tinal	tinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	155	15	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	16	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	155	17	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	18	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	155	19	primarily	primarily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	155	20	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	155	21	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	155	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	155	23	re-	re-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	155	24	sumption	sumption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	25	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	155	26	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	155	27	single	single	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	155	28	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	29	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	155	30	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	155	31	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	155	32	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	155	33	lowest	low	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	155	34	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	35	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	155	36	mortality	mortality	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	37	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	155	38	thromboembolism	thromboembolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	39	com-	com-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	40	pared	pare	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	155	41	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	155	42	nonresumption	nonresumption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	43	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	155	44	antithrombotic	antithrombotic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	155	45	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	155	46	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	156	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	156	2	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	156	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	156	4	recurrent	recurrent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	156	5	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	156	6	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	156	7	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	156	8	also	also	RB
work_vvlzsj54cvf5de6ji6py6krqlm	156	9	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	156	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	156	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	156	12	anticoagulated	anticoagulate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	156	13	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	156	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	157	1	Patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	157	2	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	3	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	157	4	comprised	comprise	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	157	5	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	157	6	very	very	RB
work_vvlzsj54cvf5de6ji6py6krqlm	157	7	small	small	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	157	8	subset	subset	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	157	11	entire	entire	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	157	12	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	13	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	157	14	therefore	therefore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	157	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	157	16	it	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	157	17	remains	remain	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	157	18	uncertain	uncertain	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	157	19	whether	whether	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	20	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	21	resump-	resump-	FW
work_vvlzsj54cvf5de6ji6py6krqlm	157	22	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	23	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	24	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	157	25	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	26	would	would	MD
work_vvlzsj54cvf5de6ji6py6krqlm	157	27	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	157	28	similarly	similarly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	157	29	linked	link	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	157	30	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	31	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	157	32	favorable	favorable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	157	33	outcomes.49	outcomes.49	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	34	MANAGEMENT	MANAGEMENT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	35	OF	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	36	PATIENTS	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	157	37	ON	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	38	NOACS	NOACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	39	WHO	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	157	40	ARE	are	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	157	41	AT	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	42	RISK	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	43	FOR	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	44	BLEEDING	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	157	45	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	46	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	47	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	157	48	Who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	157	49	Overdose	overdose	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	157	50	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	51	NOACs	NOACs	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	52	Data	Data	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	53	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	157	54	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	157	55	prevalence	prevalence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	56	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	57	overdoses	overdose	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	157	58	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	157	59	unpre-	unpre-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	157	60	scribed	scribed	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	157	61	exposures	exposure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	157	62	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	63	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	157	64	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	157	65	largely	largely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	157	66	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	157	67	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	68	ob-	ob-	CD
work_vvlzsj54cvf5de6ji6py6krqlm	157	69	servational	servational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	157	70	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	157	71	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	72	poison	poison	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	73	control	control	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	74	centers	center	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	157	75	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	157	76	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	77	reports.13,14,18,19,50–61	reports.13,14,18,19,50–61	CD
work_vvlzsj54cvf5de6ji6py6krqlm	157	78	Stevenson	Stevenson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	79	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	80	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	81	reported	report	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	157	82	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	83	be-	be-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	84	tween	tween	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	85	January	January	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	86	2011	2011	CD
work_vvlzsj54cvf5de6ji6py6krqlm	157	87	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	157	88	July	July	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	89	2013	2013	CD
work_vvlzsj54cvf5de6ji6py6krqlm	157	90	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	157	91	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	157	92	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	157	93	49	49	CD
work_vvlzsj54cvf5de6ji6py6krqlm	157	94	calls	call	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	157	95	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	96	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	157	97	single	single	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	157	98	poison	poison	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	99	control	control	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	100	center	center	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	101	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	157	102	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	103	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	157	104	rivaroxaban.18	rivaroxaban.18	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	157	105	Of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	106	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	157	107	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	157	108	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	157	109	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	157	110	cases	case	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	157	111	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	157	112	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	157	113	result	result	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	114	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	115	self	self	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	116	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	157	117	harm	harm	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	118	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	157	119	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	157	120	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	157	121	mild	mild	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	157	122	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	123	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	157	124	reported	report	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	157	125	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	157	126	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	157	127	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	157	128	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	158	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	158	2	majority	majority	NN
work_vvlzsj54cvf5de6ji6py6krqlm	158	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	158	4	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	158	5	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	158	6	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	158	7	noted	note	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	158	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	158	9	pa-	pa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	158	10	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	158	11	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	158	12	long	long	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	158	13	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	158	14	term	term	NN
work_vvlzsj54cvf5de6ji6py6krqlm	158	15	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	158	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	158	17	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	158	18	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	158	19	ingestions	ingestion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	158	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	158	21	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	158	22	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	158	23	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	158	24	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	158	25	association	association	NN
work_vvlzsj54cvf5de6ji6py6krqlm	158	26	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	158	27	coagulation	coagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	158	28	abnor-	abnor-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	158	29	malities	malitie	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	158	30	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	158	31	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	158	32	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	158	33	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	158	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	159	1	Conway	Conway	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	159	2	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	159	3	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	159	4	reported	report	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	159	5	dab-	dab-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	159	6	igatran	igatran	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	159	7	exposures	exposure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	159	8	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	9	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	159	10	national	national	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	159	11	poison	poison	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	12	control	control	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	13	center	center	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	14	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	159	15	noted	note	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	159	16	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	17	adverse	adverse	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	159	18	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	159	19	occurred	occur	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	159	20	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	21	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	159	22	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	159	23	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	24	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	25	all	all	DT
work_vvlzsj54cvf5de6ji6py6krqlm	159	26	calls	call	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	159	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	159	28	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	159	29	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	159	30	1.3	1.3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	159	31	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	32	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	159	33	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	159	34	intentional.50	intentional.50	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	159	35	An	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	159	36	observational	observational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	159	37	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	38	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	39	poison	poison	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	40	control	control	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	41	centers	center	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	159	42	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	43	9	9	CD
work_vvlzsj54cvf5de6ji6py6krqlm	159	44	states	state	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	159	45	showed	show	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	159	46	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	47	among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	48	223	223	CD
work_vvlzsj54cvf5de6ji6py6krqlm	159	49	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	159	50	exposure	exposure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	51	calls	call	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	159	52	related	relate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	159	53	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	54	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	159	55	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	159	56	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	159	57	ingestions	ingestion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	159	58	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	159	59	42	42	CD
work_vvlzsj54cvf5de6ji6py6krqlm	159	60	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	61	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	159	62	abnormal	abnormal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	159	63	coagulation	coagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	64	studies	study	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	159	65	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	159	66	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	159	67	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	68	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	159	69	bleeding.51	bleeding.51	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	159	70	Unfortunately	unfortunately	RB
work_vvlzsj54cvf5de6ji6py6krqlm	159	71	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	159	72	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	159	73	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	159	74	limited	limited	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	159	75	information	information	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	76	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	159	77	guide	guide	VB
work_vvlzsj54cvf5de6ji6py6krqlm	159	78	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	159	79	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	80	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	159	81	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	82	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	159	83	overdose	overdose	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	159	84	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	85	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	159	86	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	159	87	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	159	88	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	160	1	Collection	collection	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	160	3	information	information	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	4	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	160	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	160	6	type	type	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	160	8	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	160	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	160	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	160	11	ingested	ingest	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	160	12	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	160	14	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	160	16	ingestion	ingestion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	160	18	concomitant	concomitant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	160	19	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	160	20	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	160	21	liver	liver	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	22	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	160	24	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	160	25	relevant	relevant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	160	26	medica-	medica-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	27	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	28	coingestion	coingestion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	29	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	160	30	critically	critically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	160	31	important	important	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	160	32	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	160	33	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	160	34	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	160	35	pe-	pe-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	160	36	riod	riod	NN
work_vvlzsj54cvf5de6ji6py6krqlm	160	37	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	161	1	Therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	161	2	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	161	3	strategies	strategy	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	161	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	161	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	161	6	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	161	7	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	161	8	setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	161	9	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	161	10	largely	largely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	161	11	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	161	12	developed	develop	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	161	13	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	161	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	161	15	basis	basis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	161	16	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	161	17	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	161	18	experience	experience	NN
work_vvlzsj54cvf5de6ji6py6krqlm	161	19	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	161	20	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	161	21	understanding	understanding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	161	22	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	161	23	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	161	24	phar-	phar-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	161	25	macology	macology	NN
work_vvlzsj54cvf5de6ji6py6krqlm	161	26	rather	rather	RB
work_vvlzsj54cvf5de6ji6py6krqlm	161	27	than	than	IN
work_vvlzsj54cvf5de6ji6py6krqlm	161	28	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	161	29	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	161	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	162	1	Management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	162	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	162	3	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	162	4	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	162	5	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	162	6	Kidney	Kidney	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	162	7	Injury	Injury	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	162	8	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	162	9	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	162	10	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	162	11	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	162	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	162	13	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	162	14	kidney	kidney	NN
work_vvlzsj54cvf5de6ji6py6krqlm	162	15	injury	injury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	162	16	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	162	17	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	162	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	162	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	162	20	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	162	21	pop-	pop-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	162	22	ulation	ulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	162	23	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	162	24	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	162	25	frequently	frequently	RB
work_vvlzsj54cvf5de6ji6py6krqlm	162	26	prescribed	prescribe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	162	27	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	162	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	163	1	Andreu-	Andreu-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	163	2	Cayuelas	Cayuelas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	163	3	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	163	4	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	163	5	performed	perform	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	163	6	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	163	7	observational	observational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	163	8	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	163	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	163	10	162	162	CD
work_vvlzsj54cvf5de6ji6py6krqlm	163	11	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	163	12	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	163	13	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	163	14	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	163	15	hospitalization	hospitalization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	163	16	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	163	17	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	163	18	heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	163	19	failure	failure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	163	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	164	1	Creatinine	Creatinine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	164	2	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	164	3	measured	measure	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	164	4	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	164	5	follow	follow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	164	7	up	up	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	8	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	164	9	de-	de-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	164	10	termine	termine	VB
work_vvlzsj54cvf5de6ji6py6krqlm	164	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	164	12	need	need	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	13	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	164	14	dose	dose	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	164	15	adjustment	adjustment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	16	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	164	17	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	164	18	hypotheti-	hypotheti-	FW
work_vvlzsj54cvf5de6ji6py6krqlm	164	19	cal	cal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	20	NOACs.62	NOACs.62	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	164	21	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	164	22	investigators	investigator	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	164	23	reported	report	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	164	24	44	44	CD
work_vvlzsj54cvf5de6ji6py6krqlm	164	25	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	26	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	164	27	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	164	28	would	would	MD
work_vvlzsj54cvf5de6ji6py6krqlm	164	29	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	164	30	needed	need	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	164	31	dabigatran	dabigatran	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	164	32	dosage	dosage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	33	adjustment	adjustment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	164	35	35	35	CD
work_vvlzsj54cvf5de6ji6py6krqlm	164	36	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	37	would	would	MD
work_vvlzsj54cvf5de6ji6py6krqlm	164	38	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	164	39	needed	need	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	164	40	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	164	41	adjustment	adjustment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	164	43	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	164	44	29	29	CD
work_vvlzsj54cvf5de6ji6py6krqlm	164	45	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	46	would	would	MD
work_vvlzsj54cvf5de6ji6py6krqlm	164	47	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	164	48	needed	need	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	164	49	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	164	50	dosage	dosage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	51	adjustment	adjustment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	164	52	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	165	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	165	2	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	165	3	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	165	4	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	165	5	baseline	baseline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	165	6	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	165	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	165	8	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	165	9	60	60	CD
work_vvlzsj54cvf5de6ji6py6krqlm	165	10	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	165	11	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	165	12	min	min	NN
work_vvlzsj54cvf5de6ji6py6krqlm	165	13	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	165	14	age	age	NN
work_vvlzsj54cvf5de6ji6py6krqlm	165	15	>	>	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	165	16	75	75	CD
work_vvlzsj54cvf5de6ji6py6krqlm	165	17	years	year	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	165	18	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	165	19	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	165	20	greatest	great	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	165	21	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	165	22	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	165	23	needing	need	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	165	24	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	165	25	dose	dose	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	165	26	adjust-	adjust-	FW
work_vvlzsj54cvf5de6ji6py6krqlm	165	27	ment	ment	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	165	28	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	165	29	follow	follow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	165	30	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	165	31	up.62	up.62	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	165	32	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	165	33	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	165	34	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	165	35	nephropathy	nephropathy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	165	36	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	165	37	recently	recently	RB
work_vvlzsj54cvf5de6ji6py6krqlm	165	38	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	165	39	de-	de-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	165	40	scribed	scribe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	165	41	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	165	42	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	165	43	kidney	kidney	NN
work_vvlzsj54cvf5de6ji6py6krqlm	165	44	injury	injury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	165	45	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	165	46	supratherapeutic	supratherapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	165	47	in-	in-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	165	48	ternational	ternational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	165	49	normalized	normalized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	165	50	ratio	ratio	NN
work_vvlzsj54cvf5de6ji6py6krqlm	165	51	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	165	52	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	165	53	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	165	54	values	value	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	165	55	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	165	56	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	165	57	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	165	58	hematuria.63–65	hematuria.63–65	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	165	59	Alternatively	alternatively	RB
work_vvlzsj54cvf5de6ji6py6krqlm	165	60	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	165	61	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	165	62	do	do	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	165	63	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	165	64	appear	appear	VB
work_vvlzsj54cvf5de6ji6py6krqlm	165	65	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	165	66	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	165	67	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	165	68	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	165	69	kidney	kidney	NN
work_vvlzsj54cvf5de6ji6py6krqlm	165	70	injury	injury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	165	71	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	166	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	2	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	166	3	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	166	4	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	166	5	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	6	conduct-	conduct-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	7	ed	ed	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	8	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	9	Caldeira	Caldeira	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	10	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	11	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	166	13	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	166	14	did	do	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	166	15	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	166	16	increase	increase	VB
work_vvlzsj54cvf5de6ji6py6krqlm	166	17	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	166	18	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	20	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	166	21	failure	failure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	22	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	166	23	relative	relative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	166	24	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	25	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	166	26	RR	rr	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	27	]	]	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	166	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	166	29	0.96	0.96	CD
work_vvlzsj54cvf5de6ji6py6krqlm	166	30	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	166	31	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	166	32	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	33	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	166	35	0.87–1.07	0.87–1.07	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	36	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	166	37	I2=	I2=	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	38	17.8	17.8	CD
work_vvlzsj54cvf5de6ji6py6krqlm	166	39	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	40	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	166	41	6	6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	166	42	randomized	randomize	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	166	43	controlled	controlled	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	166	44	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	166	45	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	166	46	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	166	47	com-	com-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	48	pared	pare	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	166	49	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	50	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	166	51	VKA.63	VKA.63	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	52	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	166	53	recent	recent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	166	54	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	55	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	56	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	57	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	58	re-	re-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	166	59	vealed	veale	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	166	60	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	166	61	small	small	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	166	62	but	but	CC
work_vvlzsj54cvf5de6ji6py6krqlm	166	63	statistically	statistically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	166	64	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	166	65	decline	decline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	66	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	67	mean	mean	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	166	68	CrCl±	CrCl±	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	69	standard	standard	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	166	70	deviation	deviation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	71	among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	72	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	166	73	receiving	receive	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	166	74	war-	war-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	75	farin	farin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	76	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	166	77	−4.3±14.6	−4.3±14.6	:
work_vvlzsj54cvf5de6ji6py6krqlm	166	78	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	79	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	166	80	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	81	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	166	82	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	166	83	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	84	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	166	85	re-	re-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	166	86	ceiving	ceive	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	166	87	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	88	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	166	89	−3.5±15.1	−3.5±15.1	``
work_vvlzsj54cvf5de6ji6py6krqlm	166	90	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	91	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	166	92	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	93	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	166	94	P<0.001).66	P<0.001).66	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	95	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	166	96	post	post	FW
work_vvlzsj54cvf5de6ji6py6krqlm	166	97	hoc	hoc	FW
work_vvlzsj54cvf5de6ji6py6krqlm	166	98	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	99	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	100	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	166	101	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	102	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	166	103	LY	LY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	104	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	166	105	Randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	166	106	Evaluation	Evaluation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	107	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	108	Long	Long	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	109	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	166	110	Term	Term	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	111	Anticoagulation	Anticoagulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	112	Therapy	Therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	113	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	166	114	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	115	similarly	similarly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	166	116	re-	re-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	166	117	vealed	veale	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	166	118	greater	great	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	166	119	declines	decline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	166	120	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	121	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	122	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	123	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	124	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	166	125	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	126	dabigatran.67	dabigatran.67	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	127	Administering	administer	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	166	128	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	166	129	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	166	130	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	131	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	166	132	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	133	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	134	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	166	135	kidney	kidney	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	136	injury	injury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	137	increases	increase	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	166	138	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	166	139	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	166	140	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	166	141	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	166	142	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	167	1	All	all	DT
work_vvlzsj54cvf5de6ji6py6krqlm	167	2	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	167	3	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	167	4	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	167	5	used	use	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	167	6	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	167	7	caution	caution	NN
work_vvlzsj54cvf5de6ji6py6krqlm	167	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	167	9	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	167	10	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	167	11	hemodialysis	hemodialysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	167	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	167	13	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	167	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	167	15	limited	limited	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	167	16	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	167	17	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	167	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	168	1	Although	although	IN
work_vvlzsj54cvf5de6ji6py6krqlm	168	2	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	168	3	dosing	dose	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	168	4	recommen-	recommen-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	168	5	dation	dation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	168	6	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	168	7	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	168	8	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	168	9	provided	provide	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	168	10	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	168	11	such	such	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	168	12	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	168	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	168	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	168	15	product	product	NN
work_vvlzsj54cvf5de6ji6py6krqlm	168	16	monograph	monograph	NN
work_vvlzsj54cvf5de6ji6py6krqlm	168	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	168	18	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	168	19	recommendation	recommendation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	168	20	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	168	21	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	168	22	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	168	23	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	168	24	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	168	25	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	168	26	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	168	27	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	168	28	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	168	29	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	168	30	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	168	31	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	168	32	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	168	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	168	34	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	168	35	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	168	36	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	168	37	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	168	38	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	168	39	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	168	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	168	41	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	168	42	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	168	43	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	169	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	169	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	169	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	169	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	170	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	170	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	170	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	170	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	170	5	CIR.0000000000000477e614	CIR.0000000000000477e614	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	170	6	pharmacokinetic	pharmacokinetic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	170	7	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	170	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	170	9	fewer	few	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	170	10	than	than	IN
work_vvlzsj54cvf5de6ji6py6krqlm	170	11	20	20	CD
work_vvlzsj54cvf5de6ji6py6krqlm	170	12	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	170	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	171	1	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	171	2	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	171	3	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	171	4	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	171	5	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	171	6	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	171	7	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	171	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	171	9	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	171	10	patient	patient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	171	11	population	population	NN
work_vvlzsj54cvf5de6ji6py6krqlm	171	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	172	1	Until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	172	2	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	172	3	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	172	4	become	become	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	172	5	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	172	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	172	7	close	close	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	172	8	measurement	measurement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	172	9	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	172	10	switching	switch	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	172	11	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	172	12	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	172	13	alternative	alternative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	172	14	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	172	15	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	172	16	suggested	suggest	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	172	17	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	172	18	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	172	19	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	172	20	develop	develop	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	172	21	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	172	22	kidney	kidney	NN
work_vvlzsj54cvf5de6ji6py6krqlm	172	23	injury	injury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	172	24	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	172	25	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	172	26	result	result	NN
work_vvlzsj54cvf5de6ji6py6krqlm	172	27	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	172	28	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	172	29	illness	illness	NN
work_vvlzsj54cvf5de6ji6py6krqlm	172	30	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	172	31	injury	injury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	172	32	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	173	1	Management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	3	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	173	4	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	5	Ischemic	Ischemic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	173	6	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	173	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	8	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	173	9	Whereas	whereas	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	10	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	173	11	represent	represent	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	173	12	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	173	13	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	173	14	advance	advance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	15	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	16	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	17	prevention	prevention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	173	19	it	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	173	20	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	173	21	still	still	RB
work_vvlzsj54cvf5de6ji6py6krqlm	173	22	anticipated	anticipate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	173	23	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	24	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	173	25	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	173	26	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	27	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	173	28	AIS	AIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	173	29	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	173	30	will	will	MD
work_vvlzsj54cvf5de6ji6py6krqlm	173	31	occur	occur	VB
work_vvlzsj54cvf5de6ji6py6krqlm	173	32	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	33	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	173	34	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	35	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	36	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	173	37	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	38	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	39	individuals	individual	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	173	40	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	41	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	173	42	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	173	43	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	44	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	173	45	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	173	46	each	each	DT
work_vvlzsj54cvf5de6ji6py6krqlm	173	47	year.2–5	year.2–5	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	48	Their	-PRON-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	173	49	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	50	presents	present	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	173	51	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	173	52	number	number	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	53	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	54	challenges	challenge	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	173	55	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	56	clinicians	clinician	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	173	57	managing	manage	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	173	58	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	173	59	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	60	AIS	AIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	173	61	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	173	62	including	include	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	173	63	appropriate	appropriate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	173	64	measurement	measurement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	65	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	66	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	173	67	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	68	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	69	neurovascular	neurovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	173	70	emergencies	emergency	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	173	71	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	173	72	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	173	73	role	role	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	74	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	75	thrombolysis	thrombolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	76	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	173	77	endovascular	endovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	173	78	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	79	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	80	AIS	AIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	173	81	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	173	82	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	173	83	timing	timing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	84	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	85	reinstitution	reinstitution	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	86	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	87	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	173	88	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	173	89	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	173	90	AIS	AIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	173	91	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	174	1	Thrombolytic	thrombolytic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	174	2	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	3	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	4	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	174	5	recombinant	recombinant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	174	6	tissue	tissue	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	174	8	type	type	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	9	plasminogen	plasminogen	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	10	activator	activator	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	11	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	12	4.5	4.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	174	13	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	174	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	15	symptom	symptom	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	16	onset	onset	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	17	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	174	18	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	174	19	established	established	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	174	20	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	21	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	22	AIS68,69	AIS68,69	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	174	23	but	but	CC
work_vvlzsj54cvf5de6ji6py6krqlm	174	24	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	174	25	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	174	26	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	27	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	174	28	>	>	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	29	5-fold	5-fold	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	30	increase	increase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	31	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	32	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	174	33	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	34	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	35	ICH.70	ICH.70	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	174	36	Because	because	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	38	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	174	39	danger	danger	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	40	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	41	further	further	RB
work_vvlzsj54cvf5de6ji6py6krqlm	174	42	increasing	increase	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	174	43	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	174	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	174	45	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	174	46	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	47	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	174	48	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	174	49	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	174	50	contraindica-	contraindica-	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	174	51	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	52	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	53	thrombolytic	thrombolytic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	174	54	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	174	55	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	174	56	AIS	AIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	174	57	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	175	1	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	175	2	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	175	3	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	175	4	observational	observational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	175	5	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	175	6	support	support	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	175	7	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	175	8	thrombolysis	thrombolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	175	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	175	10	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	175	11	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	175	12	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	175	13	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	175	14	provided	provide	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	175	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	175	16	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	175	17	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	175	18	no	no	RB
work_vvlzsj54cvf5de6ji6py6krqlm	175	19	greater	great	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	175	20	than	than	IN
work_vvlzsj54cvf5de6ji6py6krqlm	175	21	1.7.71,72	1.7.71,72	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	175	22	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	175	23	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	175	24	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	175	25	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	175	26	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	175	27	thrombolysis	thrombolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	175	28	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	175	29	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	175	30	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	175	31	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	175	32	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	175	33	levels	level	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	175	34	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	175	35	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	175	36	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	175	37	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	175	38	raises	raise	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	175	39	hope	hope	NN
work_vvlzsj54cvf5de6ji6py6krqlm	175	40	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	175	41	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	175	42	same	same	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	175	43	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	175	44	apply	apply	VB
work_vvlzsj54cvf5de6ji6py6krqlm	175	45	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	175	46	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	175	47	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	176	1	Determining	determine	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	176	2	appropriate	appropriate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	176	3	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	176	4	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	176	5	AIS	AIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	176	6	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	176	7	re-	re-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	176	8	ceiving	ceive	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	176	9	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	176	10	must	must	MD
work_vvlzsj54cvf5de6ji6py6krqlm	176	11	balance	balance	VB
work_vvlzsj54cvf5de6ji6py6krqlm	176	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	176	13	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	176	14	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	176	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	176	16	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	176	17	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	176	18	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	176	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	176	20	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	176	21	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	176	22	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	176	23	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	176	24	reperfusion	reperfusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	176	25	strategies	strategy	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	176	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	177	1	As	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	177	2	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	177	3	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	177	4	mentioned	mention	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	177	5	previously	previously	RB
work_vvlzsj54cvf5de6ji6py6krqlm	177	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	177	7	routinely	routinely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	177	8	performed	perform	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	177	9	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	177	10	coagulation	coagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	177	11	studies	study	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	177	12	do	do	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	177	13	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	177	14	reliably	reliably	RB
work_vvlzsj54cvf5de6ji6py6krqlm	177	15	ex-	ex-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	177	16	clude	clude	VB
work_vvlzsj54cvf5de6ji6py6krqlm	177	17	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	177	18	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	177	19	plasma	plasma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	177	20	concentration	concentration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	177	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	177	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	177	23	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	177	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	178	1	Another	another	DT
work_vvlzsj54cvf5de6ji6py6krqlm	178	2	difficulty	difficulty	NN
work_vvlzsj54cvf5de6ji6py6krqlm	178	3	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	178	4	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	178	5	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	178	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	178	7	sensitive	sensitive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	178	8	setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	178	9	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	178	10	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	178	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	178	12	more	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	178	13	sensitive	sensitive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	178	14	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	178	15	tests	test	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	178	16	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	178	17	either	either	CC
work_vvlzsj54cvf5de6ji6py6krqlm	178	18	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	178	19	routinely	routinely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	178	20	avail-	avail-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	178	21	able	able	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	178	22	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	178	23	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	178	24	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	178	25	unacceptably	unacceptably	RB
work_vvlzsj54cvf5de6ji6py6krqlm	178	26	long	long	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	178	27	delay	delay	NN
work_vvlzsj54cvf5de6ji6py6krqlm	178	28	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	178	29	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	178	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	179	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	179	2	experimental	experimental	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	179	3	studies	study	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	179	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	179	5	pretreatment	pretreatment	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	179	6	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	179	7	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	179	8	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	179	9	rivaroxaban	rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	179	10	did	do	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	179	11	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	179	12	increase	increase	VB
work_vvlzsj54cvf5de6ji6py6krqlm	179	13	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	179	14	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	179	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	179	16	thrombolysis-	thrombolysis-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	179	17	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	179	18	ICH.72,73	ICH.72,73	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	179	19	Data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	179	20	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	179	21	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	179	22	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	179	23	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	179	24	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	179	25	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	179	26	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	179	27	thrombolysis	thrombolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	179	28	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	179	29	AIS	AIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	179	30	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	179	31	receiving	receive	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	179	32	NO-	NO-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	179	33	ACs	ac	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	179	34	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	179	35	limited	limited	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	179	36	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	179	37	approximately	approximately	RB
work_vvlzsj54cvf5de6ji6py6krqlm	179	38	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	179	39	dozen	dozen	NN
work_vvlzsj54cvf5de6ji6py6krqlm	179	40	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	179	41	reports	report	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	179	42	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	179	43	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	179	44	retrospective	retrospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	179	45	multicenter	multicenter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	179	46	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	179	47	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	179	48	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	180	1	Among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	180	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	180	3	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	4	reports	report	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	180	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	180	6	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	180	7	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	180	8	poor	poor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	180	9	outcome	outcome	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	10	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	180	11	rarely	rarely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	180	12	report-	report-	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	180	13	ed	ed	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	180	14	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	180	15	recombinant	recombinant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	180	16	tissue	tissue	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	17	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	180	18	type	type	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	19	plasminogen	plasminogen	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	20	activator	activator	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	21	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	180	22	administered	administer	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	180	23	minutes	minute	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	180	24	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	180	25	24	24	CD
work_vvlzsj54cvf5de6ji6py6krqlm	180	26	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	180	27	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	180	28	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	180	29	last	last	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	180	30	an-	an-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	180	31	ticoagulant	ticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	32	dose.74,75	dose.74,75	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	180	33	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	180	34	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	35	study76	study76	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	180	36	comprised	comprise	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	180	37	78	78	CD
work_vvlzsj54cvf5de6ji6py6krqlm	180	38	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	180	39	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	180	40	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	180	41	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	180	42	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	180	43	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	180	44	throm-	throm-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	45	bolysis	bolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	46	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	180	47	intra	intra	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	180	48	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	180	49	arterial	arterial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	180	50	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	51	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	180	52	median	median	NN
work_vvlzsj54cvf5de6ji6py6krqlm	180	53	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	180	54	13	13	CD
work_vvlzsj54cvf5de6ji6py6krqlm	180	55	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	180	56	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	180	57	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	180	58	last	last	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	180	59	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	180	60	dose	dose	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	180	61	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	180	62	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	180	63	441	441	CD
work_vvlzsj54cvf5de6ji6py6krqlm	180	64	warfarin-	warfarin-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	180	65	treated	treated	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	180	66	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	180	67	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	180	68	8938	8938	CD
work_vvlzsj54cvf5de6ji6py6krqlm	180	69	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	180	70	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	180	71	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	180	72	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	181	1	After	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	181	2	propensity	propensity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	181	3	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	181	4	matching	match	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	181	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	181	6	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	181	7	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	181	8	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	181	9	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	181	10	dif-	dif-	CC
work_vvlzsj54cvf5de6ji6py6krqlm	181	11	ference	ference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	181	12	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	181	13	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	181	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	181	15	any	any	DT
work_vvlzsj54cvf5de6ji6py6krqlm	181	16	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	181	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	181	18	symptomatic	symptomatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	181	19	ICH	ich	NN
work_vvlzsj54cvf5de6ji6py6krqlm	181	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	181	21	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	181	22	death	death	NN
work_vvlzsj54cvf5de6ji6py6krqlm	181	23	among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	181	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	181	25	groups	group	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	181	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	182	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	182	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	182	3	absence	absence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	182	5	immediately	immediately	RB
work_vvlzsj54cvf5de6ji6py6krqlm	182	6	avail-	avail-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	182	7	able	able	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	182	8	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	9	tests	test	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	182	10	sensitive	sensitive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	182	11	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	182	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	182	13	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	182	15	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	182	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	182	17	determining	determine	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	182	18	which	which	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	182	19	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	182	20	taking	take	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	182	21	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	182	22	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	182	23	might	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	182	24	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	182	25	appropriate	appropriate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	182	26	candidates	candidate	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	182	27	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	182	28	thrombolysis	thrombolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	29	requires	require	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	182	30	con-	con-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	31	sideration	sideration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	32	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	182	33	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	34	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	182	35	last	last	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	182	36	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	182	38	half	half	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	182	39	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	182	40	life	life	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	41	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	182	42	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	182	43	agent	agent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	44	used	use	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	182	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	182	46	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	182	47	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	48	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	182	49	impaired	impaired	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	182	50	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	182	51	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	52	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	182	53	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	182	54	reduce	reduce	VB
work_vvlzsj54cvf5de6ji6py6krqlm	182	55	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	56	clearance	clearance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	182	57	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	183	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	183	2	new	new	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	183	3	recommendation	recommendation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	183	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	183	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	183	6	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	183	7	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	183	8	Guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	183	9	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	183	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	183	11	Early	early	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	183	12	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	183	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	183	14	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	183	15	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	183	16	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	183	17	Ischemic	Ischemic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	183	18	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	183	19	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	183	20	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	183	21	that	that	DT
work_vvlzsj54cvf5de6ji6py6krqlm	183	22	recombinant	recombinant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	183	23	tissue-	tissue-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	183	24	type	type	NN
work_vvlzsj54cvf5de6ji6py6krqlm	183	25	plasminogen	plasminogen	NN
work_vvlzsj54cvf5de6ji6py6krqlm	183	26	activator	activator	NN
work_vvlzsj54cvf5de6ji6py6krqlm	183	27	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	183	28	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	183	29	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	183	30	administered	administer	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	183	31	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	183	32	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	183	33	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	183	34	take	take	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	183	35	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	183	36	unless	unless	IN
work_vvlzsj54cvf5de6ji6py6krqlm	183	37	sensitive	sensitive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	183	38	laboratory	laboratory	NN
work_vvlzsj54cvf5de6ji6py6krqlm	183	39	tests	test	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	183	40	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	183	41	normal	normal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	183	42	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	183	43	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	183	44	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	183	45	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	183	46	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	183	47	received	receive	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	183	48	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	183	49	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	183	50	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	183	51	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	183	52	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	183	53	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	183	54	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	183	55	48	48	CD
work_vvlzsj54cvf5de6ji6py6krqlm	183	56	hours.71	hours.71	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	183	57	Data	Data	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	183	58	guiding	guide	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	183	59	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	183	60	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	183	61	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	183	62	endovascular	endovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	183	63	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	183	64	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	183	65	AIS	AIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	183	66	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	183	67	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	183	68	take	take	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	183	69	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	183	70	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	183	71	even	even	RB
work_vvlzsj54cvf5de6ji6py6krqlm	183	72	more	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	183	73	limited	limited	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	183	74	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	184	1	Among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	184	3	pivotal	pivotal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	184	4	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	184	5	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	184	6	established	establish	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	184	7	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	184	8	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	9	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	184	10	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	12	mechanical	mechanical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	184	13	thrombectomy	thrombectomy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	14	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	15	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	184	16	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	17	AIS	AIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	184	18	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	184	19	large	large	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	184	20	vessel	vessel	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	21	occlusion	occlusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	184	23	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	184	24	receiving	receive	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	184	25	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	184	26	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	184	27	either	either	CC
work_vvlzsj54cvf5de6ji6py6krqlm	184	28	excluded77	excluded77	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	184	29	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	184	30	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	184	31	specifically	specifically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	184	32	reported.78–81	reported.78–81	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	184	33	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	184	34	handful	handful	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	35	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	36	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	37	reports	report	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	184	38	suggest	suggest	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	184	39	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	40	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	41	endovascular	endovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	184	42	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	43	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	44	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	184	45	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	46	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	184	47	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	184	48	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	49	even	even	RB
work_vvlzsj54cvf5de6ji6py6krqlm	184	50	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	51	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	184	52	setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	53	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	54	abnormal	abnormal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	184	55	coagulation	coagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	56	studies.82–87	studies.82–87	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	57	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	58	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	184	59	previously	previously	RB
work_vvlzsj54cvf5de6ji6py6krqlm	184	60	described	describe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	184	61	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	62	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	63	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	184	64	none	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	65	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	66	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	184	67	33	33	CD
work_vvlzsj54cvf5de6ji6py6krqlm	184	68	pa-	pa-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	69	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	184	70	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	184	71	underwent	undergo	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	184	72	endovascular	endovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	184	73	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	74	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	184	75	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	184	76	with-	with-	VB
work_vvlzsj54cvf5de6ji6py6krqlm	184	77	out	out	RP
work_vvlzsj54cvf5de6ji6py6krqlm	184	78	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	184	79	thrombolysis	thrombolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	184	80	experienced	experience	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	184	81	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	184	82	symptom-	symptom-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	184	83	atic	atic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	184	84	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	184	85	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	185	1	Reflecting	reflect	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	185	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	185	3	paucity	paucity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	185	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	185	5	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	185	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	185	7	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	185	8	area	area	NN
work_vvlzsj54cvf5de6ji6py6krqlm	185	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	185	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	185	11	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	185	12	’s	’s	POS
work_vvlzsj54cvf5de6ji6py6krqlm	185	13	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	185	14	provide	provide	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	185	15	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	185	16	recommendations	recommendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	185	17	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	185	18	mechanical	mechanical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	185	19	thrombectomy	thrombectomy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	185	20	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	185	21	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	185	22	whose	whose	WP$
work_vvlzsj54cvf5de6ji6py6krqlm	185	23	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	185	24	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	185	25	anti-	anti-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	185	26	coagulant	coagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	185	27	medications	medication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	185	28	excludes	exclude	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	185	29	them	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	185	30	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	185	31	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	185	32	thrombolysis.88	thrombolysis.88	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	185	33	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	185	34	optimal	optimal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	185	35	timing	timing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	185	36	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	185	37	restarting	restart	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	185	38	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	185	39	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	185	40	AIS	AIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	185	41	presents	present	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	185	42	another	another	DT
work_vvlzsj54cvf5de6ji6py6krqlm	185	43	challenge	challenge	NN
work_vvlzsj54cvf5de6ji6py6krqlm	185	44	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	185	45	healthcare	healthcare	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	185	46	profession-	profession-	FW
work_vvlzsj54cvf5de6ji6py6krqlm	185	47	als	als	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	185	48	managing	manage	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	185	49	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	185	50	population	population	NN
work_vvlzsj54cvf5de6ji6py6krqlm	185	51	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	186	1	Meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	186	3	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	5	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	186	6	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	186	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	8	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	9	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	10	started	start	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	186	11	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	12	48	48	CD
work_vvlzsj54cvf5de6ji6py6krqlm	186	13	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	186	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	15	cardioembolic	cardioembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	16	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	17	stroke89	stroke89	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	186	18	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	186	19	systematic	systematic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	20	review	review	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	22	24	24	CD
work_vvlzsj54cvf5de6ji6py6krqlm	186	23	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	186	24	involving	involve	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	186	25	23	23	CD
work_vvlzsj54cvf5de6ji6py6krqlm	186	26	748	748	CD
work_vvlzsj54cvf5de6ji6py6krqlm	186	27	participants	participant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	186	28	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	29	AIS90	AIS90	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	186	30	test-	test-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	186	31	ing	ing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	186	32	various	various	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	33	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	34	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	186	35	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	36	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	186	37	each	each	DT
work_vvlzsj54cvf5de6ji6py6krqlm	186	38	con-	con-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	39	cluded	clude	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	186	40	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	41	while	while	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	42	early	early	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	43	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	44	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	186	45	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	186	46	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	47	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	186	48	reduced	reduce	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	186	49	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	50	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	51	recurrent	recurrent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	52	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	53	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	186	55	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	186	56	benefit	benefit	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	57	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	186	58	entirely	entirely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	186	59	offset	offset	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	186	60	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	61	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	186	62	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	186	63	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	64	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	65	symptomatic	symptomatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	186	66	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	186	67	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	68	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	186	69	reduction	reduction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	70	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	71	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	72	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	186	73	death	death	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	74	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	186	75	dependency	dependency	NN
work_vvlzsj54cvf5de6ji6py6krqlm	186	76	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	187	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	187	2	decision	decision	NN
work_vvlzsj54cvf5de6ji6py6krqlm	187	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	187	4	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	187	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	187	6	restart	restart	VB
work_vvlzsj54cvf5de6ji6py6krqlm	187	7	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	187	8	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	187	9	must	must	MD
work_vvlzsj54cvf5de6ji6py6krqlm	187	10	balance	balance	VB
work_vvlzsj54cvf5de6ji6py6krqlm	187	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	187	12	competing	compete	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	187	13	risks	risk	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	187	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	187	15	recurrent	recurrent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	187	16	thrombo-	thrombo-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	187	17	embolic	embolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	187	18	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	187	19	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	187	20	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	187	21	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	187	22	transformation	transformation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	187	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	188	1	Con-	con-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	2	sideration	sideration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	188	4	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	188	5	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	188	7	type	type	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	9	event	event	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	10	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	188	11	transient	transient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	12	isch-	isch-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	13	emic	emic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	14	attack	attack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	15	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	16	cerebral	cerebral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	17	infarct	infarct	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	18	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	188	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	188	20	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	21	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	22	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	23	onset	onset	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	188	25	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	188	26	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	27	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	28	factors	factor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	188	29	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	188	30	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	31	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	188	32	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	33	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	34	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	188	35	large	large	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	36	infarct	infarct	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	37	size	size	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	188	39	uncontrolled	uncontrolled	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	40	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	41	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	188	43	hyperglycemia	hyperglycemia	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	188	45	thrombocytopenia	thrombocytopenia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	188	47	previous	previous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	48	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	49	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	188	51	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	188	52	thrombolytic	thrombolytic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	53	treatment).70,91	treatment).70,91	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	188	54	Hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	55	transformation	transformation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	56	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	57	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	58	brain	brain	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	59	tissue	tissue	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	60	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	188	61	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	188	62	relatively	relatively	RB
work_vvlzsj54cvf5de6ji6py6krqlm	188	63	common	common	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	64	occurrence	occurrence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	65	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	188	66	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	188	67	often	often	RB
work_vvlzsj54cvf5de6ji6py6krqlm	188	68	asymp-	asymp-	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	188	69	tomatic	tomatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	70	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	188	71	minimally	minimally	RB
work_vvlzsj54cvf5de6ji6py6krqlm	188	72	symptomatic	symptomatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	73	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	188	74	uncommonly	uncommonly	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	75	pro-	pro-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	76	gresses	gresse	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	188	77	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	78	extent	extent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	79	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	80	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	188	81	absence	absence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	82	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	83	predisposing	predispose	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	188	84	fac-	fac-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	85	tors.92,93	tors.92,93	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	86	Assuming	assume	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	188	87	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	188	88	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	89	transformation	transformation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	90	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	188	91	asymptomatic	asymptomatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	92	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	188	93	remains	remain	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	188	94	stable	stable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	188	95	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	188	96	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	97	series	series	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	98	support	support	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	99	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	100	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	101	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	188	102	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	103	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	104	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	188	105	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	106	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	188	107	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	188	108	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	188	109	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	188	110	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	188	111	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	112	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	113	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	188	114	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	115	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	188	116	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	188	117	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	188	118	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	119	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	120	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	188	121	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	122	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	123	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	188	124	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	189	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	189	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	189	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	189	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	190	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	190	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	190	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	190	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	190	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	190	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	190	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	190	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	190	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	190	10	e615	e615	NN
work_vvlzsj54cvf5de6ji6py6krqlm	190	11	CLINICAL	CLINICAL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	190	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	190	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	190	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	190	15	GUIDELINES	guideline	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	190	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	190	17	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	190	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	190	19	starting	start	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	190	20	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	190	21	continuing	continue	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	190	22	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	190	23	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	190	24	carefully	carefully	RB
work_vvlzsj54cvf5de6ji6py6krqlm	190	25	selected	select	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	190	26	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	190	27	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	190	28	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	190	29	compelling	compelling	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	190	30	indication.94	indication.94	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	190	31	Whether	whether	IN
work_vvlzsj54cvf5de6ji6py6krqlm	190	32	optimal	optimal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	190	33	timing	timing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	190	34	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	190	35	resumption	resumption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	190	36	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	190	37	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	190	38	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	190	39	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	190	40	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	190	41	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	190	42	follow	follow	VB
work_vvlzsj54cvf5de6ji6py6krqlm	190	43	similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	190	44	recommendations	recommendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	190	45	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	190	46	un-	un-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	190	47	known	know	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	190	48	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	191	1	Differences	difference	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	191	2	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	191	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	191	4	pharmacological	pharmacological	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	191	5	properties	property	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	191	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	191	7	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	191	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	191	9	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	191	10	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	191	11	must	must	MD
work_vvlzsj54cvf5de6ji6py6krqlm	191	12	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	191	13	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	191	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	191	15	notably	notably	RB
work_vvlzsj54cvf5de6ji6py6krqlm	191	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	191	17	more	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	191	18	rapid	rapid	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	191	19	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	191	20	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	191	21	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	191	22	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	191	23	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	191	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	191	25	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	191	26	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	191	27	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	191	28	few	few	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	191	29	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	191	30	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	191	31	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	191	32	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	191	33	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	191	34	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	191	35	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	191	36	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	191	37	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	191	38	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	191	39	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	192	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	192	2	experimental	experimental	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	192	3	models	model	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	192	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	192	5	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	192	6	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	192	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	192	8	neither	neither	CC
work_vvlzsj54cvf5de6ji6py6krqlm	192	9	dabiga-	dabiga-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	192	10	tran	tran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	192	11	pretreatment	pretreatment	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	192	12	nor	nor	CC
work_vvlzsj54cvf5de6ji6py6krqlm	192	13	continued	continued	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	192	14	administration	administration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	192	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	192	16	dabi-	dabi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	192	17	gatran	gatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	192	18	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	192	19	stroke	stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	192	20	onset	onset	NN
work_vvlzsj54cvf5de6ji6py6krqlm	192	21	significantly	significantly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	192	22	increased	increase	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	192	23	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	192	24	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	192	25	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	192	26	volume	volume	NN
work_vvlzsj54cvf5de6ji6py6krqlm	192	27	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	192	28	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	192	29	transformation	transformation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	192	30	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	192	31	middle	middle	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	192	32	cerebral	cerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	192	33	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	192	34	occlusion.95,96	occlusion.95,96	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	192	35	Clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	192	36	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	192	37	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	192	38	anecdotal	anecdotal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	192	39	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	192	40	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	193	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	193	2	phase	phase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	3	III	iii	CD
work_vvlzsj54cvf5de6ji6py6krqlm	193	4	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	193	5	establishing	establish	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	193	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	193	7	role	role	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	9	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	193	10	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	11	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	12	prevention	prevention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	14	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	193	15	excluded	exclude	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	193	16	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	193	17	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	18	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	193	19	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	193	20	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	193	21	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	193	22	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	23	stroke.2–5,97	stroke.2–5,97	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	24	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	25	general	general	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	193	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	193	27	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	193	28	support	support	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	193	29	withholding	withhold	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	193	30	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	193	31	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	32	until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	33	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	193	34	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	193	35	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	193	36	weeks	week	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	193	37	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	38	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	39	among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	40	individuals	individual	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	193	41	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	42	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	193	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	193	44	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	45	shorter	short	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	193	46	times	time	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	193	47	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	48	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	193	49	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	50	transient	transient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	193	51	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	193	52	attack	attack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	53	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	193	54	small	small	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	193	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	193	56	nondis-	nondis-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	57	abling	able	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	193	58	strokes	stroke	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	193	59	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	193	60	longer	long	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	193	61	times	time	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	193	62	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	63	moderate	moderate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	193	64	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	193	65	severe	severe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	193	66	strokes.98–100	strokes.98–100	CD
work_vvlzsj54cvf5de6ji6py6krqlm	193	67	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	68	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	193	69	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	193	70	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	193	71	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	193	72	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	193	73	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	193	74	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	193	75	AIS	AIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	193	76	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	193	77	compliance	compliance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	78	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	79	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	193	80	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	81	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	193	82	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	193	83	established	establish	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	193	84	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	193	85	alternative	alternative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	193	86	causes	cause	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	193	87	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	193	88	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	193	89	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	193	90	investigated	investigate	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	193	91	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	194	1	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	194	2	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	194	3	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	194	4	data	data	NN
work_vvlzsj54cvf5de6ji6py6krqlm	194	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	194	6	indicate	indicate	VB
work_vvlzsj54cvf5de6ji6py6krqlm	194	7	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	194	8	increasing	increase	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	194	9	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	194	10	intensity	intensity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	194	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	194	12	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	194	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	194	14	adding	add	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	194	15	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	194	16	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	194	17	agent	agent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	194	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	194	19	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	194	20	switch-	switch-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	194	21	ing	ing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	194	22	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	194	23	another	another	DT
work_vvlzsj54cvf5de6ji6py6krqlm	194	24	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	194	25	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	194	26	provides	provide	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	194	27	additional	additional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	194	28	pro-	pro-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	194	29	tection	tection	NN
work_vvlzsj54cvf5de6ji6py6krqlm	194	30	against	against	IN
work_vvlzsj54cvf5de6ji6py6krqlm	194	31	future	future	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	194	32	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	194	33	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	194	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	195	1	Because	because	IN
work_vvlzsj54cvf5de6ji6py6krqlm	195	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	195	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	195	4	short	short	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	195	5	half	half	NN
work_vvlzsj54cvf5de6ji6py6krqlm	195	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	195	7	lives	life	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	195	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	195	9	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	195	10	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	195	11	rapid	rapid	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	195	12	decline	decline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	195	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	195	14	protective	protective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	195	15	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	195	16	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	195	17	occurs	occur	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	195	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	195	19	missed	miss	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	195	20	doses	dose	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	195	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	195	22	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	195	23	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	195	24	poor	poor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	195	25	compliance	compliance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	195	26	might	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	195	27	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	195	28	more	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	195	29	appropriately	appropriately	RB
work_vvlzsj54cvf5de6ji6py6krqlm	195	30	man-	man-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	195	31	aged	age	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	195	32	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	195	33	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	195	34	longer	long	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	195	35	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	195	36	acting	act	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	195	37	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	195	38	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	196	1	TRANSITIONING	transitioning	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	2	BETWEEN	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	196	3	NOACS	NOACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	196	4	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	196	5	OTHER	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	6	ANTICOAGULANTS	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	196	7	IN	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	196	8	THE	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	196	9	ACUTE	ACUTE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	196	10	CARE	CARE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	196	11	SETTING	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	12	Indications	Indications	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	196	13	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	196	14	require	require	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	196	15	considerations	consideration	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	196	16	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	196	17	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	196	18	transition-	transition-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	196	19	ing	ing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	20	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	196	21	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	196	22	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	196	23	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	196	24	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	25	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	26	setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	27	include	include	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	196	28	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	196	29	occurrence	occurrence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	30	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	196	31	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	196	32	new	new	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	33	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	34	event	event	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	35	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	196	36	eg	eg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	196	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	196	38	myocardial	myocardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	39	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	40	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	196	41	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	196	42	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	196	43	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	196	44	established	establish	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	196	45	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	46	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	47	regimens	regimen	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	196	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	196	49	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	196	50	development	development	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	51	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	196	52	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	196	53	new	new	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	54	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	196	55	worsening	worsen	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	196	56	co-	co-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	57	morbid	morbid	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	58	medical	medical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	59	condition	condition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	60	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	196	61	eg	eg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	196	62	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	196	63	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	64	failure	failure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	65	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	196	66	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	196	67	neces-	neces-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	196	68	sitates	sitate	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	196	69	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	196	70	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	71	transition	transition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	72	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	196	73	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	196	74	need	need	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	75	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	196	76	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	196	77	invasive	invasive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	196	78	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	196	79	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	197	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	197	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	197	3	United	United	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	197	4	States	States	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	197	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	197	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	197	7	current	current	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	197	8	la-	la-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	197	9	beled	beled	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	197	10	prescribing	prescribe	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	197	11	information	information	NN
work_vvlzsj54cvf5de6ji6py6krqlm	197	12	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	197	13	each	each	DT
work_vvlzsj54cvf5de6ji6py6krqlm	197	14	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	197	15	provides	provide	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	197	16	guidance	guidance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	197	17	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	197	18	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	197	19	transition	transition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	197	20	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	197	21	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	197	22	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	197	23	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	197	24	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	197	25	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	197	26	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	197	27	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	197	28	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	197	29	however	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	197	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	197	31	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	197	32	suggestions	suggestion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	197	33	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	197	34	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	197	35	specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	197	36	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	197	37	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	197	38	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	197	39	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	197	40	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	197	41	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	197	42	setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	197	43	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	197	44	Table	table	NN
work_vvlzsj54cvf5de6ji6py6krqlm	197	45	3).33,43,101,102	3).33,43,101,102	CD
work_vvlzsj54cvf5de6ji6py6krqlm	197	46	Temporary	temporary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	197	47	interruptions	interruption	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	197	48	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	197	49	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	197	50	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	197	51	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	197	52	commonly	commonly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	197	53	encountered	encounter	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	197	54	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	197	55	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	197	56	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	197	57	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	197	58	setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	197	59	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	198	1	On	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	3	basis	basis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	5	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	6	observations	observation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	7	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	8	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	9	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	11	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	12	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	13	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	198	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	198	15	approximately	approximately	RB
work_vvlzsj54cvf5de6ji6py6krqlm	198	16	one	one	CD
work_vvlzsj54cvf5de6ji6py6krqlm	198	17	third	third	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	19	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	198	20	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	21	will	will	MD
work_vvlzsj54cvf5de6ji6py6krqlm	198	22	ex-	ex-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	198	23	perience	perience	VB
work_vvlzsj54cvf5de6ji6py6krqlm	198	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	25	need	need	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	26	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	27	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	28	temporary	temporary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	29	interruption	interruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	30	over	over	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	31	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	32	course	course	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	33	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	34	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	198	35	years.103–105	years.103–105	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	198	36	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	37	association	association	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	38	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	39	temporary	temporary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	40	interruptions	interruption	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	41	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	42	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	43	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	44	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	45	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	46	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	47	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	48	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	49	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	50	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	51	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	198	52	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	198	53	reported	report	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	198	54	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	55	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	198	56	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	57	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	58	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	59	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	60	comparing	compare	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	198	61	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	62	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	63	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	64	VKAs	vka	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	65	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	66	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	67	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	68	AF.103–105	AF.103–105	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	198	69	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	70	addition	addition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	71	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	198	72	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	73	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	74	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	198	75	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	76	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	198	77	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	78	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	79	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	80	comparing	compare	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	198	81	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	82	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	83	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	84	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	85	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	86	as-	as-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	198	87	sociated	sociate	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	198	88	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	89	temporary	temporary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	90	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	91	found	find	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	198	92	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	93	sta-	sta-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	94	tistically	tistically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	198	95	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	96	differences	difference	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	97	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	98	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	99	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	198	100	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	101	VKA	vka	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	102	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	103	groups	group	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	104	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	198	105	RR	RR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	198	106	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	198	107	1.01	1.01	CD
work_vvlzsj54cvf5de6ji6py6krqlm	198	108	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	198	109	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	198	110	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	111	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	198	112	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	198	113	0.68–1.49).106	0.68–1.49).106	LS
work_vvlzsj54cvf5de6ji6py6krqlm	198	114	Whereas	whereas	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	115	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	116	majority	majority	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	117	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	118	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	119	temporary	temporary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	120	interruptions	interruption	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	121	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	122	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	123	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	124	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	198	125	around	around	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	126	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	127	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	198	128	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	129	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	130	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	131	peripro-	peripro-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	132	cedural	cedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	198	133	bridging	bridging	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	134	regimens	regimen	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	135	varied	vary	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	198	136	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	137	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	198	138	basis	basis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	139	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	198	140	pa-	pa-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	198	141	tient	tient	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	198	142	characteristics	characteristic	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	143	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	198	144	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	198	145	protocols	protocol	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	198	146	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	199	1	Only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	199	2	6	6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	199	3	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	199	4	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	199	5	11.7	11.7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	199	6	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	199	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	199	8	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	199	9	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	199	10	temporary	temporary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	199	11	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	199	12	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	199	13	interruption	interruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	199	14	received	receive	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	199	15	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	199	16	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	199	17	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	199	18	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	199	19	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	199	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	199	21	ARISTOTLE	ARISTOTLE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	199	22	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	199	23	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	199	24	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	199	25	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	199	26	Reduction	Reduction	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	199	27	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	199	28	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	199	29	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	199	30	Other	Other	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	199	31	Thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	199	32	Events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	199	33	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	199	34	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	199	35	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	199	36	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	199	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	199	38	re-	re-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	199	39	spectively.104,105	spectively.104,105	NN
work_vvlzsj54cvf5de6ji6py6krqlm	199	40	Much	much	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	199	41	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	199	42	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	199	43	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	199	44	outcome	outcome	NN
work_vvlzsj54cvf5de6ji6py6krqlm	199	45	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	199	46	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	199	47	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	199	48	switching	switching	NN
work_vvlzsj54cvf5de6ji6py6krqlm	199	49	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	199	50	transitioning	transitioning	NN
work_vvlzsj54cvf5de6ji6py6krqlm	199	51	between	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	199	52	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	199	53	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	199	54	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	199	55	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	199	56	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	199	57	comes	come	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	199	58	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	199	59	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	199	60	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	199	61	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	199	62	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	199	63	pa-	pa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	199	64	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	199	65	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	199	66	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	199	67	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	200	1	Observations	observation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	200	2	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	200	3	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	200	4	reported	report	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	200	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	200	6	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	200	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	200	8	embolic	embolic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	200	9	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	200	10	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	200	11	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	200	12	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	200	13	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	200	14	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	200	15	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	200	16	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	200	17	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	200	18	groups	group	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	200	19	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	200	20	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	200	21	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	200	22	transitions	transition	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	200	23	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	200	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	200	25	beginning	beginning	NN
work_vvlzsj54cvf5de6ji6py6krqlm	200	26	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	200	27	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	200	28	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	200	29	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	200	30	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	200	31	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	200	32	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	200	33	published	publish	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	200	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	201	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	2	post	post	FW
work_vvlzsj54cvf5de6ji6py6krqlm	201	3	hoc	hoc	FW
work_vvlzsj54cvf5de6ji6py6krqlm	201	4	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	6	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	7	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	8	reported	report	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	201	9	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	10	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	201	11	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	13	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	14	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	16	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	17	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	18	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	19	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	21	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	22	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	201	23	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	24	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	201	25	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	26	transition	transition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	27	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	28	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	29	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	30	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	201	31	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	32	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	33	pe-	pe-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	201	34	riod.107	riod.107	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	35	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	201	36	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	201	37	received	receive	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	201	38	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	39	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	201	40	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	41	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	42	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	201	43	received	receive	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	201	44	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	45	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	201	46	observed	observe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	201	47	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	201	48	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	201	49	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	50	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	201	51	incidence	incidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	52	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	53	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	54	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	55	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	56	period	period	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	57	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	58	transi-	transi-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	59	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	60	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	201	61	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	201	62	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	201	63	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	201	64	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	201	65	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	66	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	67	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	68	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	69	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	70	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	71	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	201	72	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	73	open-	open-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	74	label	label	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	75	therapy	therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	76	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	201	77	n=22	n=22	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	78	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	79	n=6	n=6	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	201	80	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	201	81	hazard	hazard	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	82	ratio	ratio	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	83	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	201	84	HR	hr	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	85	]	]	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	201	86	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	201	87	3.72	3.72	CD
work_vvlzsj54cvf5de6ji6py6krqlm	201	88	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	201	89	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	201	90	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	91	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	92	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	201	93	1.51–9.16	1.51–9.16	CD
work_vvlzsj54cvf5de6ji6py6krqlm	201	94	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	201	95	as	as	RB
work_vvlzsj54cvf5de6ji6py6krqlm	201	96	well	well	RB
work_vvlzsj54cvf5de6ji6py6krqlm	201	97	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	98	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	99	greater	great	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	201	100	proportion	proportion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	101	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	102	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	103	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	201	104	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	201	105	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	201	106	n=25	n=25	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	107	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	108	n=7	n=7	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	201	109	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	201	110	HR	hr	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	111	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	201	112	3.62	3.62	CD
work_vvlzsj54cvf5de6ji6py6krqlm	201	113	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	201	114	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	201	115	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	116	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	117	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	201	118	1.56–8.36).107,108	1.56–8.36).107,108	CD
work_vvlzsj54cvf5de6ji6py6krqlm	201	119	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	120	addition	addition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	121	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	201	122	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	123	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	124	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	125	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	201	126	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	127	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	201	128	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	129	transition	transition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	130	period	period	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	131	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	201	132	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	133	median	median	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	134	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	135	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	136	first	first	RB
work_vvlzsj54cvf5de6ji6py6krqlm	201	137	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	138	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	139	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	201	140	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	201	141	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	201	142	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	143	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	144	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	145	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	146	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	147	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	201	148	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	149	13	13	CD
work_vvlzsj54cvf5de6ji6py6krqlm	201	150	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	201	151	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	152	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	153	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	154	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	155	group.108	group.108	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	156	Simi-	Simi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	157	lar	lar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	158	observations	observation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	201	159	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	160	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	161	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	201	162	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	163	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	164	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	165	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	201	166	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	167	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	168	assigned	assign	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	201	169	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	170	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	171	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	172	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	201	173	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	201	174	reported	report	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	201	175	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	176	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	177	ARISTOTLE	ARISTOTLE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	178	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	179	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	180	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	201	181	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	182	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	201	183	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	184	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	185	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	201	186	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	187	transi-	transi-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	188	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	189	period.109	period.109	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	190	At	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	191	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	192	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	193	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	194	ARISTOTLE	ARISTOTLE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	195	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	201	196	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	197	2-day	2-day	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	201	198	bridging	bridging	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	199	period	period	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	200	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	201	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	202	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	201	203	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	204	placebo	placebo	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	205	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	201	206	recom-	recom-	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	201	207	mended	mend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	201	208	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	209	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	201	210	initiation	initiation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	211	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	201	212	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	201	213	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	201	214	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	201	215	VKAs	vka	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	201	216	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	202	1	During	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	202	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	202	3	first	first	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	202	4	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	202	5	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	202	6	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	202	7	stopping	stop	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	202	8	blinded	blinded	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	202	9	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	202	10	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	202	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	202	12	21	21	CD
work_vvlzsj54cvf5de6ji6py6krqlm	202	13	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	202	14	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	202	15	systemic	systemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	202	16	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	202	17	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	202	18	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	202	19	noted	note	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	202	20	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	202	21	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	202	22	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	202	23	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	202	24	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	202	25	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	202	26	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	202	27	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	202	28	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	202	29	group	group	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	202	30	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	202	31	adjust-	adjust-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	202	32	ed	ed	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	202	33	HR	HR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	202	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	202	35	4.10	4.10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	202	36	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	202	37	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	202	38	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	202	39	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	202	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	202	41	1.54–10.86	1.54–10.86	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	202	42	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	202	43	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	203	1	An	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	203	2	excess	excess	NN
work_vvlzsj54cvf5de6ji6py6krqlm	203	3	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	203	4	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	203	5	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	203	6	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	203	7	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	203	8	also	also	RB
work_vvlzsj54cvf5de6ji6py6krqlm	203	9	observed	observe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	203	10	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	203	11	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	203	12	period	period	NN
work_vvlzsj54cvf5de6ji6py6krqlm	203	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	203	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	203	15	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	203	16	versus	versus	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	203	17	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	203	18	groups	group	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	203	19	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	203	20	n=26	n=26	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	203	21	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	203	22	n=10	n=10	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	203	23	;	;	,
work_vvlzsj54cvf5de6ji6py6krqlm	203	24	adjusted	adjusted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	203	25	HR	hr	NN
work_vvlzsj54cvf5de6ji6py6krqlm	203	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	203	27	2.56	2.56	CD
work_vvlzsj54cvf5de6ji6py6krqlm	203	28	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	203	29	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	203	30	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	203	31	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	203	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	203	33	1.23–5.30	1.23–5.30	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	203	34	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	203	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	204	1	On	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	204	3	basis	basis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	5	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	204	6	observations	observation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	204	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	204	8	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	204	9	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	204	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	12	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	204	13	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	14	transition	transition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	15	plan	plan	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	16	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	204	17	designed	design	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	204	18	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	19	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	204	20	enrolled	enrol	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	204	21	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	204	23	ENGAGE	ENGAGE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	24	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	25	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	204	26	Effec-	Effec-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	27	tive	tive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	204	28	Anticoagulation	Anticoagulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	29	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	30	Factor	Factor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	31	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	32	Next	Next	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	33	Generation	Generation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	34	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	35	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	36	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	37	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	204	38	trial.110	trial.110	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	39	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	40	brief	brief	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	204	42	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	43	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	204	44	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	204	45	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	204	46	planned	plan	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	204	47	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	204	48	transition	transition	VB
work_vvlzsj54cvf5de6ji6py6krqlm	204	49	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	50	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	204	51	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	204	52	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	53	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	54	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	204	56	mea-	mea-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	57	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	58	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	59	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	204	60	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	61	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	62	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	204	63	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	204	64	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	204	65	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	204	66	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	204	67	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	204	68	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	204	69	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	70	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	71	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	72	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	73	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	204	74	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	204	75	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	204	76	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	204	77	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	205	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	205	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	205	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	205	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	206	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	206	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	206	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	206	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	206	5	CIR.0000000000000477e616	CIR.0000000000000477e616	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	206	6	surement	surement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	206	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	206	8	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	206	9	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	206	10	conducted	conduct	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	206	11	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	206	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	206	13	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	206	14	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	206	15	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	206	16	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	206	17	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	206	18	initiated	initiate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	206	19	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	206	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	206	21	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	206	22	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	206	23	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	206	24	2.0	2.0	CD
work_vvlzsj54cvf5de6ji6py6krqlm	206	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	207	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	207	2	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	207	3	transi-	transi-	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	207	4	tioning	tione	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	207	5	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	207	6	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	207	7	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	207	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	207	9	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	207	10	14-day	14-day	CD
work_vvlzsj54cvf5de6ji6py6krqlm	207	11	kit	kit	NN
work_vvlzsj54cvf5de6ji6py6krqlm	207	12	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	207	13	provided	provide	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	207	14	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	207	15	included	include	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	207	16	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	207	17	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	207	18	algorithm	algorithm	NN
work_vvlzsj54cvf5de6ji6py6krqlm	207	19	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	207	20	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	207	21	modified	modify	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	207	22	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	207	23	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	207	24	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	207	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	207	26	which	which	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	207	27	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	207	28	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	207	29	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	207	30	continued	continue	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	207	31	until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	207	32	day	day	NN
work_vvlzsj54cvf5de6ji6py6krqlm	207	33	14	14	CD
work_vvlzsj54cvf5de6ji6py6krqlm	207	34	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	207	35	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	207	36	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	207	37	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	207	38	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	207	39	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	207	40	≥2.0	≥2.0	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	207	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	207	42	whichever	whichever	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	207	43	occurred	occur	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	207	44	first	first	RB
work_vvlzsj54cvf5de6ji6py6krqlm	207	45	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	208	1	Within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	208	2	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	208	3	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	208	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	208	5	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	208	6	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	208	7	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	208	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	208	9	strokes	stroke	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	208	10	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	208	11	observed	observe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	208	12	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	208	13	occur	occur	VB
work_vvlzsj54cvf5de6ji6py6krqlm	208	14	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	208	15	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	208	16	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	208	17	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	208	18	each	each	DT
work_vvlzsj54cvf5de6ji6py6krqlm	208	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	208	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	208	21	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	208	22	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	208	23	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	208	24	groups	group	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	208	25	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	208	26	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	208	27	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	208	28	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	208	29	noted	note	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	208	30	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	208	31	11	11	CD
work_vvlzsj54cvf5de6ji6py6krqlm	208	32	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	208	33	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	208	34	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	208	35	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	208	36	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	208	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	208	38	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	208	39	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	208	40	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	208	41	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	208	42	edoxaban	edoxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	208	43	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	208	44	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	208	45	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	208	46	Table	table	NN
work_vvlzsj54cvf5de6ji6py6krqlm	208	47	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	208	48	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	209	1	Overview	overview	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	3	US	US	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	4	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	209	5	Labeled	label	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	209	6	Guidance	Guidance	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	7	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	8	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	9	Anticoagulant	Anticoagulant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	10	Transitions	transition	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	209	11	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	12	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	13	Intravenous	Intravenous	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	14	Anticoagulant	Anticoagulant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	15	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	16	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	17	Other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	18	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	19	Apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	20	Apixaban→warfarin	apixaban→warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	21	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	22	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	23	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	24	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	209	25	begin	begin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	26	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	27	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	28	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	29	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	209	30	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	31	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	32	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	33	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	34	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	35	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	36	scheduled	schedule	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	209	37	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	38	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	39	would	would	MD
work_vvlzsj54cvf5de6ji6py6krqlm	209	40	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	41	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	209	42	taken	take	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	209	43	Apixaban→parenteral	apixaban→parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	44	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	45	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	46	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	47	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	48	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	209	49	begin	begin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	50	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	51	new	new	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	52	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	53	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	54	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	55	usual	usual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	56	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	57	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	58	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	59	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	60	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	61	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	62	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	63	Apixaban→LMWH	Apixaban→LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	64	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	65	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	66	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	67	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	68	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	69	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	70	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	209	71	begin	begin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	72	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	73	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	74	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	75	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	76	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	77	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	78	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	79	usual	usual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	80	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	81	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	82	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	83	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	84	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	85	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	86	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	87	Warfarin→apixaban	warfarin→apixaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	88	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	89	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	90	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	91	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	209	92	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	93	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	94	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	209	95	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	96	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	209	97	2.0	2.0	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	98	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	99	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	100	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	101	NOAC→apixaban	noac→apixaban	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	102	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	103	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	104	current	current	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	105	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	106	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	107	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	108	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	209	109	begin	begin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	110	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	111	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	112	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	113	usual	usual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	114	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	115	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	116	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	117	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	118	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	119	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	120	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	121	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	122	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	123	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	124	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	125	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	126	Dabigatran→warfarin	dabigatran→warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	127	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	128	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	129	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	130	≥50	≥50	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	131	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	132	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	133	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	134	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	209	135	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	136	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	137	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	138	d	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	139	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	140	discontinuing	discontinuing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	141	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	142	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	143	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	144	30–50	30–50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	145	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	146	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	147	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	148	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	209	149	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	150	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	151	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	152	d	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	153	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	154	discontinuing	discontinuing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	155	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	156	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	157	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	158	15–30	15–30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	159	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	160	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	161	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	162	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	209	163	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	164	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	165	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	166	d	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	167	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	168	discontinuing	discontinuing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	169	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	170	Dabigatran→parenteral	dabigatran→parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	171	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	172	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	173	Wait	wait	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	174	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	175	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	176	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	209	177	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	178	≥30	≥30	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	179	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	180	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	181	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	182	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	209	183	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	209	184	24	24	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	185	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	186	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	209	187	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	188	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	209	189	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	190	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	191	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	192	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	193	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	209	194	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	195	last	last	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	196	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	197	dose	dose	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	209	198	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	199	initiating	initiate	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	209	200	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	201	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	202	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	203	Dabigatran→LMWH	Dabigatran→LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	204	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	205	Wait	wait	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	206	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	207	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	208	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	209	209	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	210	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	209	211	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	212	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	213	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	214	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	215	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	209	216	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	209	217	24	24	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	218	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	219	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	209	220	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	221	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	209	222	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	223	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	224	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	209	225	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	226	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	209	227	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	228	last	last	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	229	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	230	dose	dose	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	209	231	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	232	initiating	initiate	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	209	233	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	234	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	235	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	236	Warfarin→dabigatran	warfarin→dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	237	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	238	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	239	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	240	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	209	241	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	242	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	243	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	209	244	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	245	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	209	246	2.0	2.0	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	247	UFH→dabigatran	UFH→dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	248	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	249	Start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	250	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	251	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	252	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	253	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	254	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	255	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	256	infusion	infusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	257	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	258	LMWH→dabigatran	LMWH→dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	259	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	260	Start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	261	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	262	0–2	0–2	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	209	263	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	264	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	265	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	266	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	267	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	209	268	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	209	269	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	270	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	209	271	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	272	would	would	MD
work_vvlzsj54cvf5de6ji6py6krqlm	209	273	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	274	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	209	275	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	209	276	Edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	277	Edoxaban→warfarin	Edoxaban→warfarin	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	209	278	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	279	Oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	280	option	option	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	281	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	209	282	Reduce	reduce	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	283	daily	daily	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	209	284	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	285	dose	dose	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	209	286	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	209	287	50	50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	209	288	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	289	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	209	290	begin	begin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	209	291	taking	take	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	209	292	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	209	293	concomitantly	concomitantly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	209	294	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	210	1	Measure	measure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	210	2	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	210	3	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	210	4	least	least	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	210	5	weekly	weekly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	210	6	just	just	RB
work_vvlzsj54cvf5de6ji6py6krqlm	210	7	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	210	8	daily	daily	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	210	9	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	210	10	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	210	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	211	1	Once	once	RB
work_vvlzsj54cvf5de6ji6py6krqlm	211	2	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	211	3	stable	stable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	211	4	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	211	5	≥2.0	≥2.0	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	211	6	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	211	7	achieved	achieve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	211	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	211	9	discontinue	discontinue	NN
work_vvlzsj54cvf5de6ji6py6krqlm	211	10	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	211	11	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	211	12	continue	continue	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	211	13	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	211	14	Parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	211	15	option	option	NN
work_vvlzsj54cvf5de6ji6py6krqlm	211	16	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	211	17	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	211	18	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	211	19	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	211	20	administer	administer	VB
work_vvlzsj54cvf5de6ji6py6krqlm	211	21	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	211	22	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	211	23	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	211	24	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	211	25	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	211	26	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	211	27	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	211	28	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	211	29	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	211	30	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	211	31	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	211	32	scheduled	schedule	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	211	33	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	211	34	dose	dose	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	211	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	212	1	Edoxaban→parenteral	edoxaban→parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	2	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	3	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	4	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	5	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	7	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	8	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	9	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	10	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	11	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	13	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	16	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	17	scheduled	schedule	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	212	18	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	20	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	21	Edoxaban→LMWH	Edoxaban→LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	22	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	212	23	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	24	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	25	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	26	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	27	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	28	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	29	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	30	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	31	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	32	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	212	33	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	34	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	35	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	36	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	37	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	38	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	39	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	40	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	41	scheduled	schedule	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	212	42	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	43	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	44	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	45	Warfarin→edoxaban	warfarin→edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	46	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	47	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	48	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	49	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	50	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	51	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	52	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	212	53	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	54	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	55	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	212	56	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	212	57	2.5	2.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	212	58	UFH→edoxaban	UFH→edoxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	59	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	60	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	61	UFH	UFH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	62	infusion	infusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	63	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	64	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	65	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	66	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	212	67	h	h	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	212	68	later	later	RB
work_vvlzsj54cvf5de6ji6py6krqlm	212	69	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	70	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	212	71	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	72	NOAC→edoxaban	noac→edoxaban	CD
work_vvlzsj54cvf5de6ji6py6krqlm	212	73	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	74	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	75	current	current	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	76	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	77	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	212	78	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	79	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	80	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	81	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	82	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	83	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	84	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	85	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	86	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	87	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	88	scheduled	schedule	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	212	89	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	90	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	91	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	212	92	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	93	dose	dose	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	212	94	Rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	95	Rivaroxaban→warfarin	rivaroxaban→warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	96	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	97	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	98	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	99	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	100	begin	begin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	101	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	102	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	103	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	104	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	105	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	106	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	107	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	108	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	109	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	110	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	111	scheduled	scheduled	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	112	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	113	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	114	would	would	MD
work_vvlzsj54cvf5de6ji6py6krqlm	212	115	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	116	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	212	117	taken	take	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	212	118	Rivaroxaban→UFH	rivaroxaban→ufh	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	119	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	120	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	121	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	122	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	123	initiate	initiate	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	124	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	125	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	126	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	127	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	128	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	129	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	130	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	131	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	132	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	133	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	134	would	would	MD
work_vvlzsj54cvf5de6ji6py6krqlm	212	135	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	136	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	212	137	taken	take	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	212	138	Rivaroxaban→LMWH	Rivaroxaban→LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	139	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	212	140	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	141	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	142	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	143	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	144	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	145	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	146	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	147	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	148	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	149	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	212	150	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	151	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	152	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	153	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	154	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	155	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	156	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	157	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	158	scheduled	schedule	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	212	159	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	160	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	161	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	162	Warfarin→rivaroxaban	warfarin→rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	163	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	164	Discontinue	Discontinue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	165	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	166	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	167	start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	168	rivaroxaban	rivaroxaban	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	212	169	as	as	RB
work_vvlzsj54cvf5de6ji6py6krqlm	212	170	soon	soon	RB
work_vvlzsj54cvf5de6ji6py6krqlm	212	171	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	172	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	173	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	212	174	3.0	3.0	CD
work_vvlzsj54cvf5de6ji6py6krqlm	212	175	UFH→rivaroxaban	UFH→rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	176	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	177	Stop	stop	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	178	UFH	UFH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	179	infusion	infusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	180	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	181	administer	administer	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	182	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	183	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	184	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	185	same	same	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	186	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	187	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	188	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	212	189	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	190	NOAC→rivaroxaban	noac→rivaroxaban	CD
work_vvlzsj54cvf5de6ji6py6krqlm	212	191	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	192	Start	start	VB
work_vvlzsj54cvf5de6ji6py6krqlm	212	193	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	194	0–2	0–2	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	195	h	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	196	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	197	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	198	next	next	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	199	scheduled	scheduled	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	200	evening	evening	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	201	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	202	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	212	203	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	204	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	205	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	206	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	207	omit	omit	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	212	208	administration	administration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	209	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	212	210	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	212	211	LMWH	LMWH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	212	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	212	213	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	214	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	215	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	216	indicates	indicate	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	212	217	creatinine	creatinine	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	218	clearance	clearance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	219	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	220	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	221	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	212	222	international	international	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	223	normalized	normalized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	224	ratio	ratio	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	225	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	226	LMWH	lmwh	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	227	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	212	228	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	229	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	212	230	molecular	molecular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	231	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	212	232	weight	weight	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	233	heparin	heparin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	234	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	235	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	236	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	212	237	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	238	–	–	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	239	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	240	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	241	antagonist	antagonist	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	242	oral	oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	243	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	244	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	245	UFH	UFH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	246	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	212	247	unfractionated	unfractionated	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	212	248	heparin	heparin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	249	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	212	250	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	212	251	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	212	252	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	212	253	vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	254	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	255	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	212	256	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	213	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	213	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	213	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	213	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	213	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	213	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	213	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	213	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	213	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	213	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	213	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	213	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	213	13	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	213	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	213	15	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	213	16	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	213	17	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	213	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	213	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	213	20	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	213	21	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	213	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	213	23	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	213	24	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	213	25	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	213	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	214	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	214	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	214	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	214	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	215	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	215	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	215	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	215	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	215	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	215	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	215	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	215	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	215	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	215	10	e617	e617	NN
work_vvlzsj54cvf5de6ji6py6krqlm	215	11	CLINICAL	clinical	NN
work_vvlzsj54cvf5de6ji6py6krqlm	215	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	215	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	215	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	215	15	GUIDELINES	GUIDELINES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	215	16	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	215	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	215	18	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	215	19	18	18	CD
work_vvlzsj54cvf5de6ji6py6krqlm	215	20	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	215	21	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	215	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	215	23	edoxaban	edoxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	215	24	low	low	RB
work_vvlzsj54cvf5de6ji6py6krqlm	215	25	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	215	26	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	215	27	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	215	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	216	1	No	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	216	2	statistically	statistically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	216	3	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	216	4	differences	difference	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	216	5	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	216	6	observed	observe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	216	7	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	216	8	primary	primary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	216	9	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	216	10	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	216	11	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	216	12	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	216	13	among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	216	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	216	15	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	216	16	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	216	17	groups	group	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	216	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	216	19	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	216	20	transitioning	transition	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	216	21	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	216	22	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	216	23	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	216	24	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	216	25	VKAs	vka	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	216	26	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	216	27	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	216	28	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	216	29	transitioning	transitioning	NN
work_vvlzsj54cvf5de6ji6py6krqlm	216	30	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	216	31	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	216	32	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	216	33	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	216	34	NOACs.110	NOACs.110	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	216	35	It	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	216	36	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	216	37	notable	notable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	216	38	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	216	39	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	216	40	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	216	41	transitioning	transition	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	216	42	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	216	43	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	216	44	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	216	45	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	216	46	VKAs	vka	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	216	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	216	48	85	85	CD
work_vvlzsj54cvf5de6ji6py6krqlm	216	49	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	216	50	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	216	51	at	at	RB
work_vvlzsj54cvf5de6ji6py6krqlm	216	52	least	least	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	216	53	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	216	54	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	216	55	≥2	≥2	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	216	56	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	216	57	day	day	NN
work_vvlzsj54cvf5de6ji6py6krqlm	216	58	14	14	CD
work_vvlzsj54cvf5de6ji6py6krqlm	216	59	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	217	1	Registry	registry	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	2	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	217	3	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	217	5	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	217	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	7	ambulatory	ambulatory	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	8	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	217	9	pa-	pa-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	10	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	217	11	transitioning	transition	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	217	12	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	13	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	217	14	VKA	vka	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	15	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	16	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	217	17	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	217	18	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	217	19	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	217	20	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	217	21	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	22	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	217	23	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	217	24	also	also	RB
work_vvlzsj54cvf5de6ji6py6krqlm	217	25	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	217	26	published.111,112	published.111,112	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	217	27	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	28	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	217	29	matched	match	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	217	30	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	217	31	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	32	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	33	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	34	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	217	35	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	217	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	217	37	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	217	38	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	217	39	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	217	40	as-	as-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	217	41	sociation	sociation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	42	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	43	transitioning	transition	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	217	44	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	45	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	217	46	VKA	vka	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	47	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	48	either	either	CC
work_vvlzsj54cvf5de6ji6py6krqlm	217	49	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	50	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	217	51	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	52	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	217	53	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	54	remaining	remain	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	217	55	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	56	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	217	57	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	58	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	59	embolic	embolic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	60	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	217	61	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	217	62	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	217	63	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	64	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	217	65	median	median	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	217	66	follow	follow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	67	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	217	68	up	up	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	69	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	70	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	217	71	months.112	months.112	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	217	72	Data	Data	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	217	73	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	74	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	217	75	large	large	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	217	76	regional	regional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	217	77	prospective	prospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	217	78	registry	registry	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	79	showed	show	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	217	80	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	217	81	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	217	82	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	217	83	relatively	relatively	RB
work_vvlzsj54cvf5de6ji6py6krqlm	217	84	infrequent	infrequent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	217	85	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	86	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	217	87	30-day	30-day	CD
work_vvlzsj54cvf5de6ji6py6krqlm	217	88	period	period	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	89	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	90	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	217	91	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	92	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	217	93	transitions	transition	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	217	94	de-	de-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	217	95	spite	spite	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	217	96	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	217	97	75	75	CD
work_vvlzsj54cvf5de6ji6py6krqlm	217	98	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	99	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	100	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	217	101	having	have	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	217	102	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	217	103	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	217	104	measurement	measurement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	105	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	217	106	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	217	107	initiation	initiation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	217	108	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	218	1	Although	although	IN
work_vvlzsj54cvf5de6ji6py6krqlm	218	2	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	218	3	decisions	decision	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	218	4	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	218	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	218	6	transition	transition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	218	7	between	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	218	8	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	218	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	218	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	218	11	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	218	12	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	218	13	setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	218	14	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	218	15	likely	likely	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	218	16	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	218	17	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	218	18	affected	affect	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	218	19	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	218	20	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	218	21	number	number	NN
work_vvlzsj54cvf5de6ji6py6krqlm	218	22	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	218	23	factors	factor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	218	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	218	25	careful	careful	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	218	26	consideration	consideration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	218	27	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	218	28	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	218	29	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	218	30	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	218	31	strategies	strategy	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	218	32	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	218	33	mini-	mini-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	218	34	mize	mize	VB
work_vvlzsj54cvf5de6ji6py6krqlm	218	35	prolonged	prolong	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	218	36	durations	duration	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	218	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	218	38	both	both	CC
work_vvlzsj54cvf5de6ji6py6krqlm	218	39	subtherapeutic	subtherapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	218	40	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	218	41	excessive	excessive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	218	42	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	218	43	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	218	44	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	218	45	transition	transition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	218	46	periods	period	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	218	47	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	219	1	Given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	219	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	219	3	relatively	relatively	RB
work_vvlzsj54cvf5de6ji6py6krqlm	219	4	infrequent	infrequent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	219	5	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	219	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	219	7	periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	219	8	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	219	9	strategies	strategy	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	219	10	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	219	11	temporary	temporary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	219	12	interruptions	interruption	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	219	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	219	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	219	15	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	219	16	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	219	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	219	18	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	219	19	consideration	consideration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	219	20	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	219	21	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	219	22	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	219	23	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	219	24	managing	manage	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	219	25	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	219	26	experiencing	experience	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	219	27	temporary	temporary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	219	28	inter-	inter-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	219	29	ruptions	ruption	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	219	30	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	219	31	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	219	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	219	33	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	219	34	outlined	outline	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	219	35	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	219	36	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	219	37	individual	individual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	219	38	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	219	39	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	219	40	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	220	1	PERIPROCEDURAL	periprocedural	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	2	MANAGEMENT	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	3	OF	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	4	PATIENTS	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	220	5	WHO	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	220	6	TAKE	take	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	220	7	NOACS	NOACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	220	8	Each	each	DT
work_vvlzsj54cvf5de6ji6py6krqlm	220	9	year	year	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	220	11	≈10	≈10	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	12	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	14	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	220	15	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	16	any	any	DT
work_vvlzsj54cvf5de6ji6py6krqlm	220	17	long	long	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	18	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	220	19	term	term	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	20	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	21	antico-	antico-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	22	agulation	agulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	23	require	require	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	220	24	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	25	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	220	26	other	other	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	27	invasive	invasive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	28	procedures.113	procedures.113	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	29	Approximately	approximately	RB
work_vvlzsj54cvf5de6ji6py6krqlm	220	30	20	20	CD
work_vvlzsj54cvf5de6ji6py6krqlm	220	31	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	32	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	33	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	220	34	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	35	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	36	undergo	undergo	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	220	37	sur-	sur-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	38	gery	gery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	39	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	220	40	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	220	41	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	220	42	extremely	extremely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	220	43	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	44	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	45	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	46	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	220	47	such	such	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	48	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	49	mi-	mi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	220	50	nor	nor	CC
work_vvlzsj54cvf5de6ji6py6krqlm	220	51	dental	dental	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	220	53	dermatologic	dermatologic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	220	55	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	220	56	ophthalmologic	ophthalmologic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	57	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	220	58	where	where	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	220	59	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	60	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	220	61	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	220	62	safely	safely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	220	63	continued	continue	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	220	64	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	65	interruption.114	interruption.114	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	220	66	It	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	220	67	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	220	68	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	220	69	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	70	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	71	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	220	72	held	hold	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	220	73	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	74	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	220	75	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	220	76	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	77	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	78	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	220	79	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	80	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	81	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	220	82	anticipated	anticipate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	220	83	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	220	84	then	then	RB
work_vvlzsj54cvf5de6ji6py6krqlm	220	85	reinitiated	reinitiate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	220	86	postoperatively	postoperatively	RB
work_vvlzsj54cvf5de6ji6py6krqlm	220	87	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	220	88	he-	he-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	220	89	mostasis	mostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	90	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	220	91	secured.115	secured.115	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	220	92	Pre-	Pre-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	220	93	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	220	94	postoperative	postoperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	95	bridging	bridging	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	96	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	220	97	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	98	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	220	99	molecular	molecular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	100	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	220	101	weight	weight	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	102	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	220	103	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	220	104	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	220	105	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	106	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	220	107	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	220	108	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	109	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	110	thrombosis	thrombosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	111	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	112	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	220	113	such	such	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	114	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	115	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	220	116	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	220	117	certain	certain	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	118	mechanical	mechanical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	119	valve	valve	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	120	prostheses	prosthesis	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	220	121	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	220	122	recent	recent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	123	pul-	pul-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	124	monary	monary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	220	125	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	220	126	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	221	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	221	2	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	221	3	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	221	4	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	221	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	221	6	intermediate	intermediate	VB
work_vvlzsj54cvf5de6ji6py6krqlm	221	7	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	221	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	221	9	thrombosis	thrombosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	221	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	221	11	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	221	12	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	221	13	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	221	14	molecular	molecular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	221	15	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	221	16	weight	weight	NN
work_vvlzsj54cvf5de6ji6py6krqlm	221	17	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	221	18	does	do	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	221	19	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	221	20	prevent	prevent	VB
work_vvlzsj54cvf5de6ji6py6krqlm	221	21	thrombotic	thrombotic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	221	22	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	221	23	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	221	24	increases	increase	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	221	25	bleed-	bleed-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	221	26	ing	ing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	221	27	events116	events116	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	221	28	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	221	29	Figure	Figure	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	221	30	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	221	31	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	221	32	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	222	1	Therefore	therefore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	222	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	222	3	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	222	4	anticoagula-	anticoagula-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	222	5	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	222	6	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	222	7	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	222	8	necessary	necessary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	222	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	222	10	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	222	11	subgroup	subgroup	NN
work_vvlzsj54cvf5de6ji6py6krqlm	222	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	222	13	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	222	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	223	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	223	2	limited	limited	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	223	3	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	223	4	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	223	5	pertaining	pertain	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	223	6	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	223	7	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	223	8	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	223	9	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	223	10	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	223	11	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	223	12	require	require	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	223	13	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	223	14	suggest	suggest	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	223	15	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	223	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	223	17	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	223	18	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	223	19	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	223	20	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	223	21	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	223	22	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	223	23	nonurgent	nonurgent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	223	24	sur-	sur-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	223	25	gery	gery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	223	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	224	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	224	2	Dresden	Dresden	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	224	3	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	224	4	registry	registry	NN
work_vvlzsj54cvf5de6ji6py6krqlm	224	5	prospectively	prospectively	RB
work_vvlzsj54cvf5de6ji6py6krqlm	224	6	evalu-	evalu-	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	224	7	ated	ate	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	224	8	2179	2179	CD
work_vvlzsj54cvf5de6ji6py6krqlm	224	9	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	224	10	taking	take	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	224	11	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	224	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	224	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	224	14	which	which	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	224	15	595	595	CD
work_vvlzsj54cvf5de6ji6py6krqlm	224	16	pa-	pa-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	224	17	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	224	18	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	224	19	27.3	27.3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	224	20	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	224	21	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	224	22	underwent	undergo	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	224	23	863	863	CD
work_vvlzsj54cvf5de6ji6py6krqlm	224	24	invasive	invasive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	224	25	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	224	26	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	224	27	most	most	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	224	28	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	224	29	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	224	30	urgent.48	urgent.48	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	224	31	Invasive	Invasive	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	224	32	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	224	33	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	224	34	cat-	cat-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	224	35	egorized	egorize	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	224	36	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	224	37	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	224	38	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	224	39	minor	minor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	224	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	224	41	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	224	42	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	224	43	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	224	44	event	event	NN
work_vvlzsj54cvf5de6ji6py6krqlm	224	45	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	224	46	categorized	categorize	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	224	47	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	224	48	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	224	49	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	224	50	clinically	clinically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	224	51	relevant	relevant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	224	52	nonmajor	nonmajor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	224	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	224	54	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	224	55	minor	minor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	224	56	per	per	IN
work_vvlzsj54cvf5de6ji6py6krqlm	224	57	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	224	58	International	International	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	224	59	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	224	60	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	224	61	Thrombosis	Thrombosis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	224	62	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	224	63	Figure	Figure	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	224	64	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	224	65	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	225	1	Periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	225	2	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	225	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	225	4	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	225	5	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	225	6	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	225	7	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	225	8	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	225	9	–	–	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	225	10	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	225	11	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	225	12	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	225	13	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	225	14	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	225	15	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	225	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	226	1	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	226	2	indicates	indicate	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	226	3	creatinine	creatinine	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	226	4	clearance	clearance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	226	5	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	226	6	ICD	ICD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	226	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	226	8	implantable	implantable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	226	9	cardioverter	cardioverter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	226	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	226	11	defibrillator	defibrillator	NN
work_vvlzsj54cvf5de6ji6py6krqlm	226	12	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	226	13	PT	PT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	226	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	226	15	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	226	16	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	226	17	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	226	18	SVT	SVT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	226	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	226	20	supraventricular	supraventricular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	226	21	tachy-	tachy-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	226	22	cardia	cardia	NN
work_vvlzsj54cvf5de6ji6py6krqlm	226	23	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	226	24	TE	TE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	226	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	226	26	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	226	27	event	event	NN
work_vvlzsj54cvf5de6ji6py6krqlm	226	28	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	226	29	TIA	TIA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	226	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	226	31	transient	transient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	226	32	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	226	33	attack	attack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	226	34	;	;	,
work_vvlzsj54cvf5de6ji6py6krqlm	226	35	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	226	36	VTE	vte	NN
work_vvlzsj54cvf5de6ji6py6krqlm	226	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	226	38	venous	venous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	226	39	thromboembolism	thromboembolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	226	40	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	227	1	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	227	2	Bridging	bridging	NN
work_vvlzsj54cvf5de6ji6py6krqlm	227	3	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	227	4	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	227	5	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	227	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	227	7	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	227	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	227	9	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	227	10	history	history	NN
work_vvlzsj54cvf5de6ji6py6krqlm	227	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	227	12	systemic	systemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	227	13	embolus	embolus	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	227	14	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	227	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	227	16	last	last	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	227	17	6	6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	227	18	weeks.110a	weeks.110a	NN
work_vvlzsj54cvf5de6ji6py6krqlm	227	19	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	227	20	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	227	21	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	227	22	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	227	23	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	227	24	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	227	25	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	227	26	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	227	27	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	227	28	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	227	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	227	30	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	227	31	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	227	32	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	227	33	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	227	34	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	227	35	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	227	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	227	37	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	227	38	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	227	39	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	228	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	228	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	228	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	228	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	229	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	229	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	229	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	229	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	229	5	CIR.0000000000000477e618	CIR.0000000000000477e618	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	229	6	Haemostasis	Haemostasis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	229	7	definition.117	definition.117	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	229	8	Of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	229	9	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	229	10	entire	entire	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	229	11	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	229	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	229	13	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	229	14	46	46	CD
work_vvlzsj54cvf5de6ji6py6krqlm	229	15	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	229	16	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	229	17	5.3	5.3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	229	18	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	229	19	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	229	20	experienced	experience	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	229	21	any	any	DT
work_vvlzsj54cvf5de6ji6py6krqlm	229	22	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	229	23	complication	complication	NN
work_vvlzsj54cvf5de6ji6py6krqlm	229	24	up	up	IN
work_vvlzsj54cvf5de6ji6py6krqlm	229	25	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	229	26	30±5	30±5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	229	27	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	229	28	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	229	29	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	229	30	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	229	31	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	230	1	Major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	230	2	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	230	3	occurred	occur	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	230	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	230	5	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	230	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	230	7	863	863	CD
work_vvlzsj54cvf5de6ji6py6krqlm	230	8	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	230	9	1.2	1.2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	230	10	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	230	11	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	230	12	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	230	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	231	1	Clinically	clinically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	231	2	relevant	relevant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	231	3	nonmajor	nonmajor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	231	4	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	231	5	occurred	occur	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	231	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	231	7	29	29	CD
work_vvlzsj54cvf5de6ji6py6krqlm	231	8	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	231	9	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	231	10	3.4	3.4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	231	11	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	231	12	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	231	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	231	14	minor	minor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	231	15	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	231	16	occurred	occur	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	231	17	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	231	18	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	231	19	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	231	20	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	231	21	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	231	22	0.8	0.8	CD
work_vvlzsj54cvf5de6ji6py6krqlm	231	23	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	231	24	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	231	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	232	1	Periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	232	2	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	232	3	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	232	4	studied	study	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	232	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	232	6	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	232	7	sub-	sub-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	232	8	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	232	9	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	232	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	232	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	232	12	RELY	RELY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	232	13	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	232	14	which	which	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	232	15	compared	compare	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	232	16	war-	war-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	232	17	farin	farin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	232	18	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	232	19	dabigatran	dabigatran	VB
work_vvlzsj54cvf5de6ji6py6krqlm	232	20	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	232	21	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	232	22	prevention	prevention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	232	23	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	232	24	NVAF.103	NVAF.103	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	232	25	Procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	232	26	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	232	27	classified	classify	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	232	28	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	232	29	being	be	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	232	30	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	232	31	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	232	32	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	232	33	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	232	34	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	232	35	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	232	36	angiography	angiography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	232	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	232	38	defibrillator	defibrillator	NN
work_vvlzsj54cvf5de6ji6py6krqlm	232	39	implantation	implantation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	232	40	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	232	41	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	232	42	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	232	43	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	232	44	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	232	45	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	232	46	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	232	47	cardiac	cardiac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	232	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	232	49	abdominal	abdominal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	232	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	232	51	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	232	52	neu-	neu-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	232	53	rosurgery	rosurgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	232	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	232	55	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	232	56	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	232	57	requiring	require	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	232	58	spinal	spinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	232	59	anesthesia	anesthesia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	232	60	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	232	61	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	233	1	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	233	2	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	233	3	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	233	4	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	233	5	difference	difference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	233	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	233	7	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	233	8	rates	rate	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	233	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	233	10	peri-	peri-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	233	11	procedural	procedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	233	12	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	233	13	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	233	14	between	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	233	15	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	233	16	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	233	17	re-	re-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	233	18	ceived	ceive	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	233	19	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	20	110	110	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	21	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	22	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	233	23	3.8	3.8	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	24	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	233	25	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	233	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	233	27	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	28	150	150	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	29	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	30	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	233	31	5.1	5.1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	32	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	233	33	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	233	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	233	35	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	233	36	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	37	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	233	38	4.6	4.6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	39	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	233	40	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	233	41	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	233	42	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	43	110	110	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	44	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	45	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	233	46	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	233	47	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	233	48	RR	rr	NN
work_vvlzsj54cvf5de6ji6py6krqlm	233	49	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	233	50	0.83	0.83	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	51	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	233	52	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	53	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	233	54	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	233	56	0.59	0.59	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	57	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	233	58	1.17	1.17	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	59	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	233	60	P=0.28	P=0.28	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	61	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	233	62	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	63	150	150	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	64	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	65	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	233	66	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	233	67	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	233	68	RR	rr	NN
work_vvlzsj54cvf5de6ji6py6krqlm	233	69	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	233	70	1.09	1.09	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	71	;	;	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	233	72	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	73	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	233	74	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	233	75	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	233	76	0.80	0.80	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	77	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	233	78	1.49	1.49	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	79	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	233	80	P=0.58	p=0.58	CD
work_vvlzsj54cvf5de6ji6py6krqlm	233	81	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	234	1	Among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	234	2	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	234	3	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	234	4	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	234	5	ur-	ur-	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	6	gent	gent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	234	7	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	234	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	234	9	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	234	10	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	234	11	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	234	12	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	234	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	234	14	occurring	occur	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	234	15	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	234	16	17.8	17.8	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	17	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	234	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	234	19	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	20	110	110	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	21	mg	mg	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	234	23	17.7	17.7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	24	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	234	25	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	234	26	dabi-	dabi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	27	gatran	gatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	28	150	150	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	29	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	234	31	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	234	32	21.6	21.6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	33	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	234	34	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	234	35	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	36	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	234	37	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	38	110	110	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	39	mg	mg	NN
work_vvlzsj54cvf5de6ji6py6krqlm	234	40	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	234	41	RR	RR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	234	43	0.82	0.82	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	44	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	234	45	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	46	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	234	47	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	234	49	0.48	0.48	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	50	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	234	51	1.41	1.41	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	52	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	234	53	P=0.47	p=0.47	UH
work_vvlzsj54cvf5de6ji6py6krqlm	234	54	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	234	55	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	56	150	150	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	57	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	58	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	234	59	RR	RR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	60	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	234	61	0.82	0.82	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	62	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	234	63	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	64	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	234	65	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	66	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	234	67	0.50	0.50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	68	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	234	69	1.35	1.35	CD
work_vvlzsj54cvf5de6ji6py6krqlm	234	70	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	234	71	P=0.44	P=0.44	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	234	72	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	235	1	Tailoring	tailor	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	235	2	periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	235	3	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	235	4	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	235	5	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	235	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	235	7	type	type	NN
work_vvlzsj54cvf5de6ji6py6krqlm	235	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	235	9	invasive	invasive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	235	10	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	235	11	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	235	12	mitigate	mitigate	VB
work_vvlzsj54cvf5de6ji6py6krqlm	235	13	against	against	IN
work_vvlzsj54cvf5de6ji6py6krqlm	235	14	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	235	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	236	1	Common	common	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	236	2	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	236	3	scenarios	scenario	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	236	4	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	236	5	subsequently	subsequently	RB
work_vvlzsj54cvf5de6ji6py6krqlm	236	6	discussed	discuss	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	236	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	237	1	Cardiac	Cardiac	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	2	Catheterization	Catheterization	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	3	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	237	4	Percutaneous	Percutaneous	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	5	Coronary	Coronary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	6	Intervention	Intervention	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	7	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	237	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	9	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	10	commonly	commonly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	237	11	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	237	12	coexisting	coexist	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	237	13	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	14	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	15	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	16	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	17	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	237	18	estimated	estimate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	237	19	20	20	CD
work_vvlzsj54cvf5de6ji6py6krqlm	237	20	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	21	requiring	require	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	237	22	per-	per-	CC
work_vvlzsj54cvf5de6ji6py6krqlm	237	23	cutaneous	cutaneous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	24	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	25	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	26	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	237	27	PCI).118	pci).118	CD
work_vvlzsj54cvf5de6ji6py6krqlm	237	28	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	237	29	2012	2012	CD
work_vvlzsj54cvf5de6ji6py6krqlm	237	30	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	31	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	32	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	33	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	34	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	237	35	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	36	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	37	Cardovas-	Cardovas-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	38	cular	cular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	39	Angiography	Angiography	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	40	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	237	41	Interventions	Interventions	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	237	42	consensus	consensus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	43	docu-	docu-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	44	ment	ment	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	45	recommends	recommend	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	237	46	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	47	elective	elective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	48	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	49	angiography	angiography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	50	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	51	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	237	52	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	53	long	long	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	54	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	237	55	term	term	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	56	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	57	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	237	58	deferred	defer	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	237	59	until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	60	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	237	61	INR	INR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	62	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	237	63	1.8	1.8	CD
work_vvlzsj54cvf5de6ji6py6krqlm	237	64	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	65	femoral	femoral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	66	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	67	access	access	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	68	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	237	69	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	237	70	2.2	2.2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	237	71	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	72	radial	radial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	73	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	74	access.119	access.119	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	75	Unfortunately	unfortunately	RB
work_vvlzsj54cvf5de6ji6py6krqlm	237	76	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	237	77	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	237	78	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	237	79	very	very	RB
work_vvlzsj54cvf5de6ji6py6krqlm	237	80	limited	limited	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	81	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	237	82	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	237	83	address	address	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	237	84	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	237	85	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	86	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	87	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	237	88	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	237	89	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	237	90	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	91	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	237	92	require	require	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	237	93	cardiac	cardiac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	237	94	catheterization	catheterization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	237	95	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	237	96	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	237	97	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	238	1	Pre-	Pre-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	238	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	238	3	peri-	peri-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	238	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	238	5	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	238	6	postprocedural	postprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	238	7	considerations	consideration	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	238	8	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	238	9	subse-	subse-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	238	10	quently	quently	RB
work_vvlzsj54cvf5de6ji6py6krqlm	238	11	discussed	discuss	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	238	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	239	1	Preprocedural	Preprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	239	2	Considerations	Considerations	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	239	3	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	239	4	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	239	5	stable	stable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	239	6	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	239	7	heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	239	8	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	239	9	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	239	10	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	239	11	symptoms	symptom	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	239	12	despite	despite	IN
work_vvlzsj54cvf5de6ji6py6krqlm	239	13	medical	medical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	239	14	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	239	15	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	239	16	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	239	17	intermediate-	intermediate-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	239	18	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	239	19	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	239	20	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	239	21	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	239	22	features	feature	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	239	23	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	239	24	stress	stress	NN
work_vvlzsj54cvf5de6ji6py6krqlm	239	25	testing	testing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	239	26	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	239	27	often	often	RB
work_vvlzsj54cvf5de6ji6py6krqlm	239	28	referred	refer	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	239	29	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	239	30	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	239	31	angiography	angiography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	239	32	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	239	33	possible	possible	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	239	34	PCI	pci	NN
work_vvlzsj54cvf5de6ji6py6krqlm	239	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	240	1	Patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	240	2	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	240	3	stable	stable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	240	4	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	240	5	heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	240	6	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	240	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	240	8	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	240	9	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	240	10	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	240	11	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	240	12	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	240	13	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	240	14	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	240	15	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	240	16	thrombosis	thrombosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	240	17	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	240	18	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	240	19	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	240	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	240	21	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	240	22	held	hold	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	240	23	until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	240	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	240	25	antico-	antico-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	240	26	agulation	agulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	240	27	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	240	28	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	240	29	dissipated	dissipate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	240	30	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	240	31	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	240	32	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	240	33	angiography	angiography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	240	34	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	240	35	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	240	36	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	241	1	From	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	241	3	prescribing	prescribing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	4	information	information	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	241	6	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	7	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	241	8	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	241	9	held	hold	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	241	10	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	11	at	at	RB
work_vvlzsj54cvf5de6ji6py6krqlm	241	12	least	least	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	241	13	24	24	CD
work_vvlzsj54cvf5de6ji6py6krqlm	241	14	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	241	15	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	16	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	17	≥50	≥50	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	18	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	19	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	241	20	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	21	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	241	22	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	23	at	at	RB
work_vvlzsj54cvf5de6ji6py6krqlm	241	24	least	least	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	241	25	72	72	CD
work_vvlzsj54cvf5de6ji6py6krqlm	241	26	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	241	27	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	28	CrCL	CrCL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	29	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	241	30	50	50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	241	31	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	32	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	241	33	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	34	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	241	35	rivar-	rivar-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	36	oxaban	oxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	241	38	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	39	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	241	40	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	41	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	241	42	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	241	43	held	hold	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	241	44	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	45	at	at	RB
work_vvlzsj54cvf5de6ji6py6krqlm	241	46	least	least	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	241	47	24	24	CD
work_vvlzsj54cvf5de6ji6py6krqlm	241	48	hours.33,43,101,102	hours.33,43,101,102	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	241	49	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	50	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	241	51	absence	absence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	52	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	53	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	241	54	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	55	features	feature	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	241	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	241	57	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	241	58	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	241	59	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	241	60	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	241	61	bridged	bridge	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	241	62	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	63	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	241	64	heparin	heparin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	65	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	66	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	241	67	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	68	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	241	69	proce-	proce-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	241	70	dure.116	dure.116	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	71	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	241	72	decision	decision	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	73	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	241	74	resume	resume	VB
work_vvlzsj54cvf5de6ji6py6krqlm	241	75	antithrombotic	antithrombotic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	241	76	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	77	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	78	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	241	79	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	80	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	241	81	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	241	82	guided	guide	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	241	83	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	84	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	241	85	throm-	throm-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	241	86	boembolic	boembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	241	87	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	88	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	89	assessed	assess	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	241	90	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	91	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	241	92	CHA	CHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	241	93	2DS2-VASc	2ds2-vasc	CD
work_vvlzsj54cvf5de6ji6py6krqlm	241	94	score.120	score.120	CD
work_vvlzsj54cvf5de6ji6py6krqlm	241	95	Clinicians	Clinicians	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	241	96	need	need	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	241	97	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	241	98	consider	consider	VB
work_vvlzsj54cvf5de6ji6py6krqlm	241	99	which	which	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	241	100	antithrom-	antithrom-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	101	botic	botic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	102	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	241	103	antiplatelet	antiplatelet	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	241	104	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	241	105	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	241	106	resume	resume	VB
work_vvlzsj54cvf5de6ji6py6krqlm	241	107	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	241	108	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	241	109	du-	du-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	241	110	ration	ration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	111	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	112	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	113	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	241	114	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	241	115	balancing	balance	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	241	116	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	241	117	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	241	118	thrombotic	thrombotic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	241	119	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	241	120	while	while	IN
work_vvlzsj54cvf5de6ji6py6krqlm	241	121	minimizing	minimize	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	241	122	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	241	123	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	241	124	complications	complication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	241	125	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	242	1	Patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	242	2	presenting	present	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	242	3	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	242	4	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	242	5	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	6	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	7	syn-	syn-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	8	drome	drome	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	9	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	242	10	ACS	ACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	11	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	242	12	often	often	RB
work_vvlzsj54cvf5de6ji6py6krqlm	242	13	undergo	undergo	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	242	14	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	15	angiography	angiography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	242	17	revascularization	revascularization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	18	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	242	19	reduce	reduce	VB
work_vvlzsj54cvf5de6ji6py6krqlm	242	20	their	-PRON-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	242	21	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	22	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	242	23	recurrent	recurrent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	24	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	242	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	242	26	especially	especially	RB
work_vvlzsj54cvf5de6ji6py6krqlm	242	27	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	242	28	they	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	242	29	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	242	30	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	242	31	elevated	elevate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	242	32	Thromboly-	Thromboly-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	33	sis	sis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	34	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	242	35	Myocardial	Myocardial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	36	Infarction	Infarction	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	37	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	242	38	TIMI	TIMI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	39	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	242	40	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	41	score.121	score.121	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	42	Where-	Where-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	43	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	242	44	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	242	45	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	242	46	unstable	unstable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	47	angina	angina	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	48	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	242	49	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	242	50	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	51	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	242	52	ST	ST	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	53	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	242	54	segment	segment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	55	elevation	elevation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	56	myocardial	myocardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	57	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	58	do	do	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	242	59	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	242	60	require	require	VB
work_vvlzsj54cvf5de6ji6py6krqlm	242	61	im-	im-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	62	mediate	mediate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	63	angiography	angiography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	242	65	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	242	66	presenting	present	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	242	67	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	242	68	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	242	69	ST-	st-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	70	segment	segment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	71	elevation	elevation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	72	myocardial	myocardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	73	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	74	require	require	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	242	75	emer-	emer-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	76	gency	gency	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	77	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	78	angiography	angiography	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	79	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	242	80	revascularization	revascularization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	81	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	242	82	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	242	83	infarct	infarct	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	84	related	relate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	242	85	artery.122	artery.122	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	86	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	242	87	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	242	88	unstable	unstable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	89	angina/	angina/	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	90	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	91	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	242	92	ST	ST	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	93	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	242	94	segment	segment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	95	elevation	elevation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	96	myocardial	myocardial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	97	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	98	pa-	pa-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	99	tient	tient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	100	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	242	101	appropriate	appropriate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	102	dual	dual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	103	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	104	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	105	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	242	106	DAPT	DAPT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	107	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	242	108	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	242	109	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	110	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	111	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	242	112	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	242	113	started	start	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	242	114	upstream	upstream	RB
work_vvlzsj54cvf5de6ji6py6krqlm	242	115	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	242	116	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	242	117	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	242	118	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	242	119	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	242	120	discontinued	discontinue	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	242	121	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	242	122	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	242	123	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	124	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	242	125	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	242	126	scheduled	schedule	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	242	127	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	242	128	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	242	129	urgent	urgent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	242	130	catheterization	catheterization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	242	131	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	243	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	243	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	243	3	ab-	ab-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	243	4	sence	sence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	243	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	243	6	electrical	electrical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	243	7	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	243	8	hemodynamic	hemodynamic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	243	9	instability	instability	NN
work_vvlzsj54cvf5de6ji6py6krqlm	243	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	243	11	it	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	243	12	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	243	13	reasonable	reasonable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	243	14	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	243	15	wait	wait	VB
work_vvlzsj54cvf5de6ji6py6krqlm	243	16	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	243	17	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	243	18	effects	effect	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	243	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	243	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	243	21	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	243	22	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	243	23	dissi-	dissi-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	243	24	pate	pate	VB
work_vvlzsj54cvf5de6ji6py6krqlm	243	25	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	243	26	then	then	RB
work_vvlzsj54cvf5de6ji6py6krqlm	243	27	perform	perform	VB
work_vvlzsj54cvf5de6ji6py6krqlm	243	28	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	243	29	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	243	30	through	through	IN
work_vvlzsj54cvf5de6ji6py6krqlm	243	31	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	243	32	radial	radial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	243	33	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	243	34	approach	approach	NN
work_vvlzsj54cvf5de6ji6py6krqlm	243	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	244	1	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	244	2	Considerations	Considerations	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	244	3	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	244	4	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	244	5	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	244	6	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	244	7	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	244	8	angiography	angiography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	244	9	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	244	10	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	244	11	will	will	MD
work_vvlzsj54cvf5de6ji6py6krqlm	244	12	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	244	13	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	244	14	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	244	15	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	244	16	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	244	17	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	244	18	com-	com-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	244	19	plications	plication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	244	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	244	21	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	244	22	therefore	therefore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	244	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	244	24	careful	careful	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	244	25	attention	attention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	244	26	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	244	27	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	244	28	made	make	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	244	29	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	244	30	choice	choice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	244	31	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	244	32	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	244	33	access	access	NN
work_vvlzsj54cvf5de6ji6py6krqlm	244	34	site	site	NN
work_vvlzsj54cvf5de6ji6py6krqlm	244	35	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	244	36	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	244	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	244	38	ad-	ad-	CC
work_vvlzsj54cvf5de6ji6py6krqlm	244	39	junctive	junctive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	244	40	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	244	41	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	245	1	Patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	245	2	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	245	3	undergo	undergo	VB
work_vvlzsj54cvf5de6ji6py6krqlm	245	4	radial	radial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	245	5	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	245	6	access	access	NN
work_vvlzsj54cvf5de6ji6py6krqlm	245	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	245	8	unless	unless	IN
work_vvlzsj54cvf5de6ji6py6krqlm	245	9	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	245	10	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	245	11	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	245	12	contraindication	contraindication	NN
work_vvlzsj54cvf5de6ji6py6krqlm	245	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	245	14	be-	be-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	245	15	cause	cause	VB
work_vvlzsj54cvf5de6ji6py6krqlm	245	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	245	17	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	245	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	245	19	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	245	20	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	245	21	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	245	22	complications	complication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	245	23	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	245	24	reduced	reduce	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	245	25	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	245	26	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	245	27	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	245	28	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	245	29	femoral	femoral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	245	30	approach.123	approach.123	NN
work_vvlzsj54cvf5de6ji6py6krqlm	245	31	If	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	245	32	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	245	33	femoral	femoral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	245	34	approach	approach	NN
work_vvlzsj54cvf5de6ji6py6krqlm	245	35	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	245	36	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	245	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	245	38	one	one	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	245	39	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	245	40	consider	consider	VB
work_vvlzsj54cvf5de6ji6py6krqlm	245	41	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	245	42	ultrasonography	ultrasonography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	245	43	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	245	44	fluoroscopy	fluoroscopy	VB
work_vvlzsj54cvf5de6ji6py6krqlm	245	45	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	245	46	guide	guide	VB
work_vvlzsj54cvf5de6ji6py6krqlm	245	47	vas-	vas-	DT
work_vvlzsj54cvf5de6ji6py6krqlm	245	48	cular	cular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	245	49	access	access	NN
work_vvlzsj54cvf5de6ji6py6krqlm	245	50	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	246	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	246	2	micropuncture	micropuncture	NN
work_vvlzsj54cvf5de6ji6py6krqlm	246	3	needle	needle	NN
work_vvlzsj54cvf5de6ji6py6krqlm	246	4	technique	technique	NN
work_vvlzsj54cvf5de6ji6py6krqlm	246	5	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	246	6	decrease	decrease	VB
work_vvlzsj54cvf5de6ji6py6krqlm	246	7	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	246	8	probability	probability	NN
work_vvlzsj54cvf5de6ji6py6krqlm	246	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	246	10	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	246	11	retroperitoneal	retroperitoneal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	246	12	bleed	bleed	NN
work_vvlzsj54cvf5de6ji6py6krqlm	246	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	247	1	Although	although	IN
work_vvlzsj54cvf5de6ji6py6krqlm	247	2	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	247	3	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	247	4	exist	exist	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	247	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	247	6	it	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	247	7	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	247	8	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	247	9	reasonable	reasonable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	247	10	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	247	11	use	use	VB
work_vvlzsj54cvf5de6ji6py6krqlm	247	12	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	247	13	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	247	14	closure	closure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	247	15	device	device	NN
work_vvlzsj54cvf5de6ji6py6krqlm	247	16	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	247	17	assist	assist	VB
work_vvlzsj54cvf5de6ji6py6krqlm	247	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	247	19	postproce-	postproce-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	247	20	dure	dure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	247	21	hemostasis	hemostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	247	22	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	247	23	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	247	24	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	247	25	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	247	26	amenable	amenable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	247	27	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	247	28	anatomy	anatomy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	247	29	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	248	1	Venous	venous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	248	2	access	access	NN
work_vvlzsj54cvf5de6ji6py6krqlm	248	3	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	248	4	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	248	5	avoided	avoid	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	248	6	unless	unless	IN
work_vvlzsj54cvf5de6ji6py6krqlm	248	7	absolutely	absolutely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	248	8	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	248	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	249	1	All	all	DT
work_vvlzsj54cvf5de6ji6py6krqlm	249	2	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	249	3	undergoing	undergoing	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	249	4	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	249	5	re-	re-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	249	6	quire	quire	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	249	7	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	249	8	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	249	9	coupled	couple	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	249	10	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	249	11	either	either	DT
work_vvlzsj54cvf5de6ji6py6krqlm	249	12	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	249	13	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	249	14	bivalirudin	bivalirudin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	249	15	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	249	16	reduce	reduce	VB
work_vvlzsj54cvf5de6ji6py6krqlm	249	17	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	249	18	periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	249	19	thrombotic	thrombotic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	249	20	complication	complication	NN
work_vvlzsj54cvf5de6ji6py6krqlm	249	21	rates	rate	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	249	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	249	23	irrespective	irrespective	RB
work_vvlzsj54cvf5de6ji6py6krqlm	249	24	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	249	25	background	background	NN
work_vvlzsj54cvf5de6ji6py6krqlm	249	26	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	249	27	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	249	28	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	249	29	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	249	30	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	249	31	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	249	32	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	249	33	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	249	34	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	249	35	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	249	36	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	249	37	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	249	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	249	39	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	249	40	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	249	41	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	249	42	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	249	43	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	249	44	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	249	45	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	249	46	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	249	47	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	249	48	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	249	49	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	249	50	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	249	51	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	249	52	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	249	53	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	250	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	250	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	250	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	250	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	251	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	251	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	251	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	251	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	251	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	251	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	251	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	251	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	251	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	251	10	e619	e619	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	251	11	CLINICAL	clinical	NN
work_vvlzsj54cvf5de6ji6py6krqlm	251	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	251	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	251	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	251	15	GUIDELINES	GUIDELINES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	251	16	VKAs	VKAs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	251	17	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	251	18	NOACs.124	noacs.124	NN
work_vvlzsj54cvf5de6ji6py6krqlm	251	19	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	251	20	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	251	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	251	22	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	251	23	glycoprotein	glycoprotein	NN
work_vvlzsj54cvf5de6ji6py6krqlm	251	24	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	251	25	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	251	26	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	251	27	discouraged	discourage	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	251	28	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	251	29	reserved	reserve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	251	30	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	251	31	bailout	bailout	NN
work_vvlzsj54cvf5de6ji6py6krqlm	251	32	scenarios	scenario	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	251	33	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	252	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	252	2	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	252	3	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	252	4	receive	receive	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	252	5	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	252	6	hepa-	hepa-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	7	rin	rin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	252	9	one	one	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	252	10	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	252	11	use	use	VB
work_vvlzsj54cvf5de6ji6py6krqlm	252	12	low	low	RB
work_vvlzsj54cvf5de6ji6py6krqlm	252	13	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	252	14	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	15	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	252	16	regimens	regimen	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	252	17	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	252	18	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	252	19	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	252	20	clotting	clotting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	21	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	22	goal	goal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	23	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	252	24	≈250	≈250	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	25	seconds	second	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	252	26	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	252	27	re-	re-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	252	28	duce	duce	VB
work_vvlzsj54cvf5de6ji6py6krqlm	252	29	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	252	30	complications.125	complications.125	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	252	31	Postprocedural	Postprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	252	32	Considerations	Considerations	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	252	33	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	252	34	clinician	clinician	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	35	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	252	36	consider	consider	VB
work_vvlzsj54cvf5de6ji6py6krqlm	252	37	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	252	38	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	39	’s	’s	POS
work_vvlzsj54cvf5de6ji6py6krqlm	252	40	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	41	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	252	42	recur-	recur-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	252	43	rent	rent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	44	myocardial	myocardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	252	45	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	252	47	stent	stent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	252	48	thrombosis	thrombosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	49	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	252	50	thromboem-	thromboem-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	252	51	bolic	bolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	252	52	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	252	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	252	54	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	252	55	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	252	56	complications	complication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	252	57	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	252	58	selecting	select	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	252	59	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	252	60	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	253	1	It	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	253	2	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	253	3	helpful	helpful	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	253	4	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	253	5	use	use	VB
work_vvlzsj54cvf5de6ji6py6krqlm	253	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	253	7	CHA	CHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	253	8	2DS2-VASc	2ds2-vasc	CD
work_vvlzsj54cvf5de6ji6py6krqlm	253	9	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	10	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	11	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	253	12	estimate	estimate	VB
work_vvlzsj54cvf5de6ji6py6krqlm	253	13	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	253	14	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	253	15	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	253	17	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	253	18	HAS-	HAS-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	253	19	BLED	BLED	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	253	20	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	21	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	22	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	253	23	estimate	estimate	VB
work_vvlzsj54cvf5de6ji6py6krqlm	253	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	253	25	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	253	26	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	27	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	253	28	in-	in-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	29	clude	clude	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	253	30	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	253	31	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	32	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	253	33	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	253	34	shared	share	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	253	35	decision	decision	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	36	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	253	37	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	253	38	selec-	selec-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	39	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	40	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	253	41	DAPT	DAPT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	253	42	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	253	43	triple	triple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	253	44	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	45	as	as	RB
work_vvlzsj54cvf5de6ji6py6krqlm	253	46	well	well	RB
work_vvlzsj54cvf5de6ji6py6krqlm	253	47	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	253	48	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	253	49	duration	duration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	50	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	253	51	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	253	52	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	254	1	Several	several	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	254	2	themes	theme	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	254	3	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	254	4	emerged	emerge	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	254	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	255	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	255	2	standard	standard	NN
work_vvlzsj54cvf5de6ji6py6krqlm	255	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	255	4	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	255	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	255	6	reduce	reduce	VB
work_vvlzsj54cvf5de6ji6py6krqlm	255	7	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	255	8	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	255	9	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	255	10	post	post	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	255	11	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	255	12	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	255	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	255	14	post	post	NN
work_vvlzsj54cvf5de6ji6py6krqlm	255	15	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	255	16	ACS	ACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	255	17	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	255	18	DAPT	dapt	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	255	19	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	256	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	256	2	duration	duration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	256	4	DAPT	DAPT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	256	5	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	256	6	directly	directly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	256	7	impact-	impact-	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	256	8	ed	ed	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	256	9	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	256	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	256	11	stent	stent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	256	12	type	type	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	13	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	256	14	bare	bare	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	256	15	metal	metal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	16	stent	stent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	17	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	256	18	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	19	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	256	20	eluting	elute	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	256	21	stent	stent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	22	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	256	23	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	256	24	whether	whether	IN
work_vvlzsj54cvf5de6ji6py6krqlm	256	25	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	256	26	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	27	underwent	undergo	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	256	28	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	256	29	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	256	30	stable	stable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	256	31	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	256	32	heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	33	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	34	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	256	35	ACS.126	acs.126	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	36	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	256	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	256	38	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	256	39	anti-	anti-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	256	40	thrombotic	thrombotic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	256	41	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	256	42	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	256	43	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	256	44	antiplatelet	antiplatelet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	256	45	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	256	46	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	256	47	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	256	48	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	256	49	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	256	50	prevent	prevent	VB
work_vvlzsj54cvf5de6ji6py6krqlm	256	51	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	256	52	related	related	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	256	53	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	54	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	256	55	VTE	vte	NN
work_vvlzsj54cvf5de6ji6py6krqlm	256	56	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	257	1	Therefore	therefore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	257	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	257	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	257	4	clini-	clini-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	257	5	cian	cian	NN
work_vvlzsj54cvf5de6ji6py6krqlm	257	6	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	257	7	faced	face	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	257	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	257	9	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	257	10	consideration	consideration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	257	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	257	12	DAPT	DAPT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	257	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	257	14	DAPT	DAPT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	257	15	plus	plus	CC
work_vvlzsj54cvf5de6ji6py6krqlm	257	16	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	257	17	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	257	18	triple	triple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	257	19	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	257	20	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	257	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	257	22	DAPT	DAPT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	257	23	plus	plus	CC
work_vvlzsj54cvf5de6ji6py6krqlm	257	24	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	257	25	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	257	26	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	257	27	triple	triple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	257	28	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	257	29	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	257	30	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	257	31	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	257	32	plus	plus	CC
work_vvlzsj54cvf5de6ji6py6krqlm	257	33	single	single	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	257	34	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	257	35	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	257	36	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	258	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	2	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	258	3	phase	phase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	258	4	II	ii	CD
work_vvlzsj54cvf5de6ji6py6krqlm	258	5	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	258	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	258	7	triple	triple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	258	8	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	258	9	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	10	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	258	11	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	12	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	258	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	14	ACS	ACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	258	15	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	258	16	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	258	17	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	18	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	258	19	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	258	20	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	258	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	22	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	258	23	complications	complication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	258	24	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	258	25	planned	plan	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	258	26	phase	phase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	258	27	III	iii	CD
work_vvlzsj54cvf5de6ji6py6krqlm	258	28	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	258	29	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	258	30	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	258	31	pursued.127	pursued.127	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	258	32	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	33	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	258	34	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	258	35	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	258	36	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	258	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	38	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	258	39	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	40	ACS	ACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	258	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	258	42	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	258	43	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	258	44	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	258	45	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	46	reducing	reduce	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	258	47	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	258	48	event	event	NN
work_vvlzsj54cvf5de6ji6py6krqlm	258	49	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	50	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	258	51	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	258	52	either	either	DT
work_vvlzsj54cvf5de6ji6py6krqlm	258	53	DAPT	dapt	NN
work_vvlzsj54cvf5de6ji6py6krqlm	258	54	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	258	55	aspirin	aspirin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	258	56	alone	alone	RB
work_vvlzsj54cvf5de6ji6py6krqlm	258	57	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	259	1	Intracranial	intracranial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	259	2	bleed	bleed	NN
work_vvlzsj54cvf5de6ji6py6krqlm	259	3	rates	rate	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	259	4	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	259	5	in-	in-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	259	6	creased	crease	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	259	7	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	259	8	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	259	9	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	259	10	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	259	11	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	259	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	260	1	Because	because	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	3	concerns	concern	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	260	4	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	260	5	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	260	6	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	7	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	260	8	signal	signal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	260	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	10	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	260	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	260	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	260	13	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	260	14	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	260	15	terminated.128	terminated.128	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	16	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	17	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	260	18	studied	study	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	260	19	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	260	21	ATLAS	ATLAS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	22	ACS	ACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	23	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	260	24	TIMI	TIMI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	25	51	51	CD
work_vvlzsj54cvf5de6ji6py6krqlm	260	26	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	260	27	Anti	Anti	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	28	-	-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	29	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	30	Therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	260	31	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	32	Lower	Lower	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	33	Cardiovascular	Cardiovascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	34	Events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	260	35	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	36	Addition	addition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	260	37	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	38	Aspirin	Aspirin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	39	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	40	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	260	41	Without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	42	Thienopyridine	Thienopyridine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	43	Therapy	Therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	44	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	45	Subjects	subject	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	260	46	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	47	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	48	Coronary	Coronary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	49	Syndrome	Syndrome	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	50	—	—	:
work_vvlzsj54cvf5de6ji6py6krqlm	260	51	Thrombolysis	Thrombolysis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	52	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	53	Myocardial	Myocardial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	54	In-	In-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	55	farction	farction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	260	56	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	260	57	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	260	58	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	260	59	which	which	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	260	60	compared	compare	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	260	61	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	260	62	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	260	63	placebo	placebo	NN
work_vvlzsj54cvf5de6ji6py6krqlm	260	64	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	65	addition	addition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	260	66	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	260	67	standard	standard	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	260	68	ACS	ACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	260	69	therapies	therapy	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	260	70	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	261	1	Compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	261	2	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	261	3	placebo	placebo	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	261	5	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	6	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	261	7	2.5	2.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	261	8	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	261	9	twice	twice	RB
work_vvlzsj54cvf5de6ji6py6krqlm	261	10	daily	daily	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	261	11	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	261	12	5.0	5.0	CD
work_vvlzsj54cvf5de6ji6py6krqlm	261	13	mg	mg	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	14	twice	twice	RB
work_vvlzsj54cvf5de6ji6py6krqlm	261	15	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	261	16	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	261	17	decreased	decrease	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	261	18	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	261	19	rates	rate	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	261	20	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	261	21	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	261	22	composite	composite	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	261	23	pri-	pri-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	261	24	mary	mary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	261	25	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	26	point	point	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	27	including	include	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	261	28	cardiovascular	cardiovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	261	29	death	death	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	261	31	myo-	myo-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	261	32	cardial	cardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	261	33	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	34	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	261	35	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	36	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	261	37	10.7	10.7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	261	38	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	39	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	261	40	8.9	8.9	CD
work_vvlzsj54cvf5de6ji6py6krqlm	261	41	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	42	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	261	43	while	while	IN
work_vvlzsj54cvf5de6ji6py6krqlm	261	44	increasing	increase	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	261	45	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	261	46	rates	rate	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	261	47	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	261	48	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	261	49	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	261	50	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	261	51	–	–	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	261	52	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	261	53	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	54	bypass	bypass	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	261	55	graft	graft	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	56	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	57	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	261	58	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	261	59	ICH.129	ICH.129	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	261	60	Only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	261	61	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	261	62	cou-	cou-	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	261	63	pled	plead	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	261	64	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	261	65	DAPT	DAPT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	261	66	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	261	67	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	261	68	demonstrated	demonstrate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	261	69	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	261	70	reduce	reduce	VB
work_vvlzsj54cvf5de6ji6py6krqlm	261	71	isch-	isch-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	261	72	emic	emic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	261	73	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	261	74	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	261	75	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	261	76	cost	cost	NN
work_vvlzsj54cvf5de6ji6py6krqlm	261	77	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	261	78	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	261	79	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	261	80	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	262	1	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	262	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	262	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	262	4	studied	study	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	262	5	doses	dose	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	262	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	262	7	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	262	8	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	262	9	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	262	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	262	11	doses	dose	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	262	12	proven	prove	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	262	13	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	262	14	reduce	reduce	VB
work_vvlzsj54cvf5de6ji6py6krqlm	262	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	262	16	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	262	17	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	262	18	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	262	19	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	262	20	secondary	secondary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	262	21	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	262	22	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	262	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	263	1	European	european	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	263	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	263	3	Canadian	canadian	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	263	4	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	263	5	suggest	suggest	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	263	6	NOACs	noac	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	263	7	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	263	8	preferred	prefer	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	263	9	over	over	IN
work_vvlzsj54cvf5de6ji6py6krqlm	263	10	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	263	11	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	263	12	it	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	263	13	comes	come	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	263	14	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	263	15	triple	triple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	263	16	ther-	ther-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	263	17	apy	apy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	263	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	264	1	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	264	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	264	3	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	264	4	recommendations	recommendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	264	5	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	264	6	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	264	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	264	8	observational	observational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	264	9	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	264	10	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	264	11	post	post	FW
work_vvlzsj54cvf5de6ji6py6krqlm	264	12	hoc	hoc	FW
work_vvlzsj54cvf5de6ji6py6krqlm	264	13	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	264	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	264	15	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	264	16	vs.	vs.	IN
work_vvlzsj54cvf5de6ji6py6krqlm	264	17	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	264	18	studies	study	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	264	19	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	264	20	limited	limited	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	264	21	number	number	NN
work_vvlzsj54cvf5de6ji6py6krqlm	264	22	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	264	23	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	264	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	265	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	265	2	ex-	ex-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	265	3	ample	ample	NN
work_vvlzsj54cvf5de6ji6py6krqlm	265	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	265	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	265	6	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	265	7	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	265	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	265	9	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	265	10	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	265	11	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	265	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	265	13	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	265	14	underwent	undergo	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	265	15	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	265	16	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	265	17	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	265	18	trial.130	trial.130	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	265	19	Until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	265	20	further	further	RB
work_vvlzsj54cvf5de6ji6py6krqlm	265	21	prospective	prospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	265	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	265	23	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	265	24	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	265	25	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	265	26	become	become	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	265	27	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	265	28	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	265	29	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	265	30	subject	subject	NN
work_vvlzsj54cvf5de6ji6py6krqlm	265	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	265	32	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	265	33	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	265	34	writ-	writ-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	265	35	ing	ing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	265	36	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	265	37	suggests	suggest	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	265	38	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	265	39	clinicians	clinician	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	265	40	use	use	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	265	41	good	good	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	265	42	judgment	judgment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	265	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	265	44	weighing	weigh	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	265	45	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	265	46	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	265	47	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	265	48	benefits	benefit	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	265	49	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	265	50	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	265	51	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	265	52	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	265	53	context	context	NN
work_vvlzsj54cvf5de6ji6py6krqlm	265	54	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	265	55	triple	triple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	265	56	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	265	57	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	265	58	their	-PRON-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	265	59	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	265	60	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	266	1	Proton	Proton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	266	2	pump	pump	NN
work_vvlzsj54cvf5de6ji6py6krqlm	266	3	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	266	4	decrease	decrease	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	266	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	266	6	rates	rate	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	266	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	266	8	upper	upper	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	266	9	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	266	10	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	266	11	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	266	12	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	266	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	266	14	DAPT	DAPT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	266	15	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	266	16	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	266	17	pa-	pa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	266	18	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	266	19	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	266	20	DAPT	dapt	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	266	21	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	266	22	antithrombotic	antithrombotic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	266	23	therapy.131	therapy.131	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	266	24	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	266	25	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	266	26	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	266	27	advised	advise	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	266	28	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	266	29	avoid	avoid	VB
work_vvlzsj54cvf5de6ji6py6krqlm	266	30	nonsteroidal	nonsteroidal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	266	31	anti	anti	NN
work_vvlzsj54cvf5de6ji6py6krqlm	266	32	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	266	33	inflammato-	inflammato-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	266	34	ry	ry	IN
work_vvlzsj54cvf5de6ji6py6krqlm	266	35	medications	medication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	266	36	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	266	37	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	266	38	risks	risk	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	266	39	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	266	40	myocardial	myocardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	266	41	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	266	42	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	266	43	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	266	44	complications	complication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	266	45	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	266	46	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	266	47	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	267	1	Ongoing	ongoing	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	267	2	ran-	ran-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	267	3	domized	domize	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	267	4	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	267	5	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	267	6	Pioneer	Pioneer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	7	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	267	9	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	10	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	267	11	Open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	267	12	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	267	13	Label	Label	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	267	15	Randomized	Randomized	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	267	17	Controlled	control	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	267	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	267	19	Multicenter	Multicenter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	20	Study	Study	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	21	Exploring	Exploring	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	22	Two	two	CD
work_vvlzsj54cvf5de6ji6py6krqlm	267	23	Treatment	Treatment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	24	Strategies	Strategies	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	267	25	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	267	26	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	27	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	267	28	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	267	29	Dose	Dose	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	30	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	267	31	Adjusted	Adjusted	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	32	Oral	Oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	33	Vi-	Vi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	34	tamin	tamin	DT
work_vvlzsj54cvf5de6ji6py6krqlm	267	35	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	36	Antagonist	Antagonist	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	37	Treatment	Treatment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	38	Strategy	Strategy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	39	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	267	40	Subjects	Subjects	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	41	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	267	42	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	43	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	44	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	267	45	Undergo	undergo	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	267	46	Percutaneous	Percutaneous	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	47	Coronary	Coronary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	48	Intervention],132	Intervention],132	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	49	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	50	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	267	51	DUAL	dual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	267	52	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	53	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	267	54	Evaluation	evaluation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	267	55	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	267	56	Dual	Dual	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	57	Therapy	Therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	58	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	267	59	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	267	60	vs.	vs.	''
work_vvlzsj54cvf5de6ji6py6krqlm	268	1	Triple	triple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	268	2	Therapy	Therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	3	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	4	Warfarin	Warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	6	Pa-	Pa-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	7	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	268	8	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	9	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	10	That	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	268	11	Undergo	Undergo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	12	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	268	13	PCI	pci	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	14	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	15	Stenting	stenting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	16	]	]	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	268	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	268	18	RT	RT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	19	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	268	20	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	21	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	268	22	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	23	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	24	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	268	25	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	26	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	27	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	28	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	268	29	Coro-	Coro-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	30	nary	nary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	268	31	Artery	Artery	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	32	Disease	Disease	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	33	Undergoing	Undergoing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	34	Percutaneous	Percutaneous	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	35	Coronary	Coronary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	36	Intervention],133	Intervention],133	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	37	SAFE	SAFE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	38	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	268	39	A	a	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	40	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	268	41	Safety	Safety	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	42	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	268	43	Effectiveness	Effectiveness	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	44	Trial	Trial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	45	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	46	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	47	Use	Use	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	48	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	49	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	50	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	51	Dual	Dual	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	52	Antiplatelet	Antiplatelet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	53	Thera-	Thera-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	54	py	py	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	55	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	56	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	268	57	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	58	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	59	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	60	Undergoing	Undergoing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	61	Percuta-	Percuta-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	62	neous	neous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	268	63	Coronary	Coronary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	64	Intervention]134	Intervention]134	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	65	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	268	66	AUGUSTUS	AUGUSTUS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	67	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	268	68	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	268	69	Study	Study	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	70	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	71	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	72	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	73	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	268	74	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	75	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	76	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	77	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	268	78	Not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	268	79	Caused	cause	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	268	80	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	81	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	268	82	Heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	83	Valve	Valve	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	84	Problem	problem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	85	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	268	86	Who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	268	87	Are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	268	88	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	89	Risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	90	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	91	Thrombo-	thrombo-	CD
work_vvlzsj54cvf5de6ji6py6krqlm	268	92	sis	sis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	93	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	268	94	Blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	95	Clots	Clots	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	268	96	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	268	97	Due	due	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	98	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	99	Having	have	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	268	100	Had	have	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	268	101	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	268	102	Recent	Recent	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	103	Coronary	Coronary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	104	Event	Event	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	105	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	268	106	Such	such	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	268	107	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	108	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	268	109	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	110	Attack	attack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	111	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	268	112	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	268	113	Procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	114	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	268	115	Open	open	VB
work_vvlzsj54cvf5de6ji6py6krqlm	268	116	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	268	117	Vessels	vessel	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	268	118	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	119	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	268	120	Heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	121	]	]	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	268	122	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	268	123	will	will	MD
work_vvlzsj54cvf5de6ji6py6krqlm	268	124	assess	assess	VB
work_vvlzsj54cvf5de6ji6py6krqlm	268	125	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	268	126	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	127	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	128	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	268	129	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	130	coupled	couple	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	268	131	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	132	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	133	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	268	134	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	268	135	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	268	136	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	268	137	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	268	138	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	269	1	Until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	269	2	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	269	3	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	269	4	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	269	5	completed	complete	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	269	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	269	7	published	publish	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	269	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	269	9	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	269	10	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	269	11	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	269	12	makes	make	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	269	13	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	269	14	following	following	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	269	15	suggestions	suggestion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	269	16	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	269	17	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	269	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	270	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	270	2	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	270	3	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	270	4	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	270	5	CHA	CHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	270	6	2DS2-VASc	2ds2-vasc	CD
work_vvlzsj54cvf5de6ji6py6krqlm	270	7	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	270	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	270	9	0	0	CD
work_vvlzsj54cvf5de6ji6py6krqlm	270	10	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	270	11	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	270	12	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	270	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	270	14	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	270	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	270	16	it	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	270	17	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	270	18	reasonable	reasonable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	270	19	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	270	20	omit	omit	VB
work_vvlzsj54cvf5de6ji6py6krqlm	270	21	anticoagu-	anticoagu-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	270	22	lant	lant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	270	23	therapy	therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	270	24	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	270	25	treat	treat	VB
work_vvlzsj54cvf5de6ji6py6krqlm	270	26	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	270	27	DAPT	DAPT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	270	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	271	1	2	2	LS
work_vvlzsj54cvf5de6ji6py6krqlm	271	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	272	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	272	2	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	272	3	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	272	4	require	require	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	272	5	DAPT	dapt	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	272	6	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	272	7	triple	triple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	272	8	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	272	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	272	10	use	use	VB
work_vvlzsj54cvf5de6ji6py6krqlm	272	11	low	low	RB
work_vvlzsj54cvf5de6ji6py6krqlm	272	12	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	272	13	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	272	14	aspirin	aspirin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	272	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	272	16	81	81	CD
work_vvlzsj54cvf5de6ji6py6krqlm	272	17	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	272	18	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	272	19	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	273	1	3	3	LS
work_vvlzsj54cvf5de6ji6py6krqlm	273	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	274	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	274	2	stable	stable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	274	3	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	274	4	heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	274	5	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	274	6	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	274	7	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	274	8	require	require	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	274	9	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	274	10	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	274	11	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	274	12	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	274	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	274	14	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	274	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	274	16	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	274	17	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	274	18	P2Y	p2y	NN
work_vvlzsj54cvf5de6ji6py6krqlm	274	19	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	274	20	inhibitor	inhibitor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	274	21	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	274	22	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	274	23	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	274	24	months	month	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	274	25	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	274	26	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	274	27	reasonable.126	reasonable.126	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	274	28	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	274	29	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	275	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	275	2	ACS	ACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	275	3	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	275	4	requiring	require	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	275	5	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	275	6	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	275	7	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	275	8	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	275	9	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	275	10	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	275	11	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	275	12	bare	bare	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	275	13	metal	metal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	275	14	stent	stent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	275	15	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	275	16	drug-	drug-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	275	17	eluting	elute	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	275	18	stent	stent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	275	19	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	275	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	275	21	continuation	continuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	275	22	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	275	23	aspirin	aspirin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	275	24	81	81	CD
work_vvlzsj54cvf5de6ji6py6krqlm	275	25	mg	mg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	275	26	daily	daily	RB
work_vvlzsj54cvf5de6ji6py6krqlm	275	27	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	275	28	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	275	29	year	year	NN
work_vvlzsj54cvf5de6ji6py6krqlm	275	30	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	275	31	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	275	32	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	275	33	P2Y	p2y	NN
work_vvlzsj54cvf5de6ji6py6krqlm	275	34	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	275	35	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	275	36	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	275	37	6	6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	275	38	months	month	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	275	39	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	275	40	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	275	41	reasonable.126	reasonable.126	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	275	42	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	275	43	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	276	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	276	2	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	276	3	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	276	4	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	276	5	moderate	moderate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	276	6	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	276	7	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	276	8	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	276	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	276	10	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	276	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	276	12	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	276	13	assessed	assess	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	276	14	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	276	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	276	16	HAS	HAS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	276	17	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	276	18	BLED	BLED	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	276	19	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	276	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	276	21	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	276	22	shortened	shorten	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	276	23	duration	duration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	276	24	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	276	25	triple	triple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	276	26	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	276	27	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	276	28	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	276	29	plus	plus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	276	30	clopidogrel	clopidogrel	NN
work_vvlzsj54cvf5de6ji6py6krqlm	276	31	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	276	32	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	276	33	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	276	34	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	276	35	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	276	36	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	276	37	exploratory	exploratory	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	276	38	WOEST	woest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	276	39	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	276	40	What	what	WP
work_vvlzsj54cvf5de6ji6py6krqlm	276	41	Is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	276	42	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	276	43	Optimal	Optimal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	276	44	Antiplatelet	Antiplatelet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	276	45	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	276	46	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	276	47	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	276	48	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	276	49	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	276	50	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	276	51	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	276	52	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	276	53	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	276	54	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	276	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	276	56	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	276	57	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	276	58	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	276	59	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	276	60	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	276	61	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	276	62	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	276	63	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	276	64	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	276	65	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	277	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	277	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	277	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	277	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	278	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	278	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	278	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	278	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	278	5	CIR.0000000000000477e620	CIR.0000000000000477e620	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	278	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	278	7	Anticoagulant	Anticoagulant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	278	8	Therapy	Therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	278	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	278	10	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	278	11	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	278	12	Oral	Oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	278	13	Anticoagulation	Anticoagulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	278	14	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	278	15	Coronary	Coronary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	278	16	Stenting	Stenting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	278	17	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	278	18	trial.135	trial.135	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	278	19	6	6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	278	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	279	1	Prasugrel	Prasugrel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	279	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	279	3	ticagrelor	ticagrelor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	279	4	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	279	5	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	279	6	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	279	7	used	use	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	279	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	279	9	conjunction	conjunction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	279	10	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	279	11	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	279	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	279	13	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	279	14	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	279	15	result	result	NN
work_vvlzsj54cvf5de6ji6py6krqlm	279	16	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	279	17	excessive	excessive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	279	18	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	279	19	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	279	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	280	1	7	7	LS
work_vvlzsj54cvf5de6ji6py6krqlm	280	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	281	1	At	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	281	2	present	present	NN
work_vvlzsj54cvf5de6ji6py6krqlm	281	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	281	4	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	281	5	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	281	6	limited	limit	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	281	7	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	281	8	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	281	9	recommend	recommend	VB
work_vvlzsj54cvf5de6ji6py6krqlm	281	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	281	11	routine	routine	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	281	12	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	281	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	281	14	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	281	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	281	16	coupled	couple	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	281	17	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	281	18	clopidogrel	clopidogrel	NN
work_vvlzsj54cvf5de6ji6py6krqlm	281	19	alone	alone	RB
work_vvlzsj54cvf5de6ji6py6krqlm	281	20	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	281	21	DAPT	dapt	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	281	22	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	281	23	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	281	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	282	1	Of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	282	2	note	note	NN
work_vvlzsj54cvf5de6ji6py6krqlm	282	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	282	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	282	5	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	282	6	prac-	prac-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	282	7	tice	tice	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	282	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	282	9	it	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	282	10	can	can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	282	11	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	282	12	challenging	challenge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	282	13	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	282	14	reach	reach	VB
work_vvlzsj54cvf5de6ji6py6krqlm	282	15	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	282	16	maintain	maintain	VB
work_vvlzsj54cvf5de6ji6py6krqlm	282	17	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	282	18	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	282	19	levels	level	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	282	20	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	282	21	certain	certain	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	282	22	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	282	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	283	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	283	2	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	283	3	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	283	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	283	5	it	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	283	6	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	283	7	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	283	8	reasonable	reasonable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	283	9	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	283	10	combine	combine	VB
work_vvlzsj54cvf5de6ji6py6krqlm	283	11	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	283	12	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	283	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	283	14	clopidogrel	clopidogrel	NN
work_vvlzsj54cvf5de6ji6py6krqlm	283	15	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	283	16	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	283	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	284	1	Cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	3	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	4	Post	Post	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	5	hoc	hoc	FW
work_vvlzsj54cvf5de6ji6py6krqlm	284	6	analyses	analysis	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	284	7	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	8	pivotal	pivotal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	9	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	10	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	11	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	284	12	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	284	13	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	284	14	shown	show	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	284	15	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	16	differences	difference	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	284	17	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	18	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	284	19	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	20	car-	car-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	21	dioversion	dioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	22	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	23	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	284	24	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	284	25	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	26	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	284	27	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	284	28	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	29	warfarin.136–138	warfarin.136–138	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	30	Meta	Meta	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	31	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	284	32	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	33	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	34	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	284	35	across	across	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	36	random-	random-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	37	ized	ized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	38	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	284	39	appears	appear	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	284	40	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	284	41	confirm	confirm	VB
work_vvlzsj54cvf5de6ji6py6krqlm	284	42	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	284	43	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	284	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	284	45	finding	find	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	284	46	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	284	47	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	48	difference	difference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	49	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	50	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	51	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	284	52	systemic	systemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	53	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	54	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	284	55	odds	odd	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	284	56	ratio	ratio	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	57	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	284	58	0.73	0.73	CD
work_vvlzsj54cvf5de6ji6py6krqlm	284	59	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	284	60	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	284	61	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	62	CI	ci	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	63	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	284	64	0.31–1.72	0.31–1.72	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	65	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	284	66	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	284	67	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	68	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	284	69	non-	non-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	70	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	71	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	72	relevant	relevant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	73	International	International	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	74	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	75	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	76	Throm-	Throm-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	77	bosis	bosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	78	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	284	79	Haemostasis	haemostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	80	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	284	81	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	284	82	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	284	83	odds	odd	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	284	84	ratio	ratio	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	85	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	284	86	1.41	1.41	CD
work_vvlzsj54cvf5de6ji6py6krqlm	284	87	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	284	88	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	284	89	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	90	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	91	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	284	92	0.87–2.28	0.87–2.28	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	93	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	284	94	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	95	cardioversion.139,140	cardioversion.139,140	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	96	Moreover	moreover	RB
work_vvlzsj54cvf5de6ji6py6krqlm	284	97	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	284	98	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	284	99	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	284	100	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	284	101	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	102	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	284	103	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	104	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	105	car-	car-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	106	dioversion	dioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	107	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	108	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	284	109	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	284	110	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	111	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	284	112	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	113	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	114	inhibitor	inhibitor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	284	115	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	284	116	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	284	117	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	285	1	More	More	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	285	2	than	than	IN
work_vvlzsj54cvf5de6ji6py6krqlm	285	3	1500	1500	CD
work_vvlzsj54cvf5de6ji6py6krqlm	285	4	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	285	5	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	285	6	early	early	RB
work_vvlzsj54cvf5de6ji6py6krqlm	285	7	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	285	8	target	target	NN
work_vvlzsj54cvf5de6ji6py6krqlm	285	9	period	period	NN
work_vvlzsj54cvf5de6ji6py6krqlm	285	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	285	11	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	285	12	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	285	13	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	285	14	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	285	15	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	285	16	randomiza-	randomiza-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	285	17	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	285	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	285	19	transesophageal	transesophageal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	285	20	echocardiography	echocardiography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	285	21	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	285	22	TEE	TEE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	285	23	]	]	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	285	24	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	285	25	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	285	26	delayed	delay	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	285	27	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	285	28	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	285	29	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	285	30	8	8	CD
work_vvlzsj54cvf5de6ji6py6krqlm	285	31	weeks	week	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	285	32	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	285	33	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	285	34	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	285	35	random-	random-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	285	36	ized	ize	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	285	37	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	285	38	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	285	39	2:1	2:1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	285	40	fashion	fashion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	285	41	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	285	42	rivaroxaban	rivaroxaban	VB
work_vvlzsj54cvf5de6ji6py6krqlm	285	43	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	285	44	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	285	45	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	286	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	286	2	primary	primary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	286	3	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	4	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	5	point	point	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	6	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	286	7	composite	composite	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	286	9	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	286	11	tran-	tran-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	12	sient	sient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	286	13	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	286	14	attack	attack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	286	16	peripheral	peripheral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	286	17	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	286	19	myocardial	myocardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	286	20	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	286	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	286	23	cardiovascular	cardiovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	286	24	death	death	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	25	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	286	26	occurred	occur	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	286	27	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	286	28	0.51	0.51	CD
work_vvlzsj54cvf5de6ji6py6krqlm	286	29	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	30	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	286	31	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	286	32	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	286	33	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	286	34	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	286	35	1.02	1.02	CD
work_vvlzsj54cvf5de6ji6py6krqlm	286	36	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	286	38	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	286	39	VKA-	VKA-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	286	40	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	286	41	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	286	42	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	286	43	RR	RR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	286	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	286	45	0.50	0.50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	286	46	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	286	47	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	286	48	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	49	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	286	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	286	51	0.15–1.73	0.15–1.73	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	286	52	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	286	53	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	286	54	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	286	55	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	286	56	difference	difference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	57	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	286	58	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	286	59	observed.141	observed.141	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	286	60	Observational	observational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	286	61	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	286	62	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	286	63	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	286	64	practice	practice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	65	demonstrate	demonstrate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	286	66	similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	286	67	findings	finding	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	286	68	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	287	1	Data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	287	2	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	287	3	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	287	4	large	large	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	287	5	nationwide	nationwide	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	287	6	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	287	7	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	287	8	demonstrated	demonstrate	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	287	9	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	287	10	difference	difference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	287	11	between	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	287	12	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	287	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	287	14	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	287	15	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	287	16	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	287	17	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	287	18	versus	versus	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	287	19	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	287	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	288	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	2	1230	1230	CD
work_vvlzsj54cvf5de6ji6py6krqlm	288	3	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	288	4	un-	un-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	288	5	dergoing	dergoing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	6	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	288	8	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	288	9	cumulative	cumulative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	288	10	incidence	incidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	12	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	288	14	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	15	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	288	16	death	death	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	17	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	18	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	288	19	weeks	week	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	288	20	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	288	21	2.0	2.0	CD
work_vvlzsj54cvf5de6ji6py6krqlm	288	22	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	23	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	24	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	288	25	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	288	26	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	27	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	28	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	288	29	1.0	1.0	CD
work_vvlzsj54cvf5de6ji6py6krqlm	288	30	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	31	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	32	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	288	33	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	288	34	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	35	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	36	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	288	37	ad-	ad-	CC
work_vvlzsj54cvf5de6ji6py6krqlm	288	38	justed	justed	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	288	39	HR	hr	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	288	41	1.33	1.33	CD
work_vvlzsj54cvf5de6ji6py6krqlm	288	42	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	288	43	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	288	44	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	45	CI	CI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	288	47	0.33–5.42).142	0.33–5.42).142	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	48	High	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	288	49	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	288	50	volume	volume	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	51	single-	single-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	52	center	center	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	53	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	288	54	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	288	55	>	>	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	56	4600	4600	CD
work_vvlzsj54cvf5de6ji6py6krqlm	288	57	cardioversions	cardioversion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	288	58	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	288	59	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	288	60	also	also	RB
work_vvlzsj54cvf5de6ji6py6krqlm	288	61	failed	fail	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	288	62	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	288	63	iden-	iden-	VB
work_vvlzsj54cvf5de6ji6py6krqlm	288	64	tify	tify	VB
work_vvlzsj54cvf5de6ji6py6krqlm	288	65	any	any	DT
work_vvlzsj54cvf5de6ji6py6krqlm	288	66	difference	difference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	67	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	68	postcardioversion	postcardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	69	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	288	70	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	288	71	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	288	72	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	288	73	across	across	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	74	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	75	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	288	76	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	77	agents.143	agents.143	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	78	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	288	79	ENSURE	ENSURE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	80	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	288	81	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	82	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	83	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	288	84	Edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	85	Versus	Versus	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	86	Enoxaparin-	Enoxaparin-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	87	Warfarin	Warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	88	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	89	Patients	Patients	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	90	Undergoing	Undergoing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	91	Cardioversion	Cardioversion	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	92	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	93	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	94	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	95	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	288	96	randomized	randomize	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	288	97	2199	2199	CD
work_vvlzsj54cvf5de6ji6py6krqlm	288	98	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	288	99	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	100	either	either	CC
work_vvlzsj54cvf5de6ji6py6krqlm	288	101	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	102	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	288	103	enoxaparin	enoxaparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	104	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	288	105	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	106	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	107	TEE	TEE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	108	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	288	109	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	288	110	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	288	111	TEE	tee	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	288	112	guided	guide	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	288	113	electrical	electrical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	288	114	cardioversion.144	cardioversion.144	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	115	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	116	TEE	TEE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	117	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	288	118	guided	guide	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	288	119	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	120	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	288	121	randomization	randomization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	122	occurred	occur	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	288	123	<3	<3	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	288	124	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	288	125	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	126	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	127	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	288	128	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	129	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	288	130	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	288	131	continued	continue	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	288	132	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	288	133	at	at	RB
work_vvlzsj54cvf5de6ji6py6krqlm	288	134	least	least	RBS
work_vvlzsj54cvf5de6ji6py6krqlm	288	135	28	28	CD
work_vvlzsj54cvf5de6ji6py6krqlm	288	136	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	288	137	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	289	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	289	2	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	289	3	–	–	NN
work_vvlzsj54cvf5de6ji6py6krqlm	289	4	TEE	tee	NN
work_vvlzsj54cvf5de6ji6py6krqlm	289	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	289	6	guided	guide	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	289	7	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	289	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	289	9	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	289	10	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	289	11	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	289	12	initiat-	initiat-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	289	13	ed	ed	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	289	14	at	at	RB
work_vvlzsj54cvf5de6ji6py6krqlm	289	15	least	least	RBS
work_vvlzsj54cvf5de6ji6py6krqlm	289	16	21	21	CD
work_vvlzsj54cvf5de6ji6py6krqlm	289	17	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	289	18	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	289	19	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	289	20	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	289	21	extended	extend	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	289	22	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	289	23	at	at	RB
work_vvlzsj54cvf5de6ji6py6krqlm	289	24	least	least	RBS
work_vvlzsj54cvf5de6ji6py6krqlm	289	25	28	28	CD
work_vvlzsj54cvf5de6ji6py6krqlm	289	26	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	289	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	290	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	290	2	primary	primary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	290	3	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	290	4	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	290	5	point	point	NN
work_vvlzsj54cvf5de6ji6py6krqlm	290	6	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	290	7	compos-	compos-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	290	8	ite	ite	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	290	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	290	10	stroke	stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	290	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	290	12	systemic	systemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	290	13	embolic	embolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	290	14	event	event	NN
work_vvlzsj54cvf5de6ji6py6krqlm	290	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	290	16	myocardial	myocardial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	290	17	infarc-	infarc-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	290	18	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	290	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	290	20	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	290	21	cardiovascular	cardiovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	290	22	mortality	mortality	NN
work_vvlzsj54cvf5de6ji6py6krqlm	290	23	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	290	24	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	290	25	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	290	26	primary	primary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	290	27	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	290	28	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	290	29	point	point	NN
work_vvlzsj54cvf5de6ji6py6krqlm	290	30	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	290	31	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	290	32	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	290	33	clinically	clinically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	290	34	relevant	relevant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	290	35	nonmajor	nonmajor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	290	36	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	290	37	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	290	38	occurred	occur	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	290	39	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	290	40	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	290	41	statistically	statistically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	290	42	similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	290	43	frequency	frequency	NN
work_vvlzsj54cvf5de6ji6py6krqlm	290	44	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	291	1	Edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	291	2	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	291	3	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	291	4	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	291	5	effective	effective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	291	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	291	7	safe	safe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	291	8	alternative	alternative	NN
work_vvlzsj54cvf5de6ji6py6krqlm	291	9	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	291	10	enoxaparin	enoxaparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	291	11	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	291	12	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	291	13	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	291	14	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	291	15	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	291	16	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	291	17	requiring	require	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	291	18	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	291	19	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	292	1	Several	several	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	292	2	practical	practical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	292	3	considerations	consideration	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	292	4	must	must	MD
work_vvlzsj54cvf5de6ji6py6krqlm	292	5	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	292	6	weighed	weigh	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	292	7	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	292	8	cardioverting	cardioverte	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	292	9	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	292	10	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	292	11	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	292	12	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	292	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	292	14	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	292	15	duration	duration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	292	16	>	>	XX
work_vvlzsj54cvf5de6ji6py6krqlm	292	17	24	24	CD
work_vvlzsj54cvf5de6ji6py6krqlm	292	18	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	292	19	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	293	1	Similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	293	2	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	293	3	recommendations	recommendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	293	4	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	293	5	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	293	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	293	7	pa-	pa-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	293	8	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	293	9	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	293	10	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	293	11	anticoagulated	anticoagulate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	293	12	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	293	13	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	293	14	minimum	minimum	NN
work_vvlzsj54cvf5de6ji6py6krqlm	293	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	293	16	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	293	17	weeks	week	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	293	18	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	293	19	elective	elective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	293	20	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	293	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	294	1	If	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	294	2	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	294	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	294	4	then	then	RB
work_vvlzsj54cvf5de6ji6py6krqlm	294	5	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	294	6	TEE	tee	NN
work_vvlzsj54cvf5de6ji6py6krqlm	294	7	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	294	8	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	294	9	performed	perform	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	294	10	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	294	11	exclude	exclude	VB
work_vvlzsj54cvf5de6ji6py6krqlm	294	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	294	13	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	294	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	294	15	left	left	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	294	16	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	294	17	append-	append-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	294	18	age	age	NN
work_vvlzsj54cvf5de6ji6py6krqlm	294	19	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	294	20	left	leave	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	294	21	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	294	22	thrombus	thrombus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	294	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	295	1	Similarly	similarly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	295	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	295	3	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	295	4	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	295	5	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	295	6	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	295	7	’s	’s	POS
work_vvlzsj54cvf5de6ji6py6krqlm	295	8	adherence	adherence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	295	9	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	295	10	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	295	11	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	295	12	suboptimal	suboptimal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	295	13	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	295	14	≥2	≥2	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	295	15	missed	miss	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	295	16	doses	dose	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	295	17	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	295	18	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	295	19	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	295	20	question	question	NN
work_vvlzsj54cvf5de6ji6py6krqlm	295	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	295	22	then	then	RB
work_vvlzsj54cvf5de6ji6py6krqlm	295	23	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	295	24	TEE	tee	NN
work_vvlzsj54cvf5de6ji6py6krqlm	295	25	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	295	26	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	295	27	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	295	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	296	1	If	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	296	2	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	296	3	pa-	pa-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	296	4	tient	tient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	296	5	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	296	6	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	296	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	296	8	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	296	9	properly	properly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	296	10	dosed	dose	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	296	11	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	296	12	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	296	13	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	296	14	weeks	week	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	296	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	296	16	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	296	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	296	18	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	296	19	found	find	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	296	20	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	296	21	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	296	22	left	leave	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	296	23	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	296	24	appendage	appendage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	296	25	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	296	26	left	leave	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	296	27	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	296	28	thrombus	thrombus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	296	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	296	30	then	then	RB
work_vvlzsj54cvf5de6ji6py6krqlm	296	31	consideration	consideration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	296	32	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	296	33	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	296	34	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	296	35	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	296	36	switching	switch	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	296	37	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	296	38	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	296	39	alternate	alternate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	296	40	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	296	41	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	296	42	special	special	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	296	43	atten-	atten-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	296	44	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	296	45	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	296	46	consistent	consistent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	296	47	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	296	48	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	296	49	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	296	50	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	296	51	transition	transition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	296	52	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	297	1	Catheter	Catheter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	297	2	Ablation	Ablation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	297	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	297	4	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	297	5	Catheter	catheter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	297	6	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	297	7	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	297	8	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	297	9	increasingly	increasingly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	297	10	used	use	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	297	11	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	297	12	option	option	NN
work_vvlzsj54cvf5de6ji6py6krqlm	297	13	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	297	14	rhythm	rhythm	NN
work_vvlzsj54cvf5de6ji6py6krqlm	297	15	control	control	NN
work_vvlzsj54cvf5de6ji6py6krqlm	297	16	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	297	17	NVAF	NVAF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	297	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	298	1	Because	because	IN
work_vvlzsj54cvf5de6ji6py6krqlm	298	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	298	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	298	4	risks	risk	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	298	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	298	6	peri-	peri-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	298	7	procedural	procedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	298	8	thromboembolism	thromboembolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	298	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	298	10	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	298	11	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	298	12	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	298	13	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	298	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	298	15	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	298	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	299	1	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	299	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	299	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	299	4	presence	presence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	299	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	299	6	anticoag-	anticoag-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	299	7	ulation	ulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	299	8	can	can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	299	9	make	make	VB
work_vvlzsj54cvf5de6ji6py6krqlm	299	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	299	11	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	299	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	299	13	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	299	14	complica-	complica-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	299	15	tions	tion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	299	16	more	more	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	299	17	difficult	difficult	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	299	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	300	1	Before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	300	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	300	3	advent	advent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	300	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	300	5	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	300	6	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	300	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	300	8	observational145,146	observational145,146	FW
work_vvlzsj54cvf5de6ji6py6krqlm	300	9	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	300	10	randomized147	randomized147	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	300	11	studies	study	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	300	12	suggested	suggest	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	300	13	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	300	14	uninterrupted	uninterrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	300	15	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	300	16	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	300	17	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	300	18	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	300	19	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	300	20	su-	su-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	300	21	perior	perior	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	300	22	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	300	23	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	300	24	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	300	25	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	300	26	interruption	interruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	300	27	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	300	28	intraprocedural	intraprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	300	29	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	300	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	301	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	301	2	particular	particular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	301	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	301	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	301	5	COMPARE	COMPARE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	301	6	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	301	7	Role	role	NN
work_vvlzsj54cvf5de6ji6py6krqlm	301	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	301	9	Coumadin	Coumadin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	301	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	301	11	Preventing	prevent	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	301	12	Thromboembolism	Thromboembolism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	301	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	301	14	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	301	15	Fi-	Fi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	301	16	brillation	brillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	301	17	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	301	18	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	301	19	]	]	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	301	20	Patients	Patients	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	301	21	Undergoing	Undergoing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	301	22	Catheter	Catheter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	301	23	Ablation	Ablation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	301	24	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	301	25	clini-	clini-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	301	26	cal	cal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	301	27	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	301	28	randomized	randomize	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	301	29	1584	1584	CD
work_vvlzsj54cvf5de6ji6py6krqlm	301	30	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	301	31	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	301	32	interrupted	interrupt	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	301	33	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	301	34	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	301	35	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	301	36	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	301	37	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	301	38	n=790	n=790	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	301	39	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	301	40	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	301	41	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	301	42	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	301	43	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	301	44	n=794	n=794	NN
work_vvlzsj54cvf5de6ji6py6krqlm	301	45	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	301	46	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	302	1	Bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	302	2	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	302	3	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	302	4	less	less	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	302	5	common	common	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	302	7	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	302	8	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	9	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	10	arm	arm	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	11	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	302	12	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	302	13	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	14	difference	difference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	15	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	302	16	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	17	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	302	18	transient	transient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	19	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	20	attack	attack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	21	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	302	22	0.4	0.4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	302	23	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	24	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	302	25	0.8	0.8	CD
work_vvlzsj54cvf5de6ji6py6krqlm	302	26	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	27	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	28	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	302	30	0.5	0.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	302	31	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	32	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	302	33	0.9	0.9	CD
work_vvlzsj54cvf5de6ji6py6krqlm	302	34	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	35	pericardial	pericardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	36	effusion	effusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	302	38	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	302	39	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	302	40	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	41	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	302	42	22	22	CD
work_vvlzsj54cvf5de6ji6py6krqlm	302	43	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	44	minor	minor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	45	bleeding).147	bleeding).147	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	46	How	how	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	302	47	interrupted	interrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	48	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	302	49	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	50	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	302	51	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	52	compares	compare	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	302	53	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	302	54	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	55	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	56	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	302	57	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	302	58	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	302	59	subject	subject	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	60	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	302	61	intense	intense	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	62	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	302	63	over	over	IN
work_vvlzsj54cvf5de6ji6py6krqlm	302	64	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	302	65	past	past	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	302	66	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	302	67	years	year	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	302	68	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	303	1	Multiple	multiple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	303	2	systematic	systematic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	303	3	assess-	assess-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	303	4	ments	ment	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	303	5	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	303	6	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	303	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	303	8	analyses	analysis	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	303	9	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	303	10	demonstrated	demonstrate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	303	11	similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	303	12	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	303	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	303	14	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	303	15	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	303	16	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	303	17	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	303	18	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	303	19	interrupted	interrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	303	20	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	303	21	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	303	22	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	303	23	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	303	24	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	303	25	warfarin.148–152	warfarin.148–152	NN
work_vvlzsj54cvf5de6ji6py6krqlm	303	26	One	one	CD
work_vvlzsj54cvf5de6ji6py6krqlm	303	27	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	303	28	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	303	29	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	303	30	uninterrupted	uninterrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	303	31	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	303	32	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	303	33	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	303	34	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	303	35	248	248	CD
work_vvlzsj54cvf5de6ji6py6krqlm	303	36	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	303	37	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	304	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	304	2	occurrence	occurrence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	304	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	304	4	any	any	DT
work_vvlzsj54cvf5de6ji6py6krqlm	304	5	throm-	throm-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	304	6	boembolic	boembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	304	7	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	304	8	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	304	9	0	0	CD
work_vvlzsj54cvf5de6ji6py6krqlm	304	10	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	304	11	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	304	12	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	304	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	304	14	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	304	15	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	304	16	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	304	17	21	21	CD
work_vvlzsj54cvf5de6ji6py6krqlm	304	18	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	304	19	18	18	CD
work_vvlzsj54cvf5de6ji6py6krqlm	304	20	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	304	21	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	304	22	similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	304	23	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	304	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	304	25	uninterrupted	uninterrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	304	26	rivaroxa-	rivaroxa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	304	27	ban	ban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	304	28	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	304	29	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	304	30	arms	arm	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	304	31	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	305	1	Although	although	IN
work_vvlzsj54cvf5de6ji6py6krqlm	305	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	305	3	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	305	4	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	305	5	relatively	relatively	RB
work_vvlzsj54cvf5de6ji6py6krqlm	305	6	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	305	7	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	305	8	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	305	9	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	305	10	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	305	11	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	305	12	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	305	13	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	305	14	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	305	15	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	305	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	305	17	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	305	18	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	305	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	305	20	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	305	21	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	305	22	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	305	23	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	305	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	305	25	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	305	26	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	305	27	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	305	28	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	305	29	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	305	30	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	305	31	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	306	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	306	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	306	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	306	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	307	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	307	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	307	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	307	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	307	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	307	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	307	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	307	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	307	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	307	10	e621	e621	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	307	11	CLINICAL	clinical	NN
work_vvlzsj54cvf5de6ji6py6krqlm	307	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	307	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	307	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	307	15	GUIDELINES	GUIDELINES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	307	16	small	small	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	307	17	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	307	18	limited	limited	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	307	19	power	power	NN
work_vvlzsj54cvf5de6ji6py6krqlm	307	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	307	21	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	307	22	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	307	23	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	307	24	largely	largely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	307	25	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	307	26	line	line	NN
work_vvlzsj54cvf5de6ji6py6krqlm	307	27	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	307	28	previous	previous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	307	29	observational	observational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	307	30	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	307	31	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	307	32	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	307	33	suggested	suggest	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	307	34	similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	307	35	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	307	36	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	307	37	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	307	38	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	307	39	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	307	40	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	307	41	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	308	1	Another	another	DT
work_vvlzsj54cvf5de6ji6py6krqlm	308	2	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	3	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	308	4	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	308	5	uninterrupted	uninterrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	6	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	308	7	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	308	8	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	9	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	308	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	308	11	200	200	CD
work_vvlzsj54cvf5de6ji6py6krqlm	308	12	subjects	subject	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	308	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	308	14	drug-	drug-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	15	refractory	refractory	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	16	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	308	17	undergoing	undergoing	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	18	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	308	19	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	308	20	found	find	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	308	21	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	308	22	differ-	differ-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	308	23	ence	ence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	308	24	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	308	25	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	26	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	308	27	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	308	28	outcomes.153	outcomes.153	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	308	29	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	308	30	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	308	31	several	several	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	32	ongoing	ongoing	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	33	larger	larger	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	308	34	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	35	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	36	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	308	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	308	38	interrupted	interrupt	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	308	39	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	308	40	uninterrupted	uninterrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	41	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	308	42	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	308	43	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	308	44	con-	con-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	308	45	tinuous	tinuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	46	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	308	47	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	308	48	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	308	49	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	308	50	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	308	51	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	309	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	309	2	recommendation	recommendation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	3	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	309	4	use	use	VB
work_vvlzsj54cvf5de6ji6py6krqlm	309	5	TEE	TEE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	309	6	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	309	7	exclude	exclude	VB
work_vvlzsj54cvf5de6ji6py6krqlm	309	8	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	309	9	pres-	pres-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	10	ence	ence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	309	12	left	left	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	309	13	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	309	14	appendage	appendage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	15	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	309	16	left	left	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	309	17	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	309	18	thrombus	thrombus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	19	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	309	20	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	309	21	similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	309	22	regardless	regardless	RB
work_vvlzsj54cvf5de6ji6py6krqlm	309	23	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	309	24	whether	whether	IN
work_vvlzsj54cvf5de6ji6py6krqlm	309	25	VKA	VKA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	309	26	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	309	27	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	309	28	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	29	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	309	30	used.154	used.154	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	309	31	If	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	309	32	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	309	33	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	34	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	309	35	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	309	36	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	309	37	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	309	38	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	309	39	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	309	40	weeks	week	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	309	41	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	309	42	pre-	pre-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	43	procedural	procedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	309	44	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	45	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	309	46	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	309	47	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	309	48	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	49	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	309	50	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	309	51	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	309	52	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	309	53	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	54	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	309	55	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	309	57	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	309	58	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	309	59	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	309	60	TEE	TEE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	309	61	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	309	62	mandatory	mandatory	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	309	63	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	310	1	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	310	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	310	3	many	many	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	310	4	laboratories	laboratory	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	310	5	conduct	conduct	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	310	6	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	310	7	TEE	tee	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	9	all	all	DT
work_vvlzsj54cvf5de6ji6py6krqlm	310	10	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	310	11	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	12	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	13	since	since	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	14	thrombus	thrombus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	15	can	can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	310	16	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	310	17	observed	observe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	310	18	even	even	RB
work_vvlzsj54cvf5de6ji6py6krqlm	310	19	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	20	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	310	21	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	310	22	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	23	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	310	24	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	25	paroxysmal	paroxysmal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	310	26	AF.155	AF.155	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	310	27	Regardless	regardless	RB
work_vvlzsj54cvf5de6ji6py6krqlm	310	28	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	29	whether	whether	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	30	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	310	31	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	310	32	interrupted	interrupt	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	310	33	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	310	34	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	35	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	310	36	used	use	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	310	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	310	38	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	39	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	310	40	basis	basis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	41	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	42	current	current	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	310	43	consensus	consensus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	44	recom-	recom-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	45	mendations	mendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	310	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	310	47	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	310	48	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	310	49	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	310	50	heparinized	heparinize	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	310	51	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	52	100-U/	100-u/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	310	53	kg	kg	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	310	54	bolus	bolus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	55	followed	follow	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	310	56	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	57	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	310	58	infusion	infusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	59	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	60	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	310	61	U	u	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	62	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	310	63	kg	kg	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	310	64	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	310	65	hour	hour	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	66	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	67	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	310	68	immediately	immediately	RB
work_vvlzsj54cvf5de6ji6py6krqlm	310	69	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	310	70	puncture	puncture	NN
work_vvlzsj54cvf5de6ji6py6krqlm	310	71	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	311	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	311	2	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	311	3	clotting	clotting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	311	4	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	311	5	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	311	6	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	311	7	checked	check	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	311	8	every	every	DT
work_vvlzsj54cvf5de6ji6py6krqlm	311	9	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	311	10	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	311	11	15	15	CD
work_vvlzsj54cvf5de6ji6py6krqlm	311	12	minutes	minute	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	311	13	until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	311	14	target	target	NN
work_vvlzsj54cvf5de6ji6py6krqlm	311	15	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	311	16	then	then	RB
work_vvlzsj54cvf5de6ji6py6krqlm	311	17	every	every	DT
work_vvlzsj54cvf5de6ji6py6krqlm	311	18	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	311	19	minutes	minute	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	311	20	thereafter	thereafter	RB
work_vvlzsj54cvf5de6ji6py6krqlm	311	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	312	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	312	2	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	312	3	clot-	clot-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	4	ting	ting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	312	5	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	6	target	target	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	7	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	312	8	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	312	9	at	at	RB
work_vvlzsj54cvf5de6ji6py6krqlm	312	10	least	least	RBS
work_vvlzsj54cvf5de6ji6py6krqlm	312	11	300	300	CD
work_vvlzsj54cvf5de6ji6py6krqlm	312	12	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	312	13	350	350	CD
work_vvlzsj54cvf5de6ji6py6krqlm	312	14	seconds	second	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	312	15	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	312	16	350	350	CD
work_vvlzsj54cvf5de6ji6py6krqlm	312	17	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	312	18	400	400	CD
work_vvlzsj54cvf5de6ji6py6krqlm	312	19	seconds	second	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	312	20	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	21	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	312	22	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	23	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	24	spontaneous	spontaneous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	312	25	echocar-	echocar-	FW
work_vvlzsj54cvf5de6ji6py6krqlm	312	26	diographic	diographic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	312	27	contrast	contrast	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	28	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	312	29	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	312	30	smoke	smoke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	31	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	312	32	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	312	33	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	312	34	severe	severe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	312	35	left	leave	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	312	36	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	312	37	enlarge-	enlarge-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	38	ment.154	ment.154	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	312	39	Heparinization	heparinization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	40	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	41	transeptal	transeptal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	312	42	access	access	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	43	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	312	44	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	312	45	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	312	46	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	47	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	312	48	lower	low	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	312	49	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	50	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	51	asymptomatic	asymptomatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	312	52	microembol-	microembol-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	53	ic	ic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	312	54	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	312	55	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	56	detected	detect	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	312	57	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	58	brain	brain	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	59	magnetic	magnetic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	312	60	resonance	resonance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	61	imag-	imag-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	62	ing.156	ing.156	.
work_vvlzsj54cvf5de6ji6py6krqlm	312	63	It	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	312	64	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	312	65	important	important	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	312	66	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	312	67	note	note	VB
work_vvlzsj54cvf5de6ji6py6krqlm	312	68	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	69	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	312	70	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	71	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	72	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	312	73	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	74	before	before	RB
work_vvlzsj54cvf5de6ji6py6krqlm	312	75	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	312	76	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	77	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	312	78	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	79	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	312	80	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	81	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	312	82	need	need	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	83	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	84	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	312	85	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	312	86	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	87	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	88	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	312	89	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	312	90	achieve	achieve	VB
work_vvlzsj54cvf5de6ji6py6krqlm	312	91	target	target	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	92	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	312	93	clotting	clot	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	312	94	times	time	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	312	95	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	96	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	312	97	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	98	procedure.157	procedure.157	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	312	99	After	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	100	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	312	101	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	102	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	312	103	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	312	104	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	105	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	312	106	generally	generally	RB
work_vvlzsj54cvf5de6ji6py6krqlm	312	107	reintroduced	reintroduce	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	312	108	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	109	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	312	110	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	312	111	8	8	CD
work_vvlzsj54cvf5de6ji6py6krqlm	312	112	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	312	113	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	114	sheath	sheath	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	115	removal	removal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	116	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	312	117	access	access	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	118	site	site	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	119	hemo-	hemo-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	120	stasis	stasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	312	121	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	312	122	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	312	123	achieved	achieve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	312	124	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	313	1	Consistent	consistent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	313	2	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	313	3	consensus	consensus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	313	4	rec-	rec-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	313	5	ommendations	ommendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	313	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	313	7	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	313	8	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	313	9	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	313	10	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	313	11	continued	continue	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	313	12	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	313	13	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	313	14	minimum	minimum	NN
work_vvlzsj54cvf5de6ji6py6krqlm	313	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	313	16	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	313	17	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	313	18	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	313	19	months	month	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	313	20	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	313	21	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	313	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	314	1	Thereafter	thereafter	RB
work_vvlzsj54cvf5de6ji6py6krqlm	314	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	314	3	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	314	4	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	314	5	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	314	6	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	314	7	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	314	8	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	314	9	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	314	10	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	314	11	’s	’s	POS
work_vvlzsj54cvf5de6ji6py6krqlm	314	12	underly-	underly-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	314	13	ing	ing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	314	14	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	314	15	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	314	16	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	314	17	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	314	18	CHA	CHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	314	19	2DS2-VASc	2ds2-vasc	CD
work_vvlzsj54cvf5de6ji6py6krqlm	314	20	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	314	21	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	314	22	rather	rather	RB
work_vvlzsj54cvf5de6ji6py6krqlm	314	23	than	than	IN
work_vvlzsj54cvf5de6ji6py6krqlm	314	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	314	25	current	current	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	314	26	rhythm	rhythm	NN
work_vvlzsj54cvf5de6ji6py6krqlm	314	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	315	1	Electronic	electronic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	315	2	Device	Device	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	315	3	Implantation	Implantation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	315	4	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	315	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	315	6	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	315	7	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	315	8	surrounding	surround	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	315	9	cardiac	cardiac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	315	10	implantable	implantable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	315	11	electronic	electronic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	315	12	device	device	NN
work_vvlzsj54cvf5de6ji6py6krqlm	315	13	insertion	insertion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	315	14	presents	present	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	315	15	several	several	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	315	16	challenges	challenge	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	315	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	316	1	Oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	316	2	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	316	3	increases	increase	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	316	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	316	5	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	316	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	316	7	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	316	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	316	9	hematoma	hematoma	RB
work_vvlzsj54cvf5de6ji6py6krqlm	316	10	formation	formation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	316	11	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	316	12	device	device	NN
work_vvlzsj54cvf5de6ji6py6krqlm	316	13	implan-	implan-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	316	14	tation	tation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	316	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	317	1	Furthermore	furthermore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	317	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	317	3	hematoma	hematoma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	317	4	formation	formation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	317	5	increases	increase	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	317	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	317	7	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	317	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	317	9	postoperative	postoperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	317	10	infection	infection	NN
work_vvlzsj54cvf5de6ji6py6krqlm	317	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	318	1	Based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	318	2	upon	upon	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	318	4	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	318	5	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	6	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	7	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	8	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	318	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	318	10	uninterrupted	uninterrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	11	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	12	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	318	13	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	318	14	shown	show	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	318	15	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	318	16	lead	lead	VB
work_vvlzsj54cvf5de6ji6py6krqlm	318	17	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	18	less	less	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	318	19	bleeding	bleeding	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	20	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	318	21	superior	superior	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	22	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	318	23	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	318	24	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	25	interrupted	interrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	26	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	27	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	318	28	par-	par-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	29	enteral	enteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	30	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	318	31	therapy.158,159	therapy.158,159	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	32	These	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	318	33	findings	finding	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	318	34	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	318	35	also	also	RB
work_vvlzsj54cvf5de6ji6py6krqlm	318	36	consistent	consistent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	37	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	38	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	318	39	BRIDGE	BRIDGE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	318	40	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	318	41	Perioperative	Perioperative	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	318	42	Bridging	Bridging	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	318	43	Anti-	Anti-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	318	44	coagulation	coagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	45	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	46	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	318	47	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	48	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	318	49	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	318	50	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	318	51	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	318	53	which	which	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	318	54	found	find	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	318	55	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	318	56	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	57	benefit	benefit	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	58	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	59	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	318	60	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	61	general	general	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	62	inter-	inter-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	318	63	ruption	ruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	64	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	65	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	66	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	67	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	68	invasive	invasive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	69	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	318	70	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	71	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	318	72	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	73	NVAF.116	NVAF.116	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	318	74	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	318	75	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	318	76	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	318	77	optimal	optimal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	78	manage-	manage-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	79	ment	ment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	80	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	318	81	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	82	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	83	surrounding	surround	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	318	84	cardiac	cardiac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	85	implantable	implantable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	86	electronic	electronic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	87	device	device	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	88	implantation	implantation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	318	89	remains	remain	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	318	90	unknown	unknown	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	318	91	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	319	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	319	2	general	general	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	319	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	319	4	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	319	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	319	6	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	319	7	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	319	8	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	319	9	cardiac	cardiac	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	319	10	implantable	implantable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	319	11	electronic	electronic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	319	12	device	device	NN
work_vvlzsj54cvf5de6ji6py6krqlm	319	13	implantation	implantation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	319	14	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	319	15	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	319	16	manner	manner	NN
work_vvlzsj54cvf5de6ji6py6krqlm	319	17	consistent	consistent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	319	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	319	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	319	20	elimination	elimination	NN
work_vvlzsj54cvf5de6ji6py6krqlm	319	21	half	half	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	319	22	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	319	23	life	life	NN
work_vvlzsj54cvf5de6ji6py6krqlm	319	24	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	319	25	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	319	26	most	most	RBS
work_vvlzsj54cvf5de6ji6py6krqlm	319	27	common	common	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	319	28	practice	practice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	319	29	pattern	pattern	NN
work_vvlzsj54cvf5de6ji6py6krqlm	319	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	320	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	320	2	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	320	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	320	4	edoxa-	edoxa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	320	5	ban	ban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	320	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	320	7	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	320	8	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	320	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	320	10	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	320	11	would	would	MD
work_vvlzsj54cvf5de6ji6py6krqlm	320	12	include	include	VB
work_vvlzsj54cvf5de6ji6py6krqlm	320	13	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	320	14	24	24	CD
work_vvlzsj54cvf5de6ji6py6krqlm	320	15	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	320	16	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	320	17	advance	advance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	320	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	320	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	320	20	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	320	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	321	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	321	3	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	5	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	321	7	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	8	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	321	9	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	321	10	24	24	CD
work_vvlzsj54cvf5de6ji6py6krqlm	321	11	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	321	12	before	before	RB
work_vvlzsj54cvf5de6ji6py6krqlm	321	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	14	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	321	15	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	16	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	321	17	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	18	≥80	≥80	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	19	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	20	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	321	21	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	321	23	36	36	CD
work_vvlzsj54cvf5de6ji6py6krqlm	321	24	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	321	25	be-	be-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	321	26	fore	fore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	321	27	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	28	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	321	29	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	30	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	31	50	50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	321	32	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	33	79	79	CD
work_vvlzsj54cvf5de6ji6py6krqlm	321	34	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	35	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	321	36	min	min	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	321	38	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	321	39	48	48	CD
work_vvlzsj54cvf5de6ji6py6krqlm	321	40	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	321	41	before	before	RB
work_vvlzsj54cvf5de6ji6py6krqlm	321	42	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	43	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	321	44	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	45	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	321	46	CrCl	CrCl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	47	<	<	XX
work_vvlzsj54cvf5de6ji6py6krqlm	321	48	50	50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	321	49	mL	mL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	50	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	321	51	min.160	min.160	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	52	Survey	Survey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	53	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	321	54	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	55	implanting	implant	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	321	56	physicians	physician	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	321	57	suggest	suggest	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	321	58	wide	wide	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	321	59	variation	variation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	60	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	61	practice	practice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	62	patterns	pattern	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	321	63	reflecting	reflect	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	321	64	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	321	65	uncertainly	uncertainly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	321	66	over	over	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	67	optimal	optimal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	321	68	management.161	management.161	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	69	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	321	70	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	321	71	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	321	72	majority	majority	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	73	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	74	physicians	physician	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	321	75	discontinue	discontinue	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	321	76	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	77	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	78	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	79	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	321	80	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	81	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	82	implantation	implantation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	83	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	321	84	82%).161	82%).161	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	85	Although	although	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	86	uninterrupted	uninterrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	321	87	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	88	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	321	89	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	321	90	best	good	JJS
work_vvlzsj54cvf5de6ji6py6krqlm	321	91	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	92	base	base	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	93	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	321	94	>	>	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	95	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	321	96	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	321	97	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	98	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	321	99	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	321	100	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	321	101	increasing	increase	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	321	102	num-	num-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	103	ber	ber	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	104	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	321	105	cardiac	cardiac	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	106	implantable	implantable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	321	107	electronic	electronic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	321	108	device	device	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	109	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	321	110	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	321	111	taking	take	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	321	112	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	321	113	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	321	114	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	322	1	Whether	whether	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	2	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	322	3	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	322	4	can	can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	322	5	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	322	6	continued	continue	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	322	7	through	through	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	8	cardiac	cardiac	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	9	implantable	implantable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	322	10	electronic	electronic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	322	11	de-	de-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	322	12	vice	vice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	322	13	implantation	implantation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	322	14	remains	remain	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	322	15	debated	debate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	322	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	322	17	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	322	18	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	322	19	subject	subject	NN
work_vvlzsj54cvf5de6ji6py6krqlm	322	20	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	21	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	322	22	large	large	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	322	23	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	322	24	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	322	25	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	322	26	BRUISE	BRUISE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	27	CONTROL-2	CONTROL-2	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	28	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	322	29	Strategy	Strategy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	30	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	31	Continued	Continued	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	32	vs	vs	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	33	Interrupted	Interrupted	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	34	Novel	Novel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	35	Oral	Oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	36	Anticoagulant	Anticoagulant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	37	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	38	Time	Time	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	39	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	40	Device	Device	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	41	Surgery	Surgery	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	42	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	43	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	322	44	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	45	Moderate	Moderate	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	46	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	47	High	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	322	48	Risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	322	49	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	50	Arterial	Arterial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	51	Thromboembolic	Thromboembolic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	52	Events	Events	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	322	53	]	]	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	322	54	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	322	55	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	322	56	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	57	which	which	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	322	58	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	322	59	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	322	60	will	will	MD
work_vvlzsj54cvf5de6ji6py6krqlm	322	61	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	322	62	randomized	randomize	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	322	63	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	64	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	322	65	strategy	strategy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	322	66	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	67	continued	continue	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	322	68	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	322	69	interrupted	interrupt	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	322	70	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	71	thera-	thera-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	322	72	py	py	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	322	73	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	323	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	323	2	few	few	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	323	3	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	323	4	observational	observational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	323	5	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	323	6	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	323	7	limited	limit	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	323	8	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	323	9	their	-PRON-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	323	10	small	small	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	323	11	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	323	12	size	size	NN
work_vvlzsj54cvf5de6ji6py6krqlm	323	13	but	but	CC
work_vvlzsj54cvf5de6ji6py6krqlm	323	14	have	have	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	323	15	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	323	16	identified	identify	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	323	17	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	323	18	risks	risk	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	323	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	323	20	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	323	21	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	323	22	uninterrupted	uninterrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	323	23	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	323	24	therapy.162,163	therapy.162,163	NN
work_vvlzsj54cvf5de6ji6py6krqlm	323	25	When	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	323	26	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	323	27	decision	decision	NN
work_vvlzsj54cvf5de6ji6py6krqlm	323	28	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	323	29	made	make	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	323	30	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	323	31	interrupt	interrupt	VB
work_vvlzsj54cvf5de6ji6py6krqlm	323	32	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	323	33	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	323	34	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	323	35	cardiac	cardiac	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	323	36	implantable	implantable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	323	37	electronic	electronic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	323	38	device	device	NN
work_vvlzsj54cvf5de6ji6py6krqlm	323	39	implantation	implantation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	323	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	323	41	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	323	42	implanting	implant	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	323	43	physician	physician	NN
work_vvlzsj54cvf5de6ji6py6krqlm	323	44	must	must	MD
work_vvlzsj54cvf5de6ji6py6krqlm	323	45	decide	decide	VB
work_vvlzsj54cvf5de6ji6py6krqlm	323	46	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	323	47	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	323	48	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	323	49	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	323	50	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	323	51	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	323	52	restarted	restart	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	323	53	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	324	1	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	324	2	decision	decision	NN
work_vvlzsj54cvf5de6ji6py6krqlm	324	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	324	4	often	often	RB
work_vvlzsj54cvf5de6ji6py6krqlm	324	5	influ-	influ-	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	324	6	enced	ence	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	324	7	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	324	8	patient	patient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	324	9	characteristics	characteristic	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	324	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	324	11	including	include	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	324	12	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	324	13	factors	factor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	324	14	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	324	15	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	324	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	324	17	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	324	18	postimplantation	postimplantation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	324	19	physical	physical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	324	20	examina-	examina-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	324	21	tion	tion	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	324	22	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	324	23	eg	eg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	324	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	324	25	hematoma	hematoma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	324	26	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	324	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	325	1	Similar	similar	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	325	2	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	325	3	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	325	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	325	5	prac-	prac-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	325	6	tice	tice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	325	7	patterns	pattern	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	325	8	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	325	9	resumption	resumption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	325	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	325	11	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	325	12	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	325	13	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	325	14	implantation	implantation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	325	15	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	325	16	highly	highly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	325	17	variable.161	variable.161	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	325	18	Typically	typically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	325	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	325	20	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	325	21	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	325	22	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	325	23	restarted	restart	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	325	24	24	24	CD
work_vvlzsj54cvf5de6ji6py6krqlm	325	25	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	325	26	48	48	CD
work_vvlzsj54cvf5de6ji6py6krqlm	325	27	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	325	28	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	325	29	surgical	surgical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	325	30	pro-	pro-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	325	31	cedures	cedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	325	32	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	325	33	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	325	34	pivotal	pivotal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	325	35	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	325	36	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	325	37	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	326	1	Patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	326	2	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	326	3	multiple	multiple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	326	4	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	326	5	factors	factor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	326	6	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	326	7	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	326	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	326	9	concomitant	concomitant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	326	10	antiplatelet	antiplatelet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	326	11	ther-	ther-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	326	12	apy	apy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	326	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	326	14	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	326	15	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	326	16	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	326	17	hematoma	hematoma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	326	18	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	326	19	their	-PRON-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	326	20	postoperative	postoperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	326	21	examination	examination	NN
work_vvlzsj54cvf5de6ji6py6krqlm	326	22	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	326	23	benefit	benefit	VB
work_vvlzsj54cvf5de6ji6py6krqlm	326	24	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	326	25	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	326	26	greater	great	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	326	27	delay	delay	NN
work_vvlzsj54cvf5de6ji6py6krqlm	326	28	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	326	29	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	326	30	resumption	resumption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	326	31	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	326	32	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	326	33	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	326	34	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	326	35	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	326	36	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	326	37	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	327	1	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	327	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	327	3	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	327	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	327	5	lack	lack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	327	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	327	7	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	327	8	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	327	9	guide	guide	VB
work_vvlzsj54cvf5de6ji6py6krqlm	327	10	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	327	11	decisions	decision	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	327	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	327	13	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	327	14	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	327	15	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	327	16	approached	approach	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	327	17	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	327	18	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	327	19	patient	patient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	327	20	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	327	21	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	327	22	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	327	23	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	327	24	basis	basis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	327	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	327	26	weighing	weigh	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	327	27	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	327	28	risks	risk	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	327	29	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	327	30	benefits	benefit	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	327	31	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	327	32	earlier	early	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	327	33	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	327	34	later	later	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	327	35	resumption	resumption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	327	36	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	327	37	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	327	38	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	327	39	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	328	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	328	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	328	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	328	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	328	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	328	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	328	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	328	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	328	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	328	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	328	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	328	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	328	13	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	328	14	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	328	15	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	328	16	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	328	17	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	328	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	328	19	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	328	20	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	328	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	329	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	329	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	329	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	329	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	330	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	330	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	330	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	330	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	330	5	CIR.0000000000000477e622	CIR.0000000000000477e622	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	330	6	Cardiovascular	Cardiovascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	330	7	Surgery	Surgery	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	330	8	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	330	9	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	330	10	limited	limited	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	330	11	information	information	NN
work_vvlzsj54cvf5de6ji6py6krqlm	330	12	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	330	13	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	330	14	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	330	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	330	16	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	330	17	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	330	18	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	330	19	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	330	20	bypass	bypass	NN
work_vvlzsj54cvf5de6ji6py6krqlm	330	21	grafting	graft	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	330	22	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	330	23	valve	valve	VB
work_vvlzsj54cvf5de6ji6py6krqlm	330	24	replacement	replacement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	330	25	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	330	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	331	1	At	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	2	present	present	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	331	4	information	information	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	5	related	relate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	331	6	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	7	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	8	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	331	9	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	11	cardiac	cardiac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	12	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	13	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	331	14	anecdotal	anecdotal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	15	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	331	16	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	331	17	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	18	limited	limited	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	19	subset	subset	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	20	analyses.48,164,165	analyses.48,164,165	.
work_vvlzsj54cvf5de6ji6py6krqlm	331	21	No	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	331	22	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	23	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	331	24	event	event	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	25	differences	difference	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	331	26	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	331	27	observed	observe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	331	28	between	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	29	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	30	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	331	31	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	32	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	331	33	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	331	34	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	331	35	underwent	undergo	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	331	36	cardiac	cardiac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	37	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	38	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	39	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	331	40	AF.110a	AF.110a	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	331	41	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	331	42	ATLAS	ATLAS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	331	43	ACS-2-TIMI-51	ACS-2-TIMI-51	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	331	44	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	45	tested	test	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	331	46	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	47	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	48	lower	low	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	331	49	cardiovascular	cardiovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	50	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	331	51	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	52	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	331	53	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	54	ACS	ACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	331	55	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	331	56	reported	report	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	331	57	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	331	58	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	331	59	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	331	60	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	61	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	62	bypass	bypass	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	63	grafting	graft	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	331	64	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	65	ST	ST	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	331	66	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	331	67	segment	segment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	68	eleva-	eleva-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	331	69	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	70	myocardial	myocardial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	71	infarction.129,166	infarction.129,166	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	72	Per	per	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	73	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	331	74	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	75	protocol	protocol	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	76	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	331	77	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	331	78	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	79	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	331	80	stopped	stop	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	331	81	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	331	82	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	331	83	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	84	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	331	85	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	86	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	331	87	resumed	resume	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	331	88	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	331	89	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	331	90	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	91	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	331	92	postprocedural	postprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	93	drains	drain	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	331	94	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	331	95	removed	remove	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	331	96	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	331	97	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	98	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	331	99	last	last	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	100	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	101	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	331	102	parenteral	parenteral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	331	103	anticoagu-	anticoagu-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	331	104	lant	lant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	331	105	therapy	therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	331	106	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	331	107	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	331	108	administered	administer	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	331	109	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	332	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	332	2	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	332	3	specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	332	4	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	332	5	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	332	6	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	332	7	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	332	8	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	332	9	reported	report	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	332	10	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	332	11	therefore	therefore	RB
work_vvlzsj54cvf5de6ji6py6krqlm	332	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	332	13	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	332	14	conclu-	conclu-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	332	15	sions	sion	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	332	16	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	332	17	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	332	18	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	332	19	bypass	bypass	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	332	20	grafting	graft	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	332	21	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	332	22	related	relate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	332	23	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	332	24	can	can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	332	25	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	332	26	made	make	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	332	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	333	1	Established	establish	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	333	2	indications	indication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	333	3	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	333	4	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	333	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	333	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	333	7	pericardiac	pericardiac	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	333	8	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	333	9	setting	set	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	333	10	include	include	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	333	11	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	333	12	prevention	prevention	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	333	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	333	14	preoperative	preoperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	333	15	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	333	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	333	17	prolonged	prolonged	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	333	18	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	333	19	frequent	frequent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	333	20	postoperative	postoperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	333	21	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	333	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	333	23	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	333	24	VTE	vte	NN
work_vvlzsj54cvf5de6ji6py6krqlm	333	25	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	333	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	334	1	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	334	2	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	334	4	contraindicated	contraindicate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	334	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	6	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	334	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	8	mechanical	mechanical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	334	9	valves	valve	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	334	10	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	334	11	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	334	13	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	14	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	334	15	ALIGN	ALIGN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	16	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	334	17	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	334	18	Randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	334	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	334	20	Phase	Phase	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	21	II	ii	CD
work_vvlzsj54cvf5de6ji6py6krqlm	334	22	Study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	23	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	334	24	Evaluate	evaluate	VB
work_vvlzsj54cvf5de6ji6py6krqlm	334	25	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	334	26	Safety	Safety	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	27	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	334	28	Pharmacoki-	Pharmacoki-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	29	netics	netic	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	334	30	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	31	Oral	Oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	32	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	33	Etexilate	Etexilate	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	34	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	35	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	334	36	After	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	37	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	38	Valve	Valve	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	39	Replacement	Replacement	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	40	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	334	41	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	42	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	43	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	44	demonstrated	demonstrate	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	334	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	334	46	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	334	47	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	334	48	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	334	49	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	334	50	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	51	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	52	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	334	53	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	334	54	bleed-	bleed-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	334	55	ing	ing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	56	complications	complication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	334	57	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	334	58	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	59	warfarin.167	warfarin.167	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	60	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	334	61	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	334	62	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	63	reports	report	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	334	64	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	65	dabigatran	dabigatran	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	334	66	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	67	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	68	left	left	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	334	69	ventricular	ventricular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	334	70	assist	assist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	71	device	device	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	72	placement168	placement168	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	73	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	334	74	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	75	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	76	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	77	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	78	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	79	induced	induce	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	334	80	thrombocytopenia	thrombocytopenia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	81	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	82	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	334	83	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	84	bypass	bypass	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	85	grafting.169	grafting.169	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	334	86	However	however	RB
work_vvlzsj54cvf5de6ji6py6krqlm	334	87	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	334	88	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	334	89	off	off	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	90	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	334	91	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	92	uses	use	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	334	93	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	334	94	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	334	95	supported	support	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	334	96	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	334	97	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	334	98	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	334	99	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	100	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	334	101	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	335	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	335	2	cardiac	cardiac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	335	3	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	335	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	335	5	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	335	6	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	335	7	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	335	8	stopped	stop	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	335	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	335	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	335	11	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	335	12	setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	335	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	335	14	restarted	restart	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	335	15	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	335	16	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	335	17	hemostasis	hemostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	335	18	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	335	19	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	335	20	established	establish	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	335	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	336	1	As	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	336	2	cardiac	cardiac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	336	3	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	336	4	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	336	5	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	336	6	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	336	7	high	high	RB
work_vvlzsj54cvf5de6ji6py6krqlm	336	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	336	9	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	336	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	336	11	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	336	12	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	336	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	336	14	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	336	15	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	336	16	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	336	17	postponed	postpone	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	336	18	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	336	19	at	at	RB
work_vvlzsj54cvf5de6ji6py6krqlm	336	20	all	all	RB
work_vvlzsj54cvf5de6ji6py6krqlm	336	21	possible	possible	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	336	22	until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	336	23	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	336	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	336	25	appropriate	appropriate	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	336	26	interruption	interruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	336	27	period	period	NN
work_vvlzsj54cvf5de6ji6py6krqlm	336	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	337	1	Bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	337	2	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	337	3	car-	car-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	337	4	diac	diac	NN
work_vvlzsj54cvf5de6ji6py6krqlm	337	5	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	337	6	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	337	7	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	337	8	monitored	monitor	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	337	9	via	via	IN
work_vvlzsj54cvf5de6ji6py6krqlm	337	10	standard	standard	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	337	11	post-	post-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	337	12	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	337	13	drains	drain	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	337	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	338	1	Life	life	NN
work_vvlzsj54cvf5de6ji6py6krqlm	338	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	338	3	threatening	threaten	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	338	4	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	338	5	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	338	6	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	338	7	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	338	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	338	9	supportive	supportive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	338	10	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	338	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	338	12	including	include	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	338	13	transfusion	transfusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	338	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	338	15	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	338	16	products	product	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	338	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	338	18	administration	administration	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	338	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	338	20	antifibrinolyt-	antifibrinolyt-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	338	21	ics	ics	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	338	22	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	338	23	indicated	indicate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	338	24	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	338	25	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	338	26	resuscitation	resuscitation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	338	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	338	28	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	338	29	return	return	VB
work_vvlzsj54cvf5de6ji6py6krqlm	338	30	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	338	31	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	338	32	operating	operating	NN
work_vvlzsj54cvf5de6ji6py6krqlm	338	33	room	room	NN
work_vvlzsj54cvf5de6ji6py6krqlm	338	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	339	1	If	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	339	2	contributing	contribute	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	339	3	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	339	4	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	339	5	on-	on-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	339	6	going	go	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	339	7	coagulopathy	coagulopathy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	339	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	339	9	administration	administration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	339	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	339	11	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	339	12	antidotes	antidote	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	339	13	as	as	RB
work_vvlzsj54cvf5de6ji6py6krqlm	339	14	previously	previously	RB
work_vvlzsj54cvf5de6ji6py6krqlm	339	15	described	describe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	339	16	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	339	17	Laboratory	Laboratory	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	339	18	Measurement	Measurement	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	339	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	339	20	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	339	21	Effect	Effect	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	339	22	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	339	23	could	could	MD
work_vvlzsj54cvf5de6ji6py6krqlm	339	24	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	339	25	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	339	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	340	1	Mild	mild	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	340	2	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	340	3	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	340	4	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	340	5	monitored	monitor	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	340	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	340	7	but	but	CC
work_vvlzsj54cvf5de6ji6py6krqlm	340	8	NOACs	noac	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	340	9	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	340	10	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	340	11	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	340	12	reinitiated	reinitiate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	340	13	until	until	IN
work_vvlzsj54cvf5de6ji6py6krqlm	340	14	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	340	15	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	340	16	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	340	17	control	control	NN
work_vvlzsj54cvf5de6ji6py6krqlm	340	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	341	1	Similarly	similarly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	341	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	341	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	341	4	published	publish	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	341	5	experience	experience	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	7	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	8	manage-	manage-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	9	ment	ment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	11	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	341	12	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	341	13	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	341	14	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	15	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	341	16	limited	limit	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	341	17	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	341	18	case	case	VB
work_vvlzsj54cvf5de6ji6py6krqlm	341	19	reports	report	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	341	20	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	341	21	very	very	RB
work_vvlzsj54cvf5de6ji6py6krqlm	341	22	small	small	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	341	23	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	24	subsets.48,164,165	subsets.48,164,165	.
work_vvlzsj54cvf5de6ji6py6krqlm	341	25	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	26	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	341	27	subgroup	subgroup	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	28	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	29	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	30	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	31	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	341	33	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	341	34	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	35	periph-	periph-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	36	eral	eral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	341	37	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	38	disease	disease	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	39	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	40	rivaroxaban	rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	41	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	341	42	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	341	43	higher	high	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	341	44	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	45	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	46	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	341	47	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	48	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	341	49	nonmajor	nonmajor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	50	clinically	clinically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	341	51	relevant	relevant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	341	52	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	53	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	341	54	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	55	warfarin.170	warfarin.170	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	56	Noncardiovascular	Noncardiovascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	57	Surgery	Surgery	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	58	Studies	Studies	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	341	59	examining	examine	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	341	60	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	341	61	among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	62	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	63	users	user	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	341	64	af-	af-	CC
work_vvlzsj54cvf5de6ji6py6krqlm	341	65	ter	ter	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	341	66	noncardiovascular	noncardiovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	341	67	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	68	largely	largely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	341	69	grouped	group	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	341	70	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	341	71	into	into	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	72	cohorts	cohort	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	341	73	spanning	span	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	341	74	minor	minor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	341	75	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	76	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	341	77	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	341	78	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	341	79	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	80	sur-	sur-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	81	gery.48,103,164,171	gery.48,103,164,171	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	82	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	341	83	do	do	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	341	84	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	341	85	increase	increase	VB
work_vvlzsj54cvf5de6ji6py6krqlm	341	86	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	341	87	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	88	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	89	post-	post-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	341	90	operative	operative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	341	91	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	341	92	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	341	93	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	341	94	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	341	95	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	341	96	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	341	97	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	342	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	342	2	pooled	pool	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	342	3	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	5	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	6	phase	phase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	7	III	III	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	342	8	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	9	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	342	10	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	342	11	demonstrated	demonstrate	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	342	12	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	342	13	difference	difference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	14	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	15	postoperative	postoperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	342	16	bleed-	bleed-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	342	17	ing	ing	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	342	18	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	342	19	between	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	20	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	342	21	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	22	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	342	23	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	342	24	warfa-	warfa-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	342	25	rin.171	rin.171	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	342	26	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	27	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	342	28	ARISTOTLE	ARISTOTLE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	342	29	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	342	31	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	342	32	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	342	33	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	342	34	difference	difference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	35	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	36	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	342	38	myocardial	myocardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	342	39	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	342	41	mortality	mortality	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	342	43	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	342	44	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	342	45	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	46	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	342	47	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	48	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	342	49	versus	versus	FW
work_vvlzsj54cvf5de6ji6py6krqlm	342	50	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	51	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	52	NVAF.105	NVAF.105	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	342	53	How-	How-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	342	54	ever	ever	RB
work_vvlzsj54cvf5de6ji6py6krqlm	342	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	342	56	small	small	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	342	57	differences	difference	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	342	58	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	342	59	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	342	60	have	have	VB
work_vvlzsj54cvf5de6ji6py6krqlm	342	61	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	342	62	detected	detect	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	342	63	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	64	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	342	65	2.9	2.9	CD
work_vvlzsj54cvf5de6ji6py6krqlm	342	66	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	67	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	68	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	342	69	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	70	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	342	71	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	72	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	342	73	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	342	74	emergent	emergent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	342	75	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	342	76	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	342	77	10.2	10.2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	342	78	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	342	79	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	342	80	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	342	81	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	342	82	consid-	consid-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	342	83	ered	ered	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	342	84	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	342	85	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	343	1	Bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	343	2	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	343	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	343	4	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	343	5	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	343	6	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	343	7	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	343	8	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	343	9	interruption	interruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	343	10	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	343	11	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	343	12	undergoing	undergoing	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	343	13	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	343	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	344	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	344	2	dabigatran	dabigatran	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	344	3	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	344	4	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	344	5	LY	LY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	344	6	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	344	7	demonstrated	demonstrate	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	344	8	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	344	9	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	344	10	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	344	11	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	344	12	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	344	13	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	344	14	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	344	15	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	344	16	therapy.165	therapy.165	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	344	17	Non-	Non-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	344	18	bridged	bridge	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	344	19	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	344	20	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	344	21	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	344	22	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	344	23	event	event	NN
work_vvlzsj54cvf5de6ji6py6krqlm	344	24	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	344	25	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	344	26	0.6	0.6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	344	27	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	344	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	345	1	Analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	345	3	periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	345	4	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	5	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	345	7	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	345	8	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	345	9	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	345	10	LY	LY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	345	11	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	12	demonstrated	demonstrate	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	345	13	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	345	14	difference	difference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	15	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	345	16	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	345	17	bleed-	bleed-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	18	ing	e	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	345	19	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	345	20	between	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	345	21	urgent	urgent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	345	22	versus	versus	FW
work_vvlzsj54cvf5de6ji6py6krqlm	345	23	elective	elective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	345	24	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	25	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	345	26	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	345	27	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	345	28	minor	minor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	345	29	surgery.103	surgery.103	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	345	30	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	345	31	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	345	32	also	also	RB
work_vvlzsj54cvf5de6ji6py6krqlm	345	33	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	345	34	difference	difference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	35	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	345	36	fatal	fatal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	345	37	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	345	39	reoperation	reoperation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	40	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	345	41	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	345	42	result	result	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	43	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	345	44	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	345	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	345	46	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	345	47	transfusion	transfusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	345	48	requirements	requirement	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	345	49	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	346	1	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	346	2	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	346	3	few-	few-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	346	4	er	er	UH
work_vvlzsj54cvf5de6ji6py6krqlm	346	5	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	346	6	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	346	7	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	346	8	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	346	9	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	346	10	shorter	short	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	346	11	interruption	interruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	346	12	periods	period	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	346	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	346	14	though	though	IN
work_vvlzsj54cvf5de6ji6py6krqlm	346	15	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	346	16	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	346	17	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	346	18	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	346	19	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	346	20	causal	causal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	346	21	relationship	relationship	NN
work_vvlzsj54cvf5de6ji6py6krqlm	346	22	given	give	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	346	23	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	346	24	shorter	short	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	346	25	interruptions	interruption	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	346	26	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	346	27	indicate	indicate	VB
work_vvlzsj54cvf5de6ji6py6krqlm	346	28	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	346	29	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	346	30	characteristics	characteristic	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	346	31	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	346	32	faster	fast	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	346	33	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	346	34	clearance	clearance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	346	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	347	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	347	2	con-	con-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	3	trast	trast	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	347	5	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	347	7	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	347	8	Dresden	Dresden	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	347	9	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	347	10	registry	registry	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	11	demon-	demon-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	12	strated	strated	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	347	13	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	347	14	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	347	16	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	347	17	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	347	18	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	347	19	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	347	20	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	347	21	procedures.48	procedures.48	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	347	22	Heparin	Heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	347	23	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	347	24	still	still	RB
work_vvlzsj54cvf5de6ji6py6krqlm	347	25	did	do	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	347	26	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	347	27	reduce	reduce	VB
work_vvlzsj54cvf5de6ji6py6krqlm	347	28	car-	car-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	29	diovascular	diovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	347	30	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	347	31	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	347	32	did	do	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	347	33	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	347	34	statistically	statistically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	347	35	affect	affect	VB
work_vvlzsj54cvf5de6ji6py6krqlm	347	36	bleed-	bleed-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	347	37	ing	e	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	347	38	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	39	once	once	IN
work_vvlzsj54cvf5de6ji6py6krqlm	347	40	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	347	41	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	347	42	were	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	347	43	adjusted	adjust	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	347	44	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	347	45	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	347	46	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	347	47	minor	minor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	347	48	procedures.48	procedures.48	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	347	49	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	347	50	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	347	51	Canadian	canadian	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	347	52	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	53	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	54	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	347	56	none	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	57	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	347	58	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	347	59	541	541	CD
work_vvlzsj54cvf5de6ji6py6krqlm	347	60	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	347	61	received	receive	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	347	62	preoperative	preoperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	347	63	bridging	bridging	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	347	65	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	347	66	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	347	67	1.7	1.7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	347	68	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	69	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	347	70	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	347	71	received	receive	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	347	72	postopera-	postopera-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	347	73	tive	tive	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	347	74	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	347	75	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	347	76	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	347	77	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	347	78	molecular	molecular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	347	79	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	347	80	weight	weight	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	81	heparin	heparin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	347	82	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	348	1	Despite	despite	IN
work_vvlzsj54cvf5de6ji6py6krqlm	348	2	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	348	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	348	4	there	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	348	5	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	348	6	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	348	7	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	348	8	transient	transient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	348	9	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	348	10	attack	attack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	348	11	event	event	NN
work_vvlzsj54cvf5de6ji6py6krqlm	348	12	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	348	13	0.2	0.2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	348	14	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	348	15	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	348	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	348	17	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	348	18	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	348	19	arterial	arterial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	348	20	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	348	21	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	348	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	349	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	349	3	ARISTOTLE	ARISTOTLE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	4	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	349	6	37.5	37.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	349	7	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	9	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	349	10	did	do	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	349	11	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	349	12	re-	re-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	349	13	quire	quire	VB
work_vvlzsj54cvf5de6ji6py6krqlm	349	14	NOAC	noac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	349	15	interruption	interruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	349	17	11.7	11.7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	349	18	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	20	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	349	21	received	receive	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	349	22	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	349	23	anticoagulation.105	anticoagulation.105	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	24	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	25	phase	phase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	26	III	iii	CD
work_vvlzsj54cvf5de6ji6py6krqlm	349	27	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	349	28	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	29	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	30	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	31	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	32	VTE	VTE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	33	prevention	prevention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	34	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	35	high	high	RB
work_vvlzsj54cvf5de6ji6py6krqlm	349	36	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	349	37	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	349	38	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	349	39	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	40	orthopedic	orthopedic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	349	41	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	349	43	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	349	44	first	first	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	349	45	pro-	pro-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	46	phylactic	phylactic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	47	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	48	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	349	49	administered	administer	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	349	50	6	6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	349	51	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	349	52	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	349	53	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	349	54	post-	post-	VB
work_vvlzsj54cvf5de6ji6py6krqlm	349	55	operatively.172	operatively.172	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	56	Real	real	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	349	57	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	349	58	world	world	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	59	registries	registry	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	349	60	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	61	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	62	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	63	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	64	orthopedic	orthopedic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	349	65	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	66	suggest	suggest	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	349	67	higher	high	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	349	68	rates	rate	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	349	69	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	70	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	349	71	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	72	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	73	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	349	74	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	75	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	76	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	349	77	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	78	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	349	79	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	349	80	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	349	81	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	349	82	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	349	83	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	84	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	85	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	349	86	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	87	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	349	88	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	349	89	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	349	90	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	91	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	92	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	349	93	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	94	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	95	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	349	96	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	350	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	350	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	350	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	350	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	351	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	351	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	351	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	351	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	351	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	351	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	351	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	351	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	351	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	351	10	e623	e623	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	351	11	CLINICAL	CLINICAL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	351	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	351	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	351	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	351	15	GUIDELINES	GUIDELINES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	351	16	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	351	17	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	351	18	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	351	19	observed	observe	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	351	20	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	351	21	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	351	22	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	351	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	352	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	352	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	352	3	Dres-	Dres-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	352	4	den	den	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	352	5	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	352	6	registry	registry	NN
work_vvlzsj54cvf5de6ji6py6krqlm	352	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	352	8	6	6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	352	9	out	out	IN
work_vvlzsj54cvf5de6ji6py6krqlm	352	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	352	11	42	42	CD
work_vvlzsj54cvf5de6ji6py6krqlm	352	12	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	352	13	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	352	14	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	352	15	orthopedic	orthopedic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	352	16	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	352	17	developed	develop	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	352	18	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	352	19	cardiovas-	cardiovas-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	352	20	cular	cular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	352	21	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	352	22	n=2	n=2	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	352	23	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	352	24	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	352	25	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	352	26	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	352	27	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	352	28	n=4).48	n=4).48	NN
work_vvlzsj54cvf5de6ji6py6krqlm	352	29	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	352	30	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	352	31	Canadian	canadian	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	352	32	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	352	33	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	352	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	352	35	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	352	36	out	out	IN
work_vvlzsj54cvf5de6ji6py6krqlm	352	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	352	38	19	19	CD
work_vvlzsj54cvf5de6ji6py6krqlm	352	39	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	352	40	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	352	41	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	352	42	orthopedic	orthopedic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	352	43	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	352	44	developed	develop	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	352	45	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	352	46	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	352	47	complications.164	complications.164	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	352	48	Caution	caution	NN
work_vvlzsj54cvf5de6ji6py6krqlm	352	49	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	352	50	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	352	51	exercised	exercise	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	352	52	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	352	53	man-	man-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	352	54	aging	age	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	352	55	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	352	56	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	352	57	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	352	58	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	352	59	require	require	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	352	60	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	352	61	orthopedic	orthopedic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	352	62	interventions	intervention	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	352	63	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	353	1	Neuraxial	Neuraxial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	353	2	Anesthesia	Anesthesia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	353	3	Spinal	spinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	353	4	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	353	5	epidural	epidural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	353	6	hematoma	hematoma	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	353	7	can	can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	353	8	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	353	9	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	353	10	devastating	devastating	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	353	11	com-	com-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	353	12	plication	plication	NN
work_vvlzsj54cvf5de6ji6py6krqlm	353	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	353	14	neuraxial	neuraxial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	353	15	anesthesia	anesthesia	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	353	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	354	1	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	354	2	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	354	3	limited	limit	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	354	4	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	354	5	pertaining	pertain	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	354	6	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	354	7	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	354	8	interval	interval	NN
work_vvlzsj54cvf5de6ji6py6krqlm	354	9	between	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	354	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	354	11	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	354	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	354	13	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	354	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	354	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	354	16	neuraxial	neuraxial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	354	17	anesthesia	anesthesia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	354	18	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	354	19	itself	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	354	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	354	21	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	354	22	subsequent	subsequent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	354	23	resumption	resumption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	354	24	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	354	25	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	354	26	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	354	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	355	1	Rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	355	2	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	355	3	prevent	prevent	VB
work_vvlzsj54cvf5de6ji6py6krqlm	355	4	VTE	vte	NN
work_vvlzsj54cvf5de6ji6py6krqlm	355	5	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	355	6	total	total	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	355	7	knee	knee	NN
work_vvlzsj54cvf5de6ji6py6krqlm	355	8	joint	joint	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	355	9	replacement	replacement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	355	10	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	355	11	total	total	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	355	12	hip	hip	NN
work_vvlzsj54cvf5de6ji6py6krqlm	355	13	arthroplasty	arthroplasty	NN
work_vvlzsj54cvf5de6ji6py6krqlm	355	14	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	355	15	neuraxial	neuraxial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	355	16	anesthesia	anesthesia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	355	17	has	have	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	355	18	also	also	RB
work_vvlzsj54cvf5de6ji6py6krqlm	355	19	been	be	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	355	20	examined	examine	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	355	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	356	1	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	2	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	356	3	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	5	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	356	6	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	356	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	356	8	neuraxial	neuraxial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	9	hematoma	hematoma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	356	10	occurred	occur	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	356	11	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	12	only	only	RB
work_vvlzsj54cvf5de6ji6py6krqlm	356	13	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	356	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	15	4086	4086	CD
work_vvlzsj54cvf5de6ji6py6krqlm	356	16	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	356	17	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	18	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	356	19	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	356	20	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	21	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	356	22	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	356	23	occurred	occur	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	356	24	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	25	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	26	administration.173	administration.173	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	27	Of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	28	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	356	29	2550	2550	CD
work_vvlzsj54cvf5de6ji6py6krqlm	356	30	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	356	31	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	356	32	underwent	undergo	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	356	33	neuraxial	neuraxial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	356	34	anesthe-	anesthe-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	356	35	sia	sia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	356	36	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	37	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	356	38	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	356	39	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	40	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	41	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	356	42	phase	phase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	43	IV	IV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	356	44	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	45	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	356	47	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	356	48	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	49	developed	develop	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	356	50	intraspinal	intraspinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	356	51	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	356	52	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	356	53	puncture.174	puncture.174	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	356	54	These	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	356	55	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	356	56	suggest	suggest	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	356	57	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	58	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	356	59	incidence	incidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	60	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	61	neuraxial	neuraxial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	62	he-	he-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	356	63	matoma	matoma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	356	64	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	356	65	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	356	66	despite	despite	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	67	concurrent	concurrent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	356	68	administration	administration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	356	69	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	70	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	356	71	doses	dose	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	356	72	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	356	73	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	356	74	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	356	75	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	357	1	There	there	EX
work_vvlzsj54cvf5de6ji6py6krqlm	357	2	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	357	3	no	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	357	4	robust	robust	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	357	5	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	357	6	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	357	7	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	357	8	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	357	9	address	address	VB
work_vvlzsj54cvf5de6ji6py6krqlm	357	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	357	11	timing	timing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	357	12	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	357	13	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	357	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	357	15	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	357	16	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	357	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	357	18	rein-	rein-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	357	19	stitution	stitution	NN
work_vvlzsj54cvf5de6ji6py6krqlm	357	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	358	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	358	2	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	3	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	358	5	Regional	Regional	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	6	Anesthesia	Anesthesia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	7	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	358	8	European	European	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	9	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	358	11	Regional	Regional	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	12	Anesthesia	Anesthesia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	358	14	Pain	Pain	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	15	Therapy	Therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	16	recommend	recommend	NN
work_vvlzsj54cvf5de6ji6py6krqlm	358	17	stopping	stop	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	358	18	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	358	19	4	4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	358	20	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	358	21	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	358	22	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	358	23	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	358	24	neuraxial	neuraxial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	358	25	block.175	block.175	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	26	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	358	27	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	358	28	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	358	29	end	end	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	358	30	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	358	31	stage	stage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	358	32	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	358	33	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	358	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	358	35	6	6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	358	36	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	358	37	off	off	IN
work_vvlzsj54cvf5de6ji6py6krqlm	358	38	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	358	39	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	358	40	recommended	recommend	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	358	41	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	359	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	359	2	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	359	3	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	359	4	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	359	5	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	359	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	359	7	VTE	VTE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	359	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	359	9	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	359	10	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	359	11	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	359	12	administered	administer	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	359	13	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	359	14	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	359	15	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	359	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	359	17	pain	pain	NN
work_vvlzsj54cvf5de6ji6py6krqlm	359	18	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	359	19	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	360	1	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	360	2	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	360	3	recommends	recommend	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	360	4	stopping	stop	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	360	5	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	360	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	360	7	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	360	8	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	360	9	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	360	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	360	11	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	360	12	before	before	IN
work_vvlzsj54cvf5de6ji6py6krqlm	360	13	neuroaxial	neuroaxial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	360	14	block	block	NN
work_vvlzsj54cvf5de6ji6py6krqlm	360	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	360	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	360	17	resuming	resume	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	360	18	either	either	CC
work_vvlzsj54cvf5de6ji6py6krqlm	360	19	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	360	20	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	360	21	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	360	22	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	360	23	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	360	24	pain	pain	NN
work_vvlzsj54cvf5de6ji6py6krqlm	360	25	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	360	26	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	360	27	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	360	28	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	360	29	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	360	30	VTE	VTE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	360	31	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	360	32	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	360	33	high	high	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	360	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	361	1	No	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	361	2	guidance	guidance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	361	3	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	361	4	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	361	5	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	361	6	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	361	7	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	361	8	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	361	9	document	document	NN
work_vvlzsj54cvf5de6ji6py6krqlm	361	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	362	1	These	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	362	2	recommendations	recommendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	362	3	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	362	4	controversial	controversial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	362	5	because	because	IN
work_vvlzsj54cvf5de6ji6py6krqlm	362	6	discontinuation	discontinuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	362	7	periods	period	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	362	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	362	9	≥4	≥4	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	362	10	days	day	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	362	11	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	362	12	inconsistent	inconsistent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	362	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	362	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	362	15	return	return	NN
work_vvlzsj54cvf5de6ji6py6krqlm	362	16	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	362	17	hemostasis	hemostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	362	18	time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	362	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	362	20	these	these	DT
work_vvlzsj54cvf5de6ji6py6krqlm	362	21	agents	agent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	362	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	362	23	which	which	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	362	24	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	362	25	expose	expose	VB
work_vvlzsj54cvf5de6ji6py6krqlm	362	26	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	362	27	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	362	28	excess	excess	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	362	29	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	362	30	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	362	31	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	363	1	CONCLUSION	CONCLUSION	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	363	2	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	363	3	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	363	4	no	no	RB
work_vvlzsj54cvf5de6ji6py6krqlm	363	5	longer	long	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	363	6	novel	novel	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	363	7	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	363	8	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	363	9	now	now	RB
work_vvlzsj54cvf5de6ji6py6krqlm	363	10	commonly	commonly	RB
work_vvlzsj54cvf5de6ji6py6krqlm	363	11	used	use	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	363	12	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	363	13	day	day	NN
work_vvlzsj54cvf5de6ji6py6krqlm	363	14	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	363	15	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	363	16	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	363	17	day	day	NN
work_vvlzsj54cvf5de6ji6py6krqlm	363	18	medical	medical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	363	19	practice	practice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	363	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	364	1	Healthcare	healthcare	NN
work_vvlzsj54cvf5de6ji6py6krqlm	364	2	providers	provider	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	364	3	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	364	4	encouraged	encourage	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	364	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	364	6	use	use	VB
work_vvlzsj54cvf5de6ji6py6krqlm	364	7	well	well	RB
work_vvlzsj54cvf5de6ji6py6krqlm	364	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	364	9	defined	define	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	364	10	protocols	protocol	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	364	11	established	establish	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	364	12	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	364	13	collaborations	collaboration	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	364	14	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	364	15	multiple	multiple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	364	16	professional	professional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	364	17	disciplines	discipline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	364	18	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	364	19	address	address	VB
work_vvlzsj54cvf5de6ji6py6krqlm	364	20	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	364	21	dose	dose	VB
work_vvlzsj54cvf5de6ji6py6krqlm	364	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	364	23	continuation	continuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	364	24	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	364	25	cessation	cessation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	364	26	when	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	364	27	invasive	invasive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	364	28	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	364	29	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	364	30	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	364	31	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	365	1	Such	such	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	365	2	protocols	protocol	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	365	3	should	should	MD
work_vvlzsj54cvf5de6ji6py6krqlm	365	4	also	also	RB
work_vvlzsj54cvf5de6ji6py6krqlm	365	5	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	365	6	encouraged	encourage	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	365	7	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	365	8	assist	assist	VB
work_vvlzsj54cvf5de6ji6py6krqlm	365	9	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	365	10	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	365	11	providers	provider	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	365	12	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	365	13	manage	manage	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	365	14	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	365	15	while	while	IN
work_vvlzsj54cvf5de6ji6py6krqlm	365	16	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	365	17	take	take	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	365	18	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	365	19	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	366	1	Simple	simple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	366	2	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	366	3	administer	administer	VB
work_vvlzsj54cvf5de6ji6py6krqlm	366	4	antidotes	antidote	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	366	5	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	366	6	either	either	RB
work_vvlzsj54cvf5de6ji6py6krqlm	366	7	approved	approve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	366	8	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	366	9	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	366	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	366	11	such	such	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	366	12	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	366	13	idarucizumab	idarucizumab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	366	14	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	366	15	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	366	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	366	17	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	366	18	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	366	19	currently	currently	RB
work_vvlzsj54cvf5de6ji6py6krqlm	366	20	under	under	IN
work_vvlzsj54cvf5de6ji6py6krqlm	366	21	investigation	investigation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	366	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	367	1	Further	further	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	367	2	studies	study	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	367	3	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	367	4	measure	measure	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	367	5	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	367	6	out-	out-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	367	7	comes	come	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	367	8	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	367	9	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	367	10	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	367	11	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	367	12	needed	need	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	367	13	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	367	14	optimize	optimize	VB
work_vvlzsj54cvf5de6ji6py6krqlm	367	15	pro-	pro-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	367	16	tocols	tocol	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	367	17	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	367	18	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	367	19	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	367	20	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	367	21	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	367	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	367	23	periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	367	24	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	367	25	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	367	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	368	1	ACKNOWLEDGMENTS	acknowledgment	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	368	2	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	368	3	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	368	4	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	368	5	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	368	6	thanks	thank	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	368	7	Taylor	Taylor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	368	8	Klein	Klein	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	368	9	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	368	10	assistance	assistance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	368	11	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	368	12	reference	reference	NN
work_vvlzsj54cvf5de6ji6py6krqlm	368	13	formatting	formatting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	368	14	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	368	15	Anne	Anne	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	368	16	Leonard	Leonard	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	368	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	368	18	Connie	Connie	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	368	19	Land	Land	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	368	20	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	368	21	administrative	administrative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	368	22	assistance	assistance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	368	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	369	1	FOOTNOTES	FOOTNOTES	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	369	2	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	369	3	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	369	4	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	369	5	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	369	6	makes	make	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	369	7	every	every	DT
work_vvlzsj54cvf5de6ji6py6krqlm	369	8	effort	effort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	369	9	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	369	10	avoid	avoid	VB
work_vvlzsj54cvf5de6ji6py6krqlm	369	11	any	any	DT
work_vvlzsj54cvf5de6ji6py6krqlm	369	12	actual	actual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	369	13	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	369	14	potential	potential	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	369	15	conflicts	conflict	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	369	16	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	369	17	interest	interest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	369	18	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	369	19	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	369	20	arise	arise	VB
work_vvlzsj54cvf5de6ji6py6krqlm	369	21	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	369	22	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	369	23	result	result	NN
work_vvlzsj54cvf5de6ji6py6krqlm	369	24	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	369	25	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	369	26	outside	outside	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	369	27	relationship	relationship	NN
work_vvlzsj54cvf5de6ji6py6krqlm	369	28	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	369	29	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	369	30	personal	personal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	369	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	369	32	professional	professional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	369	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	369	34	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	369	35	business	business	NN
work_vvlzsj54cvf5de6ji6py6krqlm	369	36	interest	interest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	369	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	369	38	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	369	39	member	member	NN
work_vvlzsj54cvf5de6ji6py6krqlm	369	40	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	369	41	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	369	42	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	369	43	panel	panel	NN
work_vvlzsj54cvf5de6ji6py6krqlm	369	44	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	370	1	Specifically	specifically	RB
work_vvlzsj54cvf5de6ji6py6krqlm	370	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	370	3	all	all	DT
work_vvlzsj54cvf5de6ji6py6krqlm	370	4	members	member	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	370	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	370	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	370	7	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	370	8	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	370	9	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	370	10	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	370	11	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	370	12	complete	complete	VB
work_vvlzsj54cvf5de6ji6py6krqlm	370	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	370	14	submit	submit	VB
work_vvlzsj54cvf5de6ji6py6krqlm	370	15	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	370	16	Disclosure	Disclosure	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	370	17	Questionnaire	Questionnaire	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	370	18	showing	show	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	370	19	all	all	DT
work_vvlzsj54cvf5de6ji6py6krqlm	370	20	such	such	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	370	21	relationships	relationship	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	370	22	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	370	23	might	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	370	24	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	370	25	perceived	perceive	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	370	26	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	370	27	real	real	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	370	28	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	370	29	potential	potential	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	370	30	conflicts	conflict	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	370	31	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	370	32	interest	interest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	370	33	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	371	1	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	371	2	statement	statement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	371	3	was	be	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	371	4	approved	approve	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	371	5	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	371	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	371	7	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	8	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	9	Asso-	asso-	IN
work_vvlzsj54cvf5de6ji6py6krqlm	371	10	ciation	ciation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	371	11	Science	Science	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	12	Advisory	Advisory	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	371	14	Coordinating	Coordinating	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	15	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	16	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	371	17	Octo-	Octo-	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	371	18	ber	ber	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	19	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	371	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	371	21	2016	2016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	371	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	371	23	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	371	24	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	371	25	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	26	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	27	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	28	Executive	Executive	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	29	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	30	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	371	31	October	October	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	371	32	25	25	CD
work_vvlzsj54cvf5de6ji6py6krqlm	371	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	371	34	2016	2016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	371	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	372	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	372	2	copy	copy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	372	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	372	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	372	5	document	document	NN
work_vvlzsj54cvf5de6ji6py6krqlm	372	6	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	372	7	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	372	8	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	372	9	http://professional.heart.org/statements	http://professional.heart.org/statements	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	372	10	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	372	11	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	372	12	either	either	DT
work_vvlzsj54cvf5de6ji6py6krqlm	372	13	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	372	14	Search	Search	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	372	15	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	372	16	Guidelines	Guidelines	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	372	17	&	&	CC
work_vvlzsj54cvf5de6ji6py6krqlm	372	18	Statements	Statements	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	372	19	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	372	20	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	372	21	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	372	22	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	372	23	Browse	Browse	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	372	24	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	372	25	Topic	Topic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	372	26	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	372	27	area	area	NN
work_vvlzsj54cvf5de6ji6py6krqlm	372	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	373	1	To	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	373	2	purchase	purchase	VB
work_vvlzsj54cvf5de6ji6py6krqlm	373	3	additional	additional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	373	4	reprints	reprint	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	373	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	373	6	call	call	VB
work_vvlzsj54cvf5de6ji6py6krqlm	373	7	843	843	CD
work_vvlzsj54cvf5de6ji6py6krqlm	373	8	-	-	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	373	9	216-	216-	CD
work_vvlzsj54cvf5de6ji6py6krqlm	373	10	2533	2533	CD
work_vvlzsj54cvf5de6ji6py6krqlm	373	11	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	373	12	e	e	NN
work_vvlzsj54cvf5de6ji6py6krqlm	373	13	-	-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	373	14	mail	mail	NN
work_vvlzsj54cvf5de6ji6py6krqlm	373	15	kelle.ramsay@wolterskluwer.com	kelle.ramsay@wolterskluwer.com	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	373	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	374	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	374	2	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	3	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	4	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	5	requests	request	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	374	6	that	that	IN
work_vvlzsj54cvf5de6ji6py6krqlm	374	7	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	374	8	docu-	docu-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	374	9	ment	ment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	374	10	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	374	11	cited	cite	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	374	12	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	374	13	follows	follow	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	374	14	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	374	15	Raval	raval	NN
work_vvlzsj54cvf5de6ji6py6krqlm	374	16	AN	AN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	374	18	Cigarroa	Cigarroa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	19	JE	JE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	374	21	Chung	Chung	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	22	MK	MK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	374	24	Diaz	Diaz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	25	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	374	26	Sandoval	Sandoval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	27	LJ	LJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	374	29	Diercks	Diercks	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	30	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	374	32	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	33	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	374	35	Jung	Jung	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	36	HS	HS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	374	38	Washam	Washam	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	39	JB	JB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	374	41	Welch	Welch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	42	BG	BG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	374	44	Zazulia	Zazulia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	45	AR	AR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	374	47	Collins	Collins	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	48	SP	SP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	49	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	374	50	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	374	51	behalf	behalf	NN
work_vvlzsj54cvf5de6ji6py6krqlm	374	52	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	374	53	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	374	54	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	55	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	56	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	57	Clinical	Clinical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	58	Pharmacology	Pharmacology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	59	Subcommittee	Subcommittee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	60	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	374	61	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	374	62	Acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	374	63	Cardiac	Cardiac	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	64	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	65	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	374	66	General	General	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	67	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	68	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	69	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	374	70	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	374	71	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	72	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	374	73	Clinical	Clinical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	74	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	75	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	374	76	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	77	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	374	78	Cardiovascu-	Cardiovascu-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	79	lar	lar	NN
work_vvlzsj54cvf5de6ji6py6krqlm	374	80	Disease	Disease	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	81	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	374	82	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	374	83	Young	Young	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	84	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	374	85	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	374	86	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	87	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	374	88	Quality	Quality	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	89	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	374	90	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	91	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	374	92	Outcomes	Outcomes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	93	Research	Research	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	374	94	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	375	1	Management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	375	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	375	3	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	375	4	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	375	5	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	375	6	–	–	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	375	7	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	375	8	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	375	9	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	375	10	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	375	11	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	375	12	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	375	13	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	375	14	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	375	15	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	375	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	375	17	peri-	peri-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	375	18	procedural	procedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	375	19	setting	setting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	375	20	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	375	21	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	375	22	scientific	scientific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	375	23	statement	statement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	375	24	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	375	25	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	375	26	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	375	27	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	375	28	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	375	29	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	376	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	376	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	377	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	377	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	377	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	377	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	378	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	378	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	378	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	378	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	378	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	378	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	379	1	Expert	expert	NN
work_vvlzsj54cvf5de6ji6py6krqlm	379	2	peer	peer	NN
work_vvlzsj54cvf5de6ji6py6krqlm	379	3	review	review	NN
work_vvlzsj54cvf5de6ji6py6krqlm	379	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	379	5	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	379	6	Scientific	Scientific	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	379	7	Statements	Statements	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	379	8	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	379	9	conducted	conduct	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	379	10	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	379	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	379	12	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	379	13	Office	Office	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	379	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	379	15	Science	Science	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	379	16	Operations	Operations	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	379	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	380	1	For	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	380	2	more	more	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	380	3	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	380	4	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	380	5	state-	state-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	380	6	ments	ment	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	380	7	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	380	8	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	380	9	development	development	NN
work_vvlzsj54cvf5de6ji6py6krqlm	380	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	380	11	visit	visit	VB
work_vvlzsj54cvf5de6ji6py6krqlm	380	12	http://professional	http://professional	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	380	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	381	1	heart.org/statements	heart.org/statements	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	381	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	382	1	Select	select	VB
work_vvlzsj54cvf5de6ji6py6krqlm	382	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	382	3	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	382	4	Guidelines	Guidelines	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	382	5	&	&	CC
work_vvlzsj54cvf5de6ji6py6krqlm	382	6	Statements	Statements	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	382	7	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	382	8	drop	drop	NN
work_vvlzsj54cvf5de6ji6py6krqlm	382	9	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	382	10	down	down	RP
work_vvlzsj54cvf5de6ji6py6krqlm	382	11	menu	menu	NN
work_vvlzsj54cvf5de6ji6py6krqlm	382	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	382	13	then	then	RB
work_vvlzsj54cvf5de6ji6py6krqlm	382	14	click	click	VB
work_vvlzsj54cvf5de6ji6py6krqlm	382	15	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	382	16	Publication	Publication	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	382	17	Development	Development	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	382	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	382	19	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	382	20	Permissions	permission	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	382	21	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	382	22	Multiple	multiple	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	382	23	copies	copy	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	382	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	382	25	modification	modification	NN
work_vvlzsj54cvf5de6ji6py6krqlm	382	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	382	27	alteration	alteration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	382	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	382	29	en-	en-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	382	30	hancement	hancement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	382	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	382	32	and/or	and/or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	382	33	distribution	distribution	NN
work_vvlzsj54cvf5de6ji6py6krqlm	382	34	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	382	35	this	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	382	36	document	document	NN
work_vvlzsj54cvf5de6ji6py6krqlm	382	37	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	382	38	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	382	39	permit-	permit-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	382	40	ted	ted	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	382	41	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	382	42	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	382	43	express	express	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	382	44	permission	permission	NN
work_vvlzsj54cvf5de6ji6py6krqlm	382	45	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	382	46	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	382	47	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	382	48	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	382	49	Asso-	asso-	IN
work_vvlzsj54cvf5de6ji6py6krqlm	382	50	ciation	ciation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	382	51	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	383	1	Instructions	instruction	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	383	2	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	383	3	obtaining	obtain	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	383	4	permission	permission	NN
work_vvlzsj54cvf5de6ji6py6krqlm	383	5	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	383	6	located	locate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	383	7	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	383	8	http://	http://	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	383	9	www.heart.org/HEARTORG/General/Copyright-Permission-	www.heart.org/heartorg/general/copyright-permission-	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	383	10	Guidelines_UCM_300404_Article.jsp	guidelines_ucm_300404_article.jsp	NN
work_vvlzsj54cvf5de6ji6py6krqlm	383	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	384	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	384	2	link	link	NN
work_vvlzsj54cvf5de6ji6py6krqlm	384	3	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	384	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	384	5	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	384	6	Copyright	copyright	NN
work_vvlzsj54cvf5de6ji6py6krqlm	384	7	Per-	Per-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	384	8	missions	mission	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	384	9	Request	Request	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	384	10	Form	Form	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	384	11	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	384	12	appears	appear	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	384	13	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	384	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	384	15	right	right	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	384	16	side	side	NN
work_vvlzsj54cvf5de6ji6py6krqlm	384	17	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	384	18	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	384	19	page	page	NN
work_vvlzsj54cvf5de6ji6py6krqlm	384	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	385	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	385	2	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	385	3	available	available	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	385	4	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	385	5	http://circ.ahajournals.org	http://circ.ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	385	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	386	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	386	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	386	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	386	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	386	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	386	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	386	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	386	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	386	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	386	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	386	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	386	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	386	13	mailto:kelle.ramsay@wolterskluwer.com	mailto:kelle.ramsay@wolterskluwer.com	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	386	14	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	386	15	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	386	16	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	386	17	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	386	18	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	386	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	386	20	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	386	21	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	386	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	387	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	387	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	387	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	387	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	388	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	388	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	388	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	388	5	CIR.0000000000000477e624	CIR.0000000000000477e624	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	6	Writing	Writing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	7	Group	Group	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	8	Disclosures	Disclosures	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	9	Writing	Writing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	10	Group	Group	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	11	Member	Member	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	12	Employment	Employment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	13	Research	Research	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	14	Grant	Grant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	15	Other	Other	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	16	Research	Research	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	17	Support	Support	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	18	Speakers	Speakers	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	388	19	’	’	POS
work_vvlzsj54cvf5de6ji6py6krqlm	388	20	Bureau/	Bureau/	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	21	Honoraria	Honoraria	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	22	Expert	Expert	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	23	Witness	Witness	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	24	Ownership	Ownership	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	25	Interest	Interest	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	26	Consultant/	Consultant/	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	27	Advisory	Advisory	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	28	Board	Board	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	29	Other	Other	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	30	Amish	Amish	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	31	N.	N.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	32	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	33	University	University	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	34	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	35	Wisconsin	Wisconsin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	36	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	37	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	38	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	39	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	40	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	41	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	42	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	43	Sean	Sean	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	44	P.	P.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	45	Collins	Collins	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	46	Vanderbilt	Vanderbilt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	47	University	University	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	48	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	49	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	50	Medicine	Medicine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	51	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	52	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	53	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	54	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	55	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	56	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	57	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	58	Mina	Mina	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	59	K.	K.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	60	Chung	Chung	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	61	Cleveland	Cleveland	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	62	Clinic	Clinic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	63	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	64	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	65	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	66	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	67	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	68	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	69	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	70	Joaquin	Joaquin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	71	E.	E.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	72	Cigarroa	Cigarroa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	73	Oregon	Oregon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	74	Health	Health	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	75	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	388	76	Science	Science	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	77	University	University	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	78	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	79	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	80	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	81	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	82	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	83	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	84	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	85	Larry	Larry	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	86	J.	J.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	87	Diaz-	Diaz-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	88	Sandoval	Sandoval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	89	Michigan	Michigan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	90	State	State	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	91	University	University	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	92	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	93	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	94	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	95	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	96	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	97	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	98	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	99	Deborah	Deborah	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	100	Diercks	Diercks	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	101	UT	UT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	102	Southwestern	Southwestern	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	103	Emergency	Emergency	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	104	Medicine	Medicine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	105	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	106	Johnson	Johnson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	107	&	&	CC
work_vvlzsj54cvf5de6ji6py6krqlm	388	108	Johnson	Johnson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	109	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	388	110	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	388	111	Steering	Steering	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	112	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	113	member	member	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	114	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	115	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	388	116	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	117	about	about	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	118	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	388	119	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	120	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	121	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	122	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	388	123	NOACS	NOACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	124	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	388	125	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	126	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	127	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	128	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	129	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	130	Hee	Hee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	131	Soo	Soo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	132	Jung	Jung	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	133	University	University	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	134	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	135	Wisconsin	Wisconsin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	136	NIH(National	NIH(National	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	137	Center	Center	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	138	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	139	Advancing	advance	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	388	140	Translational	Translational	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	141	Sciences	Sciences	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	388	142	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	388	143	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	388	144	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	388	145	National	National	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	146	Board	Board	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	147	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	148	Medical	Medical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	149	Examiners	Examiners	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	388	150	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	388	151	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	152	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	153	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	154	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	155	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	156	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	157	Jonathan	Jonathan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	158	P.	P.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	159	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	160	Duke	Duke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	161	University	University	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	162	Janssen	Janssen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	163	Pharmaceuticals†	Pharmaceuticals†	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	164	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	165	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	166	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	167	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	168	Janssen	Janssen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	169	Pharmaceuticals	Pharmaceuticals	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	170	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	388	171	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	388	172	Medtronic	medtronic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	388	173	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	388	174	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	388	175	BMS	BMS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	176	Pfizer	Pfizer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	177	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	388	178	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	179	Jeffrey	Jeffrey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	180	B.	B.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	181	Washam	Washam	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	182	Duke	Duke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	183	University	University	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	184	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	185	Center	Center	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	186	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	187	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	188	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	189	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	190	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	191	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	192	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	193	Babu	Babu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	194	G.	G.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	195	Welch	Welch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	196	UT	UT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	197	Southwestern	Southwestern	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	198	Medical	Medical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	199	Center	Center	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	200	St.	St.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	201	Paul	Paul	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	202	Medical	Medical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	203	Foundation†	foundation†	CD
work_vvlzsj54cvf5de6ji6py6krqlm	388	204	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	205	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	206	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	207	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	208	Stryker	stryker	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	209	Neurovascular	Neurovascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	210	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	388	211	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	388	212	Covidien	Covidien	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	213	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	388	214	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	215	Allyson	Allyson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	216	R.	R.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	217	Zazulia	Zazulia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	218	Washington	Washington	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	219	University	University	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	220	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	221	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	222	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	223	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	224	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	225	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	226	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	227	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	388	228	table	table	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	229	represents	represent	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	388	230	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	388	231	relationships	relationship	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	388	232	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	233	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	234	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	235	members	member	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	388	236	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	388	237	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	388	238	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	388	239	perceived	perceive	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	388	240	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	241	actual	actual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	388	242	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	388	243	reasonably	reasonably	RB
work_vvlzsj54cvf5de6ji6py6krqlm	388	244	perceived	perceive	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	388	245	conflicts	conflict	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	388	246	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	247	interest	interest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	248	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	249	reported	report	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	388	250	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	251	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	388	252	Disclosure	Disclosure	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	253	Questionnaire	Questionnaire	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	388	254	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	388	255	which	which	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	388	256	all	all	DT
work_vvlzsj54cvf5de6ji6py6krqlm	388	257	members	member	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	388	258	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	388	259	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	388	260	writing	writing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	261	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	388	262	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	388	263	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	388	264	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	388	265	complete	complete	VB
work_vvlzsj54cvf5de6ji6py6krqlm	388	266	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	388	267	submit	submit	VB
work_vvlzsj54cvf5de6ji6py6krqlm	388	268	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	389	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	389	2	relationship	relationship	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	389	4	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	389	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	389	6	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	389	7	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	389	8	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	389	9	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	389	10	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	389	11	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	389	12	a	a	LS
work_vvlzsj54cvf5de6ji6py6krqlm	389	13	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	389	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	389	15	person	person	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	16	receives	receive	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	389	17	$	$	$
work_vvlzsj54cvf5de6ji6py6krqlm	389	18	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	389	19	000	000	CD
work_vvlzsj54cvf5de6ji6py6krqlm	389	20	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	389	21	more	more	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	389	22	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	389	23	any	any	DT
work_vvlzsj54cvf5de6ji6py6krqlm	389	24	12-month	12-month	CD
work_vvlzsj54cvf5de6ji6py6krqlm	389	25	period	period	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	389	27	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	389	28	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	389	29	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	30	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	389	31	more	more	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	389	32	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	389	33	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	389	34	person	person	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	35	’s	’s	POS
work_vvlzsj54cvf5de6ji6py6krqlm	389	36	gross	gross	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	389	37	income	income	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	38	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	389	39	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	389	40	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	389	41	b	b	LS
work_vvlzsj54cvf5de6ji6py6krqlm	389	42	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	389	43	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	389	44	person	person	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	45	owns	own	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	389	46	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	389	47	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	48	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	389	49	more	more	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	389	50	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	389	51	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	389	52	voting	voting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	53	stock	stock	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	54	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	389	55	share	share	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	56	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	389	57	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	389	58	entity	entity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	59	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	389	60	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	389	61	owns	own	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	389	62	$	$	$
work_vvlzsj54cvf5de6ji6py6krqlm	389	63	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	389	64	000	000	CD
work_vvlzsj54cvf5de6ji6py6krqlm	389	65	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	389	66	more	more	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	389	67	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	389	68	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	389	69	fair	fair	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	389	70	market	market	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	71	value	value	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	72	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	389	73	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	389	74	entity	entity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	389	75	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	390	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	390	2	relationship	relationship	NN
work_vvlzsj54cvf5de6ji6py6krqlm	390	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	390	4	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	390	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	390	6	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	390	7	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	390	8	modest	modest	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	390	9	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	390	10	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	390	11	it	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	390	12	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	390	13	less	less	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	390	14	than	than	IN
work_vvlzsj54cvf5de6ji6py6krqlm	390	15	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	390	16	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	390	17	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	390	18	under	under	IN
work_vvlzsj54cvf5de6ji6py6krqlm	390	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	390	20	preceding	precede	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	390	21	definition	definition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	390	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	391	1	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	391	2	Modest	modest	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	391	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	392	1	†Significant	†significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	392	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	393	1	DISCLOSURES	DISCLOSURES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	393	2	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	393	3	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	393	4	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	393	5	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	393	6	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	393	7	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	393	8	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	393	9	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	393	10	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	393	11	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	393	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	393	13	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	393	14	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	393	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	393	16	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	393	17	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	393	18	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	393	19	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	393	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	393	21	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	393	22	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	393	23	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	393	24	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	393	25	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	393	26	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	393	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	394	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	394	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	394	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	394	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	395	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	395	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	395	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	395	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	395	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	395	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	395	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	395	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	395	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	395	10	e625	e625	NN
work_vvlzsj54cvf5de6ji6py6krqlm	395	11	CLINICAL	clinical	NN
work_vvlzsj54cvf5de6ji6py6krqlm	395	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	395	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	395	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	395	15	GUIDELINES	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	395	16	REFERENCES	reference	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	395	17	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	395	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	396	1	Barnes	barne	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	396	2	GD	GD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	396	4	Ageno	Ageno	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	5	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	396	7	Ansell	Ansell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	8	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	396	10	Kaatz	Kaatz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	11	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	12	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	396	13	Subcommittee	Subcommittee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	14	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	396	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	396	16	Control	Control	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	17	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	396	18	Anticoagulation	Anticoagulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	396	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	396	21	International	International	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	22	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	23	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	396	24	Throm-	Throm-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	396	25	bosis	bosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	396	26	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	396	27	Haemostasis	haemostasis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	396	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	397	1	Recommendation	recommendation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	397	2	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	397	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	397	4	nomenclature	nomenclature	NN
work_vvlzsj54cvf5de6ji6py6krqlm	397	5	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	397	6	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	397	7	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	397	8	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	397	9	communication	communication	NN
work_vvlzsj54cvf5de6ji6py6krqlm	397	10	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	397	11	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	397	12	SSC	SSC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	397	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	397	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	397	15	ISTH	ISTH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	397	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	398	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	398	2	Thromb	Thromb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	398	3	Haemost	Haemost	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	398	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	399	1	2015;13:1154–1156	2015;13:1154–1156	LS
work_vvlzsj54cvf5de6ji6py6krqlm	399	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	400	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	400	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	400	3	10.1111/	10.1111/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	400	4	jth.12969	jth.12969	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	400	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	401	1	2	2	LS
work_vvlzsj54cvf5de6ji6py6krqlm	401	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	402	1	Connolly	Connolly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	2	SJ	SJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	4	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	5	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	7	Yusuf	Yusuf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	8	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	10	Eikelboom	Eikelboom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	11	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	13	Oldgren	Oldgren	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	14	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	16	Parekh	Parekh	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	17	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	19	Pogue	Pogue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	20	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	22	Reilly	Reilly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	23	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	25	Themeles	Themeles	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	26	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	28	Varrone	Varrone	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	29	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	31	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	32	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	34	Alings	Alings	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	35	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	37	Xavier	Xavier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	38	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	40	Zhu	Zhu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	41	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	43	Diaz	Diaz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	44	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	46	Lewis	Lewis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	47	BS	BS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	49	Darius	Darius	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	50	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	52	Diener	Diener	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	53	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	54	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	402	55	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	57	Joyner	Joyner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	58	CD	CD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	59	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	402	60	Wallentin	Wallentin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	61	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	62	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	402	63	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	64	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	402	65	LY	LY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	66	Steering	Steering	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	67	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	402	68	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	402	69	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	402	70	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	403	1	Dabi-	Dabi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	403	2	gatran	gatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	403	3	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	403	4	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	403	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	403	6	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	403	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	403	8	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	403	9	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	403	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	404	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	404	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	404	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	404	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	404	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	405	1	2009;361:1139–1151	2009;361:1139–1151	CD
work_vvlzsj54cvf5de6ji6py6krqlm	405	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	406	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	406	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	406	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	406	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	406	5	NEJMoa0905561	nejmoa0905561	CD
work_vvlzsj54cvf5de6ji6py6krqlm	406	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	407	1	3	3	LS
work_vvlzsj54cvf5de6ji6py6krqlm	407	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	408	1	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	2	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	408	4	Mahaffey	Mahaffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	5	KW	KW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	408	7	Garg	Garg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	8	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	408	10	Pan	Pan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	11	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	408	13	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	14	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	408	16	Hacke	Hacke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	17	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	408	19	Breithardt	Breithardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	20	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	408	22	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	23	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	408	25	Hankey	Hankey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	26	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	408	28	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	29	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	408	31	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	32	Reviewer	Reviewer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	33	Disclosures	Disclosures	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	34	Reviewer	Reviewer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	35	Employment	Employment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	36	Research	Research	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	37	Grant	Grant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	38	Other	Other	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	39	Research	Research	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	40	Support	Support	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	41	Speakers	Speakers	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	408	42	’	’	POS
work_vvlzsj54cvf5de6ji6py6krqlm	408	43	Bureau/	Bureau/	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	44	Honoraria	Honoraria	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	45	Expert	Expert	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	46	Witness	Witness	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	47	Ownership	Ownership	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	48	Interest	Interest	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	49	Consultant/	Consultant/	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	50	Advisory	Advisory	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	51	Board	Board	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	52	Other	Other	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	53	Tyler	Tyler	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	54	W.	W.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	55	Barrett	Barrett	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	56	Vanderbilt	Vanderbilt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	57	University	University	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	58	NIH	NIH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	59	NHLBI	NHLBI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	60	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	408	61	PI	PI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	62	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	408	63	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	408	64	K23	K23	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	65	studying	study	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	408	66	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	408	67	Fib	Fib	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	68	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	408	69	ended	end	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	408	70	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	408	71	Sept	Sept	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	72	2015)†	2015)†	CD
work_vvlzsj54cvf5de6ji6py6krqlm	408	73	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	74	Janssen	Janssen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	75	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	408	76	Site	Site	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	77	PI	PI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	78	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	408	79	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	408	80	multicenter	multicenter	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	408	81	international	international	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	82	ORBIT-	ORBIT-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	83	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	84	II	II	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	85	registry)†	registry)†	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	86	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	87	Boehringer	Boehringer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	88	Ingelheim	Ingelheim	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	89	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	408	90	PI	PI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	91	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	408	92	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	408	93	multicenter	multicenter	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	408	94	retrospective	retrospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	408	95	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	96	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	408	97	completed	complete	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	408	98	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	408	99	early	early	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	408	100	2016	2016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	408	101	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	408	102	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	408	103	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	104	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	105	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	106	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	107	Boehringer	Boehringer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	108	Ingelheim†	Ingelheim†	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	408	109	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	110	John	John	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	111	W.	W.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	112	Eikelboom	Eikelboom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	113	McMaster	McMaster	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	114	University	University	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	115	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	408	116	Canada	Canada	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	117	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	408	118	BMS†	bms†	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	408	119	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	120	Boehringer	Boehringer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	121	Ingelheim†	Ingelheim†	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	408	122	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	123	Pfizer†	pfizer†	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	408	124	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	125	Bayer†	Bayer†	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	126	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	127	BMS†	bms†	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	128	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	129	Boehringer	Boehringer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	130	Ingelheim†	Ingelheim†	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	408	131	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	132	Pfizer†	pfizer†	CD
work_vvlzsj54cvf5de6ji6py6krqlm	408	133	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	134	Bayer†	bayer†	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	408	135	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	136	Janssen	Janssen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	137	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	408	138	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	139	Daiichi	Daiichi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	140	Sankyo	Sankyo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	141	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	408	142	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	143	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	144	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	145	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	146	David	David	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	147	A.	a.	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	148	Garcia	Garcia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	149	University	University	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	150	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	408	151	Washington	Washington	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	152	Daiichi	Daiichi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	153	Sankyo	Sankyo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	154	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	408	155	Local	Local	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	156	PI	PI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	157	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	408	158	St	St	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	159	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	160	member	member	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	161	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	408	162	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	408	163	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	164	involving	involve	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	408	165	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	166	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	408	167	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	408	168	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	169	Janssen	Janssen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	170	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	408	171	Local	Local	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	172	PI	PI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	173	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	408	174	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	408	175	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	176	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	408	177	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	408	178	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	179	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	180	Pfizer	Pfizer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	181	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	408	182	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	183	BMS	bms	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	184	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	408	185	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	186	Pfizer	Pfizer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	187	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	408	188	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	189	BMS	bms	NN
work_vvlzsj54cvf5de6ji6py6krqlm	408	190	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	408	191	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	408	192	Boehringer	Boehringer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	193	Ingelheim	Ingelheim	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	194	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	408	195	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	196	Gregory	Gregory	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	408	197	Y.H.	Y.H.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	1	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	2	City	City	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	3	Hospital	Hospital	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	4	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	409	5	United	United	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	6	Kingdom	Kingdom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	7	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	409	8	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	9	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	409	10	Bayer†	bayer†	NN
work_vvlzsj54cvf5de6ji6py6krqlm	409	11	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	12	BMS/	BMS/	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	13	Pfizer†	Pfizer†	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	409	14	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	15	Medtronic†	medtronic†	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	409	16	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	17	Boehringer	Boehringer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	18	Ingelheim†	Ingelheim†	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	409	19	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	20	Microlife†	microlife†	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	409	21	;	;	,
work_vvlzsj54cvf5de6ji6py6krqlm	409	22	Roche†	roche†	CD
work_vvlzsj54cvf5de6ji6py6krqlm	409	23	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	24	Daiichi	Daiichi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	25	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	409	26	Sankyo†	Sankyo†	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	27	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	28	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	29	Bayer	Bayer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	30	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	409	31	Janssen†	Janssen†	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	409	32	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	33	Astellas†	Astellas†	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	34	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	35	Merck†	Merck†	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	36	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	37	Sanofi†	sanofi†	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	409	38	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	39	BMS/	BMS/	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	40	Pfizer†	pfizer†	CD
work_vvlzsj54cvf5de6ji6py6krqlm	409	41	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	42	Biotronik†	biotronik†	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	409	43	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	44	Medtronic†	Medtronic†	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	45	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	46	Portola†	portola†	XX
work_vvlzsj54cvf5de6ji6py6krqlm	409	47	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	48	Boehringer	Boehringer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	49	Ingelheim†	Ingelheim†	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	409	50	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	51	Microlife†	microlife†	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	409	52	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	409	53	Daiichi-	Daiichi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	54	Sankyo†	Sankyo†	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	55	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	56	Jeffrey	Jeffrey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	57	I.	I.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	58	Weitz	Weitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	59	Thrombosis	Thrombosis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	60	&	&	CC
work_vvlzsj54cvf5de6ji6py6krqlm	409	61	Atherosclerosis	Atherosclerosis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	62	Research	Research	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	63	Institute	Institute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	64	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	409	65	Canada	Canada	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	66	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	409	67	None	None	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	68	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	409	69	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	409	70	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	409	71	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	409	72	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	409	73	None	none	NN
work_vvlzsj54cvf5de6ji6py6krqlm	409	74	This	this	DT
work_vvlzsj54cvf5de6ji6py6krqlm	409	75	table	table	NN
work_vvlzsj54cvf5de6ji6py6krqlm	409	76	represents	represent	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	409	77	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	409	78	relationships	relationship	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	409	79	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	409	80	reviewers	reviewer	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	409	81	that	that	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	409	82	may	may	MD
work_vvlzsj54cvf5de6ji6py6krqlm	409	83	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	409	84	perceived	perceive	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	409	85	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	409	86	actual	actual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	409	87	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	409	88	reasonably	reasonably	RB
work_vvlzsj54cvf5de6ji6py6krqlm	409	89	perceived	perceive	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	409	90	conflicts	conflict	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	409	91	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	409	92	interest	interest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	409	93	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	409	94	reported	report	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	409	95	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	409	96	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	409	97	Disclosure	Disclosure	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	98	Questionnaire	Questionnaire	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	409	99	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	409	100	which	which	WDT
work_vvlzsj54cvf5de6ji6py6krqlm	409	101	all	all	DT
work_vvlzsj54cvf5de6ji6py6krqlm	409	102	reviewers	reviewer	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	409	103	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	409	104	required	require	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	409	105	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	409	106	complete	complete	VB
work_vvlzsj54cvf5de6ji6py6krqlm	409	107	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	409	108	submit	submit	VB
work_vvlzsj54cvf5de6ji6py6krqlm	409	109	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	410	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	410	2	relationship	relationship	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	410	4	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	410	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	410	6	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	410	7	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	410	8	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	410	9	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	410	10	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	410	11	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	410	12	a	a	LS
work_vvlzsj54cvf5de6ji6py6krqlm	410	13	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	410	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	410	15	person	person	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	16	receives	receive	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	410	17	$	$	$
work_vvlzsj54cvf5de6ji6py6krqlm	410	18	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	410	19	000	000	CD
work_vvlzsj54cvf5de6ji6py6krqlm	410	20	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	410	21	more	more	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	410	22	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	410	23	any	any	DT
work_vvlzsj54cvf5de6ji6py6krqlm	410	24	12-month	12-month	CD
work_vvlzsj54cvf5de6ji6py6krqlm	410	25	period	period	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	410	27	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	410	28	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	410	29	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	30	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	410	31	more	more	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	410	32	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	410	33	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	410	34	person	person	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	35	’s	’s	POS
work_vvlzsj54cvf5de6ji6py6krqlm	410	36	gross	gross	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	410	37	income	income	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	38	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	410	39	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	410	40	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	410	41	b	b	LS
work_vvlzsj54cvf5de6ji6py6krqlm	410	42	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	410	43	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	410	44	person	person	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	45	owns	own	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	410	46	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	410	47	%	%	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	48	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	410	49	more	more	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	410	50	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	410	51	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	410	52	voting	voting	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	53	stock	stock	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	54	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	410	55	share	share	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	56	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	410	57	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	410	58	entity	entity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	59	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	410	60	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	410	61	owns	own	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	410	62	$	$	$
work_vvlzsj54cvf5de6ji6py6krqlm	410	63	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	410	64	000	000	CD
work_vvlzsj54cvf5de6ji6py6krqlm	410	65	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	410	66	more	more	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	410	67	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	410	68	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	410	69	fair	fair	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	410	70	market	market	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	71	value	value	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	72	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	410	73	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	410	74	entity	entity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	410	75	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	411	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	411	2	relationship	relationship	NN
work_vvlzsj54cvf5de6ji6py6krqlm	411	3	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	411	4	considered	consider	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	411	5	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	411	6	be	be	VB
work_vvlzsj54cvf5de6ji6py6krqlm	411	7	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	411	8	modest	modest	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	411	9	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	411	10	if	if	IN
work_vvlzsj54cvf5de6ji6py6krqlm	411	11	it	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	411	12	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	411	13	less	less	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	411	14	than	than	IN
work_vvlzsj54cvf5de6ji6py6krqlm	411	15	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	411	16	significant	significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	411	17	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	411	18	under	under	IN
work_vvlzsj54cvf5de6ji6py6krqlm	411	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	411	20	preceding	precede	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	411	21	definition	definition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	411	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	412	1	*	*	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	412	2	Modest	modest	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	412	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	413	1	†Significant	†significant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	413	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	414	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	414	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	414	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	414	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	414	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	414	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	414	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	414	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	414	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	414	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	414	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	414	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	414	13	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	414	14	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	414	15	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	414	16	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	414	17	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	414	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	414	19	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	414	20	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	414	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	415	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	415	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	415	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	415	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	416	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	416	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	416	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	416	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	416	5	CIR.0000000000000477e626	CIR.0000000000000477e626	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	6	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	416	8	Nessel	Nessel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	9	CC	CC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	416	11	Paolini	Paolini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	12	JF	JF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	416	14	Berkowitz	Berkowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	15	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	416	17	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	18	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	416	20	Califf	Califf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	21	RM	RM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	22	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	416	23	ROCKET	rocket	VB
work_vvlzsj54cvf5de6ji6py6krqlm	416	24	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	25	Steering	Steering	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	26	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	416	28	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	416	29	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	416	30	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	31	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	32	Inves-	Inves-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	416	33	tigators	tigator	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	416	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	417	1	Rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	417	2	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	417	3	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	417	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	417	5	nonvalvular	nonvalvular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	417	6	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	417	7	fi-	fi-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	417	8	brillation	brillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	417	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	418	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	418	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	418	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	418	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	418	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	419	1	2011;365:883–891	2011;365:883–891	CD
work_vvlzsj54cvf5de6ji6py6krqlm	419	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	420	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	420	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	420	3	10.1056/	10.1056/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	420	4	NEJMoa1009638	nejmoa1009638	UH
work_vvlzsj54cvf5de6ji6py6krqlm	420	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	421	1	4	4	LS
work_vvlzsj54cvf5de6ji6py6krqlm	421	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	422	1	Granger	grang	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	422	2	CB	CB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	4	Alexander	Alexander	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	5	JH	JH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	7	McMurray	McMurray	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	8	JJ	JJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	10	Lopes	Lopes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	11	RD	RD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	13	Hylek	Hylek	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	14	EM	EM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	16	Hanna	Hanna	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	17	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	19	Al	Al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	20	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	422	21	Khalidi	Khalidi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	22	HR	HR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	24	Ansell	Ansell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	25	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	27	Atar	Atar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	28	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	30	Avezum	Avezum	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	31	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	33	Bahit	Bahit	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	34	MC	MC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	36	Diaz	Diaz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	37	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	39	Easton	Easton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	40	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	42	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	43	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	45	Flaker	Flaker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	46	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	48	Garcia	Garcia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	49	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	51	Geraldes	Geraldes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	52	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	54	Gersh	Gersh	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	55	BJ	BJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	57	Golitsyn	Golitsyn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	58	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	59	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	60	Goto	Goto	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	61	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	62	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	63	Hermosillo	Hermosillo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	64	AG	AG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	65	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	66	Hohnloser	Hohnloser	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	67	SH	SH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	68	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	69	Horowitz	Horowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	70	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	71	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	72	Mohan	Mohan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	73	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	74	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	75	Jansky	Jansky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	76	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	77	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	78	Lewis	Lewis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	79	BS	BS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	80	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	81	Lopez	Lopez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	82	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	422	83	Sendon	Sendon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	84	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	85	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	86	Pais	Pais	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	87	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	88	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	89	Parkhomenko	Parkhomenko	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	90	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	91	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	92	Verheugt	Verheugt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	93	FW	FW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	94	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	95	Zhu	Zhu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	96	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	97	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	422	98	Wallentin	Wallentin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	99	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	100	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	422	101	ARISTOTLE	ARISTOTLE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	422	102	Committees	Committees	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	422	103	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	422	104	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	422	105	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	423	1	Apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	423	2	versus	versus	FW
work_vvlzsj54cvf5de6ji6py6krqlm	423	3	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	423	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	423	5	pa-	pa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	423	6	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	423	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	423	8	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	423	9	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	423	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	424	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	424	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	424	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	424	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	424	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	425	1	2011;365:981–992	2011;365:981–992	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	425	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	426	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	426	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	426	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	426	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	426	5	NEJMoa1107039	nejmoa1107039	UH
work_vvlzsj54cvf5de6ji6py6krqlm	426	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	427	1	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	427	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	428	1	Giugliano	Giugliano	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	2	RP	RP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	4	Ruff	Ruff	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	5	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	7	Braunwald	Braunwald	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	8	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	10	Murphy	Murphy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	11	SA	SA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	13	Wiviott	Wiviott	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	14	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	16	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	17	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	19	Waldo	Waldo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	20	AL	AL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	22	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	23	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	25	Weitz	Weitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	26	JI	JI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	28	Špinar	Špinar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	29	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	31	Ruzyllo	Ruzyllo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	32	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	34	Ruda	Ruda	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	35	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	37	Koretsune	Koretsune	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	38	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	40	Betcher	Betcher	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	41	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	43	Shi	Shi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	44	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	46	Grip	Grip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	47	LT	LT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	49	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	50	SP	SP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	52	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	53	I	I	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	55	Hanyok	Hanyok	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	56	JJ	JJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	57	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	58	Mercuri	Mercuri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	59	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	60	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	428	61	Antman	Antman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	62	EM	EM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	63	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	428	64	ENGAGE	engage	VB
work_vvlzsj54cvf5de6ji6py6krqlm	428	65	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	66	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	428	67	TIMI	TIMI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	428	68	48	48	CD
work_vvlzsj54cvf5de6ji6py6krqlm	428	69	Investigators	investigator	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	428	70	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	429	1	Edoxa-	edoxa-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	429	2	ban	ban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	429	3	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	429	4	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	429	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	429	6	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	429	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	429	8	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	429	9	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	429	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	430	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	430	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	430	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	430	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	430	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	431	1	2013;369:2093–2104	2013;369:2093–2104	CD
work_vvlzsj54cvf5de6ji6py6krqlm	431	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	432	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	432	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	432	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	432	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	432	5	NEJMoa1310907	NEJMoa1310907	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	432	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	433	1	6	6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	433	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	434	1	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	2	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	4	Hellkamp	Hellkamp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	5	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	7	Washam	Washam	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	8	JB	JB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	10	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	11	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	13	Breithardt	Breithardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	14	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	16	Berkowitz	Berkowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	17	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	19	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	20	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	22	Hankey	Hankey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	23	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	25	Hacke	Hacke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	26	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	28	Mahaffey	Mahaffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	29	KW	KW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	31	Nessel	Nessel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	32	CC	CC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	34	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	35	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	37	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	38	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	434	40	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	41	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	42	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	434	43	Polypharmacy	Polypharmacy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	44	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	434	45	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	434	46	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	434	47	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	434	48	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	434	49	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	434	50	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	434	51	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	434	52	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	434	53	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	434	54	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	434	55	preven-	preven-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	434	56	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	434	57	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	434	58	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	434	59	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	434	60	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	434	61	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	434	62	nonvalvular	nonvalvular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	434	63	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	434	64	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	434	65	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	435	1	Cir-	Cir-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	435	2	culation	culation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	435	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	436	1	2016;133:352–360	2016;133:352–360	CD
work_vvlzsj54cvf5de6ji6py6krqlm	436	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	437	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	437	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	437	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	437	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	437	5	CIRCULATIONAHA	CIRCULATIONAHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	437	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	438	1	115.018544	115.018544	LS
work_vvlzsj54cvf5de6ji6py6krqlm	438	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	439	1	7	7	LS
work_vvlzsj54cvf5de6ji6py6krqlm	439	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	440	1	Levy	Levy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	440	2	JH	JH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	440	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	440	4	Faraoni	Faraoni	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	440	5	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	440	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	440	7	Spring	Spring	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	440	8	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	440	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	440	10	Douketis	Douketis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	440	11	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	440	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	440	13	Samama	Samama	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	440	14	CM	CM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	440	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	441	1	Man-	Man-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	441	2	aging	age	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	441	3	new	new	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	441	4	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	441	5	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	441	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	441	7	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	441	8	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	441	9	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	441	10	intensive	intensive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	441	11	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	441	12	unit	unit	NN
work_vvlzsj54cvf5de6ji6py6krqlm	441	13	setting	set	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	441	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	442	1	Anesthesiology	Anesthesiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	442	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	443	1	2013;118:1466–1474	2013;118:1466–1474	CD
work_vvlzsj54cvf5de6ji6py6krqlm	443	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	444	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	444	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	444	3	10.1097	10.1097	CD
work_vvlzsj54cvf5de6ji6py6krqlm	444	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	444	5	ALN.0b013e318289bcba	ALN.0b013e318289bcba	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	444	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	445	1	8	8	LS
work_vvlzsj54cvf5de6ji6py6krqlm	445	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	446	1	Gehrie	gehrie	NN
work_vvlzsj54cvf5de6ji6py6krqlm	446	2	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	446	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	446	4	Tormey	Tormey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	446	5	C.	C.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	446	6	Novel	Novel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	446	7	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	446	8	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	446	9	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	446	10	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	446	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	446	12	labora-	labora-	VB
work_vvlzsj54cvf5de6ji6py6krqlm	446	13	tory	tory	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	446	14	measurement	measurement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	446	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	446	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	446	17	approaches	approach	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	446	18	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	446	19	emergent	emergent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	446	20	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	446	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	447	1	Arch	Arch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	447	2	Pathol	Pathol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	447	3	Lab	Lab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	447	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	447	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	448	1	2015;139:687–692	2015;139:687–692	CD
work_vvlzsj54cvf5de6ji6py6krqlm	448	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	449	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	449	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	449	3	10.5858	10.5858	CD
work_vvlzsj54cvf5de6ji6py6krqlm	449	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	449	5	arpa.2013-	arpa.2013-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	449	6	0677-RS	0677-rs	CD
work_vvlzsj54cvf5de6ji6py6krqlm	449	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	450	1	9	9	CD
work_vvlzsj54cvf5de6ji6py6krqlm	450	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	451	1	Cuker	Cuker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	451	2	A	a	NN
work_vvlzsj54cvf5de6ji6py6krqlm	451	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	451	4	Siegal	Siegal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	451	5	DM	DM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	451	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	451	7	Crowther	Crowther	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	451	8	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	451	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	451	10	Garcia	Garcia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	451	11	DA	DA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	451	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	452	1	Laboratory	laboratory	NN
work_vvlzsj54cvf5de6ji6py6krqlm	452	2	mea-	mea-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	452	3	surement	surement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	452	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	452	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	452	6	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	452	7	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	452	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	452	9	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	452	10	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	452	11	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	452	12	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	452	13	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	452	14	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	452	15	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	452	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	453	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	453	2	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	453	3	Coll	Coll	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	453	4	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	453	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	454	1	2014;64:1128–1139	2014;64:1128–1139	CD
work_vvlzsj54cvf5de6ji6py6krqlm	454	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	455	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	455	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	455	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	455	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	455	5	j.jacc.2014.05.065	j.jacc.2014.05.065	CD
work_vvlzsj54cvf5de6ji6py6krqlm	455	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	456	1	10	10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	456	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	457	1	Mar	Mar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	2	PL	PL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	457	4	Familtsev	Familtsev	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	5	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	457	7	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	8	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	457	10	Lakkireddy	Lakkireddy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	11	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	457	13	Gopinathannair	Gopinathannair	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	14	R.	R.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	15	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	16	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	457	17	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	457	18	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	457	19	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	457	20	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	457	21	tak-	tak-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	457	22	ing	e	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	457	23	novel	novel	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	457	24	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	457	25	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	457	26	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	457	27	review	review	NN
work_vvlzsj54cvf5de6ji6py6krqlm	457	28	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	457	29	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	457	30	literature	literature	NN
work_vvlzsj54cvf5de6ji6py6krqlm	457	31	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	457	32	recom-	recom-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	457	33	mendations	mendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	457	34	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	457	35	specific	specific	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	457	36	populations	population	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	457	37	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	457	38	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	457	39	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	458	1	Int	Int	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	458	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	458	3	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	458	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	459	1	2016;202:578–585	2016;202:578–585	CD
work_vvlzsj54cvf5de6ji6py6krqlm	459	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	460	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	460	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	460	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	460	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	460	5	j.ijcard.2015.09.035	j.ijcard.2015.09.035	XX
work_vvlzsj54cvf5de6ji6py6krqlm	460	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	461	1	11	11	CD
work_vvlzsj54cvf5de6ji6py6krqlm	461	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	462	1	Pollack	Pollack	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	2	CV	CV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	3	Jr	Jr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	5	Reilly	Reilly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	6	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	8	Eikelboom	Eikelboom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	9	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	11	Glund	Glund	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	12	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	14	Verhamme	Verhamme	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	15	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	17	Bern-	Bern-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	18	stein	stein	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	19	RA	RA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	21	Dubiel	Dubiel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	22	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	24	Huisman	Huisman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	25	MV	MV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	27	Hylek	Hylek	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	28	EM	EM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	30	Kamphuisen	Kamphuisen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	31	PW	PW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	33	Kreu-	Kreu-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	34	zer	zer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	35	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	37	Levy	Levy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	38	JH	JH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	40	Sellke	Sellke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	41	FW	FW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	43	Stangier	Stangier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	44	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	46	Steiner	Steiner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	47	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	49	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	50	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	52	Kam	Kam	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	53	CW	CW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	462	55	Weitz	Weitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	56	JI	JI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	462	57	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	463	1	Idarucizumab	Idarucizumab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	463	2	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	463	3	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	463	4	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	463	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	464	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	464	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	464	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	464	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	464	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	465	1	2015;373:511–520	2015;373:511–520	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	465	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	466	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	466	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	466	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	466	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	466	5	NEJMoa1502000	nejmoa1502000	CD
work_vvlzsj54cvf5de6ji6py6krqlm	466	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	467	1	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	467	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	468	1	Eerenberg	Eerenberg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	2	ES	ES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	468	4	Kamphuisen	Kamphuisen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	5	PW	PW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	468	7	Sijpkens	Sijpkens	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	8	MK	MK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	468	10	Meijers	Meijers	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	11	JC	JC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	468	13	Buller	Buller	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	14	HR	hr	NN
work_vvlzsj54cvf5de6ji6py6krqlm	468	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	468	16	Levi	Levi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	17	M.	M.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	18	Reversal	Reversal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	468	20	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	468	21	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	468	22	dabigatran	dabigatran	VB
work_vvlzsj54cvf5de6ji6py6krqlm	468	23	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	468	24	prothrom-	prothrom-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	25	bin	bin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	26	complex	complex	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	468	27	concentrate	concentrate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	468	28	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	468	29	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	468	30	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	468	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	468	32	placebo	placebo	NN
work_vvlzsj54cvf5de6ji6py6krqlm	468	33	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	468	34	controlled	control	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	468	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	468	36	crossover	crossover	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	468	37	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	468	38	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	468	39	healthy	healthy	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	468	40	subjects	subject	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	468	41	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	469	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	469	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	470	1	2011;124:1573	2011;124:1573	CD
work_vvlzsj54cvf5de6ji6py6krqlm	470	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	470	3	1579	1579	CD
work_vvlzsj54cvf5de6ji6py6krqlm	470	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	470	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	470	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	470	7	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	470	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	470	9	CIRCULATIONAHA.111.029017	CIRCULATIONAHA.111.029017	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	470	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	471	1	13	13	CD
work_vvlzsj54cvf5de6ji6py6krqlm	471	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	472	1	Claisse	Claisse	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	2	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	472	4	Delavenne	Delavenne	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	5	X	X	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	472	7	Masson	Masson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	8	I	I	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	472	10	Maillard	Maillard	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	11	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	472	13	Alamartine	Alamartine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	14	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	472	16	Mariat	Mariat	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	17	C.	C.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	18	Venovenous	venovenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	472	19	haemodiafiltration	haemodiafiltration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	472	20	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	472	21	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	472	22	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	472	23	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	472	24	dabiga-	dabiga-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	472	25	tran	tran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	472	26	overdose	overdose	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	472	27	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	472	28	intensive	intensive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	472	29	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	472	30	unit	unit	NN
work_vvlzsj54cvf5de6ji6py6krqlm	472	31	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	473	1	Clin	Clin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	473	2	Kidney	Kidney	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	473	3	J.	J.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	474	1	2015;8:199	2015;8:199	CD
work_vvlzsj54cvf5de6ji6py6krqlm	474	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	474	3	201	201	CD
work_vvlzsj54cvf5de6ji6py6krqlm	474	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	474	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	474	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	474	7	10.1093	10.1093	CD
work_vvlzsj54cvf5de6ji6py6krqlm	474	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	474	9	ckj	ckj	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	474	10	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	474	11	sfv001	sfv001	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	474	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	475	1	14	14	CD
work_vvlzsj54cvf5de6ji6py6krqlm	475	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	476	1	Chen	Chen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	2	BC	BC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	476	4	Sheth	Sheth	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	5	NR	NR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	476	7	Dadzie	Dadzie	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	8	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	476	10	Smith	Smith	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	11	SW	SW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	476	13	Nelson	Nelson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	14	LS	LS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	476	16	Hoffman	Hoffman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	17	RS	RS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	476	19	Winchester	Winchester	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	20	JF	JF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	476	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	477	1	Hemodialysis	hemodialysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	477	2	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	477	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	477	4	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	477	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	477	6	pulmo-	pulmo-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	477	7	nary	nary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	477	8	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	477	9	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	477	10	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	477	11	overdose	overdose	RB
work_vvlzsj54cvf5de6ji6py6krqlm	477	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	478	1	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	478	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	478	3	Kidney	Kidney	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	478	4	Dis	Dis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	478	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	479	1	2013;62:591–594	2013;62:591–594	LS
work_vvlzsj54cvf5de6ji6py6krqlm	479	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	480	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	480	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	480	3	10.1053	10.1053	CD
work_vvlzsj54cvf5de6ji6py6krqlm	480	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	480	5	j.ajkd.2013.02.361	j.ajkd.2013.02.361	CD
work_vvlzsj54cvf5de6ji6py6krqlm	480	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	481	1	15	15	CD
work_vvlzsj54cvf5de6ji6py6krqlm	481	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	482	1	Siegal	Siegal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	2	DM	DM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	4	Curnutte	Curnutte	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	5	JT	JT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	7	Connolly	Connolly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	8	SJ	SJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	10	Lu	Lu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	11	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	13	Conley	Conley	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	14	PB	PB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	16	Wiens	Wiens	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	17	BL	BL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	19	Mathur	Mathur	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	20	VS	VS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	22	Castillo	Castillo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	23	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	25	Bronson	Bronson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	26	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	28	Leeds	Leeds	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	29	JM	JM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	31	Mar	Mar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	32	FA	FA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	34	Gold	Gold	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	35	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	482	37	Crowther	Crowther	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	38	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	482	39	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	483	1	Andexanet	andexanet	VB
work_vvlzsj54cvf5de6ji6py6krqlm	483	2	alfa	alfa	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	483	3	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	483	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	483	5	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	483	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	483	7	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	483	8	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	483	9	inhibi-	inhibi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	483	10	tor	tor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	483	11	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	483	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	484	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	484	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	484	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	484	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	484	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	485	1	2015;373:2413–2424	2015;373:2413–2424	CD
work_vvlzsj54cvf5de6ji6py6krqlm	485	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	486	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	486	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	486	3	10.1056/	10.1056/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	486	4	NEJMoa1510991	nejmoa1510991	NN
work_vvlzsj54cvf5de6ji6py6krqlm	486	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	487	1	16	16	CD
work_vvlzsj54cvf5de6ji6py6krqlm	487	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	488	1	Connolly	Connolly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	2	SJ	SJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	4	Milling	Milling	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	5	TJ	TJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	6	Jr	Jr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	8	Eikelboom	Eikelboom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	9	JW	JW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	11	Gibson	Gibson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	12	CM	CM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	14	Curnutte	Curnutte	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	15	JT	JT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	17	Gold	Gold	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	18	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	20	Bronson	Bronson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	21	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	23	Lu	Lu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	24	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	26	Conley	Conley	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	27	PB	PB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	29	Verhamme	Verhamme	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	30	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	32	Schmidt	Schmidt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	33	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	35	Middeldorp	Middeldorp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	36	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	38	Cohen	Cohen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	39	AT	AT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	41	Beyer	Beyer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	42	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	488	43	Westendorf	Westendorf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	44	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	46	Albaladejo	Albaladejo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	47	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	49	Lopez-	Lopez-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	50	Sendon	Sendon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	51	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	53	Goodman	Goodman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	54	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	56	Leeds	Leeds	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	57	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	58	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	59	Wiens	Wiens	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	60	BL	BL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	61	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	62	Siegal	Siegal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	63	DM	DM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	65	Zotova	zotova	NN
work_vvlzsj54cvf5de6ji6py6krqlm	488	66	E	e	NN
work_vvlzsj54cvf5de6ji6py6krqlm	488	67	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	68	Meeks	Meeks	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	69	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	70	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	71	Nakamya	Nakamya	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	72	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	73	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	74	Lim	Lim	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	75	WT	WT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	76	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	488	77	Crowther	Crowther	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	78	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	79	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	488	80	ANNEXA-4	ANNEXA-4	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	81	Investi-	Investi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	488	82	gators	gator	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	488	83	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	489	1	Andexanet	andexanet	VB
work_vvlzsj54cvf5de6ji6py6krqlm	489	2	alfa	alfa	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	489	3	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	489	4	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	489	5	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	489	6	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	489	7	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	489	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	489	9	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	489	10	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	489	11	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	489	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	490	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	490	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	490	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	490	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	490	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	491	1	2016;375:1131–1141	2016;375:1131–1141	CD
work_vvlzsj54cvf5de6ji6py6krqlm	491	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	492	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	492	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	492	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	492	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	492	5	NEJMoa1607887	nejmoa1607887	RB
work_vvlzsj54cvf5de6ji6py6krqlm	492	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	493	1	17	17	CD
work_vvlzsj54cvf5de6ji6py6krqlm	493	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	494	1	Perzborn	Perzborn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	494	2	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	494	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	494	4	Heitmeier	Heitmeier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	494	5	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	494	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	494	7	Laux	Laux	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	494	8	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	494	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	494	10	Buchmüller	Buchmüller	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	494	11	A.	A.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	495	1	Reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	495	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	495	3	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	495	4	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	495	5	induced	induce	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	495	6	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	495	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	495	8	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	495	9	com-	com-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	495	10	plex	plex	NN
work_vvlzsj54cvf5de6ji6py6krqlm	495	11	concentrate	concentrate	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	495	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	495	13	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	495	14	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	495	15	complex	complex	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	495	16	concentrate	concentrate	VB
work_vvlzsj54cvf5de6ji6py6krqlm	495	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	495	18	recombinant	recombinant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	495	19	activated	activate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	495	20	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	495	21	VII	VII	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	495	22	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	495	23	vitro	vitro	FW
work_vvlzsj54cvf5de6ji6py6krqlm	495	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	496	1	Thromb	Thromb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	496	2	Res	Res	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	496	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	497	1	2014;133:671–681	2014;133:671–681	CD
work_vvlzsj54cvf5de6ji6py6krqlm	497	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	498	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	498	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	498	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	498	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	498	5	j.thromres.2014.01.017	j.thromres.2014.01.017	NN
work_vvlzsj54cvf5de6ji6py6krqlm	498	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	499	1	18	18	CD
work_vvlzsj54cvf5de6ji6py6krqlm	499	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	500	1	Stevenson	Stevenson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	2	JW	JW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	500	4	Minns	Minns	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	5	AB	AB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	500	7	Smollin	Smollin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	8	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	500	10	Albertson	Albertson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	11	TE	TE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	500	13	Cantrell	Cantrell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	14	FL	FL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	500	16	Tomaszewski	Tomaszewski	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	17	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	500	19	Clark	Clark	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	20	RF	RF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	500	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	501	1	An	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	501	2	observational	observational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	501	3	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	501	4	series	series	NN
work_vvlzsj54cvf5de6ji6py6krqlm	501	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	501	6	dabi-	dabi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	501	7	gatran	gatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	501	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	501	9	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	501	10	exposures	exposure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	501	11	reported	report	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	501	12	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	501	13	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	501	14	poison	poison	NN
work_vvlzsj54cvf5de6ji6py6krqlm	501	15	control	control	NN
work_vvlzsj54cvf5de6ji6py6krqlm	501	16	system	system	NN
work_vvlzsj54cvf5de6ji6py6krqlm	501	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	502	1	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	502	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	502	3	Emerg	Emerg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	502	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	502	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	503	1	2014;32:1077–1084	2014;32:1077–1084	CD
work_vvlzsj54cvf5de6ji6py6krqlm	503	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	504	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	504	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	504	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	504	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	504	5	j	j	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	504	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	505	1	ajem.2014.04.031	ajem.2014.04.031	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	505	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	506	1	19	19	CD
work_vvlzsj54cvf5de6ji6py6krqlm	506	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	507	1	Lehmann	Lehmann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	2	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	507	4	Hofer	Hofer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	5	KE	KE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	507	7	Baumann	Baumann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	8	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	507	10	Hasler	Hasler	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	11	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	507	13	Ceschi	Ceschi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	14	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	507	16	Kupfer-	Kupfer-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	17	schmidt	schmidt	NN
work_vvlzsj54cvf5de6ji6py6krqlm	507	18	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	507	20	Rohde	Rohde	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	21	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	507	23	Korte	Korte	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	24	W.	W.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	25	Massive	Massive	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	507	26	human	human	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	507	27	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	507	28	over-	over-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	507	29	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	507	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	508	1	Thromb	Thromb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	508	2	Haemost	Haemost	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	508	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	509	1	2014;112:834–836	2014;112:834–836	CD
work_vvlzsj54cvf5de6ji6py6krqlm	509	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	510	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	510	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	510	3	10.1160/	10.1160/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	510	4	TH14	TH14	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	510	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	510	6	02	02	CD
work_vvlzsj54cvf5de6ji6py6krqlm	510	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	510	8	0138	0138	CD
work_vvlzsj54cvf5de6ji6py6krqlm	510	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	511	1	20	20	CD
work_vvlzsj54cvf5de6ji6py6krqlm	511	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	512	1	Dibu	Dibu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	512	2	JR	JR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	512	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	512	4	Weimer	Weimer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	512	5	JM	JM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	512	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	512	7	Ahrens	Ahrens	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	512	8	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	512	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	512	10	Manno	Manno	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	512	11	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	512	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	512	13	Frontera	Frontera	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	512	14	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	512	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	513	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	513	2	role	role	NN
work_vvlzsj54cvf5de6ji6py6krqlm	513	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	513	4	FEIBA	FEIBA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	513	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	513	6	reversing	reverse	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	513	7	novel	novel	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	513	8	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	513	9	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	513	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	513	11	intracerebral	intracerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	513	12	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	513	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	514	1	Neurocrit	Neurocrit	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	514	2	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	514	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	515	1	2015;24:413–419	2015;24:413–419	LS
work_vvlzsj54cvf5de6ji6py6krqlm	515	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	516	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	516	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	516	3	10.1007/	10.1007/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	516	4	s12028	s12028	CD
work_vvlzsj54cvf5de6ji6py6krqlm	516	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	516	6	015	015	CD
work_vvlzsj54cvf5de6ji6py6krqlm	516	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	516	8	0213-y	0213-y	NN
work_vvlzsj54cvf5de6ji6py6krqlm	516	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	517	1	21	21	CD
work_vvlzsj54cvf5de6ji6py6krqlm	517	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	518	1	Zahir	Zahir	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	2	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	4	Brown	Brown	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	5	KS	KS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	7	Vandell	Vandell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	8	AG	AG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	10	Desai	Desai	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	13	Maa	Maa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	14	JF	JF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	16	Dishy	Dishy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	17	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	19	Lom-	Lom-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	20	eli	eli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	21	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	23	Feussner	Feussner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	24	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	26	Feng	Feng	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	27	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	29	He	He	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	30	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	32	Grosso	Grosso	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	33	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	35	Lanz	Lanz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	36	HJ	HJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	518	38	Antman	Antman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	39	EM	EM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	518	40	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	519	1	Edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	519	2	effects	effect	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	519	3	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	519	4	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	519	5	following	follow	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	519	6	punch	punch	NN
work_vvlzsj54cvf5de6ji6py6krqlm	519	7	biopsy	biopsy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	519	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	519	9	reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	519	10	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	519	11	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	519	12	4-factor	4-factor	CD
work_vvlzsj54cvf5de6ji6py6krqlm	519	13	prothrombin	prothrombin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	519	14	complex	complex	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	519	15	concentrate	concentrate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	519	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	520	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	520	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	521	1	2015;131:82–90	2015;131:82–90	CD
work_vvlzsj54cvf5de6ji6py6krqlm	521	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	522	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	522	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	522	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	522	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	522	5	CIRCULATIONAHA	CIRCULATIONAHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	522	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	523	1	114.013445	114.013445	LS
work_vvlzsj54cvf5de6ji6py6krqlm	523	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	524	1	22	22	CD
work_vvlzsj54cvf5de6ji6py6krqlm	524	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	525	1	Ansell	Ansell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	2	JE	JE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	525	4	Bakhru	Bakhru	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	5	SH	SH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	525	7	Laulicht	Laulicht	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	8	BE	BE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	525	10	Steiner	Steiner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	11	SS	SS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	525	13	Grosso	Grosso	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	14	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	525	16	Brown	Brown	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	17	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	525	19	Dishy	Dishy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	20	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	525	22	Noveck	Noveck	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	23	RJ	RJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	525	25	Costin	Costin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	26	JC	JC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	525	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	526	1	Use	Use	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	526	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	526	3	PER977	PER977	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	526	4	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	526	5	reverse	reverse	VB
work_vvlzsj54cvf5de6ji6py6krqlm	526	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	526	7	an-	an-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	526	8	ticoagulant	ticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	526	9	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	526	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	526	11	edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	526	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	527	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	527	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	527	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	527	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	527	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	528	1	2014;371:2141	2014;371:2141	CD
work_vvlzsj54cvf5de6ji6py6krqlm	528	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	528	3	2142	2142	CD
work_vvlzsj54cvf5de6ji6py6krqlm	528	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	528	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	528	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	528	7	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	528	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	528	9	NEJMc1411800	nejmc1411800	NN
work_vvlzsj54cvf5de6ji6py6krqlm	528	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	529	1	23	23	CD
work_vvlzsj54cvf5de6ji6py6krqlm	529	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	530	1	Ansell	Ansell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	2	JE	JE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	530	4	Laulicht	Laulicht	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	5	BE	BE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	530	7	Bakhru	Bakhru	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	8	SH	SH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	530	10	Hoffman	Hoffman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	530	13	Steiner	Steiner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	14	SS	SS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	530	16	Cos-	Cos-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	17	tin	tin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	530	18	JC	JC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	530	19	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	531	1	Ciraparantag	Ciraparantag	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	531	2	safely	safely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	531	3	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	531	4	completely	completely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	531	5	reverses	reverse	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	531	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	531	7	antico-	antico-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	531	8	agulant	agulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	531	9	effects	effect	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	531	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	531	11	low	low	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	531	12	molecular	molecular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	531	13	weight	weight	NN
work_vvlzsj54cvf5de6ji6py6krqlm	531	14	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	531	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	532	1	Thromb	Thromb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	532	2	Res	Res	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	532	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	533	1	2016;146:113–118	2016;146:113–118	CD
work_vvlzsj54cvf5de6ji6py6krqlm	533	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	534	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	534	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	534	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	534	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	534	5	j.thromres.2016.07.008	j.thromres.2016.07.008	NN
work_vvlzsj54cvf5de6ji6py6krqlm	534	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	535	1	24	24	CD
work_vvlzsj54cvf5de6ji6py6krqlm	535	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	536	1	Ruff	ruff	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	536	2	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	536	4	Giugliano	Giugliano	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	5	RP	RP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	536	7	Braunwald	Braunwald	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	8	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	536	10	Hoffman	Hoffman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	11	EB	EB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	536	13	Deenadayalu	Deenadayalu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	14	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	536	16	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	17	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	536	19	Camm	Camm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	20	AJ	AJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	536	22	Weitz	Weitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	23	JI	JI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	536	25	Lewis	Lewis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	26	BS	BS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	536	28	Parkhomenko	Parkhomenko	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	29	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	536	31	Yamashita	Yamashita	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	32	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	536	34	Antman	Antman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	35	EM	EM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	536	36	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	537	1	Comparison	comparison	NN
work_vvlzsj54cvf5de6ji6py6krqlm	537	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	537	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	537	4	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	537	5	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	537	6	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	537	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	537	8	new	new	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	537	9	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	537	10	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	537	11	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	537	12	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	537	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	537	14	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	537	15	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	537	16	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	537	17	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	537	18	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	537	19	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	537	20	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	537	21	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	537	22	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	537	23	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	537	24	randomised	randomised	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	537	25	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	537	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	538	1	Lancet	Lancet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	538	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	539	1	2014;383:955–962	2014;383:955–962	CD
work_vvlzsj54cvf5de6ji6py6krqlm	539	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	540	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	540	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	540	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	540	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	540	5	S0140	S0140	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	540	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	540	7	6736(13)62343	6736(13)62343	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	540	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	540	9	0	0	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	540	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	541	1	25	25	CD
work_vvlzsj54cvf5de6ji6py6krqlm	541	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	542	1	Linkins	Linkins	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	542	2	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	542	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	542	4	O’Donnell	O’Donnell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	542	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	542	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	542	7	Julian	Julian	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	542	8	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	542	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	542	10	Kearon	Kearon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	542	11	C.	C.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	542	12	Intracranial	Intracranial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	542	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	542	14	fatal	fatal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	542	15	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	542	16	according	accord	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	542	17	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	542	18	indication	indication	NN
work_vvlzsj54cvf5de6ji6py6krqlm	542	19	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	542	20	long	long	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	542	21	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	542	22	term	term	NN
work_vvlzsj54cvf5de6ji6py6krqlm	542	23	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	542	24	antico-	antico-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	542	25	agulant	agulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	542	26	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	542	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	543	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	543	2	Thromb	Thromb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	543	3	Haemost	Haemost	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	543	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	544	1	2010;8:2201–2207	2010;8:2201–2207	CD
work_vvlzsj54cvf5de6ji6py6krqlm	544	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	545	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	545	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	545	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	545	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	545	5	j.1538	j.1538	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	545	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	545	7	7836.2010.04016.x	7836.2010.04016.x	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	545	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	546	1	26	26	CD
work_vvlzsj54cvf5de6ji6py6krqlm	546	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	547	1	Hemphill	Hemphill	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	2	JC	JC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	3	3rd	3rd	NN
work_vvlzsj54cvf5de6ji6py6krqlm	547	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	5	Greenberg	Greenberg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	6	SM	SM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	8	Anderson	Anderson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	9	CS	CS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	11	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	12	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	14	Bendok	Bendok	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	15	BR	BR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	17	Cushman	Cushman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	18	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	20	Fung	Fung	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	21	GL	GL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	23	Goldstein	Goldstein	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	24	JN	JN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	26	Macdonald	Macdonald	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	27	RL	RL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	29	Mitch-	Mitch-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	30	ell	ell	NN
work_vvlzsj54cvf5de6ji6py6krqlm	547	31	PH	PH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	33	Scott	Scott	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	34	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	36	Selim	Selim	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	37	MH	MH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	547	39	Woo	Woo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	40	D.	D.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	41	Guidelines	Guidelines	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	42	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	547	43	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	547	44	manage-	manage-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	547	45	ment	ment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	547	46	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	547	47	spontaneous	spontaneous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	547	48	intracerebral	intracerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	547	49	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	547	50	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	547	51	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	547	52	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	547	53	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	547	54	healthcare	healthcare	NN
work_vvlzsj54cvf5de6ji6py6krqlm	547	55	professionals	professional	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	547	56	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	547	57	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	547	58	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	59	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	60	Association/	association/	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	547	61	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	62	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	63	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	547	64	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	548	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	548	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	549	1	2015;46:2032–2060	2015;46:2032–2060	CD
work_vvlzsj54cvf5de6ji6py6krqlm	549	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	550	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	550	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	550	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	550	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	550	5	STR.0000000000000069	STR.0000000000000069	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	550	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	551	1	27	27	CD
work_vvlzsj54cvf5de6ji6py6krqlm	551	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	552	1	Hemphill	Hemphill	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	552	2	JC	JC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	552	3	3rd	3rd	NN
work_vvlzsj54cvf5de6ji6py6krqlm	552	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	552	5	Farrant	Farrant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	552	6	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	552	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	552	8	Neill	Neill	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	552	9	TA	TA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	552	10	Jr.	Jr.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	553	1	Prospective	prospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	553	2	validation	validation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	553	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	553	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	553	5	ICH	ICH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	553	6	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	553	7	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	553	8	12-month	12-month	CD
work_vvlzsj54cvf5de6ji6py6krqlm	553	9	functional	functional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	553	10	outcome	outcome	NN
work_vvlzsj54cvf5de6ji6py6krqlm	553	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	554	1	Neurology	neurology	NN
work_vvlzsj54cvf5de6ji6py6krqlm	554	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	555	1	2009;73:1088–1094	2009;73:1088–1094	CD
work_vvlzsj54cvf5de6ji6py6krqlm	555	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	556	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	556	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	556	3	10.1212	10.1212	CD
work_vvlzsj54cvf5de6ji6py6krqlm	556	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	556	5	WNL.0b013e3181b8b332	wnl.0b013e3181b8b332	CD
work_vvlzsj54cvf5de6ji6py6krqlm	556	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	557	1	28	28	CD
work_vvlzsj54cvf5de6ji6py6krqlm	557	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	558	1	Wada	Wada	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	2	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	558	4	Aviv	Aviv	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	5	RI	RI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	558	7	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	8	AJ	AJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	558	10	Sahlas	Sahlas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	11	DJ	DJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	558	13	Gladstone	Gladstone	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	14	DJ	DJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	558	16	Tomlinson	Tomlinson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	17	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	558	19	Sy-	Sy-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	20	mons	mon	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	558	21	SP	SP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	558	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	559	1	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	559	2	angiography	angiography	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	559	3	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	559	4	spot	spot	NN
work_vvlzsj54cvf5de6ji6py6krqlm	559	5	sign	sign	NN
work_vvlzsj54cvf5de6ji6py6krqlm	559	6	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	559	7	predicts	predict	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	559	8	hematoma	hematoma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	559	9	expan-	expan-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	559	10	sion	sion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	559	11	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	559	12	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	559	13	intracerebral	intracerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	559	14	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	559	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	560	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	560	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	561	1	2007;38:1257	2007;38:1257	CD
work_vvlzsj54cvf5de6ji6py6krqlm	561	2	–	–	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	561	3	1262	1262	CD
work_vvlzsj54cvf5de6ji6py6krqlm	561	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	561	5	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	561	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	561	7	10.1161/01.STR.0000259633.59404.f3	10.1161/01.str.0000259633.59404.f3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	561	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	562	1	29	29	CD
work_vvlzsj54cvf5de6ji6py6krqlm	562	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	563	1	Chakraborty	Chakraborty	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	563	2	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	563	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	563	4	Blacquiere	Blacquiere	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	563	5	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	563	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	563	7	Lum	Lum	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	563	8	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	563	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	563	10	Stotts	Stotts	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	563	11	G.	G.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	563	12	Dynamic	Dynamic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	563	13	nature	nature	NN
work_vvlzsj54cvf5de6ji6py6krqlm	563	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	563	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	563	16	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	563	17	angiographic	angiographic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	563	18	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	563	19	spot	spot	NN
work_vvlzsj54cvf5de6ji6py6krqlm	563	20	sign	sign	NN
work_vvlzsj54cvf5de6ji6py6krqlm	563	21	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	563	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	564	1	Br	br	IN
work_vvlzsj54cvf5de6ji6py6krqlm	564	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	564	3	Radiol	Radiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	564	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	565	1	2010;83	2010;83	CD
work_vvlzsj54cvf5de6ji6py6krqlm	565	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	565	3	e216	e216	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	565	4	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	565	5	e219	e219	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	565	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	566	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	566	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	566	3	10.1259	10.1259	CD
work_vvlzsj54cvf5de6ji6py6krqlm	566	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	566	5	bjr/74416385	bjr/74416385	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	566	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	567	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	567	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	567	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	567	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	567	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	567	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	567	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	567	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	567	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	567	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	567	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	567	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	567	13	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	567	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	567	15	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	567	16	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	567	17	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	567	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	567	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	567	20	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	567	21	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	567	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	567	23	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	567	24	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	567	25	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	567	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	568	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	568	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	568	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	568	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	569	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	569	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	569	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	569	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	569	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	569	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	569	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	569	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	569	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	569	10	e627	e627	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	569	11	CLINICAL	clinical	NN
work_vvlzsj54cvf5de6ji6py6krqlm	569	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	569	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	569	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	569	15	GUIDELINES	GUIDELINES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	569	16	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	569	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	570	1	Sakamoto	Sakamoto	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	2	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	4	Koga	Koga	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	7	Yamagami	Yamagami	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	8	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	10	Okuda	Okuda	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	11	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	13	Okada	Okada	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	14	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	16	Kimura	Kimura	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	17	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	19	Shiokawa	Shiokawa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	20	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	22	Nakagawara	Nakagawara	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	23	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	25	Furui	Furui	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	26	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	28	Hasegawa	Hasegawa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	29	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	31	Kario	Kario	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	32	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	34	Arihiro	Arihiro	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	35	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	37	Sato	Sato	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	38	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	40	Kobayashi	Kobayashi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	41	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	43	Tanaka	Tanaka	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	44	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	46	Nagatsuka	Nagatsuka	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	47	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	49	Minematsu	Minematsu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	50	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	570	52	Toyoda	Toyoda	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	53	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	54	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	570	55	SAMURAI	SAMURAI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	56	Study	Study	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	570	57	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	570	58	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	571	1	Systolic	systolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	571	2	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	571	3	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	571	4	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	571	5	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	571	6	antihypertensive	antihypertensive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	571	7	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	571	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	571	9	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	571	10	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	571	11	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	571	12	hyperacute	hyperacute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	571	13	intracerebral	intracerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	571	14	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	571	15	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	571	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	571	17	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	571	18	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	571	19	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	571	20	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	571	21	Urgent	Urgent	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	571	22	Risk	Risk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	571	23	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	571	24	Factor	Factor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	571	25	Assessment	Assessment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	571	26	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	571	27	Improvement	Improvement	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	571	28	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	571	29	Intracerebral	Intracerebral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	571	30	Hemorrhage	Hemorrhage	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	571	31	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	571	32	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	572	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	572	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	573	1	2013;44:1846–1851	2013;44:1846–1851	CD
work_vvlzsj54cvf5de6ji6py6krqlm	573	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	574	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	574	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	574	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	574	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	574	5	STROKEAHA.113.001212	strokeaha.113.001212	NN
work_vvlzsj54cvf5de6ji6py6krqlm	574	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	575	1	31	31	CD
work_vvlzsj54cvf5de6ji6py6krqlm	575	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	576	1	Rodriguez	Rodriguez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	576	3	Luna	Luna	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	4	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	576	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	6	Piñeiro	Piñeiro	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	7	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	9	Rubiera	Rubiera	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	10	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	12	Ribo	Ribo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	13	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	15	Coscojuela	Coscojuela	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	16	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	18	Pagola	Pagola	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	19	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	21	Flores	Flores	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	22	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	24	Muchada	Muchada	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	25	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	27	Ibarra	Ibarra	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	28	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	30	Meler	Meler	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	31	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	33	Sanjuan	Sanjuan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	34	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	36	Hernandez	Hernandez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	37	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	576	38	Guillamon	Guillamon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	39	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	41	Alvarez	Alvarez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	42	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	576	43	Sabin	Sabin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	44	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	46	Montaner	Montaner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	47	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	576	49	Molina	Molina	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	50	CA	CA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	576	51	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	577	1	Impact	impact	NN
work_vvlzsj54cvf5de6ji6py6krqlm	577	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	577	3	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	577	4	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	577	5	changes	change	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	577	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	577	7	course	course	NN
work_vvlzsj54cvf5de6ji6py6krqlm	577	8	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	577	9	hema-	hema-	PRP$
work_vvlzsj54cvf5de6ji6py6krqlm	577	10	toma	toma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	577	11	growth	growth	NN
work_vvlzsj54cvf5de6ji6py6krqlm	577	12	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	577	13	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	577	14	intracerebral	intracerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	577	15	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	577	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	578	1	Eur	Eur	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	578	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	578	3	Neurol	Neurol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	578	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	579	1	2013;20:1277–1283	2013;20:1277–1283	LS
work_vvlzsj54cvf5de6ji6py6krqlm	579	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	580	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	580	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	580	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	580	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	580	5	ene.12180	ene.12180	NN
work_vvlzsj54cvf5de6ji6py6krqlm	580	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	581	1	32	32	CD
work_vvlzsj54cvf5de6ji6py6krqlm	581	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	582	1	Anderson	Anderson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	2	CS	CS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	4	Heeley	Heeley	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	5	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	7	Huang	Huang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	8	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	10	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	11	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	13	Stapf	Stapf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	14	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	16	Delcourt	Delcourt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	17	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	19	Lindley	Lindley	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	20	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	22	Robinson	Robinson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	23	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	25	Lavados	Lavados	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	26	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	28	Neal	Neal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	29	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	31	Hata	Hata	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	32	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	34	Arima	Arima	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	35	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	37	Parsons	Parsons	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	38	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	40	Li	Li	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	41	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	43	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	44	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	46	Heritier	Heritier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	47	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	49	Li	Li	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	50	Q	Q	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	52	Woodward	Woodward	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	53	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	55	Simes	Simes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	56	RJ	RJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	57	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	58	Davis	Davis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	59	SM	SM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	60	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	582	61	Chalmers	Chalmers	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	62	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	63	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	582	64	INTERACT2	INTERACT2	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	582	65	Investigators	investigator	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	582	66	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	583	1	Rapid	rapid	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	583	2	blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	583	3	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	583	4	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	583	5	lowering	lower	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	583	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	583	7	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	583	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	583	9	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	583	10	intracerebral	intracerebral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	583	11	hem-	hem-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	583	12	orrhage	orrhage	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	583	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	584	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	584	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	584	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	584	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	584	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	585	1	2013;368:2355–2365	2013;368:2355–2365	CD
work_vvlzsj54cvf5de6ji6py6krqlm	585	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	586	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	586	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	586	3	10.1056/	10.1056/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	586	4	NEJMoa1214609	NEJMoa1214609	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	586	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	587	1	32a	32a	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	587	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	588	1	Qureshi	Qureshi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	2	AI	AI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	4	Palesch	Palesch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	5	YY	YY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	7	Barsan	Barsan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	8	WG	WG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	10	Hanley	Hanley	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	11	DF	DF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	13	Hsu	Hsu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	14	CY	CY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	16	Martin	Martin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	17	RL	RL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	19	Moy	Moy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	20	CS	CS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	22	Silbergleit	Silbergleit	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	23	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	25	Steiner	Steiner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	26	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	28	Suarez	Suarez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	29	JI	JI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	31	Toyoda	Toyoda	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	32	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	34	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	35	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	37	Yamamoto	Yamamoto	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	38	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	588	40	Yoon	Yoon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	41	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	42	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	588	43	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	44	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	588	45	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	588	46	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	588	47	ATACH-2	ATACH-2	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	48	Trial	Trial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	49	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	588	50	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	588	51	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	588	52	Neurological	Neurological	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	53	Emergency	Emergency	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	54	Treatment	Treatment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	55	Trials	Trials	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	588	56	Network	Network	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	588	57	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	589	1	Intensive	intensive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	589	2	blood-	blood-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	589	3	pressure	pressure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	589	4	lowering	lower	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	589	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	589	6	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	589	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	589	8	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	589	9	cerebral	cerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	589	10	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	589	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	590	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	590	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	590	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	590	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	590	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	591	1	2016;375:1033–1043	2016;375:1033–1043	CD
work_vvlzsj54cvf5de6ji6py6krqlm	591	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	592	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	592	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	592	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	592	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	592	5	NEJMoa1603460	NEJMoa1603460	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	592	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	593	1	33	33	CD
work_vvlzsj54cvf5de6ji6py6krqlm	593	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	594	1	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	594	2	GY	GY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	594	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	594	4	Lane	Lane	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	594	5	DA	DA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	594	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	595	1	Assessing	assess	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	595	2	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	595	3	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	595	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	595	5	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	595	6	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	595	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	595	8	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	595	9	HAS	HAS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	595	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	595	11	BLED	BLED	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	595	12	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	595	13	ORBIT	ORBIT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	595	14	scores	score	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	595	15	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	595	16	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	595	17	application	application	NN
work_vvlzsj54cvf5de6ji6py6krqlm	595	18	re-	re-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	595	19	quires	quire	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	595	20	focus	focus	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	595	21	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	595	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	595	23	reversible	reversible	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	595	24	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	595	25	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	595	26	factors	factor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	595	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	596	1	Eur	Eur	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	596	2	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	596	3	J.	j.	NN
work_vvlzsj54cvf5de6ji6py6krqlm	597	1	2015;36:3265–3267	2015;36:3265–3267	CD
work_vvlzsj54cvf5de6ji6py6krqlm	597	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	598	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	598	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	598	3	10.1093	10.1093	CD
work_vvlzsj54cvf5de6ji6py6krqlm	598	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	598	5	eurheartj	eurheartj	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	598	6	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	598	7	ehv415	ehv415	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	598	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	599	1	34	34	CD
work_vvlzsj54cvf5de6ji6py6krqlm	599	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	600	1	Verheugt	Verheugt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	600	2	FW	FW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	600	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	600	4	Granger	Granger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	600	5	CB	CB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	600	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	601	1	Oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	601	2	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	601	3	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	601	4	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	601	5	pre-	pre-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	601	6	vention	vention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	601	7	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	601	8	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	601	9	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	601	10	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	601	11	current	current	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	601	12	status	status	NN
work_vvlzsj54cvf5de6ji6py6krqlm	601	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	601	14	special	special	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	601	15	situations	situation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	601	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	601	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	601	18	unmet	unmet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	601	19	needs	need	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	601	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	602	1	Lancet	Lancet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	602	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	603	1	2015;386:303–310	2015;386:303–310	CD
work_vvlzsj54cvf5de6ji6py6krqlm	603	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	604	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	604	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	604	3	10.1016/	10.1016/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	604	4	S0140	S0140	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	604	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	604	6	6736(15)60245	6736(15)60245	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	604	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	604	8	8	8	CD
work_vvlzsj54cvf5de6ji6py6krqlm	604	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	605	1	35	35	CD
work_vvlzsj54cvf5de6ji6py6krqlm	605	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	606	1	Caldeira	caldeira	NN
work_vvlzsj54cvf5de6ji6py6krqlm	606	2	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	606	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	606	4	Barra	Barra	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	606	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	606	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	606	7	Pinto	Pinto	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	606	8	FJ	FJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	606	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	606	10	Ferreira	Ferreira	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	606	11	JJ	JJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	606	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	606	13	Costa	Costa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	606	14	J.	J.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	606	15	Intracranial	Intracranial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	606	16	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	606	17	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	606	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	606	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	606	20	new	new	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	606	21	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	606	22	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	606	23	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	606	24	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	606	25	systematic	systematic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	606	26	review	review	NN
work_vvlzsj54cvf5de6ji6py6krqlm	606	27	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	606	28	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	606	29	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	606	30	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	606	31	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	607	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	607	2	Neurol	Neurol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	607	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	608	1	2015;262:516–522	2015;262:516–522	CD
work_vvlzsj54cvf5de6ji6py6krqlm	608	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	609	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	609	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	609	3	10.1007	10.1007	CD
work_vvlzsj54cvf5de6ji6py6krqlm	609	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	609	5	s00415	s00415	NN
work_vvlzsj54cvf5de6ji6py6krqlm	609	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	609	7	014	014	CD
work_vvlzsj54cvf5de6ji6py6krqlm	609	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	609	9	7462	7462	CD
work_vvlzsj54cvf5de6ji6py6krqlm	609	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	609	11	0	0	CD
work_vvlzsj54cvf5de6ji6py6krqlm	609	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	610	1	36	36	CD
work_vvlzsj54cvf5de6ji6py6krqlm	610	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	611	1	Dossett	Dossett	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	611	2	LA	LA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	611	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	611	4	Riesel	Riesel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	611	5	JN	JN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	611	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	611	7	Griffin	Griffin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	611	8	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	611	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	611	10	Cotton	Cotton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	611	11	BA	BA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	611	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	612	1	Prevalence	prevalence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	612	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	612	3	implications	implication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	612	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	612	5	preinjury	preinjury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	612	6	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	612	7	use	use	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	612	8	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	612	9	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	612	10	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	612	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	612	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	612	13	National	National	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	612	14	Trauma	Trauma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	612	15	Databank	Databank	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	612	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	613	1	Arch	Arch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	613	2	Surg	Surg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	613	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	614	1	2011;146:565–570	2011;146:565–570	CD
work_vvlzsj54cvf5de6ji6py6krqlm	614	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	615	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	615	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	615	3	10.1001	10.1001	CD
work_vvlzsj54cvf5de6ji6py6krqlm	615	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	615	5	archsurg.2010.313	archsurg.2010.313	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	615	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	616	1	37	37	CD
work_vvlzsj54cvf5de6ji6py6krqlm	616	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	617	1	Durie	Durie	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	617	2	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	617	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	617	4	Kohute	Kohute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	617	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	617	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	617	7	Fernandez	Fernandez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	617	8	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	617	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	617	10	Knight	Knight	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	617	11	M.	M.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	617	12	Prothrombin	Prothrombin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	617	13	complex	complex	NN
work_vvlzsj54cvf5de6ji6py6krqlm	617	14	concentrate	concentrate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	617	15	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	617	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	617	17	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	617	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	617	19	severe	severe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	617	20	traumatic	traumatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	617	21	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	617	22	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	617	23	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	617	24	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	617	25	anticoagulated	anticoagulate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	617	26	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	617	27	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	617	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	618	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	618	2	Clin	Clin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	618	3	Pharm	Pharm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	618	4	Ther	Ther	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	618	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	619	1	2016;41:92–93	2016;41:92–93	CD
work_vvlzsj54cvf5de6ji6py6krqlm	619	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	620	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	620	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	620	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	620	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	620	5	jcpt.12339	jcpt.12339	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	620	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	621	1	38	38	CD
work_vvlzsj54cvf5de6ji6py6krqlm	621	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	622	1	Cotton	Cotton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	622	2	BA	BA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	622	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	622	4	McCarthy	McCarthy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	622	5	JJ	JJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	622	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	622	7	Holcomb	Holcomb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	622	8	JB	JB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	622	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	623	1	Acutely	acutely	RB
work_vvlzsj54cvf5de6ji6py6krqlm	623	2	injured	injured	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	623	3	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	623	4	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	623	5	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	623	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	624	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	624	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	624	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	624	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	624	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	625	1	2011;365:2039–2040	2011;365:2039–2040	CD
work_vvlzsj54cvf5de6ji6py6krqlm	625	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	626	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	626	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	626	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	626	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	626	5	NEJMc1111095	nejmc1111095	CD
work_vvlzsj54cvf5de6ji6py6krqlm	626	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	627	1	39	39	CD
work_vvlzsj54cvf5de6ji6py6krqlm	627	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	628	1	Croft	croft	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	628	2	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	628	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	628	4	Cabral	Cabral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	628	5	KP	KP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	628	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	628	7	Strout	Strout	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	628	8	TD	TD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	628	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	628	10	Baumann	Baumann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	628	11	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	628	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	628	13	Gibbs	Gibbs	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	628	14	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	628	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	628	16	Delaney	Delaney	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	628	17	MC	MC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	628	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	629	1	Managing	manage	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	629	2	blunt	blunt	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	629	3	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	629	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	629	5	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	629	6	receiving	receive	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	629	7	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	629	8	etexilate	etexilate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	629	9	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	629	10	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	629	11	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	629	12	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	629	13	review	review	NN
work_vvlzsj54cvf5de6ji6py6krqlm	629	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	629	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	629	16	literature	literature	NN
work_vvlzsj54cvf5de6ji6py6krqlm	629	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	630	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	630	2	Emerg	Emerg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	630	3	Nurs	Nurs	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	630	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	631	1	2013;39:302–308	2013;39:302–308	LS
work_vvlzsj54cvf5de6ji6py6krqlm	631	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	632	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	632	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	632	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	632	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	632	5	j.jen.2013.01.016	j.jen.2013.01.016	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	632	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	633	1	40	40	CD
work_vvlzsj54cvf5de6ji6py6krqlm	633	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	634	1	Huang	Huang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	634	2	GS	GS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	634	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	634	4	Chance	Chance	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	634	5	EA	EA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	634	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	635	1	When	when	WRB
work_vvlzsj54cvf5de6ji6py6krqlm	635	2	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	635	3	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	635	4	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	635	5	collide	collide	NN
work_vvlzsj54cvf5de6ji6py6krqlm	635	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	636	1	Am	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	636	2	Surg	Surg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	636	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	637	1	2013;79:113–114	2013;79:113–114	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	637	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	638	1	41	41	CD
work_vvlzsj54cvf5de6ji6py6krqlm	638	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	639	1	Joseph	Joseph	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	2	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	639	4	Ditillo	Ditillo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	639	7	Pandit	Pandit	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	8	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	639	10	Aziz	Aziz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	11	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	639	13	Sadoun	Sadoun	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	14	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	639	16	Hays	Hays	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	17	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	639	19	Davis	Davis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	20	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	639	22	Friese	Friese	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	23	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	639	25	Rhee	Rhee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	26	P.	P.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	27	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	639	28	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	639	29	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	639	30	minor	minor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	639	31	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	639	32	injuries	injury	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	639	33	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	639	34	no	no	RB
work_vvlzsj54cvf5de6ji6py6krqlm	639	35	longer	long	RBR
work_vvlzsj54cvf5de6ji6py6krqlm	639	36	minor	minor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	639	37	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	640	1	Am	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	640	2	Surg	Surg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	640	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	641	1	2014;80	2014;80	CD
work_vvlzsj54cvf5de6ji6py6krqlm	641	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	641	3	E116–E118	e116–e118	CD
work_vvlzsj54cvf5de6ji6py6krqlm	641	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	642	1	42	42	CD
work_vvlzsj54cvf5de6ji6py6krqlm	642	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	643	1	Obeng	Obeng	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	643	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	643	3	Gyasi	Gyasi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	643	4	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	643	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	643	6	Loor	Loor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	643	7	MM	MM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	643	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	643	9	Samotowka	Samotowka	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	643	10	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	643	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	643	12	Moorman	Moorman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	643	13	ML	ML	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	643	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	644	1	Management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	644	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	644	3	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	644	4	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	644	5	induced	induce	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	644	6	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	644	7	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	644	8	trauma	trauma	NN
work_vvlzsj54cvf5de6ji6py6krqlm	644	9	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	644	10	acute	acute	NN
work_vvlzsj54cvf5de6ji6py6krqlm	644	11	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	644	12	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	644	13	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	644	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	645	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	645	2	Trauma	Trauma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	645	3	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	645	4	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	645	5	Surg	Surg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	645	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	646	1	2012;73:1064–1069	2012;73:1064–1069	CD
work_vvlzsj54cvf5de6ji6py6krqlm	646	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	647	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	647	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	647	3	10.1097	10.1097	CD
work_vvlzsj54cvf5de6ji6py6krqlm	647	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	647	5	TA.0b013e31827019c9	ta.0b013e31827019c9	CD
work_vvlzsj54cvf5de6ji6py6krqlm	647	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	648	1	43	43	CD
work_vvlzsj54cvf5de6ji6py6krqlm	648	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	649	1	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	649	2	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	649	3	Trauma	Trauma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	649	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	649	5	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	649	6	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	649	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	649	8	Surgeons	Surgeons	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	649	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	650	1	Advanced	Advanced	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	650	2	Trauma	Trauma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	650	3	Life	life	NN
work_vvlzsj54cvf5de6ji6py6krqlm	650	4	Support	Support	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	650	5	Student	Student	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	650	6	Course	Course	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	650	7	Manual	Manual	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	650	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	651	1	Chicago	Chicago	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	651	2	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	651	3	IL	IL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	651	4	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	651	5	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	651	6	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	651	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	651	8	Surgeons	Surgeons	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	651	9	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	651	10	2012	2012	CD
work_vvlzsj54cvf5de6ji6py6krqlm	651	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	652	1	44	44	CD
work_vvlzsj54cvf5de6ji6py6krqlm	652	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	653	1	Dias	Dias	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	2	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	653	4	Norem	Norem	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	5	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	653	7	Doorneweerd	Doorneweerd	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	8	DD	DD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	653	10	Thurer	Thurer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	11	RL	RL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	653	13	Popovsky	Popovsky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	14	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	653	16	Omert	Omert	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	17	LA	LA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	653	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	654	1	Use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	654	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	654	3	thromboelastography	thromboelastography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	654	4	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	654	5	TEG	teg	NN
work_vvlzsj54cvf5de6ji6py6krqlm	654	6	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	654	7	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	654	8	detection	detection	NN
work_vvlzsj54cvf5de6ji6py6krqlm	654	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	654	10	new	new	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	654	11	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	654	12	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	654	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	655	1	Arch	Arch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	655	2	Pathol	Pathol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	655	3	Lab	Lab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	655	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	655	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	656	1	2015;139:665–673	2015;139:665–673	CD
work_vvlzsj54cvf5de6ji6py6krqlm	656	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	657	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	657	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	657	3	10.5858	10.5858	CD
work_vvlzsj54cvf5de6ji6py6krqlm	657	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	657	5	arpa.2014	arpa.2014	CD
work_vvlzsj54cvf5de6ji6py6krqlm	657	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	657	7	0170-OA	0170-oa	CD
work_vvlzsj54cvf5de6ji6py6krqlm	657	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	658	1	45	45	CD
work_vvlzsj54cvf5de6ji6py6krqlm	658	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	659	1	Oswald	Oswald	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	2	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	659	4	Velik	Velik	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	659	6	Salchner	Salchner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	7	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	659	9	Innerhofer	Innerhofer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	10	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	659	12	Tauber	Tauber	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	13	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	659	15	Auckenthaler	Auckenthaler	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	16	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	659	18	Ulmer	Ulmer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	19	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	659	21	Streif	Streif	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	22	W.	W.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	23	Results	Results	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	24	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	659	25	rotational	rotational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	659	26	thromboelastometry	thromboelastometry	NN
work_vvlzsj54cvf5de6ji6py6krqlm	659	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	659	28	co-	co-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	659	29	agulation	agulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	659	30	activation	activation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	659	31	markers	marker	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	659	32	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	659	33	thrombin	thrombin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	659	34	generation	generation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	659	35	assays	assays	RB
work_vvlzsj54cvf5de6ji6py6krqlm	659	36	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	659	37	or-	or-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	659	38	thopedic	thopedic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	659	39	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	659	40	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	659	41	thromboprophylaxis	thromboprophylaxi	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	659	42	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	659	43	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	659	44	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	659	45	enoxaparin	enoxaparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	659	46	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	659	47	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	659	48	prospective	prospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	659	49	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	659	50	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	659	51	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	660	1	Blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	660	2	Coagul	Coagul	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	660	3	Fibrinolysis	Fibrinolysis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	660	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	661	1	2015;26:136–144	2015;26:136–144	CD
work_vvlzsj54cvf5de6ji6py6krqlm	661	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	662	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	662	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	662	3	10.1097	10.1097	CD
work_vvlzsj54cvf5de6ji6py6krqlm	662	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	662	5	MBC.0000000000000203	mbc.0000000000000203	NN
work_vvlzsj54cvf5de6ji6py6krqlm	662	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	663	1	46	46	CD
work_vvlzsj54cvf5de6ji6py6krqlm	663	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	664	1	Sherwood	Sherwood	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	2	MW	MW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	4	Nessel	Nessel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	5	CC	CC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	7	Hellkamp	Hellkamp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	8	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	10	Mahaffey	Mahaffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	11	KW	KW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	13	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	14	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	16	Suh	Suh	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	17	EY	EY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	19	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	20	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	22	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	23	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	25	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	26	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	28	Hankey	Hankey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	29	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	31	Berkowitz	Berkowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	32	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	34	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	35	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	664	37	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	38	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	39	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	664	40	Gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	664	41	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	664	42	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	664	43	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	664	44	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	664	45	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	664	46	fibrilla-	fibrilla-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	664	47	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	664	48	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	664	49	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	664	50	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	664	51	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	664	52	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	664	53	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	664	54	ROCKET	rocket	VB
work_vvlzsj54cvf5de6ji6py6krqlm	664	55	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	56	Trial	Trial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	664	57	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	665	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	665	2	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	665	3	Coll	Coll	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	665	4	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	665	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	666	1	2015;66:2271–2281	2015;66:2271–2281	CD
work_vvlzsj54cvf5de6ji6py6krqlm	666	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	667	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	667	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	667	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	667	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	667	5	j.jacc.2015.09.024	j.jacc.2015.09.024	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	667	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	668	1	47	47	CD
work_vvlzsj54cvf5de6ji6py6krqlm	668	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	669	1	Fang	Fang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	2	MC	MC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	669	4	Go	go	VB
work_vvlzsj54cvf5de6ji6py6krqlm	669	5	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	669	7	Chang	Chang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	8	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	669	10	Hylek	Hylek	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	11	EM	EM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	669	13	Henault	Henault	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	14	LE	LE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	669	16	Jensvold	Jensvold	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	17	NG	NG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	669	19	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	20	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	669	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	670	1	Death	death	NN
work_vvlzsj54cvf5de6ji6py6krqlm	670	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	670	3	disability	disability	NN
work_vvlzsj54cvf5de6ji6py6krqlm	670	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	670	5	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	670	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	670	7	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	670	8	intracra-	intracra-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	670	9	nial	nial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	670	10	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	670	11	extracranial	extracranial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	670	12	hemorrhages	hemorrhage	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	670	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	671	1	Am	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	671	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	671	3	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	671	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	672	1	2007;120:700	2007;120:700	LS
work_vvlzsj54cvf5de6ji6py6krqlm	672	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	672	3	705	705	CD
work_vvlzsj54cvf5de6ji6py6krqlm	672	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	672	5	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	672	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	672	7	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	672	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	672	9	j.amjmed.2006.07.034	j.amjmed.2006.07.034	CD
work_vvlzsj54cvf5de6ji6py6krqlm	672	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	673	1	48	48	CD
work_vvlzsj54cvf5de6ji6py6krqlm	673	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	674	1	Beyer	Beyer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	674	3	Westendorf	Westendorf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	4	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	674	6	Gelbricht	Gelbricht	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	7	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	674	9	Förster	Förster	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	10	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	674	12	Ebertz	Ebertz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	13	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	674	15	Köhler	Köhler	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	16	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	674	18	Werth	Werth	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	19	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	674	21	Kuhlisch	Kuhlisch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	22	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	674	24	Stange	Stange	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	25	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	674	27	Thieme	Thieme	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	28	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	674	30	Daschkow	Daschkow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	31	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	674	33	Weiss	Weiss	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	34	N.	N.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	35	Peri	Peri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	36	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	674	37	interventional	interventional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	674	38	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	674	39	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	674	40	novel	novel	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	674	41	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	674	42	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	674	43	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	674	44	dai-	dai-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	45	ly	ly	XX
work_vvlzsj54cvf5de6ji6py6krqlm	674	46	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	674	47	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	674	48	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	674	49	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	674	50	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	674	51	prospective	prospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	674	52	Dresden	Dresden	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	53	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	674	54	registry	registry	NN
work_vvlzsj54cvf5de6ji6py6krqlm	674	55	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	675	1	Eur	Eur	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	675	2	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	675	3	J.	j.	NN
work_vvlzsj54cvf5de6ji6py6krqlm	676	1	2014;35:1888–1896	2014;35:1888–1896	CD
work_vvlzsj54cvf5de6ji6py6krqlm	676	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	677	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	677	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	677	3	10.1093	10.1093	CD
work_vvlzsj54cvf5de6ji6py6krqlm	677	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	677	5	eurheartj	eurheartj	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	677	6	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	677	7	eht557	eht557	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	677	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	678	1	49	49	CD
work_vvlzsj54cvf5de6ji6py6krqlm	678	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	679	1	Staerk	Staerk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	2	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	679	4	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	5	GY	GY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	679	7	Olesen	Olesen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	8	JB	JB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	679	10	Fosbøl	Fosbøl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	11	EL	EL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	679	13	Pallisgaard	Pallisgaard	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	14	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	679	16	Bonde	Bonde	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	17	AN	AN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	679	19	Gundlund	Gundlund	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	20	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	679	22	Lindhardt	Lindhardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	23	TB	TB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	679	25	Hansen	Hansen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	26	ML	ML	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	679	28	Torp	Torp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	29	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	679	30	Pedersen	Pedersen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	31	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	679	33	Gislason	Gislason	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	34	GH	GH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	679	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	680	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	680	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	680	3	recurrent	recurrent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	680	4	haemorrhage	haemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	680	5	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	680	6	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	680	7	antithrom-	antithrom-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	680	8	botic	botic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	680	9	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	680	10	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	680	11	gastrointestinal	gastrointestinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	680	12	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	680	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	680	14	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	680	15	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	680	16	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	680	17	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	680	18	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	680	19	nationwide	nationwide	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	680	20	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	680	21	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	680	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	681	1	BMJ	BMJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	681	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	682	1	2015;351	2015;351	LS
work_vvlzsj54cvf5de6ji6py6krqlm	682	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	682	3	h5876	h5876	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	682	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	683	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	683	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	683	3	10.1136	10.1136	CD
work_vvlzsj54cvf5de6ji6py6krqlm	683	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	683	5	bmj.h5876	bmj.h5876	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	683	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	684	1	50	50	CD
work_vvlzsj54cvf5de6ji6py6krqlm	684	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	685	1	Conway	Conway	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	685	2	SE	SE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	685	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	685	4	Schaeffer	Schaeffer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	685	5	SE	SE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	685	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	685	7	Harrison	Harrison	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	685	8	DL	DL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	685	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	686	1	Evaluation	evaluation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	686	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	686	3	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	686	4	exposures	exposure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	686	5	reported	report	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	686	6	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	686	7	poison	poison	NN
work_vvlzsj54cvf5de6ji6py6krqlm	686	8	control	control	NN
work_vvlzsj54cvf5de6ji6py6krqlm	686	9	centers	center	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	686	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	687	1	Ann	Ann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	687	2	Pharmacother	Pharmacother	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	687	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	688	1	2014;48:354–360	2014;48:354–360	LS
work_vvlzsj54cvf5de6ji6py6krqlm	688	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	689	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	689	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	689	3	10.1177/1060028013513883	10.1177/1060028013513883	CD
work_vvlzsj54cvf5de6ji6py6krqlm	689	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	690	1	51	51	CD
work_vvlzsj54cvf5de6ji6py6krqlm	690	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	691	1	Spiller	Spiller	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	2	HA	HA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	691	4	Mowry	Mowry	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	5	JB	JB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	691	7	Aleguas	Aleguas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	8	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	9	Jr	Jr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	691	11	Griffith	Griffith	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	12	JR	JR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	691	14	Goetz	Goetz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	15	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	691	17	Ryan	Ryan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	18	ML	ML	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	691	20	Bangh	Bangh	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	21	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	691	23	Klein	Klein	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	24	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	691	25	Schwartz	Schwartz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	26	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	691	28	Schaeffer	Schaeffer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	29	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	691	31	Casavant	Casavant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	32	MJ	MJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	691	33	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	692	1	An	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	692	2	observational	observational	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	692	3	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	692	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	692	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	692	6	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	692	7	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	692	8	inhibitors	inhibitor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	692	9	rivaroxaban	rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	692	10	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	692	11	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	692	12	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	692	13	reported	report	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	692	14	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	692	15	eight	eight	CD
work_vvlzsj54cvf5de6ji6py6krqlm	692	16	poison	poison	NN
work_vvlzsj54cvf5de6ji6py6krqlm	692	17	centers	center	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	692	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	693	1	Ann	Ann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	693	2	Emerg	Emerg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	693	3	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	693	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	694	1	2016;67:189–195	2016;67:189–195	LS
work_vvlzsj54cvf5de6ji6py6krqlm	694	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	695	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	695	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	695	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	695	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	695	5	j.annemergmed.2015.07.014	j.annemergmed.2015.07.014	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	695	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	696	1	52	52	CD
work_vvlzsj54cvf5de6ji6py6krqlm	696	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	697	1	Alikhan	Alikhan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	2	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	697	4	Rayment	Rayment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	5	R	r	NN
work_vvlzsj54cvf5de6ji6py6krqlm	697	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	697	7	Keeling	Keeling	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	8	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	697	10	Baglin	Baglin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	11	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	697	13	Benson	Benson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	14	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	697	16	Green	Green	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	17	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	697	19	Marshall	Marshall	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	20	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	697	22	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	23	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	697	25	Pavord	Pavord	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	26	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	697	28	Rose	Rose	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	29	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	697	31	Tait	Tait	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	32	C.	C.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	33	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	697	34	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	697	35	manage-	manage-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	697	36	ment	ment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	697	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	697	38	haemorrhage	haemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	697	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	697	40	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	697	41	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	697	42	overdose	overdose	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	697	43	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	697	44	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	697	45	receiv-	receiv-	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	697	46	ing	ing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	697	47	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	697	48	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	698	1	Emerg	Emerg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	698	2	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	698	3	J.	J.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	699	1	2014;31:163–168	2014;31:163–168	LS
work_vvlzsj54cvf5de6ji6py6krqlm	699	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	700	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	700	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	700	3	10.1136/	10.1136/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	700	4	emermed-2012	emermed-2012	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	700	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	700	6	201976	201976	CD
work_vvlzsj54cvf5de6ji6py6krqlm	700	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	701	1	53	53	CD
work_vvlzsj54cvf5de6ji6py6krqlm	701	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	702	1	Chang	Chang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	702	2	DN	DN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	702	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	702	4	Dager	Dager	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	702	5	WE	WE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	702	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	702	7	Chin	Chin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	702	8	AI	AI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	702	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	703	1	Removal	removal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	703	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	703	3	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	703	4	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	703	5	hemo-	hemo-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	703	6	dialysis	dialysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	703	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	704	1	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	704	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	704	3	Kidney	Kidney	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	704	4	Dis	Dis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	704	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	705	1	2013;61:487–489	2013;61:487–489	LS
work_vvlzsj54cvf5de6ji6py6krqlm	705	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	706	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	706	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	706	3	10.1053	10.1053	CD
work_vvlzsj54cvf5de6ji6py6krqlm	706	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	706	5	j	j	NN
work_vvlzsj54cvf5de6ji6py6krqlm	706	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	707	1	ajkd.2012.08.047	ajkd.2012.08.047	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	707	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	708	1	54	54	CD
work_vvlzsj54cvf5de6ji6py6krqlm	708	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	709	1	Woo	Woo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	709	2	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	709	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	709	4	Kapadia	Kapadia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	709	5	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	709	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	709	7	Phanco	Phanco	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	709	8	SE	SE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	709	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	709	10	Lynch	Lynch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	709	11	CA	CA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	709	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	710	1	Positive	positive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	710	2	outcome	outcome	NN
work_vvlzsj54cvf5de6ji6py6krqlm	710	3	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	710	4	intentional	intentional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	710	5	overdose	overdose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	710	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	710	7	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	710	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	711	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	711	2	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	711	3	Toxicol	Toxicol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	711	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	712	1	2013;9:192	2013;9:192	CD
work_vvlzsj54cvf5de6ji6py6krqlm	712	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	712	3	195	195	CD
work_vvlzsj54cvf5de6ji6py6krqlm	712	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	712	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	712	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	712	7	10.1007	10.1007	CD
work_vvlzsj54cvf5de6ji6py6krqlm	712	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	712	9	s13181	s13181	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	712	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	712	11	012	012	CD
work_vvlzsj54cvf5de6ji6py6krqlm	712	12	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	712	13	0276	0276	CD
work_vvlzsj54cvf5de6ji6py6krqlm	712	14	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	712	15	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	712	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	713	1	55	55	CD
work_vvlzsj54cvf5de6ji6py6krqlm	713	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	714	1	Sajkov	sajkov	NN
work_vvlzsj54cvf5de6ji6py6krqlm	714	2	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	714	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	714	4	Gallus	Gallus	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	714	5	A.	A.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	715	1	Accidental	accidental	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	715	2	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	715	3	overdose	overdose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	715	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	715	5	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	715	6	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	715	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	715	8	pulmonary	pulmonary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	715	9	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	715	10	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	715	11	some	some	DT
work_vvlzsj54cvf5de6ji6py6krqlm	715	12	lessons	lesson	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	715	13	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	715	14	managing	manage	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	715	15	new	new	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	715	16	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	715	17	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	715	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	716	1	Clin	Clin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	716	2	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	716	3	Insights	Insights	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	716	4	Case	Case	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	716	5	Rep.	Rep.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	716	6	2015;8:57–59	2015;8:57–59	CD
work_vvlzsj54cvf5de6ji6py6krqlm	716	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	717	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	717	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	717	3	10.4137	10.4137	CD
work_vvlzsj54cvf5de6ji6py6krqlm	717	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	717	5	CCRep	CCRep	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	717	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	717	7	S27992	S27992	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	717	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	718	1	56	56	CD
work_vvlzsj54cvf5de6ji6py6krqlm	718	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	719	1	Chiew	Chiew	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	719	2	AL	AL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	719	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	719	4	Khamoudes	Khamoudes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	719	5	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	719	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	719	7	Chan	Chan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	719	8	BS	BS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	719	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	720	1	Use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	720	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	720	3	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	720	4	veno	veno	NN
work_vvlzsj54cvf5de6ji6py6krqlm	720	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	720	6	venous	venous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	720	7	haemodiafiltration	haemodiafiltration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	720	8	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	720	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	720	10	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	720	11	overdose	overdose	RB
work_vvlzsj54cvf5de6ji6py6krqlm	720	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	721	1	Clin	Clin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	721	2	Toxicol	Toxicol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	721	3	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	721	4	Phi-	Phi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	721	5	la	la	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	721	6	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	721	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	722	1	2014;52:283–287	2014;52:283–287	CD
work_vvlzsj54cvf5de6ji6py6krqlm	722	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	723	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	723	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	723	3	10.3109/15563650.2014.900179	10.3109/15563650.2014.900179	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	723	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	724	1	57	57	CD
work_vvlzsj54cvf5de6ji6py6krqlm	724	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	725	1	Fountzilas	Fountzilas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	725	2	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	725	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	725	4	George	George	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	725	5	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	725	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	725	7	Levine	Levine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	725	8	R.	R.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	725	9	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	725	10	overdose	overdose	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	725	11	sec-	sec-	DT
work_vvlzsj54cvf5de6ji6py6krqlm	725	12	ondary	ondary	NN
work_vvlzsj54cvf5de6ji6py6krqlm	725	13	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	725	14	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	725	15	kidney	kidney	NN
work_vvlzsj54cvf5de6ji6py6krqlm	725	16	injury	injury	NN
work_vvlzsj54cvf5de6ji6py6krqlm	725	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	725	18	amiodarone	amiodarone	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	725	19	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	725	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	726	1	N	n	CD
work_vvlzsj54cvf5de6ji6py6krqlm	726	2	Z	Z	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	726	3	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	726	4	J.	J.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	727	1	2013;126:110–112	2013;126:110–112	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	727	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	728	1	58	58	CD
work_vvlzsj54cvf5de6ji6py6krqlm	728	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	729	1	Linkins	Linkins	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	729	2	LA	LA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	729	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	729	4	Moffat	Moffat	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	729	5	K.	K.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	729	6	Monitoring	Monitoring	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	729	7	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	729	8	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	729	9	effect	effect	NN
work_vvlzsj54cvf5de6ji6py6krqlm	729	10	af-	af-	IN
work_vvlzsj54cvf5de6ji6py6krqlm	729	11	ter	ter	VB
work_vvlzsj54cvf5de6ji6py6krqlm	729	12	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	729	13	massive	massive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	729	14	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	729	15	overdose	overdose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	729	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	730	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	730	2	Thromb	Thromb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	730	3	Haemost	Haemost	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	730	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	731	1	2014;12:1570–1571	2014;12:1570–1571	CD
work_vvlzsj54cvf5de6ji6py6krqlm	731	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	732	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	732	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	732	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	732	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	732	5	jth.12669	jth.12669	NN
work_vvlzsj54cvf5de6ji6py6krqlm	732	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	733	1	59	59	CD
work_vvlzsj54cvf5de6ji6py6krqlm	733	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	734	1	Montaruli	Montaruli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	2	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	734	4	Erroi	Erroi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	5	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	734	7	Vitale	Vitale	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	8	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	734	10	Berutti	Berutti	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	11	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	734	13	Cosseddu	Cosseddu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	14	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	734	16	Sivera	Sivera	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	17	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	734	19	Co-	Co-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	20	glitore	glitore	NN
work_vvlzsj54cvf5de6ji6py6krqlm	734	21	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	734	23	Marangella	Marangella	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	24	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	734	26	Migliardi	Migliardi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	27	M.	M.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	28	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	734	29	overdose	overdose	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	734	30	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	734	31	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	734	32	report	report	NN
work_vvlzsj54cvf5de6ji6py6krqlm	734	33	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	734	34	laboratory	laboratory	NN
work_vvlzsj54cvf5de6ji6py6krqlm	734	35	coagulation	coagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	734	36	parameters	parameter	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	734	37	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	734	38	hemodialysis	hemodialysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	734	39	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	734	40	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	734	41	85-year	85-year	CD
work_vvlzsj54cvf5de6ji6py6krqlm	734	42	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	734	43	old	old	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	734	44	man	man	NN
work_vvlzsj54cvf5de6ji6py6krqlm	734	45	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	735	1	Blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	735	2	Coagul	Coagul	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	735	3	Fibrinolysis	Fibrinolysis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	735	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	736	1	2015;26:225	2015;26:225	CD
work_vvlzsj54cvf5de6ji6py6krqlm	736	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	736	3	229	229	CD
work_vvlzsj54cvf5de6ji6py6krqlm	736	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	736	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	736	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	736	7	10.1097	10.1097	CD
work_vvlzsj54cvf5de6ji6py6krqlm	736	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	736	9	MBC.0000000000000221	mbc.0000000000000221	NN
work_vvlzsj54cvf5de6ji6py6krqlm	736	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	737	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	737	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	737	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	737	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	737	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	737	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	737	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	737	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	737	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	737	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	737	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	737	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	737	13	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	737	14	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	737	15	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	737	16	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	737	17	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	737	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	737	19	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	737	20	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	737	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	738	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	738	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	738	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	738	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	739	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	739	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	739	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	739	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	739	5	CIR.0000000000000477e628	CIR.0000000000000477e628	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	739	6	60	60	CD
work_vvlzsj54cvf5de6ji6py6krqlm	739	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	740	1	Ratanapo	Ratanapo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	740	2	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	740	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	740	4	Ungprasert	Ungprasert	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	740	5	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	740	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	740	7	Srivali	Srivali	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	740	8	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	740	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	740	10	Cheungpasitporn	Cheungpasitporn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	740	11	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	740	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	740	13	Bischof	Bischof	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	740	14	EF	EF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	740	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	741	1	Reversal	reversal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	741	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	741	3	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	741	4	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	741	5	overdose	overdose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	741	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	741	7	what	what	WP
work_vvlzsj54cvf5de6ji6py6krqlm	741	8	are	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	741	9	possible	possible	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	741	10	options	option	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	741	11	?	?	.
work_vvlzsj54cvf5de6ji6py6krqlm	742	1	Am	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	742	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	742	3	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	742	4	Sci	Sci	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	742	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	743	1	2013;346:259	2013;346:259	LS
work_vvlzsj54cvf5de6ji6py6krqlm	743	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	743	3	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	743	4	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	743	5	10.1097	10.1097	CD
work_vvlzsj54cvf5de6ji6py6krqlm	743	6	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	743	7	MAJ.0b013e318295cc72	MAJ.0b013e318295cc72	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	743	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	744	1	61	61	CD
work_vvlzsj54cvf5de6ji6py6krqlm	744	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	745	1	Mumoli	Mumoli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	2	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	745	4	Cei	Cei	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	745	7	Fiorini	Fiorini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	8	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	745	10	Pennati	Pennati	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	11	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	745	13	Testa	Testa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	14	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	745	16	Dentali	Dentali	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	17	F.	F.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	18	Conser-	Conser-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	745	19	vative	vative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	745	20	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	745	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	745	22	intentional	intentional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	745	23	massive	massive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	745	24	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	745	25	overdose	overdose	RB
work_vvlzsj54cvf5de6ji6py6krqlm	745	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	746	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	746	2	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	746	3	Geriatr	Geriatr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	746	4	Soc	Soc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	746	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	747	1	2015;63:2205–2207	2015;63:2205–2207	CD
work_vvlzsj54cvf5de6ji6py6krqlm	747	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	748	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	748	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	748	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	748	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	748	5	jgs.13684	jgs.13684	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	748	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	749	1	62	62	CD
work_vvlzsj54cvf5de6ji6py6krqlm	749	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	750	1	Andreu	Andreu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	750	3	Cayuelas	Cayuelas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	4	JM	JM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	750	6	Pastor	Pastor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	750	8	Perez	Perez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	9	FJ	FJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	750	11	Puche	Puche	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	12	CM	CM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	750	14	Mateo	Mateo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	15	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	750	16	Martinez	Martinez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	17	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	750	19	Garcia	Garcia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	20	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	750	21	Alberola	Alberola	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	22	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	750	24	Flores	Flores	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	25	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	750	26	Blanco	Blanco	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	27	PJ	PJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	750	29	Valdes	Valdes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	30	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	750	32	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	33	GY	GY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	750	35	Roldan	Roldan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	36	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	750	38	Manzano	Manzano	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	39	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	750	40	Fernandez	Fernandez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	41	S.	S.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	42	Impact	Impact	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	43	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	750	44	variations	variation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	750	45	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	750	46	kidney	kidney	NN
work_vvlzsj54cvf5de6ji6py6krqlm	750	47	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	750	48	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	750	49	nonvitamin	nonvitamin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	50	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	51	oral	oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	750	52	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	750	53	dosing	dosing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	750	54	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	750	55	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	750	56	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	750	57	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	750	58	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	750	59	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	750	60	recent	recent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	750	61	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	750	62	heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	750	63	failure	failure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	750	64	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	751	1	Rev	Rev	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	751	2	Esp	Esp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	751	3	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	751	4	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	751	5	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	751	6	Ed	Ed	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	751	7	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	751	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	752	1	2015;69:134–140	2015;69:134–140	CD
work_vvlzsj54cvf5de6ji6py6krqlm	752	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	753	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	753	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	753	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	753	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	753	5	j.rec.2015.06.021	j.rec.2015.06.021	NN
work_vvlzsj54cvf5de6ji6py6krqlm	753	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	754	1	63	63	CD
work_vvlzsj54cvf5de6ji6py6krqlm	754	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	755	1	Caldeira	caldeira	NN
work_vvlzsj54cvf5de6ji6py6krqlm	755	2	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	755	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	755	4	Gonçalves	gonçalve	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	755	5	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	755	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	755	7	Pinto	Pinto	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	755	8	FJ	FJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	755	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	755	10	Costa	Costa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	755	11	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	755	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	755	13	Ferreira	Ferreira	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	755	14	JJ	JJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	755	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	756	1	Risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	756	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	756	3	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	756	4	failure	failure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	756	5	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	756	6	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	756	7	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	756	8	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	756	9	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	756	10	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	756	11	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	756	12	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	756	13	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	756	14	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	756	15	systematic	systematic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	756	16	review	review	NN
work_vvlzsj54cvf5de6ji6py6krqlm	756	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	756	18	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	756	19	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	756	20	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	756	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	757	1	Pharmacoepidemiol	Pharmacoepidemiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	757	2	Drug	Drug	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	757	3	Saf	Saf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	757	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	758	1	2015;24:757–764	2015;24:757–764	CD
work_vvlzsj54cvf5de6ji6py6krqlm	758	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	759	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	759	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	759	3	10.1002	10.1002	CD
work_vvlzsj54cvf5de6ji6py6krqlm	759	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	759	5	pds.3791	pds.3791	NN
work_vvlzsj54cvf5de6ji6py6krqlm	759	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	760	1	64	64	CD
work_vvlzsj54cvf5de6ji6py6krqlm	760	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	761	1	Narasimha	Narasimha	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	761	2	Krishna	Krishna	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	761	3	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	761	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	761	5	Warnock	Warnock	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	761	6	DG	DG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	761	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	761	8	Saxena	Saxena	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	761	9	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	761	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	761	11	Rizk	Rizk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	761	12	DV	DV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	761	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	762	1	Oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	762	2	an-	an-	CC
work_vvlzsj54cvf5de6ji6py6krqlm	762	3	ticoagulants	ticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	762	4	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	762	5	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	762	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	762	7	nephropathy	nephropathy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	762	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	763	1	Drug	Drug	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	763	2	Saf	Saf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	763	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	764	1	2015;38:527	2015;38:527	CD
work_vvlzsj54cvf5de6ji6py6krqlm	764	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	764	3	533	533	CD
work_vvlzsj54cvf5de6ji6py6krqlm	764	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	764	5	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	764	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	764	7	10.1007	10.1007	CD
work_vvlzsj54cvf5de6ji6py6krqlm	764	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	764	9	s40264	s40264	CD
work_vvlzsj54cvf5de6ji6py6krqlm	764	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	764	11	015	015	CD
work_vvlzsj54cvf5de6ji6py6krqlm	764	12	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	764	13	0290-z	0290-z	NN
work_vvlzsj54cvf5de6ji6py6krqlm	764	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	765	1	65	65	CD
work_vvlzsj54cvf5de6ji6py6krqlm	765	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	766	1	Brodsky	Brodsky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	2	SV	SV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	766	4	Nadasdy	Nadasdy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	5	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	766	7	Rovin	Rovin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	8	BH	BH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	766	10	Satoskar	Satoskar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	11	AA	AA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	766	13	Nadasdy	Nadasdy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	14	GM	GM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	766	16	Wu	Wu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	17	HM	HM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	766	19	Bhatt	Bhatt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	20	UY	UY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	766	22	Hebert	Hebert	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	23	LA	LA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	766	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	767	1	Warfarin	Warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	767	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	767	3	related	relate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	767	4	nephropathy	nephropathy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	767	5	occurs	occur	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	767	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	767	7	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	767	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	767	9	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	767	10	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	767	11	chronic	chronic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	767	12	kidney	kidney	NN
work_vvlzsj54cvf5de6ji6py6krqlm	767	13	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	767	14	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	767	15	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	767	16	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	767	17	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	767	18	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	767	19	increased	increase	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	767	20	mortality	mortality	NN
work_vvlzsj54cvf5de6ji6py6krqlm	767	21	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	767	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	768	1	Kidney	Kidney	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	768	2	Int	Int	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	768	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	769	1	2011;80:181–189	2011;80:181–189	LS
work_vvlzsj54cvf5de6ji6py6krqlm	769	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	770	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	770	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	770	3	10.1038	10.1038	CD
work_vvlzsj54cvf5de6ji6py6krqlm	770	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	770	5	ki.2011.44	ki.2011.44	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	770	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	771	1	66	66	CD
work_vvlzsj54cvf5de6ji6py6krqlm	771	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	772	1	Fordyce	Fordyce	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	2	CB	CB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	4	Hellkamp	Hellkamp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	5	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	7	Lokhnygina	Lokhnygina	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	8	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	10	Lindner	Lindner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	11	SM	SM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	13	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	14	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	16	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	17	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	19	Berkowitz	Berkowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	20	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	22	Breithardt	Breithardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	23	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	25	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	26	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	28	Mahaffey	Mahaffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	29	KW	KW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	31	Nessel	Nessel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	32	CC	CC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	34	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	35	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	772	37	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	38	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	39	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	772	40	ROCKET	rocket	VB
work_vvlzsj54cvf5de6ji6py6krqlm	772	41	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	42	Steering	Steering	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	43	Commit-	Commit-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	772	44	tee	tee	NN
work_vvlzsj54cvf5de6ji6py6krqlm	772	45	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	772	46	Investigators	investigator	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	772	47	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	773	1	On	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	773	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	773	3	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	773	4	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	773	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	773	6	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	773	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	773	8	worsening	worsen	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	773	9	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	773	10	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	773	11	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	773	12	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	773	13	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	773	14	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	773	15	warfa-	warfa-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	773	16	rin	rin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	773	17	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	773	18	insights	insight	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	773	19	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	773	20	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	773	21	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	773	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	774	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	774	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	775	1	2016;134:37–47	2016;134:37–47	CD
work_vvlzsj54cvf5de6ji6py6krqlm	775	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	776	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	776	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	776	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	776	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	776	5	CIRCULATIONAHA.116.021890	CIRCULATIONAHA.116.021890	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	776	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	777	1	67	67	CD
work_vvlzsj54cvf5de6ji6py6krqlm	777	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	778	1	Böhm	Böhm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	2	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	4	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	5	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	7	Connolly	Connolly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	8	SJ	SJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	10	Eikelboom	Eikelboom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	11	JW	JW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	13	Hohnloser	Hohnloser	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	14	SH	SH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	16	Reilly	Reilly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	17	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	19	Schumacher	Schumacher	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	20	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	22	Brueckmann	Brueckmann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	23	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	25	Schirmer	Schirmer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	26	SH	SH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	28	Kratz	Kratz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	29	MT	MT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	31	Yu-	Yu-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	32	suf	suf	NN
work_vvlzsj54cvf5de6ji6py6krqlm	778	33	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	35	Diener	Diener	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	36	HC	HC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	38	Hijazi	Hijazi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	39	Z	Z	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	778	41	Wallentin	Wallentin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	42	L.	L.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	43	Changes	Changes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	44	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	778	45	renal	renal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	778	46	function	function	NN
work_vvlzsj54cvf5de6ji6py6krqlm	778	47	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	778	48	pa-	pa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	778	49	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	778	50	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	778	51	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	778	52	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	778	53	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	778	54	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	778	55	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	778	56	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	778	57	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	778	58	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	59	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	778	60	LY	LY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	61	Trial	Trial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	778	62	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	779	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	779	2	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	779	3	Coll	Coll	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	779	4	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	779	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	780	1	2015;65:2481–2493	2015;65:2481–2493	CD
work_vvlzsj54cvf5de6ji6py6krqlm	780	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	781	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	781	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	781	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	781	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	781	5	j.jacc.2015.03.577	j.jacc.2015.03.577	CD
work_vvlzsj54cvf5de6ji6py6krqlm	781	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	782	1	68	68	CD
work_vvlzsj54cvf5de6ji6py6krqlm	782	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	783	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	783	2	National	National	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	783	3	Institute	Institute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	783	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	783	5	Neurological	Neurological	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	783	6	Disorders	Disorders	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	783	7	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	783	8	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	783	9	rt	rt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	783	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	783	11	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	783	12	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	783	13	Study	Study	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	783	14	Group	Group	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	783	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	784	1	Tissue	tissue	NN
work_vvlzsj54cvf5de6ji6py6krqlm	784	2	plasminogen	plasminogen	NN
work_vvlzsj54cvf5de6ji6py6krqlm	784	3	activator	activator	NN
work_vvlzsj54cvf5de6ji6py6krqlm	784	4	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	784	5	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	784	6	isch-	isch-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	784	7	emic	emic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	784	8	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	784	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	785	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	785	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	785	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	785	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	785	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	786	1	1995;333:1581–1587	1995;333:1581–1587	CD
work_vvlzsj54cvf5de6ji6py6krqlm	786	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	787	1	69	69	CD
work_vvlzsj54cvf5de6ji6py6krqlm	787	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	788	1	Hacke	Hacke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	2	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	4	Kaste	Kaste	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	7	Bluhmki	Bluhmki	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	8	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	10	Brozman	Brozman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	13	Dávalos	Dávalos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	14	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	16	Guidetti	Guidetti	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	17	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	19	Larrue	Larrue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	20	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	22	Lees	Lees	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	23	KR	KR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	25	Medeghri	Medeghri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	26	Z	Z	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	28	Machnig	Machnig	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	29	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	31	Schneider	Schneider	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	32	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	34	von	von	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	35	Kum-	Kum-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	36	mer	mer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	37	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	39	Wahlgren	Wahlgren	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	40	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	788	42	Toni	Toni	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	43	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	788	44	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	788	45	ECASS	ECASS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	788	46	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	788	47	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	789	1	Thrombolysis	thrombolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	789	2	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	789	3	alteplase	alteplase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	789	4	3	3	CD
work_vvlzsj54cvf5de6ji6py6krqlm	789	5	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	789	6	4.5	4.5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	789	7	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	789	8	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	789	9	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	789	10	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	789	11	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	789	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	790	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	790	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	790	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	790	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	790	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	791	1	2008;359:1317–1329	2008;359:1317–1329	LS
work_vvlzsj54cvf5de6ji6py6krqlm	791	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	792	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	792	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	792	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	792	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	792	5	NEJMoa0804656	nejmoa0804656	UH
work_vvlzsj54cvf5de6ji6py6krqlm	792	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	793	1	70	70	CD
work_vvlzsj54cvf5de6ji6py6krqlm	793	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	794	1	Lees	Lees	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	2	KR	KR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	4	Bluhmki	Bluhmki	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	5	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	7	von	von	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	8	Kummer	Kummer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	9	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	11	Brott	Brott	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	12	TG	TG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	14	Toni	Toni	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	15	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	17	Grotta	Grotta	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	18	JC	JC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	20	Albers	Albers	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	21	GW	GW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	23	Kaste	Kaste	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	24	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	26	Marler	Marler	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	27	JR	JR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	29	Hamilton	Hamilton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	30	SA	SA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	32	Tilley	Tilley	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	33	BC	BC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	35	Davis	Davis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	36	SM	SM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	38	Donnan	Donnan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	39	GA	GA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	41	Hacke	Hacke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	42	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	44	Allen	Allen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	45	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	47	Mau	Mau	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	48	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	49	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	50	Meier	Meier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	51	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	53	del	del	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	54	Zoppo	Zoppo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	55	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	57	De	De	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	58	Silva	Silva	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	59	DA	DA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	60	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	61	Butcher	Butcher	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	62	KS	KS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	63	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	64	Parsons	Parsons	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	65	MW	MW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	66	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	67	Barber	Barber	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	68	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	69	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	70	Levi	Levi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	71	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	72	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	73	Bladin	Bladin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	74	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	75	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	76	Byrnes	Byrnes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	77	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	78	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	794	79	ECASS	ECASS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	80	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	81	ATLANTIS	ATLANTIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	82	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	794	83	NINDS	NINDS	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	794	84	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	794	85	EPITHET	EPITHET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	86	rt	rt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	87	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	794	88	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	89	Study	Study	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	90	Group	Group	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	794	91	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	795	1	Time	time	NN
work_vvlzsj54cvf5de6ji6py6krqlm	795	2	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	795	3	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	795	4	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	795	5	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	795	6	alteplase	alteplase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	795	7	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	795	8	out-	out-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	795	9	come	come	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	795	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	795	11	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	795	12	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	795	13	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	795	14	updated	update	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	795	15	pooled	pool	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	795	16	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	795	17	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	795	18	ECASS	ECASS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	795	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	795	20	ATLANTIS	ATLANTIS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	795	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	795	22	NINDS	NINDS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	795	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	795	24	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	795	25	EPITHET	EPITHET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	795	26	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	795	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	796	1	Lancet	Lancet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	796	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	797	1	2010;375:1695–1703	2010;375:1695–1703	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	797	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	798	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	798	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	798	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	798	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	798	5	S0140	S0140	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	798	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	798	7	6736(10)60491	6736(10)60491	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	798	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	798	9	6	6	CD
work_vvlzsj54cvf5de6ji6py6krqlm	798	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	799	1	71	71	CD
work_vvlzsj54cvf5de6ji6py6krqlm	799	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	800	1	Jauch	Jauch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	2	EC	EC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	4	Saver	Saver	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	5	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	7	Adams	Adams	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	8	HP	HP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	9	Jr	Jr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	11	Bruno	Bruno	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	12	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	14	Connors	Connors	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	15	JJ	JJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	17	Demaer-	Demaer-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	18	schalk	schalk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	800	19	BM	BM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	21	Khatri	Khatri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	22	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	24	McMullan	McMullan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	25	PW	PW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	26	Jr	Jr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	28	Qureshi	Qureshi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	29	AI	AI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	31	Rosenfield	Rosenfield	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	32	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	34	Scott	Scott	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	35	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	37	Summers	Summers	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	38	DR	DR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	40	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	41	DZ	DZ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	43	Wintermark	Wintermark	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	44	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	800	46	Yonas	Yonas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	47	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	48	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	800	49	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	800	50	behalf	behalf	NN
work_vvlzsj54cvf5de6ji6py6krqlm	800	51	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	800	52	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	800	53	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	54	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	55	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	56	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	57	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	58	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	800	59	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	60	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	800	61	Cardiovascular	Cardiovascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	62	Nursing	Nursing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	63	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	800	64	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	65	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	800	66	Peripheral	Peripheral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	67	Vascular	Vascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	68	Dis-	Dis-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	69	ease	ease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	800	70	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	800	71	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	72	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	800	73	Clinical	Clinical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	74	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	800	75	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	801	1	Guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	801	2	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	801	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	801	4	early	early	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	801	5	man-	man-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	801	6	agement	agement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	801	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	801	8	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	801	9	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	801	10	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	801	11	ischemic	ischemic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	801	12	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	801	13	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	801	14	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	801	15	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	801	16	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	801	17	healthcare	healthcare	NN
work_vvlzsj54cvf5de6ji6py6krqlm	801	18	professionals	professional	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	801	19	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	801	20	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	801	21	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	801	22	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	801	23	Association/	association/	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	801	24	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	801	25	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	801	26	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	801	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	802	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	802	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	803	1	2013;44:870–947	2013;44:870–947	CD
work_vvlzsj54cvf5de6ji6py6krqlm	803	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	804	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	804	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	804	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	804	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	804	5	STR.0b013e318284056a	str.0b013e318284056a	NN
work_vvlzsj54cvf5de6ji6py6krqlm	804	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	805	1	72	72	CD
work_vvlzsj54cvf5de6ji6py6krqlm	805	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	806	1	Sun	Sun	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	806	2	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	806	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	806	4	Zhou	Zhou	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	806	5	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	806	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	806	7	Ploen	Ploen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	806	8	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	806	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	806	10	Zorn	Zorn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	806	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	806	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	806	13	Veltkamp	Veltkamp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	806	14	R.	R.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	806	15	Anticoagulation	Anticoagulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	806	16	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	806	17	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	806	18	does	do	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	806	19	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	806	20	increase	increase	VB
work_vvlzsj54cvf5de6ji6py6krqlm	806	21	secondary	secondary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	806	22	intracerebral	intracerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	806	23	haemorrhage	haemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	806	24	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	806	25	thrombolysis	thrombolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	806	26	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	806	27	experimental	experimental	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	806	28	cerebral	cerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	806	29	ischaemia	ischaemia	NN
work_vvlzsj54cvf5de6ji6py6krqlm	806	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	807	1	Thromb	Thromb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	807	2	Hae-	Hae-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	807	3	most	most	RBS
work_vvlzsj54cvf5de6ji6py6krqlm	807	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	808	1	2013;110:153–161	2013;110:153–161	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	808	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	809	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	809	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	809	3	10.1160	10.1160	CD
work_vvlzsj54cvf5de6ji6py6krqlm	809	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	809	5	TH12	TH12	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	809	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	809	7	12	12	CD
work_vvlzsj54cvf5de6ji6py6krqlm	809	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	809	9	0942	0942	CD
work_vvlzsj54cvf5de6ji6py6krqlm	809	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	810	1	73	73	CD
work_vvlzsj54cvf5de6ji6py6krqlm	810	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	811	1	Ploen	Ploen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	2	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	811	4	Sun	Sun	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	5	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	811	7	Zhou	Zhou	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	8	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	811	10	Heitmeier	Heitmeier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	11	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	811	13	Zorn	Zorn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	14	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	811	16	Jenetzky	Jenetzky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	17	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	811	19	Velt-	Velt-	.
work_vvlzsj54cvf5de6ji6py6krqlm	811	20	kamp	kamp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	21	R.	R.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	22	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	811	23	does	do	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	811	24	not	not	RB
work_vvlzsj54cvf5de6ji6py6krqlm	811	25	increase	increase	VB
work_vvlzsj54cvf5de6ji6py6krqlm	811	26	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	811	27	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	811	28	throm-	throm-	CD
work_vvlzsj54cvf5de6ji6py6krqlm	811	29	bolysis	bolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	811	30	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	811	31	experimental	experimental	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	811	32	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	811	33	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	811	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	812	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	812	2	Cereb	Cereb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	812	3	Blood	Blood	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	812	4	Flow	Flow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	812	5	Metab	Metab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	812	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	813	1	2014;34:495–501	2014;34:495–501	LS
work_vvlzsj54cvf5de6ji6py6krqlm	813	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	814	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	814	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	814	3	10.1038	10.1038	CD
work_vvlzsj54cvf5de6ji6py6krqlm	814	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	814	5	jcbfm.2013.226	jcbfm.2013.226	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	814	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	815	1	74	74	CD
work_vvlzsj54cvf5de6ji6py6krqlm	815	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	816	1	Jayathissa	Jayathissa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	816	2	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	816	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	816	4	Gommans	Gommans	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	816	5	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	816	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	816	7	Harper	Harper	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	816	8	P.	P.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	816	9	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	816	10	thrombolysis	thrombolysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	816	11	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	816	12	pa-	pa-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	816	13	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	816	14	taking	take	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	816	15	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	816	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	817	1	Intern	Intern	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	817	2	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	817	3	J.	J.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	818	1	2013;43:826–828	2013;43:826–828	LS
work_vvlzsj54cvf5de6ji6py6krqlm	818	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	819	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	819	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	819	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	819	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	819	5	imj.12182	imj.12182	NN
work_vvlzsj54cvf5de6ji6py6krqlm	819	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	820	1	75	75	CD
work_vvlzsj54cvf5de6ji6py6krqlm	820	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	821	1	Casado	Casado	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	2	Naranjo	Naranjo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	3	I	I	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	821	5	Portilla	Portilla	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	821	7	Cuenca	Cuenca	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	8	JC	JC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	821	10	Jiménez	Jiménez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	11	Caballero	Caballero	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	12	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	821	14	Calle	Calle	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	15	Escobar	Escobar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	16	ML	ML	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	821	18	Romero	Romero	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	19	Sevilla	Sevilla	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	20	RM	RM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	821	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	822	1	Fatal	fatal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	822	2	intracerebral	intracerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	822	3	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	822	4	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	822	5	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	822	6	administration	administration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	822	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	822	8	recombinant	recombinant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	822	9	tissue	tissue	NN
work_vvlzsj54cvf5de6ji6py6krqlm	822	10	plasminogen	plasminogen	NN
work_vvlzsj54cvf5de6ji6py6krqlm	822	11	activator	activator	NN
work_vvlzsj54cvf5de6ji6py6krqlm	822	12	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	822	13	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	822	14	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	822	15	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	822	16	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	822	17	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	822	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	822	19	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	822	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	823	1	Cere-	cere-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	823	2	brovasc	brovasc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	823	3	Dis	Dis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	823	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	824	1	2011;32:614–615	2011;32:614–615	CD
work_vvlzsj54cvf5de6ji6py6krqlm	824	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	825	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	825	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	825	3	10.1159/000334578	10.1159/000334578	LS
work_vvlzsj54cvf5de6ji6py6krqlm	825	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	826	1	76	76	CD
work_vvlzsj54cvf5de6ji6py6krqlm	826	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	827	1	Seiffge	seiffge	NN
work_vvlzsj54cvf5de6ji6py6krqlm	827	2	DJ	DJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	4	Hooff	Hooff	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	5	RJ	RJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	7	Nolte	Nolte	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	8	CH	CH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	10	Béjot	Béjot	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	11	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	13	Turc	Turc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	14	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	16	Ikenberg	Ikenberg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	17	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	19	Berge	Berge	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	20	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	22	Persike	Persike	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	23	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	25	Dequatre	Dequatre	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	26	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	827	27	Ponchelle	Ponchelle	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	28	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	30	Strbian	Strbian	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	31	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	827	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	33	Pfeilschifter	Pfeilschifter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	34	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	36	Zini	Zini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	37	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	39	Tveiten	Tveiten	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	40	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	42	Næss	Næss	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	43	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	45	Michel	Michel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	46	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	48	Sztajzel	Sztajzel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	49	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	51	Luft	Luft	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	52	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	54	Gensicke	Gensicke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	55	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	57	Traenka	Traenka	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	58	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	59	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	60	Hert	Hert	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	61	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	62	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	63	Scheitz	Scheitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	64	JF	JF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	65	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	66	De	De	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	67	Marchis	Marchis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	68	GM	GM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	69	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	70	Bonati	Bonati	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	71	LH	LH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	72	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	73	Peters	Peters	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	74	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	75	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	76	Charidimou	Charidimou	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	77	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	78	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	79	Werring	Werring	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	80	DJ	DJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	81	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	82	Palm	Palm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	83	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	84	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	85	Reinhard	Reinhard	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	86	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	87	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	88	Niesen	Niesen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	89	WD	WD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	90	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	91	Nagao	Nagao	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	92	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	93	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	94	Pezzini	Pezzini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	95	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	96	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	97	Caso	Caso	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	98	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	99	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	100	Nederkoorn	Nederkoorn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	101	PJ	PJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	102	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	103	Kägi	Kägi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	104	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	105	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	106	von	von	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	107	Hessling	hessle	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	827	108	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	109	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	110	Padjen	Padjen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	111	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	112	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	113	Cordonnier	Cordonnier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	114	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	115	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	116	Erdur	Erdur	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	117	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	118	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	119	Lyrer	Lyrer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	120	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	121	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	122	Brouns	Brouns	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	123	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	124	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	125	Steiner	Steiner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	126	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	127	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	128	Tatlisumak	Tatlisumak	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	129	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	130	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	827	131	Engelter	Engelter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	132	ST	ST	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	133	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	827	134	NOACISP	NOACISP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	135	Study	Study	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	136	Group	Group	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	827	137	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	828	1	Recanalization	recanalization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	828	2	therapies	therapy	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	828	3	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	828	4	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	828	5	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	828	6	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	828	7	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	828	8	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	828	9	impact	impact	NN
work_vvlzsj54cvf5de6ji6py6krqlm	828	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	828	11	prior	prior	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	828	12	treat-	treat-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	828	13	ment	ment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	828	14	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	828	15	novel	novel	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	828	16	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	828	17	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	828	18	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	828	19	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	828	20	complications	complication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	828	21	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	828	22	outcome	outcome	NN
work_vvlzsj54cvf5de6ji6py6krqlm	828	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	829	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	829	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	830	1	2015;132:1261–1269	2015;132:1261–1269	CD
work_vvlzsj54cvf5de6ji6py6krqlm	830	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	831	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	831	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	831	3	10.1161/	10.1161/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	831	4	CIRCULATIONAHA.115.015484	circulationaha.115.015484	NN
work_vvlzsj54cvf5de6ji6py6krqlm	831	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	832	1	77	77	CD
work_vvlzsj54cvf5de6ji6py6krqlm	832	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	833	1	Berkhemer	Berkhemer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	2	OA	OA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	4	Fransen	Fransen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	5	PS	PS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	7	Beumer	Beumer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	8	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	10	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	11	den	den	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	12	Berg	Berg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	13	LA	LA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	15	Lings-	Lings-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	16	ma	ma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	17	HF	HF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	19	Yoo	Yoo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	20	AJ	AJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	22	Schonewille	Schonewille	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	23	WJ	WJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	25	Vos	Vos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	26	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	28	Nederkoorn	Nederkoorn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	29	PJ	PJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	31	Wermer	Wermer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	32	MJ	MJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	34	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	35	Walderveen	Walderveen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	36	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	38	Staals	Staals	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	39	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	41	Hofmeijer	Hofmeijer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	42	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	44	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	45	Oostayen	Oostayen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	46	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	48	Lycklama	Lycklama	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	49	à	à	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	50	Nijeholt	Nijeholt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	51	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	53	Boiten	Boiten	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	54	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	56	Brouwer	Brouwer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	57	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	58	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	59	Emmer	Emmer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	60	BJ	BJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	61	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	62	de	de	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	63	Bruijn	Bruijn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	64	SF	SF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	65	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	66	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	67	Dijk	Dijk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	68	LC	LC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	69	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	70	Kappelle	Kappelle	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	71	LJ	LJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	72	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	73	Lo	Lo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	74	RH	RH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	75	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	76	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	77	Dijk	Dijk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	78	EJ	EJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	79	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	80	de	de	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	81	Vries	Vries	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	82	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	83	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	84	de	de	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	85	Kort	Kort	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	86	PL	PL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	87	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	88	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	89	Rooij	Rooij	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	90	WJ	WJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	91	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	92	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	93	den	den	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	94	Berg	Berg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	95	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	96	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	97	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	98	Hasselt	Hasselt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	99	BA	BA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	100	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	101	Aerden	Aerden	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	102	LA	LA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	103	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	104	Dal-	Dal-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	105	linga	linga	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	833	106	RJ	RJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	107	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	108	Visser	Visser	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	109	MC	MC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	110	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	111	Bot	Bot	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	112	JC	JC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	113	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	114	Vroomen	Vroomen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	115	PC	PC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	116	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	117	Eshghi	Eshghi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	118	O	O	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	119	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	120	Schreuder	Schreuder	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	121	TH	TH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	122	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	123	Heijboer	Heijboer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	124	RJ	RJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	125	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	126	Keizer	Keizer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	127	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	128	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	129	Tielbeek	Tielbeek	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	130	AV	AV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	131	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	132	den	den	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	133	Hertog	Hertog	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	134	HM	HM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	135	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	136	Gerrits	Gerrits	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	137	DG	DG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	138	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	139	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	140	den	den	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	141	Berg	Berg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	142	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	833	143	Vos	Vos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	144	RM	RM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	145	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	146	Karas	Karas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	147	GB	GB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	148	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	149	Steyerberg	Steyerberg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	150	EW	EW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	151	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	152	Flach	Flach	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	153	HZ	HZ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	154	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	155	Marquering	Marquering	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	156	HA	HA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	157	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	158	Sprengers	Sprengers	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	159	ME	ME	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	160	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	161	Jenniskens	Jenniskens	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	162	SF	SF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	163	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	164	Beenen	Beenen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	165	LF	LF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	166	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	167	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	168	den	den	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	169	Berg	Berg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	170	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	171	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	172	Koudstaal	Koudstaal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	173	PJ	PJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	174	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	175	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	176	Zwam	Zwam	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	177	WH	WH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	178	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	179	Roos	Roos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	180	YB	YB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	181	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	182	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	183	der	der	NN
work_vvlzsj54cvf5de6ji6py6krqlm	833	184	Lugt	Lugt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	185	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	186	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	187	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	188	Oosten-	Oosten-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	189	brugge	brugge	NN
work_vvlzsj54cvf5de6ji6py6krqlm	833	190	RJ	RJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	191	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	192	Majoie	Majoie	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	193	CB	CB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	194	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	833	195	Dippel	Dippel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	196	DW	DW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	197	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	833	198	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	199	CLEAN	CLEAN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	833	200	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	833	201	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	834	1	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	834	2	ran-	ran-	RB
work_vvlzsj54cvf5de6ji6py6krqlm	834	3	domized	domize	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	834	4	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	834	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	834	6	intraarterial	intraarterial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	834	7	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	834	8	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	834	9	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	834	10	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	834	11	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	834	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	835	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	835	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	835	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	835	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	835	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	836	1	2015;372:11–20	2015;372:11–20	LS
work_vvlzsj54cvf5de6ji6py6krqlm	836	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	837	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	837	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	837	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	837	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	837	5	NEJMoa1411587	nejmoa1411587	UH
work_vvlzsj54cvf5de6ji6py6krqlm	837	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	838	1	78	78	CD
work_vvlzsj54cvf5de6ji6py6krqlm	838	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	839	1	Campbell	Campbell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	2	BC	BC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	4	Mitchell	Mitchell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	5	PJ	PJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	7	Kleinig	Kleinig	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	8	TJ	TJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	10	Dewey	Dewey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	11	HM	HM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	13	Churilov	Churilov	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	14	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	16	Yassi	Yassi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	17	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	19	Yan	Yan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	20	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	22	Dowling	Dowling	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	23	RJ	RJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	25	Parsons	Parsons	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	839	26	MW	MW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	28	Oxley	Oxley	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	29	TJ	TJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	31	Wu	Wu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	32	TY	TY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	34	Brooks	Brooks	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	35	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	37	Simpson	Simpson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	38	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	40	Miteff	Miteff	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	41	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	43	Levi	Levi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	44	CR	CR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	46	Krause	Krause	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	47	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	49	Harrington	Harrington	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	50	TJ	TJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	52	Faulder	Faulder	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	53	KC	KC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	55	Steinfort	Steinfort	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	56	BS	BS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	57	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	58	Priglinger	Priglinger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	59	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	60	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	61	Ang	Ang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	62	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	63	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	64	Scroop	Scroop	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	65	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	66	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	67	Barber	Barber	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	68	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	69	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	70	Mc-	Mc-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	71	Guinness	Guinness	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	72	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	73	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	74	Wijeratne	Wijeratne	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	75	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	76	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	77	Phan	Phan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	78	TG	TG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	79	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	80	Chong	Chong	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	81	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	82	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	83	Chandra	Chandra	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	84	RV	RV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	85	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	86	Bladin	Bladin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	87	CF	CF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	88	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	89	Badve	Badve	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	90	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	91	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	92	Rice	Rice	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	93	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	94	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	95	de	de	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	96	Villiers	Villiers	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	97	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	98	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	99	Ma	Ma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	100	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	101	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	102	Desmond	Desmond	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	103	PM	PM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	104	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	105	Donnan	Donnan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	106	GA	GA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	107	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	839	108	Davis	Davis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	109	SM	SM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	110	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	839	111	EXTEND	EXTEND	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	112	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	839	113	IA	IA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	839	114	Investigators	investigator	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	839	115	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	840	1	Endovascular	endovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	840	2	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	840	3	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	840	4	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	840	5	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	840	6	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	840	7	perfusion	perfusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	840	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	840	9	imaging	image	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	840	10	selection	selection	NN
work_vvlzsj54cvf5de6ji6py6krqlm	840	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	841	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	841	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	841	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	841	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	841	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	842	1	2015;372:1009–1018	2015;372:1009–1018	CD
work_vvlzsj54cvf5de6ji6py6krqlm	842	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	843	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	843	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	843	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	843	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	843	5	NEJMoa1414792	NEJMoa1414792	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	843	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	844	1	79	79	CD
work_vvlzsj54cvf5de6ji6py6krqlm	844	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	845	1	Saver	Saver	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	2	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	4	Goyal	Goyal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	7	Bonafe	Bonafe	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	8	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	10	Diener	Diener	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	11	HC	HC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	13	Levy	Levy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	14	EI	EI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	16	Pereira	Pereira	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	17	VM	VM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	19	Albers	Albers	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	20	GW	GW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	22	Cognard	Cognard	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	23	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	25	Cohen	Cohen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	26	DJ	DJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	28	Hacke	Hacke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	29	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	31	Jansen	Jansen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	32	O	O	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	34	Jovin	Jovin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	35	TG	TG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	37	Mattle	Mattle	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	38	HP	HP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	40	Nogueira	Nogueira	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	41	RG	RG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	43	Siddiqui	Siddiqui	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	44	AH	AH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	46	Yavagal	Yavagal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	47	DR	DR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	49	Baxter	Baxter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	50	BW	BW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	52	Dev-	Dev-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	53	lin	lin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	54	TG	TG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	56	Lopes	Lopes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	57	DK	DK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	58	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	59	Reddy	Reddy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	60	VK	VK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	61	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	62	du	du	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	63	Mesnil	Mesnil	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	64	de	de	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	65	Rochemont	Rochemont	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	66	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	67	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	68	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	69	OC	OC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	70	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	845	71	Jahan	Jahan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	72	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	73	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	845	74	SWIFT	SWIFT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	75	PRIME	PRIME	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	845	76	Investigators	investigator	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	845	77	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	846	1	Stent	Stent	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	846	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	846	3	retriever	retriever	NN
work_vvlzsj54cvf5de6ji6py6krqlm	846	4	throm-	throm-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	846	5	bectomy	bectomy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	846	6	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	846	7	intravenous	intravenous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	846	8	t	t	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	846	9	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	846	10	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	846	11	vs.	vs.	IN
work_vvlzsj54cvf5de6ji6py6krqlm	846	12	t	t	NN
work_vvlzsj54cvf5de6ji6py6krqlm	846	13	-	-	:
work_vvlzsj54cvf5de6ji6py6krqlm	846	14	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	846	15	alone	alone	RB
work_vvlzsj54cvf5de6ji6py6krqlm	846	16	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	846	17	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	846	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	847	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	847	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	847	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	847	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	847	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	848	1	2015;372:2285–2295	2015;372:2285–2295	CD
work_vvlzsj54cvf5de6ji6py6krqlm	848	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	849	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	849	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	849	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	849	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	849	5	NEJMoa1415061	nejmoa1415061	UH
work_vvlzsj54cvf5de6ji6py6krqlm	849	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	850	1	80	80	CD
work_vvlzsj54cvf5de6ji6py6krqlm	850	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	851	1	Goyal	Goyal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	2	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	4	Demchuk	Demchuk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	5	AM	am	NN
work_vvlzsj54cvf5de6ji6py6krqlm	851	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	7	Menon	Menon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	8	BK	BK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	10	Eesa	Eesa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	13	Rempel	Rempel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	14	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	16	Thornton	Thornton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	17	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	19	Roy	Roy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	20	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	22	Jovin	Jovin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	23	TG	TG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	25	Willinsky	Willinsky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	26	RA	RA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	28	Sapkota	Sapkota	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	29	BL	BL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	31	Dowlatshahi	Dowlatshahi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	32	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	34	Frei	Frei	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	35	DF	DF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	37	Kamal	Kamal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	38	NR	NR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	40	Montanera	Montanera	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	41	WJ	WJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	43	Poppe	Poppe	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	44	AY	AY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	46	Ryckborst	Ryckborst	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	47	KJ	KJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	49	Silver	Silver	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	50	FL	FL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	52	Shuaib	Shuaib	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	53	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	55	Tampieri	Tampieri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	56	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	57	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	58	Williams	Williams	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	59	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	60	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	61	Bang	Bang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	62	OY	OY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	63	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	64	Baxter	Baxter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	65	BW	BW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	66	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	67	Burns	Burns	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	68	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	69	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	70	Choe	Choe	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	71	H	h	NN
work_vvlzsj54cvf5de6ji6py6krqlm	851	72	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	73	Heo	Heo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	74	JH	JH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	75	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	76	Holmstedt	Holmstedt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	77	CA	CA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	78	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	79	Jankowitz	Jankowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	80	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	81	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	82	Kelly	Kelly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	83	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	84	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	85	Linares	Linares	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	86	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	87	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	88	Mandzia	Mandzia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	89	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	90	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	91	Shankar	Shankar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	92	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	93	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	94	Sohn	Sohn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	95	SI	SI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	96	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	97	Swartz	Swartz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	98	RH	RH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	99	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	100	Barber	Barber	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	101	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	102	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	103	Coutts	Coutts	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	104	SB	SB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	105	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	106	Smith	Smith	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	107	EE	EE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	108	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	109	Morrish	Morrish	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	110	WF	WF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	111	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	112	Weill	Weill	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	113	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	114	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	115	Subramaniam	Subramaniam	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	116	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	117	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	118	Mitha	Mitha	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	119	AP	AP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	120	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	121	Wong	Wong	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	122	JH	JH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	123	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	124	Lowerison	Lowerison	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	125	MW	MW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	126	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	127	Sajobi	Sajobi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	128	TT	TT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	129	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	130	Hill	Hill	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	131	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	132	;	;	,
work_vvlzsj54cvf5de6ji6py6krqlm	851	133	ESCAPE	ESCAPE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	134	Trial	Trial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	135	Investiga-	Investiga-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	851	136	tors	tor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	851	137	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	852	1	Randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	852	2	assessment	assessment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	852	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	852	4	rapid	rapid	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	852	5	endovascular	endovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	852	6	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	852	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	852	8	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	852	9	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	852	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	853	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	853	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	853	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	853	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	853	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	854	1	2015;372:1019–1030	2015;372:1019–1030	CD
work_vvlzsj54cvf5de6ji6py6krqlm	854	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	855	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	855	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	855	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	855	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	855	5	NEJMoa1414905	nejmoa1414905	NN
work_vvlzsj54cvf5de6ji6py6krqlm	855	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	856	1	81	81	CD
work_vvlzsj54cvf5de6ji6py6krqlm	856	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	857	1	Jovin	Jovin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	2	TG	TG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	4	Chamorro	Chamorro	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	5	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	7	Cobo	Cobo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	8	E	e	NN
work_vvlzsj54cvf5de6ji6py6krqlm	857	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	10	de	de	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	11	Miquel	Miquel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	12	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	14	Molina	Molina	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	15	CA	CA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	17	Rovira	Rovira	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	18	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	20	San	San	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	21	Román	Román	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	22	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	24	Serena	Serena	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	25	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	27	Abilleira	Abilleira	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	28	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	30	Ribó	Ribó	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	31	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	33	Millán	Millán	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	34	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	36	Urra	Urra	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	37	X	X	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	39	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	857	40	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	857	41	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	857	42	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	857	43	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	44	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	857	45	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	857	46	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	857	47	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	857	48	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	857	49	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	857	50	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	857	51	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	52	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	857	53	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	857	54	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	857	55	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	857	56	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	857	57	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	857	58	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	59	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	60	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	857	61	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	62	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	63	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	857	64	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	858	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	858	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	858	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	858	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	859	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	859	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	859	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	859	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	859	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	859	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	859	10	e629	e629	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	11	CLINICAL	clinical	NN
work_vvlzsj54cvf5de6ji6py6krqlm	859	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	859	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	859	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	859	15	GUIDELINES	GUIDELINES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	16	Cardona	Cardona	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	17	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	19	López	López	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	20	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	859	21	Cancio	Cancio	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	22	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	24	Tomasello	Tomasello	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	25	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	27	Castaño	Castaño	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	28	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	30	Blasco	Blasco	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	31	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	33	Aja	Aja	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	34	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	36	Dorado	Dorado	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	37	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	39	Quesada	Quesada	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	40	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	42	Rubiera	Rubiera	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	43	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	45	Hernandez	Hernandez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	46	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	859	47	Pérez	Pérez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	48	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	49	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	50	Goyal	Goyal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	51	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	53	Demchuk	Demchuk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	54	AM	AM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	56	von	von	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	57	Kummer	Kummer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	58	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	59	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	60	Gallofré	Gallofré	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	61	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	62	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	859	63	Dávalos	Dávalos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	64	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	65	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	859	66	REVASCAT	REVASCAT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	67	Trial	Trial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	859	68	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	859	69	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	860	1	Thrombectomy	thrombectomy	IN
work_vvlzsj54cvf5de6ji6py6krqlm	860	2	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	860	3	8	8	CD
work_vvlzsj54cvf5de6ji6py6krqlm	860	4	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	860	5	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	860	6	symptom	symptom	NN
work_vvlzsj54cvf5de6ji6py6krqlm	860	7	onset	onset	NN
work_vvlzsj54cvf5de6ji6py6krqlm	860	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	860	9	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	860	10	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	860	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	861	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	861	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	861	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	861	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	861	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	862	1	2015;372:2296–2306	2015;372:2296–2306	CD
work_vvlzsj54cvf5de6ji6py6krqlm	862	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	863	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	863	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	863	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	863	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	863	5	NEJMoa1503780	nejmoa1503780	NN
work_vvlzsj54cvf5de6ji6py6krqlm	863	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	864	1	82	82	CD
work_vvlzsj54cvf5de6ji6py6krqlm	864	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	865	1	Javedani	Javedani	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	865	2	PP	PP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	865	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	865	4	Horowitz	Horowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	865	5	BZ	BZ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	865	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	865	7	Clark	Clark	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	865	8	WM	WM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	865	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	865	10	Lutsep	Lutsep	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	865	11	HL	HL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	865	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	866	1	Dabigatran	dabigatran	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	866	2	etexilate	etexilate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	866	3	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	866	4	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	866	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	866	6	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	866	7	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	866	8	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	866	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	867	1	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	867	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	867	3	Crit	Crit	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	867	4	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	867	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	868	1	2013;22:169–176	2013;22:169–176	CD
work_vvlzsj54cvf5de6ji6py6krqlm	868	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	869	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	869	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	869	3	10.4037	10.4037	CD
work_vvlzsj54cvf5de6ji6py6krqlm	869	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	869	5	ajcc2013125	ajcc2013125	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	869	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	870	1	83	83	CD
work_vvlzsj54cvf5de6ji6py6krqlm	870	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	871	1	Moey	Moey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	871	2	AW	AW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	871	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	871	4	Koblar	Koblar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	871	5	SA	SA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	871	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	871	7	Chryssidis	Chryssidis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	871	8	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	871	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	871	10	Robinson	Robinson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	871	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	871	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	871	13	Jannes	Jannes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	871	14	J.	J.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	871	15	Endo-	endo-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	871	16	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	871	17	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	871	18	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	871	19	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	871	20	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	871	21	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	871	22	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	871	23	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	871	24	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	871	25	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	871	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	872	1	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	872	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	872	3	Aust	Aust	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	872	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	873	1	2012;196:469–471	2012;196:469–471	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	873	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	874	1	84	84	CD
work_vvlzsj54cvf5de6ji6py6krqlm	874	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	875	1	Müller	Müller	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	2	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	875	4	Topakian	Topakian	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	5	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	875	7	Sonnberger	Sonnberger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	8	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	875	10	Nußbaumer	Nußbaumer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	11	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	875	13	Windpessl	Windpessl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	14	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	875	16	Eder	Eder	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	17	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	875	19	Nesser	Nesser	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	20	HJ	HJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	875	22	Trenkler	Trenkler	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	23	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	875	25	Haring	Haring	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	26	HP	HP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	875	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	876	1	Endovascular	endovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	876	2	throm-	throm-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	876	3	bectomy	bectomy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	876	4	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	876	5	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	876	6	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	876	7	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	876	8	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	876	9	anticoagulated	anticoagulate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	876	10	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	876	11	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	876	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	877	1	Clin	Clin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	877	2	Neurol	Neurol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	877	3	Neurosurg	Neurosurg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	877	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	878	1	2013;115:2257–2259	2013;115:2257–2259	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	878	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	879	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	879	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	879	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	879	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	879	5	j.clineuro.2013.07.017	j.clineuro.2013.07.017	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	879	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	880	1	85	85	CD
work_vvlzsj54cvf5de6ji6py6krqlm	880	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	881	1	Freeman	Freeman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	881	2	WD	WD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	881	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	881	4	Kuo	Kuo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	881	5	RS	RS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	881	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	881	7	Hanel	Hanel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	881	8	RA	RA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	881	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	882	1	Letter	letter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	882	2	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	882	3	Freeman	Freeman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	882	4	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	882	5	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	882	6	regard-	regard-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	882	7	ing	ing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	882	8	article	article	NN
work_vvlzsj54cvf5de6ji6py6krqlm	882	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	882	10	“	"	``
work_vvlzsj54cvf5de6ji6py6krqlm	882	11	Using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	882	12	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	882	13	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	882	14	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	882	15	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	882	16	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	882	17	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	882	18	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	882	19	practical	practical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	882	20	guide	guide	NN
work_vvlzsj54cvf5de6ji6py6krqlm	882	21	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	882	22	clinicians	clinician	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	882	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	882	24	”	"	''
work_vvlzsj54cvf5de6ji6py6krqlm	882	25	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	882	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	883	1	2012;43	2012;43	CD
work_vvlzsj54cvf5de6ji6py6krqlm	883	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	883	3	e48	e48	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	883	4	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	883	5	author	author	NN
work_vvlzsj54cvf5de6ji6py6krqlm	883	6	reply	reply	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	883	7	e49	e49	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	883	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	884	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	884	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	884	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	884	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	884	5	STROKEAHA.112.652313	STROKEAHA.112.652313	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	884	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	885	1	86	86	CD
work_vvlzsj54cvf5de6ji6py6krqlm	885	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	886	1	Mehta	Mehta	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	886	2	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	886	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	886	4	Dababneh	Dababneh	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	886	5	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	886	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	886	7	Hussain	Hussain	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	886	8	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	886	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	886	10	Moussavi	Moussavi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	886	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	886	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	886	13	Kirmani	Kirmani	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	886	14	JF	JF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	886	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	887	1	Endo-	endo-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	887	2	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	887	3	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	887	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	887	5	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	887	6	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	887	7	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	887	8	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	887	9	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	887	10	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	887	11	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	887	12	inhibitor	inhibitor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	887	13	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	888	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	888	2	Vasc	Vasc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	888	3	Interv	Interv	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	888	4	Neurol	Neurol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	888	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	889	1	2014;7:5–7	2014;7:5–7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	889	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	890	1	87	87	CD
work_vvlzsj54cvf5de6ji6py6krqlm	890	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	891	1	Kimura	Kimura	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	2	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	891	4	Ogata	Ogata	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	5	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	891	7	Fukae	Fukae	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	8	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	891	10	Okawa	Okawa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	891	13	Higashi	Higashi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	14	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	891	16	Iwaasa	Iwaasa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	17	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	891	19	Inoue	Inoue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	20	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	891	22	Tsuboi	Tsuboi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	23	Y.	Y.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	24	Revascularization	Revascularization	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	891	25	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	891	26	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	891	27	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	891	28	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	891	29	is	be	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	891	30	safe	safe	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	891	31	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	891	32	rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	891	33	users	user	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	891	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	892	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	892	2	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	892	3	Cerebrovasc	Cerebrovasc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	892	4	Dis	Dis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	892	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	893	1	2014;23	2014;23	CD
work_vvlzsj54cvf5de6ji6py6krqlm	893	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	893	3	e427	e427	NN
work_vvlzsj54cvf5de6ji6py6krqlm	893	4	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	893	5	e431	e431	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	893	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	894	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	894	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	894	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	894	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	894	5	j.jstrokecerebrovasdis.2014.05.015	j.jstrokecerebrovasdis.2014.05.015	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	894	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	895	1	88	88	CD
work_vvlzsj54cvf5de6ji6py6krqlm	895	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	896	1	Powers	power	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	896	2	WJ	WJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	4	Derdeyn	Derdeyn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	5	CP	CP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	7	Biller	Biller	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	8	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	10	Coffey	Coffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	11	CS	CS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	13	Hoh	Hoh	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	14	BL	BL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	16	Jauch	Jauch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	17	EC	EC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	19	Johnston	Johnston	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	20	KC	KC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	22	Johnston	Johnston	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	23	SC	SC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	25	Khalessi	Khalessi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	26	AA	AA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	28	Kidwell	Kidwell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	29	CS	CS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	31	Meschia	Meschia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	32	JF	JF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	34	Ovbiagele	Ovbiagele	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	35	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	896	37	Yavagal	Yavagal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	38	DR	DR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	39	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	896	40	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	896	41	behalf	behalf	NN
work_vvlzsj54cvf5de6ji6py6krqlm	896	42	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	896	43	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	896	44	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	45	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	46	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	47	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	48	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	896	49	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	897	1	2015	2015	CD
work_vvlzsj54cvf5de6ji6py6krqlm	897	2	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	3	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	4	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	5	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	897	6	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	7	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	8	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	9	focused	focus	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	897	10	update	update	NN
work_vvlzsj54cvf5de6ji6py6krqlm	897	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	897	12	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	897	13	2013	2013	CD
work_vvlzsj54cvf5de6ji6py6krqlm	897	14	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	897	15	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	897	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	897	17	early	early	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	897	18	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	897	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	897	20	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	897	21	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	897	22	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	897	23	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	897	24	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	897	25	regarding	regard	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	897	26	endo-	endo-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	897	27	vascular	vascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	897	28	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	897	29	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	897	30	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	897	31	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	897	32	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	897	33	healthcare	healthcare	NN
work_vvlzsj54cvf5de6ji6py6krqlm	897	34	professionals	professional	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	897	35	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	897	36	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	897	37	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	38	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	39	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	40	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	897	41	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	42	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	43	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	897	44	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	898	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	898	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	899	1	2015;46:3020–3035	2015;46:3020–3035	CD
work_vvlzsj54cvf5de6ji6py6krqlm	899	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	900	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	900	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	900	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	900	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	900	5	STR.0000000000000074	STR.0000000000000074	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	900	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	901	1	89	89	CD
work_vvlzsj54cvf5de6ji6py6krqlm	901	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	902	1	Paciaroni	Paciaroni	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	902	2	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	902	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	902	4	Agnelli	Agnelli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	902	5	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	902	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	902	7	Micheli	Micheli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	902	8	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	902	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	902	10	Caso	Caso	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	902	11	V.	V.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	902	12	Efficacy	Efficacy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	902	13	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	902	14	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	902	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	902	16	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	902	17	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	902	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	902	19	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	902	20	cardioembolic	cardioembolic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	902	21	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	902	22	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	902	23	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	902	24	meta-	meta-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	902	25	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	902	26	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	902	27	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	902	28	controlled	controlled	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	902	29	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	902	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	903	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	903	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	904	1	2007;38:423	2007;38:423	CD
work_vvlzsj54cvf5de6ji6py6krqlm	904	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	904	3	430	430	CD
work_vvlzsj54cvf5de6ji6py6krqlm	904	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	904	5	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	904	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	904	7	10.1161/01.STR.0000254600.92975.1f	10.1161/01.str.0000254600.92975.1f	CD
work_vvlzsj54cvf5de6ji6py6krqlm	904	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	905	1	90	90	CD
work_vvlzsj54cvf5de6ji6py6krqlm	905	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	906	1	Sandercock	Sandercock	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	906	2	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	906	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	906	4	Counsell	Counsell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	906	5	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	906	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	906	7	Kane	Kane	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	906	8	EJ	EJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	906	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	907	1	Anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	907	2	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	907	3	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	907	4	isch-	isch-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	907	5	aemic	aemic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	907	6	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	907	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	908	1	Cochrane	Cochrane	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	908	2	Database	Database	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	908	3	Syst	Syst	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	908	4	Rev.	Rev.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	909	1	2015;3	2015;3	LS
work_vvlzsj54cvf5de6ji6py6krqlm	909	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	909	3	CD000024	CD000024	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	909	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	910	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	910	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	910	3	10.1002/14651858.CD000024.pub4	10.1002/14651858.cd000024.pub4	CD
work_vvlzsj54cvf5de6ji6py6krqlm	910	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	911	1	91	91	CD
work_vvlzsj54cvf5de6ji6py6krqlm	911	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	912	1	Paciaroni	Paciaroni	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	2	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	4	Agnelli	Agnelli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	5	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	7	Corea	Corea	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	8	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	10	Ageno	Ageno	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	11	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	13	Alberti	Alberti	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	14	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	16	Lanari	Lanari	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	17	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	19	Caso	Caso	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	20	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	22	Micheli	Micheli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	23	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	25	Bertolani	Bertolani	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	26	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	28	Venti	Venti	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	29	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	31	Palmerini	Palmerini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	32	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	34	Biagini	Biagini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	35	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	37	Comi	Comi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	38	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	40	Previdi	Previdi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	41	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	43	Silvestrelli	Silvestrelli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	44	G.	G.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	45	Early	early	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	912	46	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	912	47	transformation	transformation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	912	48	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	912	49	brain	brain	NN
work_vvlzsj54cvf5de6ji6py6krqlm	912	50	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	912	51	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	912	52	rate	rate	NN
work_vvlzsj54cvf5de6ji6py6krqlm	912	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	54	predictive	predictive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	912	55	factors	factor	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	912	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	912	57	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	912	58	influence	influence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	912	59	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	912	60	clini-	clini-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	912	61	cal	cal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	912	62	outcome	outcome	NN
work_vvlzsj54cvf5de6ji6py6krqlm	912	63	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	912	64	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	912	65	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	912	66	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	912	67	prospective	prospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	912	68	multicenter	multicenter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	912	69	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	912	70	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	913	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	913	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	914	1	2008;39:2249–2256	2008;39:2249–2256	CD
work_vvlzsj54cvf5de6ji6py6krqlm	914	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	915	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	915	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	915	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	915	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	915	5	STROKEAHA.107.510321	strokeaha.107.510321	NN
work_vvlzsj54cvf5de6ji6py6krqlm	915	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	916	1	92	92	CD
work_vvlzsj54cvf5de6ji6py6krqlm	916	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	917	1	Fiorelli	Fiorelli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	2	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	917	4	Bastianello	Bastianello	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	5	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	917	7	von	von	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	8	Kummer	Kummer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	9	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	917	11	del	del	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	12	Zoppo	Zoppo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	13	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	917	15	Larrue	Larrue	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	16	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	917	18	Lesaffre	Lesaffre	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	19	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	917	21	Ringleb	Ringleb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	22	AP	AP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	917	24	Lorenzano	Lorenzano	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	25	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	917	27	Manelfe	Manelfe	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	28	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	917	30	Bozzao	Bozzao	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	31	L.	L.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	32	Hem-	Hem-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	33	orrhagic	orrhagic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	917	34	transformation	transformation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	917	35	within	within	IN
work_vvlzsj54cvf5de6ji6py6krqlm	917	36	36	36	CD
work_vvlzsj54cvf5de6ji6py6krqlm	917	37	hours	hour	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	917	38	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	917	39	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	917	40	cerebral	cerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	917	41	infarct	infarct	NN
work_vvlzsj54cvf5de6ji6py6krqlm	917	42	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	917	43	rela-	rela-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	917	44	tionships	tionship	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	917	45	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	917	46	early	early	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	917	47	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	917	48	deterioration	deterioration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	917	49	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	917	50	3-month	3-month	CD
work_vvlzsj54cvf5de6ji6py6krqlm	917	51	outcome	outcome	NN
work_vvlzsj54cvf5de6ji6py6krqlm	917	52	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	917	53	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	917	54	European	European	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	55	Cooperative	Cooperative	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	56	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	57	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	58	Study	Study	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	59	I	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	917	60	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	917	61	ECASS	ECASS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	917	62	I	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	917	63	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	917	64	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	917	65	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	918	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	918	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	919	1	1999;30:2280–2284	1999;30:2280–2284	CD
work_vvlzsj54cvf5de6ji6py6krqlm	919	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	920	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	920	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	920	3	10.1161/01.STR.30.11.2280	10.1161/01.STR.30.11.2280	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	920	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	921	1	93	93	CD
work_vvlzsj54cvf5de6ji6py6krqlm	921	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	922	1	Berger	Berger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	2	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	922	4	Fiorelli	Fiorelli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	922	7	Steiner	Steiner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	8	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	922	10	Schäbitz	Schäbitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	11	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	12	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	922	13	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	922	15	Bozzao	Bozzao	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	16	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	922	18	Bluhm-	Bluhm-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	19	ki	ki	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	20	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	922	22	Hacke	Hacke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	23	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	922	25	von	von	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	26	Kummer	Kummer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	27	R.	R.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	28	Hemorrhagic	Hemorrhagic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	922	29	transformation	transformation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	922	30	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	922	31	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	922	32	brain	brain	NN
work_vvlzsj54cvf5de6ji6py6krqlm	922	33	tissue	tissue	NN
work_vvlzsj54cvf5de6ji6py6krqlm	922	34	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	922	35	asymptomatic	asymptomatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	922	36	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	922	37	symptomatic	symptomatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	922	38	?	?	.
work_vvlzsj54cvf5de6ji6py6krqlm	923	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	923	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	924	1	2001;32:1330–1335	2001;32:1330–1335	LS
work_vvlzsj54cvf5de6ji6py6krqlm	924	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	925	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	925	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	925	3	10.1161/01.STR.32.6.1330	10.1161/01.str.32.6.1330	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	925	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	926	1	94	94	CD
work_vvlzsj54cvf5de6ji6py6krqlm	926	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	927	1	Pessin	Pessin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	927	2	MS	MS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	927	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	927	4	Estol	Estol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	927	5	CJ	CJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	927	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	927	7	Lafranchise	Lafranchise	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	927	8	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	927	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	927	10	Caplan	Caplan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	927	11	LR	LR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	927	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	928	1	Safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	928	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	928	3	anticoagula-	anticoagula-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	928	4	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	928	5	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	928	6	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	928	7	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	928	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	929	1	Neurology	neurology	NN
work_vvlzsj54cvf5de6ji6py6krqlm	929	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	930	1	1993;43:1298–1303	1993;43:1298–1303	CD
work_vvlzsj54cvf5de6ji6py6krqlm	930	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	931	1	95	95	CD
work_vvlzsj54cvf5de6ji6py6krqlm	931	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	932	1	Bohmann	Bohmann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	2	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	932	4	Mirceska	Mirceska	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	5	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	932	7	Pfeilschifter	Pfeilschifter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	8	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	932	10	Lindhoff	Lindhoff	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	11	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	932	12	Last	Last	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	13	E	e	NN
work_vvlzsj54cvf5de6ji6py6krqlm	932	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	932	15	Steinmetz	Steinmetz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	16	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	932	18	Foerch	Foerch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	19	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	932	21	Pfeilschifter	Pfeilschifter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	22	W.	W.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	23	No	no	DT
work_vvlzsj54cvf5de6ji6py6krqlm	932	24	influence	influence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	932	25	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	932	26	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	932	27	anticoagu-	anticoagu-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	932	28	lation	lation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	932	29	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	932	30	hemorrhagic	hemorrhagic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	932	31	transformation	transformation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	932	32	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	932	33	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	932	34	experimental	experimental	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	932	35	model	model	NN
work_vvlzsj54cvf5de6ji6py6krqlm	932	36	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	932	37	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	932	38	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	932	39	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	933	1	PLoS	PLoS	:
work_vvlzsj54cvf5de6ji6py6krqlm	933	2	One	one	CD
work_vvlzsj54cvf5de6ji6py6krqlm	933	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	934	1	2012;7	2012;7	LS
work_vvlzsj54cvf5de6ji6py6krqlm	934	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	934	3	e40804	e40804	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	934	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	935	1	doi	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	935	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	935	3	10.1371/	10.1371/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	935	4	journal.pone.0040804	journal.pone.0040804	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	935	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	936	1	96	96	CD
work_vvlzsj54cvf5de6ji6py6krqlm	936	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	937	1	Gliem	Gliem	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	2	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	937	4	Hermsen	Hermsen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	5	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	937	7	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	8	Rooijen	Rooijen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	9	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	937	11	Hartung	Hartung	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	12	HP	HP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	937	14	Jander	Jander	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	15	S.	S.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	16	Secondary	secondary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	937	17	intracerebral	intracerebral	NN
work_vvlzsj54cvf5de6ji6py6krqlm	937	18	hemorrhage	hemorrhage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	937	19	due	due	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	937	20	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	937	21	early	early	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	937	22	initiation	initiation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	937	23	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	937	24	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	937	25	anticoagula-	anticoagula-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	937	26	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	937	27	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	937	28	ischemic	ischemic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	937	29	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	937	30	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	937	31	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	937	32	experimental	experimental	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	937	33	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	937	34	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	937	35	mice	mouse	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	937	36	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	938	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	938	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	939	1	2012;43:3352–3357	2012;43:3352–3357	CD
work_vvlzsj54cvf5de6ji6py6krqlm	939	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	940	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	940	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	940	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	940	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	940	5	STROKEAHA.112.666818	STROKEAHA.112.666818	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	940	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	941	1	97	97	CD
work_vvlzsj54cvf5de6ji6py6krqlm	941	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	942	1	Connolly	Connolly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	2	SJ	SJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	4	Eikelboom	Eikelboom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	5	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	7	Joyner	Joyner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	8	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	10	Diener	Diener	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	11	HC	HC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	13	Hart	Hart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	14	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	16	Golitsyn	Golitsyn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	17	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	19	Flaker	Flaker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	20	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	22	Avezum	Avezum	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	23	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	25	Hohnloser	Hohnloser	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	26	SH	SH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	28	Diaz	Diaz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	29	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	31	Talajic	Talajic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	32	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	34	Zhu	Zhu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	35	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	37	Pais	Pais	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	38	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	40	Budaj	Budaj	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	41	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	43	Parkhomenko	Parkhomenko	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	44	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	46	Jansky	Jansky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	47	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	49	Commerford	Commerford	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	50	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	52	Tan	Tan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	53	RS	RS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	55	Sim	Sim	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	56	KH	KH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	57	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	58	Lewis	Lewis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	59	BS	BS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	60	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	61	Van	Van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	62	Mieghem	Mieghem	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	63	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	65	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	66	GY	GY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	67	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	68	Kim	Kim	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	69	JH	JH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	70	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	71	Lanas-	Lanas-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	72	Zanetti	Zanetti	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	73	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	74	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	75	Gonzalez	Gonzalez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	76	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	942	77	Hermosillo	Hermosillo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	78	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	79	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	80	Dans	Dans	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	942	81	AL	AL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	82	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	83	Munawar	Munawar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	84	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	85	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	86	O’Donnell	O’Donnell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	87	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	88	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	89	Lawrence	Lawrence	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	90	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	91	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	92	Lewis	Lewis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	93	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	94	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	95	Afzal	Afzal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	96	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	97	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	942	98	Yusuf	Yusuf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	99	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	100	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	942	101	AVERROES	AVERROES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	102	Steering	Steering	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	103	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	942	104	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	942	105	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	942	106	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	943	1	Apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	943	2	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	943	3	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	943	4	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	943	5	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	943	6	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	943	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	944	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	944	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	944	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	944	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	944	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	945	1	2011;364:806–817	2011;364:806–817	CD
work_vvlzsj54cvf5de6ji6py6krqlm	945	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	946	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	946	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	946	3	10.1056/	10.1056/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	946	4	NEJMoa1007432	nejmoa1007432	NN
work_vvlzsj54cvf5de6ji6py6krqlm	946	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	947	1	98	98	CD
work_vvlzsj54cvf5de6ji6py6krqlm	947	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	948	1	Lansberg	Lansberg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	2	MG	MG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	4	O’Donnell	O’Donnell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	5	MJ	MJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	7	Khatri	Khatri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	8	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	10	Lang	Lang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	11	ES	ES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	13	Nguyen	Nguyen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	14	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	948	15	Huynh	Huynh	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	16	MN	MN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	18	Schwartz	Schwartz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	19	NE	NE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	21	Sonnenberg	Sonnenberg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	22	FA	FA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	24	Schulman	Schulman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	25	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	27	Vandvik	Vandvik	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	28	PO	PO	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	30	Spencer	Spencer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	31	FA	FA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	33	Alonso	Alonso	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	34	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	948	35	Coello	Coello	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	36	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	38	Guyatt	Guyatt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	39	GH	GH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	948	41	Akl	Akl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	42	EA	EA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	948	43	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	949	1	Antithrombotic	antithrombotic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	949	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	949	3	thrombolytic	thrombolytic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	949	4	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	949	5	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	949	6	ischemic	ischemic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	949	7	stroke	stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	949	8	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	949	9	antithrombotic	antithrombotic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	949	10	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	949	11	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	949	12	prevention	prevention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	949	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	949	14	thrombosis	thrombosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	949	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	949	16	9th	9th	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	949	17	ed	ed	NN
work_vvlzsj54cvf5de6ji6py6krqlm	949	18	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	949	19	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	949	20	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	949	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	949	22	Chest	Chest	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	949	23	Physicians	Physicians	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	949	24	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	949	25	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	949	26	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	949	27	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	949	28	practice	practice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	949	29	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	949	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	950	1	Chest	chest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	950	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	951	1	2012;141	2012;141	LS
work_vvlzsj54cvf5de6ji6py6krqlm	951	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	951	3	e601S–636S.	e601s–636s.	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	952	1	99	99	CD
work_vvlzsj54cvf5de6ji6py6krqlm	952	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	953	1	Heidbuchel	Heidbuchel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	2	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	953	4	Verhamme	Verhamme	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	5	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	953	7	Alings	Alings	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	8	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	953	10	Antz	Antz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	953	13	Hacke	Hacke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	14	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	953	16	Oldgren	Oldgren	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	17	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	953	19	Sinnaeve	Sinnaeve	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	20	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	953	22	Camm	Camm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	23	AJ	AJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	953	25	Kirchhof	Kirchhof	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	26	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	27	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	953	28	European	European	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	29	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	30	Rhythm	Rhythm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	31	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	953	32	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	954	1	European	European	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	954	2	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	954	3	Rhythm	Rhythm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	954	4	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	954	5	Practical	Practical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	954	6	Guide	Guide	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	954	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	954	8	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	954	9	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	954	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	954	11	new	new	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	954	12	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	954	13	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	954	14	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	954	15	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	954	16	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	954	17	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	954	18	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	954	19	valvular	valvular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	954	20	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	954	21	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	954	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	955	1	Europace	Europace	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	955	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	956	1	2013;15:625–651	2013;15:625–651	LS
work_vvlzsj54cvf5de6ji6py6krqlm	956	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	957	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	957	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	957	3	10.1093/	10.1093/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	957	4	europace	europace	NN
work_vvlzsj54cvf5de6ji6py6krqlm	957	5	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	957	6	eut083	eut083	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	957	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	958	1	100	100	CD
work_vvlzsj54cvf5de6ji6py6krqlm	958	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	959	1	Kernan	Kernan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	2	WN	WN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	4	Ovbiagele	Ovbiagele	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	5	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	7	Black	black	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	959	8	HR	hr	NN
work_vvlzsj54cvf5de6ji6py6krqlm	959	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	10	Bravata	Bravata	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	11	DM	DM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	13	Chimowitz	Chimowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	14	MI	MI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	16	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	17	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	19	Fang	Fang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	20	MC	MC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	22	Fisher	Fisher	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	23	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	25	Furie	Furie	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	26	KL	KL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	28	Heck	Heck	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	29	DV	DV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	31	Johnston	Johnston	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	32	SC	SC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	34	Kasner	Kasner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	35	SE	SE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	37	Kittner	Kittner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	38	SJ	SJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	40	Mitchell	Mitchell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	41	PH	PH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	43	Rich	Rich	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	44	MW	MW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	46	Richardson	Richardson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	47	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	49	Schwamm	Schwamm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	50	LH	LH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	52	Wilson	Wilson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	53	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	54	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	959	55	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	959	56	behalf	behalf	NN
work_vvlzsj54cvf5de6ji6py6krqlm	959	57	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	959	58	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	959	59	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	60	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	61	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	62	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	63	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	65	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	66	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	959	67	Cardiovascular	Cardiovascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	68	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	959	69	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	70	Nursing	Nursing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	71	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	72	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	73	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	959	74	Clinical	Clinical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	75	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	76	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	959	77	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	959	78	Council	Council	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	79	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	959	80	Peripheral	Peripheral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	81	Vascular	Vascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	82	Disease	Disease	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	959	83	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	960	1	Guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	960	2	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	960	3	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	960	4	prevention	prevention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	960	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	960	6	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	960	7	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	960	8	pa-	pa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	960	9	tients	tient	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	960	10	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	960	11	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	960	12	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	960	13	transient	transient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	960	14	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	960	15	attack	attack	NN
work_vvlzsj54cvf5de6ji6py6krqlm	960	16	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	960	17	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	960	18	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	960	19	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	960	20	healthcare	healthcare	NN
work_vvlzsj54cvf5de6ji6py6krqlm	960	21	professionals	professional	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	960	22	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	960	23	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	960	24	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	960	25	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	960	26	Association/	association/	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	960	27	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	960	28	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	960	29	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	960	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	961	1	Stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	961	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	962	1	2014;45:2160–2236	2014;45:2160–2236	CD
work_vvlzsj54cvf5de6ji6py6krqlm	962	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	963	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	963	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	963	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	963	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	963	5	STR.0000000000000024	STR.0000000000000024	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	963	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	964	1	101	101	CD
work_vvlzsj54cvf5de6ji6py6krqlm	964	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	965	1	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	965	2	GY	GY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	965	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	966	1	Assessing	assess	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	966	2	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	966	3	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	966	4	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	966	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	966	6	HAS	HAS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	966	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	966	8	BLED	BLED	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	966	9	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	966	10	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	966	11	balancing	balance	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	966	12	simplicity	simplicity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	966	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	966	14	practicality	practicality	NN
work_vvlzsj54cvf5de6ji6py6krqlm	966	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	966	16	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	966	17	predictive	predictive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	966	18	value	value	NN
work_vvlzsj54cvf5de6ji6py6krqlm	966	19	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	966	20	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	966	21	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	966	22	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	966	23	assess-	assess-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	966	24	ment	ment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	966	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	967	1	Clin	Clin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	967	2	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	967	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	968	1	2015;38:562–564	2015;38:562–564	CD
work_vvlzsj54cvf5de6ji6py6krqlm	968	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	969	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	969	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	969	3	10.1002	10.1002	CD
work_vvlzsj54cvf5de6ji6py6krqlm	969	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	969	5	clc.22436	clc.22436	FW
work_vvlzsj54cvf5de6ji6py6krqlm	969	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	970	1	102	102	CD
work_vvlzsj54cvf5de6ji6py6krqlm	970	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	971	1	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	971	2	GY	GY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	971	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	971	4	Lane	Lane	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	971	5	DA	DA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	971	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	972	1	Assessing	assess	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	972	2	eligibility	eligibility	NN
work_vvlzsj54cvf5de6ji6py6krqlm	972	3	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	972	4	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	972	5	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	972	6	diagnosis	diagnosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	972	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	972	8	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	972	9	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	972	10	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	972	11	reply	reply	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	972	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	973	1	JAMA	JAMA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	973	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	974	1	2015;314:949–950	2015;314:949–950	CD
work_vvlzsj54cvf5de6ji6py6krqlm	974	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	975	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	975	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	975	3	10.1001	10.1001	CD
work_vvlzsj54cvf5de6ji6py6krqlm	975	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	975	5	jama.2015.8995	jama.2015.8995	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	975	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	976	1	103	103	CD
work_vvlzsj54cvf5de6ji6py6krqlm	976	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	977	1	Healey	Healey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	2	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	4	Eikelboom	Eikelboom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	5	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	7	Douketis	Douketis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	8	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	10	Wallentin	Wallentin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	11	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	13	Oldgren	Oldgren	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	14	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	16	Yang	Yang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	17	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	19	Themeles	Themeles	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	20	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	22	Heidbuchel	Heidbuchel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	23	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	25	Heidbuchle	Heidbuchle	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	26	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	28	Avezum	Avezum	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	29	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	31	Reilly	Reilly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	32	P	p	NN
work_vvlzsj54cvf5de6ji6py6krqlm	977	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	34	Connolly	Connolly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	35	SJ	SJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	37	Yusuf	Yusuf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	38	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	977	40	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	41	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	42	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	977	43	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	44	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	977	45	LY	LY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	977	46	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	977	47	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	978	1	Periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	978	2	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	978	3	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	978	4	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	978	5	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	978	6	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	978	7	dabi-	dabi-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	978	8	gatran	gatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	978	9	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	978	10	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	978	11	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	978	12	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	978	13	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	978	14	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	978	15	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	978	16	Randomized	Randomized	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	978	17	Evaluation	Evaluation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	978	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	978	19	Long	Long	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	978	20	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	978	21	Term	Term	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	978	22	Anticoagulation	Anticoagulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	978	23	Therapy	Therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	978	24	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	978	25	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	978	26	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	978	27	LY	LY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	978	28	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	978	29	ran-	ran-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	978	30	domized	domize	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	978	31	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	978	32	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	979	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	979	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	980	1	2012;126:343–348	2012;126:343–348	CD
work_vvlzsj54cvf5de6ji6py6krqlm	980	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	981	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	981	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	981	3	10.1161/	10.1161/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	981	4	CIRCULATIONAHA.111.090464	CIRCULATIONAHA.111.090464	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	981	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	982	1	104	104	CD
work_vvlzsj54cvf5de6ji6py6krqlm	982	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	983	1	Sherwood	Sherwood	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	2	MW	MW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	4	Douketis	Douketis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	5	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	7	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	8	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	10	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	11	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	13	Hellkamp	Hellkamp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	14	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	16	Lokhnygina	Lokhnygina	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	17	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	19	Spyropoulos	Spyropoulos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	20	AC	AC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	22	Hankey	Hankey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	23	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	25	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	26	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	28	Nessel	Nessel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	29	CC	CC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	31	Mahaffey	Mahaffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	32	KW	KW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	34	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	35	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	37	Califf	Califf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	38	RM	RM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	983	40	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	41	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	42	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	983	43	ROCKET	rocket	VB
work_vvlzsj54cvf5de6ji6py6krqlm	983	44	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	983	45	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	983	46	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	984	1	Outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	984	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	984	3	temporary	temporary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	984	4	interruption	interruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	984	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	984	6	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	984	7	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	984	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	984	9	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	984	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	984	11	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	984	12	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	984	13	nonvalvular	nonvalvular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	984	14	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	984	15	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	984	16	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	984	17	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	984	18	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	984	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	984	20	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	21	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	984	22	Once	once	RB
work_vvlzsj54cvf5de6ji6py6krqlm	984	23	Daily	Daily	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	984	25	Oral	Oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	984	27	Direct	Direct	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	28	Factor	Factor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	29	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	30	Inhibition	Inhibition	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	31	Compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	984	32	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	984	33	Vitamin	Vitamin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	34	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	35	Antagonism	Antagonism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	36	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	984	37	Prevention	Prevention	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	38	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	984	39	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	40	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	984	41	Embolism	Embolism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	42	Trial	Trial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	43	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	984	44	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	45	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	46	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	984	47	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	48	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	984	49	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	984	50	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	985	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	985	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	986	1	2014;129:1850	2014;129:1850	CD
work_vvlzsj54cvf5de6ji6py6krqlm	986	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	986	3	1859	1859	CD
work_vvlzsj54cvf5de6ji6py6krqlm	986	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	986	5	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	986	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	986	7	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	986	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	986	9	CIRCULATIONAHA.113.005754	CIRCULATIONAHA.113.005754	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	986	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	987	1	105	105	CD
work_vvlzsj54cvf5de6ji6py6krqlm	987	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	988	1	Garcia	Garcia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	2	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	4	Alexander	Alexander	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	5	JH	JH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	7	Wallentin	Wallentin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	8	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	10	Wojdyla	Wojdyla	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	11	DM	DM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	13	Thomas	Thomas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	14	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	16	Hanna	Hanna	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	17	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	19	Al	Al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	20	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	988	21	Khatib	Khatib	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	22	SM	SM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	24	Dorian	Dorian	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	25	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	27	Ansell	Ansell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	28	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	30	Commerford	Commerford	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	31	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	33	Flaker	Flaker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	34	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	36	Lanas	Lanas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	37	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	39	Vinereanu	Vinereanu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	40	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	42	Xavier	Xavier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	43	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	45	Hylek	Hylek	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	46	EM	EM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	48	Held	Held	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	49	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	51	Verheugt	Verheugt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	52	FW	FW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	54	Granger	Granger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	55	CB	CB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	988	57	Lopes	Lopes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	58	RD	RD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	988	59	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	989	1	Management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	989	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	989	3	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	989	4	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	989	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	989	6	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	989	7	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	989	8	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	989	9	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	989	10	vs	vs	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	989	11	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	989	12	undergo-	undergo-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	989	13	ing	ing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	989	14	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	989	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	990	1	Blood	blood	NN
work_vvlzsj54cvf5de6ji6py6krqlm	990	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	991	1	2014;124:3692–3698	2014;124:3692–3698	CD
work_vvlzsj54cvf5de6ji6py6krqlm	991	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	992	1	doi	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	992	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	992	3	10.1182/	10.1182/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	992	4	blood-2014	blood-2014	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	992	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	992	6	08	08	CD
work_vvlzsj54cvf5de6ji6py6krqlm	992	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	992	8	595496	595496	CD
work_vvlzsj54cvf5de6ji6py6krqlm	992	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	993	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	993	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	993	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	993	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	993	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	993	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	993	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	993	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	993	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	993	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	993	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	993	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	993	13	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	993	14	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	993	15	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	993	16	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	993	17	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	993	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	993	19	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	993	20	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	993	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	994	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	994	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	994	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	994	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	995	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	995	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	995	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	995	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	995	5	CIR.0000000000000477e630	CIR.0000000000000477e630	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	995	6	106	106	CD
work_vvlzsj54cvf5de6ji6py6krqlm	995	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	996	1	Caldeira	caldeira	NN
work_vvlzsj54cvf5de6ji6py6krqlm	996	2	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	996	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	996	4	Costa	Costa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	996	5	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	996	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	996	7	Ferreira	Ferreira	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	996	8	JJ	JJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	996	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	996	10	Pinto	Pinto	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	996	11	FJ	FJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	996	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	997	1	Thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	997	2	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	997	3	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	997	4	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	997	5	initiation	initiation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	997	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	997	7	switch	switch	NN
work_vvlzsj54cvf5de6ji6py6krqlm	997	8	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	997	9	interruption	interruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	997	10	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	997	11	re	re	NN
work_vvlzsj54cvf5de6ji6py6krqlm	997	12	-	-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	997	13	initiation	initiation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	997	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	997	15	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	997	16	anti-	anti-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	997	17	coagulants	coagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	997	18	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	997	19	do	do	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	997	20	newcomers	newcomer	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	997	21	improve	improve	VB
work_vvlzsj54cvf5de6ji6py6krqlm	997	22	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	997	23	?	?	.
work_vvlzsj54cvf5de6ji6py6krqlm	998	1	Insights	insight	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	998	2	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	998	3	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	998	4	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	998	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	998	6	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	998	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	998	8	RCTs	RCTs	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	998	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	999	1	Int	Int	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	999	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	999	3	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	999	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1000	1	2014;177:117–119	2014;177:117–119	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1000	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1001	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1001	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1001	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1001	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1001	5	j.ijcard.2014.09.099	j.ijcard.2014.09.099	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1001	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1002	1	107	107	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1002	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1003	1	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	2	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	4	Hellkamp	Hellkamp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	5	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	7	Lokhnygina	Lokhnygina	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	8	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	10	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	11	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	13	Zhang	Zhang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	14	Z	Z	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	16	Mohanty	Mohanty	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	17	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	19	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	20	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	22	Hacke	Hacke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	23	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	25	Breithardt	Breithardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	26	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	28	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	29	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	31	Hankey	Hankey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	32	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	34	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	35	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	37	Nessel	Nessel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	38	CC	CC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	40	Berkowitz	Berkowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	41	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	43	Califf	Califf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	44	RM	RM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	46	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	47	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1003	49	Mahaffey	Mahaffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	50	KW	KW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1003	51	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1004	1	Outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1004	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	3	discontinuing	discontinue	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1004	4	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	5	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	6	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	7	warfa-	warfa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1004	8	rin	rin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	10	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1004	11	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	12	nonvalvular	nonvalvular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1004	13	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1004	14	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	15	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1004	16	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	17	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	18	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1004	19	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	20	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	21	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	22	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1004	23	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	24	Once	Once	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	25	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1004	26	Daily	Daily	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1004	28	Oral	Oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1004	30	Direct	Direct	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	31	Factor	Factor	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	32	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	33	Inhibition	Inhibition	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	34	Compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	35	With	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	36	Vitamin	Vitamin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	37	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	38	Antagonism	Antagonism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	39	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	40	Prevention	Prevention	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	41	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	42	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	43	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1004	44	Embolism	Embolism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	45	Trial	Trial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	46	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1004	47	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	48	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1004	49	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1004	50	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1005	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1005	2	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1005	3	Coll	Coll	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1005	4	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1005	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1006	1	2013;61:651–658	2013;61:651–658	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1006	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1007	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1007	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1007	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1007	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1007	5	j.jacc.2012.09.057	j.jacc.2012.09.057	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1007	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1008	1	108	108	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1008	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1009	1	Mahaffey	Mahaffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	2	KW	KW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	4	Hellkamp	Hellkamp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	5	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	7	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	8	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	10	Hannan	Hannan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	11	KL	KL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	13	Schwabe	Schwabe	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	14	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	16	Nessel	Nessel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	17	CC	CC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	19	Berkowitz	Berkowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	20	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	22	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	23	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	25	Hankey	Hankey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	26	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	28	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	29	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	31	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	32	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	34	Breithardt	Breithardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	35	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	37	Hacke	Hacke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	38	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	40	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	41	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	43	Califf	Califf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	44	RM	RM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1009	46	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	47	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1009	48	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1010	1	End	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1010	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	4	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1010	5	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	6	transition	transition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	7	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	8	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	9	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	10	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	1010	11	open	open	VB
work_vvlzsj54cvf5de6ji6py6krqlm	1010	12	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1010	13	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	14	vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	15	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	16	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	17	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	18	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1010	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1010	20	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1010	21	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1010	22	experience	experience	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1010	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1011	1	Circ	Circ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1011	2	Cardiovasc	Cardiovasc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1011	3	Qual	Qual	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1011	4	Outcomes	Outcomes	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1011	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1012	1	2013;6:470–478	2013;6:470–478	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1012	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1013	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1013	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1013	3	10.1161/	10.1161/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1013	4	CIRCOUTCOMES.113.000132	circoutcomes.113.000132	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1013	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1014	1	109	109	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1014	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1015	1	Granger	grang	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	1015	2	CB	CB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	4	Lopes	Lopes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	5	RD	RD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	7	Hanna	Hanna	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	8	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	10	Ansell	Ansell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	11	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	13	Hylek	Hylek	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	14	EM	EM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	16	Alexander	Alexander	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	17	JH	JH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	19	Thomas	Thomas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	20	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	22	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	23	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	25	Bahit	Bahit	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	26	MC	MC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	28	Verheugt	Verheugt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	29	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	31	Lawrence	Lawrence	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	32	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	34	Xavier	Xavier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	35	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1015	37	Wallentin	Wallentin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	38	L.	L.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	39	Clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1015	40	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1015	41	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1015	42	transitioning	transition	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1015	43	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1015	44	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	45	versus	versus	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	46	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1015	47	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	1015	48	warfarin	warfarin	VB
work_vvlzsj54cvf5de6ji6py6krqlm	1015	49	at	at	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1015	50	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1015	51	end	end	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1015	52	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1015	53	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1015	54	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	55	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1015	56	Reduction	Reduction	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	57	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1015	58	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	59	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1015	60	Other	Other	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	61	Thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1015	62	Events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1015	63	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1015	64	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	65	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	66	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1015	67	ARISTOTLE	ARISTOTLE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1015	68	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1015	69	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1015	70	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1016	1	Am	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	1016	2	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1016	3	J.	J.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1017	1	2015;169:25	2015;169:25	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1017	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1017	3	30	30	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1017	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1017	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1017	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1017	7	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1017	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1017	9	j.ahj.2014.09.006	j.ahj.2014.09.006	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1017	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1018	1	110	110	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1018	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1019	1	Ruff	ruff	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1019	2	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1019	4	Giugliano	Giugliano	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	5	RP	RP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1019	7	Braunwald	Braunwald	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	8	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1019	10	Mercuri	Mercuri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1019	13	Curt	Curt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	14	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1019	16	Betcher	Betcher	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	17	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1019	19	Grip	Grip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	20	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1019	22	Cange	Cange	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	23	AL	AL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1019	25	Crompton	Crompton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	26	AE	AE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1019	28	Murphy	Murphy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	29	SA	SA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1019	31	Deenadayalu	Deenadayalu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	32	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1019	34	Antman	Antman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	35	EM	EM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1019	36	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1020	1	Transition	transition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1020	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1020	3	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1020	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1020	5	blinded	blinded	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1020	6	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1020	7	drug	drug	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1020	8	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	1020	9	open	open	VB
work_vvlzsj54cvf5de6ji6py6krqlm	1020	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1020	11	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1020	12	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1020	13	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1020	14	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1020	15	ENGAGE	ENGAGE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1020	16	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1020	17	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1020	18	TIMI	TIMI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1020	19	48	48	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1020	20	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1020	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1021	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1021	2	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1021	3	Coll	Coll	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1021	4	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1021	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1022	1	2014;64:576–584	2014;64:576–584	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1022	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1023	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1023	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1023	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1023	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1023	5	j.jacc.2014.05.028	j.jacc.2014.05.028	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1023	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1024	1	110a	110a	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1024	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1025	1	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	2	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	4	Garg	Garg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	5	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	7	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	8	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	10	Lokhnygina	Lokhnygina	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	11	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	13	Goodman	Goodman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	14	SG	SG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	16	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	17	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	19	Berkowitz	Berkowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	20	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	22	Breithardt	Breithardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	23	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	25	Hacke	Hacke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	26	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	28	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	29	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	31	Hankey	Hankey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	32	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	34	Nessel	Nessel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	35	CC	CC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	37	Mahaffey	Mahaffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	38	KW	KW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	40	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	41	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	43	Califf	Califf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	44	RM	RM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1025	46	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	47	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	48	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1025	49	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	50	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1025	51	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1025	52	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1026	1	Management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1026	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1026	3	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1026	4	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1026	5	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1026	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1026	7	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1026	8	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1026	9	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1026	10	rivaroxaban	rivaroxaban	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	1026	11	vs.	vs.	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1026	12	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1026	13	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1026	14	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1026	15	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1026	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1026	17	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1026	18	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1026	19	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1026	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1027	1	Eur	Eur	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1027	2	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1027	3	J.	j.	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1028	1	2014;35:1873–1880	2014;35:1873–1880	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1028	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1029	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1029	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1029	3	10.1093	10.1093	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1029	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1029	5	eurheartj	eurheartj	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1029	6	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1029	7	ehu083	ehu083	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1029	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1030	1	111	111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1030	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1031	1	Beyer	Beyer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1031	3	Westendorf	Westendorf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	4	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	5	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	6	Gelbricht	Gelbricht	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	7	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	9	Förster	Förster	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	10	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	12	Ebertz	Ebertz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	13	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	15	Röllig	Röllig	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	16	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	18	Schreier	Schreier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	19	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	21	Tittl	Tittl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	22	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	24	Thieme	Thieme	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	25	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	27	Hänsel	Hänsel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	28	U	U	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	30	Köhler	Köhler	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	31	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	33	Werth	Werth	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	34	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	36	Kuhlisch	Kuhlisch	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	37	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	39	Stange	Stange	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	40	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	42	Röder	Röder	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	43	I	I	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1031	45	Weiss	Weiss	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	46	N.	N.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	47	Safety	Safety	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	48	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1031	49	switching	switch	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1031	50	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1031	51	vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1031	52	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	53	antagonists	antagonist	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1031	54	to	to	TO
work_vvlzsj54cvf5de6ji6py6krqlm	1031	55	dabigatran	dabigatran	VB
work_vvlzsj54cvf5de6ji6py6krqlm	1031	56	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1031	57	rivaroxaban	rivaroxaban	VB
work_vvlzsj54cvf5de6ji6py6krqlm	1031	58	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1031	59	daily	daily	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1031	60	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1031	61	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1031	62	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1031	63	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1031	64	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1031	65	Dresden	Dresden	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	66	NOAC	NOAC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1031	67	registry	registry	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1031	68	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1032	1	Br	br	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1032	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1032	3	Clin	Clin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1032	4	Pharmacol	Pharmacol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1032	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1033	1	2014;78:908–917	2014;78:908–917	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1033	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1034	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1034	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1034	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1034	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1034	5	bcp.12391	bcp.12391	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1034	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1035	1	112	112	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1035	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1036	1	Bouillon	Bouillon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	2	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1036	4	Bertrand	Bertrand	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1036	7	Maura	Maura	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	8	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1036	10	Blotière	Blotière	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	11	PO	PO	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1036	13	Ricordeau	Ricordeau	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	14	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1036	16	Zureik	Zureik	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	17	M.	M.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	18	Risk	Risk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	20	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1036	21	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1036	22	arterial	arterial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1036	23	thromboembolism	thromboembolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	24	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	25	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1036	26	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	27	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1036	28	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1036	29	valvular	valvular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1036	30	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1036	31	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	32	either	either	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1036	33	maintained	maintain	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	1036	34	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	35	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1036	36	vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	37	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	38	an-	an-	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1036	39	tagonist	tagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	40	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1036	41	switched	switch	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	1036	42	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	43	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1036	44	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1036	45	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1036	46	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1036	47	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	48	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1036	49	antagonist	antagonist	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	50	oral	oral	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	51	anticoagu-	anticoagu-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	52	lant	lant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1036	53	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1036	54	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1036	55	retrospective	retrospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1036	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1036	57	matched	match	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	58	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1036	59	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	60	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1036	61	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1037	1	Lancet	Lancet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1037	2	Haematol	Haematol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1037	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1038	1	2015;2	2015;2	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1038	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1038	3	e150–e159	e150–e159	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1038	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1039	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1039	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1039	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1039	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1039	5	S2352	S2352	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1039	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1039	7	3026(15)00027	3026(15)00027	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1039	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1039	9	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1039	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1040	1	113	113	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1040	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1041	1	Douketis	Douketis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	2	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1041	4	Berger	Berger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	5	PB	PB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1041	7	Dunn	Dunn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	8	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1041	10	Jaffer	Jaffer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	11	AK	AK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1041	13	Spyropoulos	Spyropoulos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	14	AC	AC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1041	16	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	17	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1041	19	Ansell	Ansell	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1041	20	J.	J.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1042	1	The	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1042	2	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1042	3	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1042	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1042	5	anti-	anti-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1042	6	thrombotic	thrombotic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1042	7	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1042	8	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1042	9	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1042	10	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1042	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1042	12	Chest	Chest	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1042	13	Physicians	Physicians	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1042	14	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1042	15	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1042	16	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1042	17	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1042	18	practice	practice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1042	19	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1042	20	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1042	21	8th	8th	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1042	22	edition	edition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1042	23	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1042	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1043	1	Chest	chest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1043	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1044	1	2008;133:299S–339S.	2008;133:299s–339s.	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1045	1	114	114	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1045	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1046	1	Douketis	Douketis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	2	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1046	4	Spyropoulos	Spyropoulos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	5	AC	AC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1046	7	Spencer	Spencer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	8	FA	FA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1046	10	Mayr	Mayr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1046	13	Jaffer	Jaffer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	14	AK	AK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1046	16	Eckman	Eckman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	17	MH	MH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1046	19	Dunn	Dunn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	20	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1046	22	Kunz	Kunz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	23	R.	R.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	24	Perioperative	Perioperative	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	25	manage-	manage-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1046	26	ment	ment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	27	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	28	antithrombotic	antithrombotic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1046	29	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	30	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1046	31	antithrombotic	antithrombotic	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	32	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	33	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1046	34	prevention	prevention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	35	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	36	thrombosis	thrombosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1046	38	9th	9th	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1046	39	ed	ed	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	40	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1046	41	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	42	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	43	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	44	Chest	Chest	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	45	Physicians	Physicians	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1046	46	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	47	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1046	48	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	49	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1046	50	practice	practice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1046	51	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1046	52	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1047	1	Chest	chest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1047	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1048	1	2012;141	2012;141	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1048	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1048	3	e326S–350S	e326S–350S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1048	4	115	115	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1048	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1049	1	Gallego	Gallego	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1049	2	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1049	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1049	4	Apostolakis	Apostolakis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1049	5	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1049	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1049	7	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1049	8	GY	GY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1049	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1050	1	Bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1050	2	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1050	3	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1050	4	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1050	5	practice	practice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1050	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1050	7	practice	practice	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1050	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1050	9	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1050	10	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1050	11	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1050	12	periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1050	13	antico-	antico-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1050	14	agulation	agulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1050	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1051	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1051	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1052	1	2012;126:1573–1576	2012;126:1573–1576	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1052	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1053	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1053	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1053	3	10.1161/	10.1161/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1053	4	CIRCULATIONAHA.112.135681	circulationaha.112.135681	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1053	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1054	1	116	116	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1054	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1055	1	Douketis	Douketis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	2	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	4	Spyropoulos	Spyropoulos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	5	AC	AC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	7	Kaatz	Kaatz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	8	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	10	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	11	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	13	Caprini	Caprini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	14	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	16	Dunn	Dunn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	17	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	19	Garcia	Garcia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	20	DA	DA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	22	Jacobson	Jacobson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	23	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	25	Jaffer	Jaffer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	26	AK	AK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	28	Kong	Kong	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	29	DF	DF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	31	Schulman	Schulman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	32	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	34	Turpie	Turpie	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	35	AG	AG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	37	Hasselblad	Hasselblad	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	38	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1055	40	Ortel	Ortel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	41	TL	TL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	42	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1055	43	BRIDGE	BRIDGE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1055	44	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1055	45	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1056	1	Perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1056	2	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1056	3	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1056	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1056	5	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1056	6	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1056	7	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1056	8	fi-	fi-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1056	9	brillation	brillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1056	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1057	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1057	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1057	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1057	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1057	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1058	1	2015;373:823–833	2015;373:823–833	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1058	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1059	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1059	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1059	3	10.1056/	10.1056/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1059	4	NEJMoa1501035	nejmoa1501035	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1059	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1060	1	117	117	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1060	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1061	1	Schulman	Schulman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	2	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1061	4	Kearon	Kearon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	5	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	6	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1061	7	Subcommittee	Subcommittee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	8	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1061	9	Control	Control	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1061	11	Anticoagulation	Anticoagulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1061	13	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1061	14	Scientific	Scientific	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	15	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1061	16	Standardization	Standardization	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	17	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1061	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1061	20	International	International	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	21	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	22	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1061	23	Thrombosis	Thrombosis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	24	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1061	25	Haemostasis	Haemostasis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1061	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1062	1	Definition	definition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1062	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1062	3	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1062	4	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1062	5	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1062	6	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1062	7	investigations	investigation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1062	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1062	9	antihemostatic	antihemostatic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1062	10	medicinal	medicinal	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1062	11	products	product	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1062	12	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1062	13	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1062	14	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1062	15	surgical	surgical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1062	16	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1062	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1063	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1063	2	Thromb	Thromb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1063	3	Haemost	Haemost	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1063	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1064	1	2005;3:692–694	2005;3:692–694	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1064	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1065	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1065	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1065	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1065	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1065	5	j.1538	j.1538	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1065	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1065	7	7836.2005.01204.x	7836.2005.01204.x	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1065	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1066	1	118	118	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1066	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1067	1	Kralev	Kralev	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	2	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1067	4	Haag	Haag	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	5	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1067	7	Spannenberger	Spannenberger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	8	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1067	10	Lang	Lang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	11	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1067	13	Brockmann	Brockmann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	14	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1067	16	Bartling	Bartling	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	17	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1067	19	Marx	Marx	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	20	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1067	22	Haase	Haase	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	23	KK	KK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1067	25	Borggrefe	Borggrefe	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	26	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1067	28	Süselbeck	Süselbeck	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	29	T.	T.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	30	Expansion	Expansion	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	31	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1067	32	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1067	33	Multi	Multi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	34	-	-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	35	Link	Link	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	36	Frontier	Frontier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1067	37	™	™	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1067	38	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1067	39	bifurcation	bifurcation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1067	40	stent	stent	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1067	41	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1067	42	micro	micro	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1067	43	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1067	44	computed	compute	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1067	45	tomographic	tomographic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1067	46	assessment	assessment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1067	47	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1067	48	human	human	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1067	49	autopsy	autopsy	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1067	50	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1067	51	porcine	porcine	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1067	52	heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1067	53	samples	sample	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1067	54	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1068	1	PLoS	PLoS	:
work_vvlzsj54cvf5de6ji6py6krqlm	1068	2	One	one	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1068	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1069	1	2011;6	2011;6	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1069	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1069	3	e21778	e21778	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1069	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1070	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1070	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1070	3	10.1371	10.1371	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1070	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1070	5	journal.pone.0021778	journal.pone.0021778	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1070	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1071	1	119	119	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1071	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1072	1	Bashore	Bashore	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	2	TM	TM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	4	Balter	Balter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	5	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	7	Barac	Barac	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	8	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	10	Byrne	Byrne	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	11	JG	JG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	13	Cavendish	Cavendish	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	14	JJ	JJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	16	Chambers	Chambers	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	17	CE	CE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	19	Hermiller	Hermiller	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	20	JB	JB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	21	Jr	Jr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	23	Kinlay	Kinlay	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	24	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	26	Landzberg	Landzberg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	27	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	29	Laskey	Laskey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	30	WK	WK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	32	McKay	McKay	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	33	CR	CR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	35	Miller	Miller	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	36	JM	JM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	38	Moliterno	Moliterno	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	39	DJ	DJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	41	Moore	Moore	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	42	JW	JW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	44	Oliver	Oliver	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	45	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1072	46	McNeil	McNeil	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	47	SM	SM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	49	Popma	Popma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	50	JJ	JJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1072	52	Tommaso	Tommaso	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	53	CL	CL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	54	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1072	55	ACCF	ACCF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	56	Task	Task	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	57	Force	Force	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1072	58	Members	Members	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1072	59	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1073	1	2012	2012	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1073	2	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	3	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	5	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	6	Foundation	Foundation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	7	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1073	8	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	9	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	10	Cardiovascular	Cardiovascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	11	Angiography	Angiography	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	12	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1073	13	Interventions	Interventions	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1073	14	expert	expert	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	15	consensus	consensus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	16	document	document	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	17	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	18	cardiac	cardiac	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	19	catheterization	catheterization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	20	laboratory	laboratory	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	21	standards	standard	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1073	22	up-	up-	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1073	23	date	date	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	24	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1073	25	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1073	26	report	report	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	27	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	28	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1073	29	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	30	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	31	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	32	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	33	Foundation	Foundation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	34	Task	Task	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	35	Force	Force	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1073	36	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	37	expert	expert	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	38	consensus	consensus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1073	39	documents	document	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1073	40	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1074	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1074	2	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1074	3	Coll	Coll	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1074	4	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1074	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1075	1	2012;59:2221–2305	2012;59:2221–2305	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1075	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1076	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1076	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1076	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1076	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1076	5	j.jacc.2012.02.010	j.jacc.2012.02.010	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1076	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1077	1	120	120	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1077	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1078	1	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1078	2	GY	GY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1078	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1078	4	Nieuwlaat	Nieuwlaat	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1078	5	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1078	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1078	7	Pisters	Pisters	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1078	8	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1078	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1078	10	Lane	Lane	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1078	11	DA	DA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1078	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1078	13	Crijns	Crijns	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1078	14	HJ	HJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1078	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1079	1	Refining	refine	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1079	2	clini-	clini-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1079	3	cal	cal	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	4	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	5	stratification	stratification	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	6	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	7	predicting	predict	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1079	8	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	9	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1079	10	thromboembolism	thromboembolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	11	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	12	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1079	13	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	14	using	use	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1079	15	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1079	16	novel	novel	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1079	17	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	18	factor	factor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	19	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1079	20	based	base	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	21	approach	approach	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	22	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1079	23	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1079	24	Euro	Euro	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1079	25	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1079	26	Survey	Survey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1079	27	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	28	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1079	29	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1079	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1080	1	Chest	chest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1080	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1081	1	2010;137:263	2010;137:263	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1081	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1081	3	272	272	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1081	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1081	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1081	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1081	7	10.1378	10.1378	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1081	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1081	9	chest.09	chest.09	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1081	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1081	11	1584	1584	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1081	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1082	1	121	121	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1082	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1083	1	Cannon	Cannon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	2	CP	CP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1083	4	Weintraub	Weintraub	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	5	WS	WS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1083	7	Demopoulos	Demopoulos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	8	LA	LA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1083	10	Vicari	Vicari	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	11	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1083	13	Frey	Frey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	14	MJ	MJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1083	16	Lakkis	Lakkis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	17	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1083	19	Neumann	Neumann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	20	FJ	FJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1083	22	Robertson	Robertson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	23	DH	DH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1083	25	DeLucca	DeLucca	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	26	PT	PT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1083	28	DiBattiste	DiBattiste	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	29	PM	PM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1083	31	Gibson	Gibson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	32	CM	CM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1083	34	Braunwald	Braunwald	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	35	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	36	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1083	37	TACTICS	TACTICS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	38	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1083	39	Treat	Treat	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	40	Angina	Angina	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	41	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1083	42	Aggrastat	aggrastat	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1083	43	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1083	44	Determine	Determine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	45	Cost	cost	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1083	46	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1083	47	Therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1083	48	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1083	49	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1083	50	Invasive	Invasive	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	51	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1083	52	Conservative	conservative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1083	53	Strategy)–Thrombolysis	strategy)–thrombolysis	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1083	54	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1083	55	Myocardial	Myocardial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	56	Infarction	Infarction	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1083	57	18	18	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1083	58	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1083	59	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1084	1	Comparison	comparison	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1084	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1084	3	early	early	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1084	4	invasive	invasive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1084	5	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1084	6	conservative	conservative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1084	7	strategies	strategy	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1084	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1084	9	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1084	10	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1084	11	unstable	unstable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1084	12	coronary	coronary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1084	13	syndromes	syndrome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1084	14	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1084	15	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1084	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1084	17	glycoprotein	glycoprotein	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1084	18	IIb	IIb	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1084	19	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1084	20	IIIa	IIIa	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1084	21	inhibitor	inhibitor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1084	22	tirofiban	tirofiban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1084	23	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1085	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1085	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1085	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1085	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1085	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1086	1	2001;344:1879–1887	2001;344:1879–1887	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1086	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1087	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1087	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1087	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1087	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1087	5	NEJM200106213442501	nejm200106213442501	UH
work_vvlzsj54cvf5de6ji6py6krqlm	1087	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1088	1	122	122	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1088	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1089	1	O’Gara	O’Gara	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	2	PT	PT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	4	Kushner	Kushner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	5	FG	FG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	7	Ascheim	Ascheim	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	8	DD	DD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	10	Casey	Casey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	11	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	12	Jr	Jr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	14	Chung	Chung	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	15	MK	MK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	17	de	de	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	18	Lemos	Lemos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	19	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	21	Ettinger	Ettinger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	22	SM	SM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	24	Fang	Fang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	25	JC	JC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	27	Fesmire	Fesmire	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	28	FM	FM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	30	Franklin	Franklin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	31	BA	BA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	33	Granger	Granger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	34	CB	CB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	36	Krumholz	Krumholz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	37	HM	HM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	39	Linderbaum	Linderbaum	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	40	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	42	Morrow	Morrow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	43	DA	DA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	45	Newby	Newby	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	46	LK	LK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	48	Ornato	Ornato	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	49	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	51	Ou	Ou	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	52	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	54	Radford	Radford	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	55	MJ	MJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	57	Tamis	Tamis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	58	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1089	59	Holland	Holland	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	60	JE	JE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	61	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	62	Tommaso	Tommaso	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	63	CL	CL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	65	Tracy	Tracy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	66	CM	CM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	67	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	68	Woo	Woo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	69	YJ	YJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	70	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	71	Zhao	Zhao	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	72	DX	DX	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	73	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	74	Anderson	Anderson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	75	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	76	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	77	Jacobs	Jacobs	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	78	AK	AK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	79	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	80	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	81	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	82	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	83	Albert	Albert	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	84	NM	NM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	85	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	86	Brindis	Brindis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	87	RG	RG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	88	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	89	Creager	Creager	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	90	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	91	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	92	DeMets	DeMets	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	93	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1089	94	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	95	Guyton	Guyton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	96	RA	RA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	97	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	98	Hochman	Hochman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	99	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	100	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	101	Kovacs	Kovacs	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	102	RJ	RJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	103	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	104	Kushner	Kushner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	105	FG	FG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	106	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	107	Ohman	Ohman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	108	EM	EM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	109	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	110	Stevenson	Stevenson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	111	WG	WG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	112	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1089	113	Yancy	Yancy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	114	CW	CW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	115	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1089	116	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	117	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	118	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1089	119	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	120	Foundation	Foundation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	121	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1089	122	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	123	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	124	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	125	Task	Task	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	126	Force	Force	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	127	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1089	128	Practice	Practice	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1089	129	Guidelines	Guidelines	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1089	130	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1090	1	2013	2013	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1090	2	ACCF	ACCF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	3	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1090	4	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	5	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1090	6	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1090	7	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1090	8	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1090	9	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1090	10	ST	ST	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	11	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1090	12	elevation	elevation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1090	13	myocardial	myocardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1090	14	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1090	15	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1090	16	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1090	17	report	report	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1090	18	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1090	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1090	20	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	21	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	22	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1090	23	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	24	Foundation	Foundation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	25	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1090	26	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	27	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	28	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	29	Task	Task	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	30	Force	Force	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	31	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1090	32	Practice	Practice	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1090	33	Guidelines	Guidelines	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1090	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1091	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1091	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1092	1	2013;127	2013;127	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1092	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1092	3	e362–e425	e362–e425	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1092	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1093	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1093	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1093	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1093	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1093	5	CIR.0b013e3182742cf6	cir.0b013e3182742cf6	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1093	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1094	1	123	123	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1094	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1095	1	Jolly	Jolly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	2	SS	SS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	4	Yusuf	Yusuf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	5	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	7	Cairns	Cairns	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	8	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	10	Niemelä	Niemelä	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	11	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	13	Xavier	Xavier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	14	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	16	Widimsky	Widimsky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	17	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	19	Budaj	Budaj	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	20	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	22	Niemelä	Niemelä	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	23	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	25	Valentin	Valentin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	26	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	28	Lewis	Lewis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	29	BS	BS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	31	Avezum	Avezum	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	32	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	34	Steg	Steg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	35	PG	PG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	37	Rao	Rao	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	38	SV	SV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	40	Gao	Gao	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	41	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	43	Afzal	Afzal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	44	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	46	Joyner	Joyner	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	47	CD	CD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	49	Chrolavicius	Chrolavicius	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	50	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1095	52	Mehta	Mehta	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	53	SR	SR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	54	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1095	55	RIVAL	RIVAL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1095	56	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1095	57	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1095	58	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1096	1	Radial	radial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1096	2	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1096	3	femoral	femoral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1096	4	access	access	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1096	5	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1096	6	coro-	coro-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1096	7	nary	nary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1096	8	angiography	angiography	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1096	9	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1096	10	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1096	11	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1096	12	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1096	13	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1096	14	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1096	15	coronary	coronary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1096	16	syndromes	syndrome	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	1096	17	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1096	18	RIVAL	RIVAL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1096	19	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1096	20	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1096	21	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1096	22	randomised	randomised	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1096	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1096	24	parallel	parallel	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1096	25	group	group	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1096	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1096	27	multicentre	multicentre	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1096	28	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1096	29	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1097	1	Lancet	Lancet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1097	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1098	1	2011;377:1409–1420	2011;377:1409–1420	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1098	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1099	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1099	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1099	3	10.1016/	10.1016/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1099	4	S0140	S0140	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1099	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1099	6	6736(11)60404	6736(11)60404	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1099	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1099	8	2	2	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1099	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1100	1	124	124	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1100	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1101	1	Levine	Levine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	2	GN	GN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	4	Bates	Bates	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	5	ER	ER	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	7	Blankenship	Blankenship	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	8	JC	JC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	10	Bailey	Bailey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	11	SR	SR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	13	Bittl	Bittl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	14	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	16	Cercek	Cercek	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	17	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	19	Chambers	Chambers	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	20	CE	CE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	22	Ellis	Ellis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	23	SG	SG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	25	Guyton	Guyton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	26	RA	RA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	28	Hollenberg	Hollenberg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	29	SM	SM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	31	Khot	Khot	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	32	UN	UN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	34	Lange	Lange	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	35	RA	RA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	37	Mauri	Mauri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	38	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	40	Mehran	Mehran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	41	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	43	Moussa	Moussa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	44	ID	ID	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	46	Mukherjee	Mukherjee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	47	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	49	Nallamothu	Nallamothu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	50	BK	BK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1101	52	Ting	Ting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	53	HH	HH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1101	54	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1102	1	2011	2011	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1102	2	ACCF	ACCF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1102	3	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1102	4	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1102	5	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1102	6	SCAI	SCAI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1102	7	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1102	8	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1102	9	percutaneous	percutaneous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1102	10	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1102	11	ow	ow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1102	12	nloaded	nloade	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1102	13	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1102	14	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1102	15	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	1102	16	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1102	17	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1102	18	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1102	19	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1102	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1102	21	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1102	22	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1102	23	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1102	24	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1102	25	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1102	26	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1102	27	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1102	28	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1102	29	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1102	30	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1102	31	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1102	32	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1102	33	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1102	34	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1102	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1103	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1103	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1103	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1103	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1104	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1104	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1104	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1104	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1104	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1104	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1104	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1104	10	e631	e631	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1104	11	CLINICAL	clinical	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1104	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1104	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1104	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1104	15	GUIDELINES	GUIDELINES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	16	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1104	17	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1104	18	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1104	19	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1104	20	report	report	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1104	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1104	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1104	23	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	24	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	25	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1104	26	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	27	Foundation	Foundation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	28	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1104	29	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	30	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	31	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	32	Task	Task	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	33	Force	Force	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	34	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1104	35	Practice	Practice	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	36	Guidelines	Guidelines	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1104	37	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1104	38	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1104	39	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	40	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1104	41	Cardiovascular	Cardiovascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	42	Angiography	Angiography	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1104	43	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1104	44	Interventions	Interventions	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1104	45	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1105	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1105	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1106	1	2011;124	2011;124	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1106	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1106	3	e574	e574	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1106	4	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1106	5	e651	e651	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1106	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1107	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1107	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1107	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1107	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1107	5	CIR.0b013e31823ba622	cir.0b013e31823ba622	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1107	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1108	1	125	125	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1108	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1109	1	Gupta	Gupta	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1109	2	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1109	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1109	4	Cigarroa	Cigarroa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1109	5	JE	JE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1109	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1110	1	Bivalirudin	Bivalirudin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1110	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1110	3	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1110	4	expensive	expensive	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1110	5	heparin	heparin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1110	6	?	?	.
work_vvlzsj54cvf5de6ji6py6krqlm	1111	1	Catheter	Catheter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1111	2	Cardiovasc	Cardiovasc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1111	3	Interv	Interv	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1111	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1112	1	2015;86:397–399	2015;86:397–399	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1112	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1113	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1113	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1113	3	10.1002/	10.1002/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1113	4	ccd.26124	ccd.26124	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1113	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1114	1	126	126	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1114	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1115	1	Levine	Levine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	2	GN	GN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	4	Bates	Bates	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	5	ER	ER	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	7	Bittl	Bittl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	8	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	10	Brindis	Brindis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	11	RG	RG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	13	Fihn	Fihn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	14	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	16	Fleisher	Fleisher	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	17	LA	LA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	19	Granger	Granger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	20	CB	CB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	22	Lange	Lange	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	23	RA	RA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	25	Mack	Mack	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	26	MJ	MJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	28	Mauri	Mauri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	29	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	31	Mehran	Mehran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	32	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	34	Mukherjee	Mukherjee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	35	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	37	Newby	Newby	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	38	LK	LK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	40	O’Gara	O’Gara	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	41	PT	PT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	43	Sabatine	Sabatine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	44	MS	MS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	46	Smith	Smith	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	47	PK	PK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	49	Smith	Smith	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	50	SC	SC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	52	Jr.	Jr.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	53	2016	2016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1115	54	ACC	ACC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	55	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	56	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	57	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	58	focused	focus	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	1115	59	update	update	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	60	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	61	duration	duration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	62	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	63	dual	dual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	64	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	65	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	66	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	67	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1115	68	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	69	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	70	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	71	disease	disease	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	72	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1115	73	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1115	74	report	report	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	75	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	76	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1115	77	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	78	College	College	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	79	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	80	Cardiology	Cardiology	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	81	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	82	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	83	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	84	Association	Association	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	85	Task	Task	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	86	Force	Force	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	87	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	88	Clinical	Clinical	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	89	Practice	Practice	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	90	Guidelines	Guidelines	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1115	91	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1115	92	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1115	93	update	update	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	94	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	95	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1115	96	2011	2011	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1115	97	ACCF	ACCF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	98	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	99	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	100	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	101	SCAI	SCAI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	102	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	103	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	104	percutaneous	percutaneous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	105	coro-	coro-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	106	nary	nary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	107	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	108	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	109	2011	2011	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1115	110	ACCF	ACCF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	111	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	112	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	113	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	114	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	115	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	116	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	117	bypass	bypass	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	118	graft	graft	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	119	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	120	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	121	2012	2012	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1115	122	ACC	ACC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	123	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	124	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	125	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	126	ACP	ACP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	127	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	128	AATS	AATS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	129	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	130	PCNA	PCNA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	131	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	132	SCAI/	SCAI/	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	133	STS	STS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	134	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	135	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	136	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1115	137	diagnosis	diagnosis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	138	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1115	139	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	140	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	141	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1115	142	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	143	stable	stable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	144	ischemic	ischemic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	145	heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	146	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	147	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	148	2013	2013	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1115	149	ACCF	ACCF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	150	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	151	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	152	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	153	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	154	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1115	155	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	156	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	157	ST	ST	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	158	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1115	159	elevation	elevation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	160	myocardial	myocardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	161	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	162	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	163	2014	2014	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1115	164	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	165	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	166	ACC	ACC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	167	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	168	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	169	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1115	170	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	171	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	172	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1115	173	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	174	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	175	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1115	176	ST	ST	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	177	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1115	178	elevation	elevation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	179	acute	acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	180	coronary	coronary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	181	syndromes	syndrome	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	182	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1115	183	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1115	184	2014	2014	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1115	185	ACC	ACC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	186	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1115	187	AHA	AHA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1115	188	guideline	guideline	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	189	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	190	perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	191	cardiovascular	cardiovascular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1115	192	evaluation	evaluation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	193	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1115	194	man-	man-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	195	agement	agement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	196	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	197	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1115	198	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1115	199	noncardiac	noncardiac	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	200	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1115	201	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1116	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1116	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1117	1	2016;134:1–33	2016;134:1–33	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1117	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1118	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1118	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1118	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1118	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1118	5	CIR.0000000000000404	cir.0000000000000404	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1118	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1119	1	127	127	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1119	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1120	1	Oldgren	Oldgren	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1120	4	Budaj	Budaj	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	5	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1120	7	Granger	Granger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	8	CB	CB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1120	10	Khder	Khder	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	11	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1120	13	Roberts	Roberts	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	14	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1120	16	Siegbahn	Siegbahn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	17	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1120	19	Tijssen	Tijssen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	20	JG	JG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1120	22	Van	Van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	23	de	de	FW
work_vvlzsj54cvf5de6ji6py6krqlm	1120	24	Werf	Werf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	25	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1120	27	Wallentin	Wallentin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	28	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	29	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1120	30	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	31	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1120	32	DEEM	DEEM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1120	33	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1120	34	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1121	1	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1121	2	vs.	vs.	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1121	3	placebo	placebo	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1121	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1121	5	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1121	6	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1121	7	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1121	8	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1121	9	syn-	syn-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1121	10	dromes	drome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1121	11	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1121	12	dual	dual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1121	13	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1121	14	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1121	15	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1121	16	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1121	17	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1121	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1121	19	double	double	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1121	20	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1121	21	blind	blind	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1121	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1121	23	phase	phase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1121	24	II	II	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1121	25	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1121	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1122	1	Eur	Eur	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1122	2	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1122	3	J.	j.	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1123	1	2011;32:2781–2789	2011;32:2781–2789	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1123	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1124	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1124	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1124	3	10.1093/	10.1093/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1124	4	eurheartj	eurheartj	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1124	5	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1124	6	ehr113	ehr113	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1124	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1125	1	128	128	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1125	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1126	1	Alexander	Alexander	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	2	JH	JH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	4	Lopes	Lopes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	5	RD	RD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	7	James	James	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	8	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	10	Kilaru	Kilaru	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	11	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	13	He	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	14	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	16	Mohan	Mohan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	17	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	19	Bhatt	Bhatt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	20	DL	DL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	22	Goodman	Goodman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	23	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	25	Verheugt	Verheugt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	26	FW	FW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	28	Flather	Flather	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	29	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	31	Huber	Huber	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	32	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	34	Liaw	Liaw	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	35	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	37	Husted	Husted	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	38	SE	SE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	40	Lopez	Lopez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	41	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1126	42	Sendon	Sendon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	43	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	45	De	De	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	46	Caterina	Caterina	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	47	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	49	Jansky	Jansky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	50	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	51	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	52	Darius	Darius	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	53	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	55	Vinereanu	Vinereanu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	56	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	57	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	58	Cornel	Cornel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	59	JH	JH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	60	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	61	Cools	Cools	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	62	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	63	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	64	Atar	Atar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	65	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	66	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	67	Leiva	Leiva	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	68	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1126	69	Pons	Pons	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	70	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	71	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	72	Keltai	Keltai	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	73	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	74	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	75	Ogawa	Ogawa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	76	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	77	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	78	Pais	Pais	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	79	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	80	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	81	Parkhomenko	Parkhomenko	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	82	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	83	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	84	Ruzyllo	Ruzyllo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	85	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	86	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	87	Diaz	Diaz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	88	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	89	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	90	White	White	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	91	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	92	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	93	Ruda	Ruda	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	94	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	95	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	96	Geraldes	Geraldes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	97	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	98	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	99	Lawrence	Lawrence	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	100	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	101	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	102	Harrington	Harrington	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	103	RA	RA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	104	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1126	105	Wallentin	Wallentin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	106	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	107	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1126	108	APPRAISE-2	APPRAISE-2	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1126	109	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1126	110	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1127	1	Apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1127	2	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1127	3	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1127	4	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1127	5	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1127	6	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1127	7	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1127	8	syndrome	syndrome	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1127	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1128	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1128	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1128	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1128	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1128	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1129	1	2011;365:699	2011;365:699	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1129	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1129	3	708	708	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1129	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1129	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1129	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1129	7	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1129	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1129	9	NEJMoa1105819	nejmoa1105819	RB
work_vvlzsj54cvf5de6ji6py6krqlm	1129	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1130	1	129	129	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1130	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1131	1	Mega	Mega	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	2	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	4	Braunwald	Braunwald	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	5	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	7	Wiviott	Wiviott	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	8	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	10	Bassand	Bassand	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	11	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	13	Bhatt	Bhatt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	14	DL	DL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	16	Bode	Bode	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	17	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	19	Burton	Burton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	20	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	22	Cohen	Cohen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	23	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	25	Cook	Cook	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	26	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1131	27	Bruns	Bruns	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	28	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	30	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	31	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	33	Goto	Goto	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	34	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	36	Murphy	Murphy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	37	SA	SA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	39	Plotnikov	Plotnikov	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	40	AN	AN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	42	Schneider	schneider	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1131	43	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	45	Sun	Sun	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	46	X	X	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	48	Verheugt	Verheugt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	49	FW	FW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1131	51	Gibson	Gibson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	52	CM	CM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	53	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1131	54	ATLAS	ATLAS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	55	ACS	ACS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1131	56	2–TIMI	2–timi	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1131	57	51	51	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1131	58	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1131	59	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1132	1	Rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1132	2	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1132	3	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1132	4	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1132	5	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1132	6	recent	recent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1132	7	acute	acute	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1132	8	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1132	9	syndrome	syndrome	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1132	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1133	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1133	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1133	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1133	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1133	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1134	1	2012;366:9	2012;366:9	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1134	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1134	3	19	19	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1134	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1134	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1134	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1134	7	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1134	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1134	9	NEJMoa1112277	nejmoa1112277	UH
work_vvlzsj54cvf5de6ji6py6krqlm	1134	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1135	1	130	130	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1135	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1136	1	Sherwood	Sherwood	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	2	MW	MW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	4	Cyr	Cyr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	5	DD	DD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	7	Jones	Jones	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	8	WS	WS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	10	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	11	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	13	Berkowitz	Berkowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	14	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	16	Washam	Washam	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	17	JB	JB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	19	Breithardt	Breithardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	20	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	22	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	23	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	25	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	26	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	28	Hankey	Hankey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	29	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	31	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	32	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	34	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	35	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	37	Nessel	Nessel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	38	CC	CC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	40	Mahaffey	Mahaffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	41	KW	KW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1136	43	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	44	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	45	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1136	46	Use	Use	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	47	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1136	48	dual	dual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1136	49	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1136	50	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1136	51	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1136	52	patient	patient	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1136	53	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1136	54	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1136	55	those	those	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1136	56	undergo-	undergo-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1136	57	ing	ing	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1136	58	percutaneous	percutaneous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1136	59	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1136	60	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1136	61	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1136	62	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1136	63	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	64	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1136	65	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1136	66	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1137	1	JACC	JACC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1137	2	Cardiovasc	Cardiovasc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1137	3	Interv	Interv	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1137	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1138	1	2016;9:1694–1702	2016;9:1694–1702	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1138	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1139	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1139	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1139	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1139	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1139	5	j	j	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1139	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1140	1	jcin.2016.05.039	jcin.2016.05.039	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1140	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1141	1	131	131	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1141	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1142	1	Bhatt	Bhatt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	2	DL	DL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	4	Cryer	Cryer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	5	BL	BL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	7	Contant	Contant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	8	CF	CF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	10	Cohen	Cohen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	13	Lanas	Lanas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	14	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	16	Schnitzer	Schnitzer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	17	TJ	TJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	19	Shook	shake	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	1142	20	TL	TL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	22	Lapuerta	Lapuerta	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	23	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	25	Goldsmith	Goldsmith	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	26	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	28	Laine	Laine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	29	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	31	Scirica	Scirica	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	32	BM	BM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	34	Murphy	Murphy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	35	SA	SA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1142	37	Cannon	Cannon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	38	CP	CP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	39	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1142	40	COGENT	COGENT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1142	41	Investigators	investigator	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1142	42	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1143	1	Clopidogrel	clopidogrel	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1143	2	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1143	3	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1143	4	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1143	5	omeprazole	omeprazole	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1143	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1143	7	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1143	8	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1143	9	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1143	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1144	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1144	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1144	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1144	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1144	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1145	1	2010;363:1909–1917	2010;363:1909–1917	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1145	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1146	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1146	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1146	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1146	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1146	5	NEJMoa1007964	nejmoa1007964	UH
work_vvlzsj54cvf5de6ji6py6krqlm	1146	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1147	1	132	132	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1147	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1148	1	Gibson	Gibson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	2	CM	CM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	4	Mehran	Mehran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	5	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	7	Bode	Bode	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	8	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	10	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	11	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	13	Verheugt	Verheugt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	14	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	16	Wildgoose	Wildgoose	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	17	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	19	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	20	Eickels	Eickels	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	21	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	23	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	24	GY	GY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	26	Cohen	Cohen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	27	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	29	Husted	Husted	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	30	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	32	Peterson	Peterson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	33	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	35	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	36	K.	K.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	37	An	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1148	38	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1148	39	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1148	40	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	42	randomized	randomize	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	44	controlled	control	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1148	46	multicenter	multicenter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	47	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	48	explor-	explor-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	49	ing	ing	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	50	two	two	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1148	51	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	52	strategies	strategy	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1148	53	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	54	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	55	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1148	56	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1148	57	dose	dose	RB
work_vvlzsj54cvf5de6ji6py6krqlm	1148	58	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1148	59	adjusted	adjust	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	60	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1148	61	vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	62	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	63	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	64	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	65	strategy	strategy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	66	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	67	subjects	subject	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1148	68	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	69	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1148	70	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	71	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	72	undergo	undergo	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	73	percutaneous	percutaneous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1148	74	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1148	75	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1148	76	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1148	77	PIONEER	PIONEER	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	78	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	79	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1148	80	PCI	PCI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1148	81	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1148	82	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1149	1	Am	be	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	1149	2	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1149	3	J.	J.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1150	1	2015;169:472–478	2015;169:472–478	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1150	2	e475	e475	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1150	3	133	133	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1150	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1151	1	Gao	Gao	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	2	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1151	4	Shen	Shen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	5	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1151	7	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	8	ZJ	ZJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1151	10	Yang	Yang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	11	SW	SW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1151	13	Liu	Liu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	14	XL	XL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1151	16	Zhou	Zhou	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	17	YJ	YJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1151	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1152	1	Rationale	rationale	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1152	3	design	design	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1152	6	RT	RT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1152	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1152	8	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1152	9	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	10	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1152	11	combination	combination	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	13	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	14	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1152	15	ticagre-	ticagre-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	16	lor	lor	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	17	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	18	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1152	19	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	20	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1152	21	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1152	23	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1152	24	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	25	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	26	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1152	27	percutaneous	percutaneous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1152	28	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1152	29	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1152	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1153	1	Contemp	Contemp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1153	2	Clin	Clin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1153	3	Trials	Trials	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1153	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1154	1	2015;43:129–132	2015;43:129–132	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1154	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1155	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1155	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1155	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1155	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1155	5	j.cct.2015.05.012	j.cct.2015.05.012	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1155	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1156	1	134	134	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1156	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1157	1	Hoshi	Hoshi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1157	2	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1157	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1157	4	Sato	Sato	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1157	5	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1157	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1157	7	Nogami	Nogami	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1157	8	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1157	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1157	10	Gosho	Gosho	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1157	11	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1157	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1157	13	Aonuma	Aonuma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1157	14	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1157	15	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1157	16	SAFE	SAFE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1157	17	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1157	18	A	a	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1157	19	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1157	20	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1158	1	Rationale	rationale	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1158	3	design	design	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	5	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1158	6	SAFE	SAFE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1158	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1158	8	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1158	9	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	10	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1158	11	SAFety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	12	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1158	13	Effectiveness	Effectiveness	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1158	14	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	16	apixaban	apixaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1158	17	use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	19	association	association	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	20	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	21	dual	dual	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1158	22	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	23	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	24	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	25	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1158	26	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	27	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1158	28	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	29	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1158	30	percutaneous	percutaneous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1158	31	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1158	32	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	33	[	[	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1158	34	published	publish	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	35	on-	on-	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1158	36	line	line	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	37	ahead	ahead	RB
work_vvlzsj54cvf5de6ji6py6krqlm	1158	38	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	39	print	print	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1158	40	July	July	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1158	41	18	18	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1158	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1158	43	2016	2016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1158	44	]	]	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1158	45	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1159	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1159	2	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1159	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1160	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1160	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1160	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1160	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1160	5	j	j	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1160	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1161	1	jjcc.2016.06.007	jjcc.2016.06.007	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1161	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1162	1	http://www.sciencedirect.com/science/article/	http://www.sciencedirect.com/science/article/	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1162	2	pii	pii	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1162	3	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1162	4	S0914508716301344	s0914508716301344	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1162	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1163	1	Accessed	access	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1163	2	January	January	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1163	3	17	17	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1163	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1163	5	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1163	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1164	1	135	135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1164	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1165	1	Dewilde	Dewilde	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	2	WJ	WJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	4	Oirbans	Oirbans	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	5	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	7	Verheugt	Verheugt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	8	FW	FW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	10	Kelder	Kelder	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	11	JC	JC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	13	De	De	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	14	Smet	Smet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	15	BJ	BJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	17	Herrman	Herrman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	18	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	20	Adriaenssens	Adriaenssens	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	21	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	23	Vrolix	Vrolix	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	24	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	26	Heestermans	Heestermans	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	27	AA	AA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	29	Vis	Vis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	30	MM	MM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	32	Tijsen	Tijsen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	33	JG	JG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	35	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	36	‘	'	``
work_vvlzsj54cvf5de6ji6py6krqlm	1165	37	t	t	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	38	Hof	Hof	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	39	AW	AW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1165	41	ten	ten	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1165	42	Berg	Berg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	43	JM	JM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	44	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1165	45	WOEST	WOEST	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	46	Study	Study	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1165	47	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1165	48	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1166	1	Use	use	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	3	clopidogrel	clopidogrel	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	4	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	5	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1166	6	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	7	aspirin	aspirin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	9	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1166	10	taking	take	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1166	11	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1166	12	anticoagulant	anticoagulant	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	13	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	14	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1166	15	undergoing	undergoing	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1166	16	percutaneous	percutaneous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1166	17	coronary	coronary	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1166	18	intervention	intervention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	19	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1166	20	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1166	21	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1166	22	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1166	23	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1166	25	randomised	randomise	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1166	27	controlled	control	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	28	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1166	29	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1167	1	Lancet	Lancet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1167	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1168	1	2013;381:1107–1115	2013;381:1107–1115	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1168	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1169	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1169	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1169	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1169	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1169	5	S0140	S0140	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1169	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1169	7	6736(12)62177	6736(12)62177	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1169	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1169	9	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1169	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1170	1	136	136	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1170	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1171	1	Nagarakanti	Nagarakanti	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	2	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	4	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	5	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	7	Oldgren	Oldgren	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	8	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	10	Yang	Yang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	11	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	13	Chernick	Chernick	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	14	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	16	Aikens	Aikens	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1171	17	TH	TH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	19	Flaker	Flaker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	20	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	22	Brugada	Brugada	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	23	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	25	Kamensky	Kamensky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	26	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	28	Parekh	Parekh	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	29	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	31	Reilly	Reilly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	32	PA	PA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	34	Yusuf	Yusuf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	35	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1171	37	Connolly	Connolly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	38	SJ	SJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1171	39	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1172	1	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1172	2	versus	versus	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1172	3	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1172	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1172	5	pa-	pa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1172	6	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1172	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1172	8	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1172	9	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1172	10	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1172	11	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1172	12	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1172	13	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1172	14	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1172	15	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1172	16	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1172	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1173	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1173	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1174	1	2011;123:131–136	2011;123:131–136	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1174	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1175	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1175	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1175	3	10.1161/	10.1161/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1175	4	CIRCULATIONAHA.110.977546	CIRCULATIONAHA.110.977546	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1175	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1176	1	137	137	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1176	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1177	1	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	2	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	4	Stevens	Stevens	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	5	SR	SR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	7	Lokhnygina	Lokhnygina	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	8	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	10	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	11	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	13	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	14	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	16	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	17	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	19	Hankey	Hankey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	20	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	22	Hacke	Hacke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	23	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	25	Becker	Becker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	26	RC	RC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	28	Nessel	Nessel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	29	CC	CC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	31	Mahaffey	Mahaffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	32	KW	KW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	34	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	35	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	37	Califf	Califf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	38	RM	RM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1177	40	Breithardt	Breithardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	41	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	42	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1177	43	ROCKET	rocket	VB
work_vvlzsj54cvf5de6ji6py6krqlm	1177	44	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	45	Steering	Steering	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	46	Committee	Committee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1177	47	&	&	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1177	48	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1177	49	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1178	1	Outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1178	2	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	3	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	4	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1178	5	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1178	6	fibrilla-	fibrilla-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	7	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	8	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	9	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	10	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1178	11	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	12	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	13	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	14	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1178	15	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	16	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	17	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1178	18	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1178	19	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1178	20	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1178	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1179	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1179	2	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1179	3	Coll	Coll	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1179	4	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1179	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1180	1	2013;61:1998–2006	2013;61:1998–2006	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1180	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1181	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1181	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1181	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1181	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1181	5	j.jacc.2013.02.025	j.jacc.2013.02.025	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1181	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1182	1	138	138	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1182	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1183	1	Flaker	flaker	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1183	2	G	g	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1183	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	4	Lopes	Lopes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	5	RD	RD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	7	Al	Al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1183	9	Khatib	Khatib	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	10	SM	SM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	12	Hermosillo	Hermosillo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	13	AG	AG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	15	Hohnloser	Hohnloser	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	16	SH	SH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	17	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	18	Tinga	Tinga	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	19	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	20	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	21	Zhu	Zhu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	22	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	24	Mohan	Mohan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	25	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	27	Garcia	Garcia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	28	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	30	Bartunek	Bartunek	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	31	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	33	Vinereanu	Vinereanu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	34	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	36	Husted	Husted	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	37	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	39	Harjola	Harjola	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	40	VP	VP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	42	Rosenqvist	Rosenqvist	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	43	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	45	Alexander	Alexander	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	46	JH	JH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1183	48	Granger	Granger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	49	CB	CB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	50	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1183	51	ARISTOTLE	ARISTOTLE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1183	52	Committees	Committees	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1183	53	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1183	54	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1183	55	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1184	1	Efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1184	3	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	5	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1184	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	7	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1184	8	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	9	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	10	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	11	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1184	12	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	13	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1184	14	insights	insight	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1184	15	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1184	17	ARISTOTLE	ARISTOTLE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1184	18	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	19	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1184	20	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1184	21	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	22	Reduction	Reduction	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1184	23	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	24	Stroke	Stroke	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1184	25	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1184	26	Other	Other	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1184	27	Thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1184	28	Events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1184	29	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1184	30	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1184	31	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1184	32	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1184	33	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1185	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1185	2	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1185	3	Coll	Coll	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1185	4	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1185	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1186	1	2014;63:1082–1087	2014;63:1082–1087	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1186	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1187	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1187	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1187	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1187	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1187	5	j.jacc.2013.09.062	j.jacc.2013.09.062	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1187	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1188	1	139	139	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1188	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1189	1	Sen	Sen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	2	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1189	4	Kundu	Kundu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	5	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1189	7	Sardar	Sardar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	8	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1189	10	Chatterjee	Chatterjee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	11	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1189	13	Nairooz	Nairooz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	14	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1189	16	Amin	Amin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	17	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1189	19	Aronow	Aronow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	20	WS	WS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1189	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1190	1	Outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1190	2	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1190	3	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1190	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1190	5	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1190	6	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1190	7	pa-	pa-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1190	8	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1190	9	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1190	10	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1190	11	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1190	12	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1190	13	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1190	14	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1190	15	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1190	16	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1190	17	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1190	18	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1190	19	NOACs	NOACs	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1190	20	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1190	21	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1190	22	insights	insight	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1190	23	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1190	24	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1190	25	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1190	26	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1190	27	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1190	28	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1191	1	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1191	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1191	3	Cardiovasc	Cardiovasc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1191	4	Drugs	drug	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1191	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1192	1	2015;16:33–41	2015;16:33–41	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1192	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1193	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1193	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1193	3	10.1007	10.1007	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1193	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1193	5	s40256	s40256	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1193	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1193	7	015	015	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1193	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1193	9	0136	0136	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1193	10	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1193	11	1	1	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1193	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1194	1	140	140	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1194	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1195	1	Caldeira	caldeira	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1195	2	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1195	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1195	4	Costa	Costa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1195	5	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1195	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1195	7	Ferreira	Ferreira	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1195	8	JJ	JJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1195	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1195	10	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1195	11	GY	GY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1195	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1195	13	Pinto	Pinto	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1195	14	FJ	FJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1195	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1196	1	Non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1196	2	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1196	3	vitamin	vitamin	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1196	4	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1196	5	antagonist	antagonist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1196	6	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1196	7	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1196	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1196	9	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1196	10	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1196	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1196	12	pa-	pa-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1196	13	tients	tient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1196	14	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1196	15	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1196	16	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1196	17	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1196	18	systematic	systematic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1196	19	review	review	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1196	20	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1196	21	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1196	22	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1196	23	anal-	anal-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1196	24	ysis	ysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1196	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1197	1	Clin	Clin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1197	2	Res	Res	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1197	3	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1197	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1198	1	2015;104:582–590	2015;104:582–590	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1198	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1199	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1199	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1199	3	10.1007/	10.1007/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1199	4	s00392	s00392	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1199	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1199	6	015	015	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1199	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1199	8	0821	0821	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1199	9	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1199	10	8	8	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1199	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1200	1	141	141	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1200	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1201	1	Cappato	Cappato	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	2	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	4	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	5	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	7	Klein	Klein	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	8	AL	AL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	10	Camm	Camm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	11	AJ	AJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	13	Ma	Ma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	14	CS	CS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	16	Le	Le	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	17	Heuzey	Heuzey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	18	JY	JY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	20	Talajic	Talajic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	21	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	23	Scanavacca	Scanavacca	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	24	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	26	Vardas	Vardas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	27	PE	PE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	29	Kirchhof	Kirchhof	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	30	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	32	Hemmrich	Hemmrich	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	33	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	35	Lanius	Lanius	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	36	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	38	Meng	Meng	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	39	IL	IL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	41	Wildgoose	Wildgoose	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	42	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	44	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	45	Eickels	Eickels	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	46	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1201	48	Hohnloser	Hohnloser	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	49	SH	SH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1201	50	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1201	51	X	x	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1201	52	-	-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1201	53	VeRT	vert	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1201	54	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1201	55	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1202	1	Rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1202	2	vs.	vs.	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1202	3	vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1202	4	K	k	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1202	5	antagonists	antagonist	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1202	6	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1202	7	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1202	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1202	9	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1202	10	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1202	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1203	1	Eur	Eur	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1203	2	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1203	3	J.	j.	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1204	1	2014;35:3346	2014;35:3346	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1204	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1204	3	3355	3355	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1204	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1204	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1204	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1204	7	10.1093	10.1093	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1204	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1204	9	eurheartj	eurheartj	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1204	10	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1204	11	ehu367	ehu367	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1204	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1205	1	142	142	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1205	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1206	1	Pallisgaard	Pallisgaard	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	2	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1206	4	Lindhardt	Lindhardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	5	TB	TB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1206	7	Hansen	Hansen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	8	ML	ML	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1206	10	Schjerning	schjerne	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1206	11	AM	am	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1206	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1206	13	Olesen	Olesen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	14	JB	JB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1206	16	Staerk	Staerk	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	17	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1206	19	Torp	Torp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	20	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1206	21	Pedersen	Pedersen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	22	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	23	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1206	24	Gislason	Gislason	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	25	GH	GH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1206	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1207	1	Cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1207	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1207	3	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1207	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1207	5	adverse	adverse	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1207	6	events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1207	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1207	8	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1207	9	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1207	10	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1207	11	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1207	12	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1207	13	nationwide	nationwide	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1207	14	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1207	15	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1207	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1208	1	PLoS	PLoS	:
work_vvlzsj54cvf5de6ji6py6krqlm	1208	2	One	one	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1208	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1209	1	2015;10	2015;10	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1209	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1209	3	e0141377	e0141377	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1209	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1210	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1210	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1210	3	10.1371	10.1371	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1210	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1210	5	journal.pone.0141377	journal.pone.0141377	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1210	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1211	1	143	143	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1211	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1212	1	Coleman	Coleman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	2	CM	CM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1212	4	Khalaf	Khalaf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	5	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1212	7	Mould	Mould	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	8	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1212	10	Wazni	Wazni	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	11	O	O	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1212	13	Kanj	Kanj	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	14	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1212	16	Saliba	Saliba	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	17	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1212	19	Cantillon	Cantillon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	20	D.	D.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	21	Novel	Novel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	22	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1212	23	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1212	24	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1212	25	DC	DC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1212	26	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1212	27	proce-	proce-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1212	28	dures	dure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1212	29	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1212	30	utilization	utilization	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1212	31	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1212	32	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1212	33	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1212	34	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1212	35	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1212	36	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1212	37	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1213	1	Pacing	pace	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1213	2	Clin	Clin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1213	3	Electrophysiol	Electrophysiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1213	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1214	1	2015;38:731–737	2015;38:731–737	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1214	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1215	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1215	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1215	3	10.1111/	10.1111/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1215	4	pace.12618	pace.12618	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1215	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1216	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1216	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1216	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	1216	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1216	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1216	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	1216	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1216	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1216	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1216	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1216	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1216	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1216	13	Raval	Raval	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1216	14	et	et	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1216	15	al	al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1216	16	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1216	17	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1216	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1216	19	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1216	20	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1216	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1217	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1217	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1217	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1217	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1218	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1218	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1218	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1218	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1218	5	CIR.0000000000000477e632	CIR.0000000000000477e632	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1218	6	144	144	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1218	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1219	1	Goette	Goette	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	2	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	4	Merino	Merino	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	5	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	7	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	8	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	10	Zamoryakhin	Zamoryakhin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	11	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	13	Melino	Melino	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	14	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	16	Jin	Jin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	17	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	19	Mercuri	Mercuri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	20	MF	MF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	22	Grosso	Grosso	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	23	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	25	Fernandez	Fernandez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	26	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	28	Al	Al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	29	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1219	30	Saady	Saady	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	31	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	33	Pelekh	Pelekh	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	34	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	36	Merkely	Merkely	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	37	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	38	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	39	Zenin	Zenin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	40	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	41	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	42	Kushnir	Kushnir	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	43	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	45	Spinar	Spinar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	46	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	48	Batushkin	Batushkin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	49	V	v	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1219	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	51	de	de	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	52	Groot	Groot	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	53	JR	JR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	54	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1219	55	Lip	Lip	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	56	GY	GY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	57	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1219	58	ENSURE	ENSURE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	59	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1219	60	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1219	61	investigators	investigator	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1219	62	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1220	1	Edoxaban	edoxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	2	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	3	enoxaparin	enoxaparin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	4	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1220	5	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	7	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1220	8	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1220	9	cardiover-	cardiover-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	10	sion	sion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	11	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	12	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1220	13	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	14	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1220	15	ENSURE	ENSURE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1220	16	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1220	17	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1220	18	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1220	19	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1220	20	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1220	21	randomised	randomised	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1220	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1220	23	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1220	24	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1220	25	label	label	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1220	27	phase	phase	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	28	3b	3b	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1220	29	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1220	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1221	1	Lancet	Lancet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1221	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1222	1	2016;388:1995–2003	2016;388:1995–2003	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1222	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1223	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1223	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1223	3	10.1016/	10.1016/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1223	4	S0140	S0140	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1223	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1223	6	6736(16)31474-X.	6736(16)31474-X.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1224	1	145	145	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1224	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1225	1	Di	Di	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	2	Biase	Biase	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	3	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	5	Burkhardt	Burkhardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	6	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	8	Mohanty	Mohanty	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	9	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	11	Sanchez	Sanchez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	12	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	14	Horton	Horton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	15	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	17	Gallinghouse	Gallinghouse	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	18	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	20	Lakkireddy	Lakkireddy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	21	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	23	Verma	Verma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	24	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	26	Khaykin	Khaykin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	27	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	29	Hongo	Hongo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	30	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	32	Hao	Hao	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	33	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	35	Beheiry	Beheiry	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	36	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	38	Pelargonio	Pelargonio	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	39	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	41	Dello	Dello	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	42	Russo	Russo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	43	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	44	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	45	Casella	Casella	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	46	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	48	Santarelli	Santarelli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	49	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	50	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	51	Santangeli	Santangeli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	52	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	54	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	55	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	56	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	57	Al	Al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	58	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1225	59	Ahmad	Ahmad	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	60	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	61	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	62	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	63	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	65	Themistoclakis	Themistoclakis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	66	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	67	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	68	Bonso	Bonso	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	69	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	70	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	71	Rossillo	Rossillo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	72	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	73	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	74	Corrado	Corrado	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	75	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	76	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	77	Raviele	Raviele	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	78	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	79	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	80	Cummings	Cummings	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	81	JE	JE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	82	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	83	Schweikert	Schweikert	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	84	RA	RA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	85	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	86	Lewis	Lewis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	87	WR	WR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	88	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1225	89	Natale	Natale	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	90	A.	A.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	91	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	92	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	93	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1225	94	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	95	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	96	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1225	97	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	98	complications	complication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1225	99	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	100	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1225	101	undergoing	undergoing	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1225	102	catheter	catheter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	103	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	104	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	105	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1225	106	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	107	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1225	108	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1225	109	impact	impact	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	110	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	111	periprocedural	periprocedural	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	112	therapeu-	therapeu-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	113	tic	tic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1225	114	international	international	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1225	115	normalized	normalized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1225	116	ratio	ratio	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1225	117	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1226	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1226	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1227	1	2010;121:2550	2010;121:2550	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1227	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1227	3	2556	2556	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1227	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1227	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1227	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1227	7	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1227	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1227	9	CIRCULATIONAHA.109.921320	CIRCULATIONAHA.109.921320	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1227	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1228	1	146	146	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1228	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1229	1	Santangeli	Santangeli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	2	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1229	4	Di	Di	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	5	Biase	Biase	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	6	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1229	8	Horton	Horton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	9	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1229	11	Burkhardt	Burkhardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	12	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1229	14	Sanchez	Sanchez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	15	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1229	17	Al	Al	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	18	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1229	19	Ahmad	Ahmad	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	20	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1229	22	Hongo	Hongo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	23	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1229	25	Beheiry	Beheiry	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	26	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1229	28	Bai	Bai	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	29	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1229	31	Mohanty	Mohanty	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	32	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1229	34	Lewis	Lewis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	35	WR	WR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1229	37	Natale	Natale	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	38	A.	A.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	39	Ablation	Ablation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1229	40	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1229	41	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1229	42	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1229	43	under	under	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1229	44	therapeutic	therapeutic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1229	45	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1229	46	reduces	reduce	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	1229	47	periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1229	48	complications	complication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1229	49	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1229	50	evidence	evidence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1229	51	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1229	52	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1229	53	meta-	meta-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1229	54	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1229	55	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1230	1	Circ	Circ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1230	2	Arrhythm	Arrhythm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1230	3	Electrophysiol	Electrophysiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1230	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1231	1	2012;5:302–311	2012;5:302–311	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1231	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1232	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1232	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1232	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1232	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1232	5	CIRCEP.111.964916	CIRCEP.111.964916	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1232	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1233	1	147	147	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1233	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1234	1	Di	Di	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	2	Biase	Biase	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	3	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	5	Burkhardt	Burkhardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	6	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	8	Santangeli	Santangeli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	9	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	11	Mohanty	Mohanty	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	12	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	14	Sanchez	Sanchez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	15	JE	JE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	17	Horton	Horton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	18	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	20	Gallinghouse	Gallinghouse	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	21	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	23	Themistoclakis	Themistoclakis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	24	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	26	Rossillo	Rossillo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	27	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	29	Lakkireddy	Lakkireddy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	30	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	32	Reddy	Reddy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	33	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	35	Hao	Hao	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	36	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	38	Hongo	Hongo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	39	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	41	Beheiry	Beheiry	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	42	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	44	Zagrodzky	Zagrodzky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	45	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	47	Rong	Rong	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	48	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	49	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	50	Mohanty	Mohanty	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	51	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	53	Elayi	Elayi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	54	CS	CS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	56	Forleo	Forleo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	57	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	58	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	59	Pelargonio	Pelargonio	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	60	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	61	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	62	Narducci	Narducci	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	63	ML	ML	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	65	Dello	Dello	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	66	Russo	Russo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	67	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	68	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	69	Casella	Casella	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	70	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	71	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	72	Fassini	Fassini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	73	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	74	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	75	Tondo	Tondo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	76	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	77	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	78	Schweikert	Schweikert	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	79	RA	RA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	80	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1234	81	Natale	Natale	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	82	A.	A.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	83	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	84	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	85	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1234	86	bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1234	87	complications	complication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1234	88	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	89	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1234	90	undergoing	undergoing	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1234	91	catheter	catheter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	92	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	93	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	94	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1234	95	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	96	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	97	different	different	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1234	98	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	99	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	100	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1234	101	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1234	102	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	103	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1234	104	Role	Role	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	105	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	106	Coumadin	Coumadin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	107	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	108	Preventing	prevent	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1234	109	Thromboembolism	Thromboembolism	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	110	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	111	Atrial	Atrial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	112	Fibrillation	Fibrillation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	113	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1234	114	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1234	115	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1234	116	Patients	patient	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	1234	117	Undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1234	118	Catheter	catheter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	119	Ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	120	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1234	121	COMPARE	compare	VB
work_vvlzsj54cvf5de6ji6py6krqlm	1234	122	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1234	123	random-	random-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	124	ized	ize	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	125	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1234	126	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1235	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1235	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1236	1	2014;129:2638–2644	2014;129:2638–2644	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1236	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1237	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1237	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1237	3	10.1161/	10.1161/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1237	4	CIRCULATIONAHA.113.006426	CIRCULATIONAHA.113.006426	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1237	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1238	1	148	148	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1238	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1239	1	Shurrab	Shurrab	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	2	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1239	4	Morillo	Morillo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	5	CA	CA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1239	7	Schulman	Schulman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	8	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1239	10	Kansal	Kansal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	11	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1239	13	Danon	Danon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	14	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1239	16	Newman	Newman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	17	D	d	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1239	19	Lashevsky	Lashevsky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	20	I	I	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1239	22	Healey	Healey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	23	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1239	25	Crystal	Crystal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	26	E.	E.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	27	Safety	Safety	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1239	28	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1239	29	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	30	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	31	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	32	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	33	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	34	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	35	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	36	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1239	37	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1239	38	radiofrequency	radiofrequency	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1239	39	catheter	catheter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	40	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	41	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	42	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1239	43	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	44	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1239	45	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1239	46	meta-	meta-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1239	47	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1239	48	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1240	1	Can	Can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	1240	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1240	3	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1240	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1241	1	2013;29:1203–1210	2013;29:1203–1210	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1241	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1242	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1242	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1242	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1242	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1242	5	j	j	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1242	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1243	1	cjca.2013.07.005	cjca.2013.07.005	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1243	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1244	1	149	149	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1244	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1245	1	Providência	Providência	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	2	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1245	4	Albenque	Albenque	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	5	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1245	7	Combes	Combes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	8	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1245	10	Bouzeman	Bouzeman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	11	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1245	13	Casteigt	Casteigt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	14	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1245	16	Combes	Combes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	17	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1245	19	Narayanan	Narayanan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	20	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1245	22	Marijon	Marijon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	23	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1245	25	Boveda	Boveda	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	26	S.	S.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	27	Safety	Safety	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	28	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1245	29	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1245	30	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1245	31	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	32	versus	versus	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	33	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	34	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1245	35	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1245	36	undergo-	undergo-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1245	37	ing	ing	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1245	38	catheter	catheter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1245	39	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1245	40	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1245	41	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1245	42	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1245	43	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1245	44	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1245	45	systematic	systematic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1245	46	review	review	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1245	47	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1245	48	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1245	49	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1245	50	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1245	51	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1246	1	Heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1246	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1247	1	2014;100:324–335	2014;100:324–335	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1247	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1248	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1248	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1248	3	10.1136/	10.1136/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1248	4	heartjnl-2013	heartjnl-2013	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1248	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1248	6	304386	304386	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1248	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1249	1	150	150	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1249	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1250	1	Lu	Lu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1250	2	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1250	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1250	4	Zhang	Zhang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1250	5	Q	Q	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1250	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1250	7	Liu	Liu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1250	8	Q	Q	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1250	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1250	10	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1250	11	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1250	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1250	13	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1250	14	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1250	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1250	16	Shan	Shan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1250	17	Q.	Q.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1251	1	Bleeding	bleed	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1251	2	risks	risk	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1251	3	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1251	4	novel	novel	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1251	5	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1251	6	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1251	7	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1251	8	catheter	cathet	JJR
work_vvlzsj54cvf5de6ji6py6krqlm	1251	9	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1251	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1251	11	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1251	12	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1251	13	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1251	14	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1251	15	systematic	systematic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1251	16	review	review	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1251	17	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1251	18	network	network	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1251	19	meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1251	20	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1251	21	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1251	22	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1252	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1252	2	Interv	Interv	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1252	3	Card	Card	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1252	4	Electrophysiol	Electrophysiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1252	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1253	1	2015;44:105–111	2015;44:105–111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1253	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1254	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1254	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1254	3	10.1007/	10.1007/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1254	4	s10840	s10840	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1254	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1254	6	015	015	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1254	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1254	8	0053-x	0053-x	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1254	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1255	1	151	151	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1255	2	Nairooz	Nairooz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	3	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1255	5	Sardar	Sardar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	6	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1255	8	Pino	Pino	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	9	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1255	11	Aronow	Aronow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	12	WS	WS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1255	14	Sewani	Sewani	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	15	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1255	17	Mukherjee	Mukherjee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	18	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1255	20	Paydak	Paydak	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	21	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1255	23	Maskoun	Maskoun	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	24	W.	W.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	25	Meta	Meta	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	26	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1255	27	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	28	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	29	risk	risk	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	30	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	31	stroke	stroke	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	32	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1255	33	thrombo	thrombo	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1255	34	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1255	35	embolism	embolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	36	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	37	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	38	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	39	vitamin	vitamin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	40	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1255	41	antagonists	antagonist	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1255	42	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	43	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	44	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1255	45	cardioversion	cardioversion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	46	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	47	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1255	48	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1255	49	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1256	1	Int	Int	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1256	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1256	3	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1256	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1257	1	2015;187:345–353	2015;187:345–353	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1257	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1258	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1258	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1258	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1258	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1258	5	j.ijcard.2015.03.323	j.ijcard.2015.03.323	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1258	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1259	1	152	152	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1259	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1260	1	Lu	Lu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1260	2	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1260	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1260	4	Liu	Liu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1260	5	Q	Q	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1260	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1260	7	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1260	8	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1260	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1260	10	Zhang	Zhang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1260	11	QI	QI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1260	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1260	13	Shan	Shan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1260	14	QJ	QJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1260	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1261	1	Meta	meta	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1261	2	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1261	3	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1261	4	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1261	5	efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1261	6	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1261	7	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1261	8	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1261	9	apixaban	apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1261	10	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1261	11	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1261	12	undergoing	undergoing	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1261	13	catheter	catheter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1261	14	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1261	15	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1261	16	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1261	17	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1261	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1262	1	Pacing	pace	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1262	2	Clin	Clin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1262	3	Electrophysiol	Electrophysiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1262	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1263	1	2016;39:54–59	2016;39:54–59	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1263	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1264	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1264	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1264	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1264	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1264	5	pace.12771	pace.12771	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1264	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1265	1	153	153	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1265	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1266	1	Kuwahara	Kuwahara	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	2	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	4	Abe	Abe	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	7	Yamaki	Yamaki	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	8	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	10	Fujieda	Fujieda	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	11	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	13	Abe	Abe	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	14	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	16	Hashimoto	Hashimoto	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	17	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	19	Ishiba	Ishiba	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	20	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	22	Sakai	Sakai	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	23	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	25	Hishikari	Hishikari	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	26	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	28	Takigawa	Takigawa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	29	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	31	Okubo	Okubo	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	32	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	34	Takagi	Takagi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	35	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	37	Tanaka	Tanaka	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	38	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	40	Nakajima	Nakajima	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	41	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1266	43	Takahashi	Takahashi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	44	A.	a.	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1266	45	Apixaban	Apixaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	46	versus	versus	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1266	47	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1266	48	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1266	49	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1266	50	prevention	prevention	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1266	51	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1266	52	periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1266	53	cerebral	cerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1266	54	thromboembolism	thromboembolism	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1266	55	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1266	56	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1266	57	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1266	58	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1266	59	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1266	60	multicenter	multicenter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1266	61	prospective	prospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1266	62	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1266	63	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1266	64	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1267	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1267	2	Cardiovasc	Cardiovasc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1267	3	Electrophysiol	Electrophysiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1267	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1268	1	2016;27:549–554	2016;27:549–554	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1268	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1269	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1269	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1269	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1269	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1269	5	jce.12928	jce.12928	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1269	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1270	1	154	154	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1270	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1271	1	Calkins	calkin	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1271	2	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	4	Kuck	Kuck	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	5	KH	KH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	7	Cappato	Cappato	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	8	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	10	Brugada	Brugada	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	11	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	13	Camm	Camm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	14	AJ	AJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	16	Chen	Chen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	17	SA	SA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	19	Crijns	Crijns	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	20	HJ	HJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	22	Damiano	Damiano	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	23	RJ	RJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	24	Jr	Jr	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	26	Davies	Davies	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	27	DW	DW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	29	DiMarco	DiMarco	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	30	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	32	Edgerton	Edgerton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	33	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	35	Ellenbogen	Ellenbogen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	36	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	38	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	39	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	41	Haines	Haines	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	42	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	44	Haissaguerre	Haissaguerre	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	45	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	47	Hindricks	Hindricks	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	48	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	49	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	50	Iesaka	Iesaka	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	51	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	53	Jackman	Jackman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	54	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	56	Jalife	Jalife	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	57	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	58	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	59	Jais	Jais	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	60	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	61	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	62	Kalman	Kalman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	63	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	65	Keane	Keane	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	66	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	67	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	68	Kim	Kim	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	69	YH	YH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	70	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	71	Kirchhof	Kirchhof	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	72	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	73	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	74	Klein	Klein	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	75	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	76	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	77	Kottkamp	Kottkamp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	78	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	79	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	80	Kumagai	Kumagai	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	81	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	82	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	83	Lindsay	Lindsay	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	84	BD	BD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	85	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	86	Mansour	Mansour	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	87	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	88	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	89	Marchlinski	Marchlinski	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	90	FE	FE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	91	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	92	McCarthy	McCarthy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	93	PM	PM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	94	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	95	Mont	Mont	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	96	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	97	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	98	Morady	Morady	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	99	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	100	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	101	Nademanee	Nademanee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	102	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	103	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	104	Nakagawa	Nakagawa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	105	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	106	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	107	Natale	Natale	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	108	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	109	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	110	Nattel	Nattel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	111	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	112	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	113	Packer	Packer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	114	DL	DL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	115	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	116	Pappone	Pappone	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	117	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	118	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	119	Prystowsky	Prystowsky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	120	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	121	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	122	Raviele	Raviele	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	123	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	124	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	125	Reddy	Reddy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	126	V	V	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	127	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	128	Ruskin	Ruskin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	129	JN	JN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	130	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	131	Shemin	Shemin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	132	RJ	RJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	133	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	134	Tsao	Tsao	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	135	HM	HM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	136	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	137	Wilber	Wilber	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	138	D.	D.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	139	2012	2012	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1271	140	HRS	HRS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	141	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1271	142	EHRA	EHRA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	143	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1271	144	ECAS	ECAS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1271	145	ex-	ex-	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1271	146	pert	pert	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1271	147	consensus	consensus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	148	statement	statement	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	149	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	150	catheter	catheter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	151	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1271	152	surgical	surgical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1271	153	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	154	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	155	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1271	156	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	157	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1271	158	recommendations	recommendation	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1271	159	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	160	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	161	selection	selection	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	162	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	163	proce-	proce-	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1271	164	dural	dural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1271	165	techniques	technique	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1271	166	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	167	patient	patient	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	168	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	169	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1271	170	follow	follow	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	171	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1271	172	up	up	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	173	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	174	definitions	definition	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1271	175	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	176	endpoints	endpoint	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1271	177	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1271	178	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1271	179	research	research	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	180	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	181	design	design	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1271	182	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1272	1	Europace	Europace	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1272	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1273	1	2012;14:528	2012;14:528	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1273	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1273	3	606	606	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1273	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1273	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1273	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1273	7	10.1093	10.1093	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1273	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1273	9	europace	europace	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1273	10	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1273	11	eus027	eus027	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	1273	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1274	1	155	155	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1274	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1275	1	Wallace	Wallace	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	2	TW	TW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1275	4	Atwater	Atwater	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	5	BD	BD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1275	7	Daubert	Daubert	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	8	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1275	10	Voora	Voora	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	11	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1275	13	Crowley	Crowley	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	14	AL	AL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1275	16	Bahnson	Bahnson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	17	TD	TD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1275	19	Hranitzky	Hranitzky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	20	PM	PM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1275	21	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1276	1	Prevalence	Prevalence	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1276	2	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1276	3	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1276	4	characteris-	characteris-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	5	tics	tic	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1276	6	associated	associate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	7	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	8	left	left	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1276	9	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1276	10	appendage	appendage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	11	thrombus	thrombus	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	12	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	13	fully	fully	RB
work_vvlzsj54cvf5de6ji6py6krqlm	1276	14	antico-	antico-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	15	agulated	agulate	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	16	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1276	17	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1276	18	catheter	catheter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	19	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1276	20	directed	direct	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	21	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1276	22	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	23	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1276	24	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1277	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1277	2	Cardiovasc	Cardiovasc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1277	3	Electrophysiol	Electrophysiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1277	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1278	1	2010;21:849–852	2010;21:849–852	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1278	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1279	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1279	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1279	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1279	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1279	5	j.1540	j.1540	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1279	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1279	7	8167.2010.01729.x	8167.2010.01729.x	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1279	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1280	1	156	156	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1280	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1281	1	Di	Di	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	2	Biase	Biase	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	3	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	4	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	5	Gaita	Gaita	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	6	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	7	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	8	Toso	Toso	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	9	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	10	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	11	Santangeli	Santangeli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	12	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	13	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	14	Mohanty	Mohanty	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	15	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	17	Rutledge	Rutledge	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	18	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	20	Yan	Yan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	21	X	X	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	23	Mohanty	Mohanty	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	24	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	26	Trivedi	Trivedi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	27	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	29	Bai	Bai	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	30	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	31	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	32	Price	Price	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	33	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	34	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	35	Horton	Horton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	36	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	37	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	38	Gallinghouse	Gallinghouse	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	39	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	40	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	41	Beheiry	Beheiry	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	42	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	43	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	44	Zagrodzky	Zagrodzky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	45	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	46	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	47	Canby	Canby	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	48	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	49	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	50	Leclercq	Leclercq	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	51	JF	JF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	52	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	53	Halimi	Halimi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	54	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	55	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	56	Scaglione	Scaglione	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	57	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	58	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	59	Cesarani	Cesarani	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	60	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	61	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	62	Faletti	Faletti	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	63	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	64	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	65	Sanchez	Sanchez	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	66	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	67	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	68	Burkhardt	Burkhardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	69	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	70	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1281	71	Natale	Natale	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1281	72	A.	A.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1282	1	Does	do	VBZ
work_vvlzsj54cvf5de6ji6py6krqlm	1282	2	periprocedural	periprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1282	3	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	4	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	5	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	6	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1282	7	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	8	af-	af-	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1282	9	fect	fect	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	1282	10	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1282	11	prevalence	prevalence	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	12	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	13	silent	silent	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1282	14	thromboembolic	thromboembolic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1282	15	lesion	lesion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	16	detected	detect	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	17	by	by	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	18	diffusion	diffusion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	19	cerebral	cerebral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1282	20	magnetic	magnetic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1282	21	resonance	resonance	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	22	imaging	imaging	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	23	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	24	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1282	25	under-	under-	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	26	going	go	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1282	27	radiofrequency	radiofrequency	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1282	28	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1282	29	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	30	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	31	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1282	32	open	open	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1282	33	irrigated	irrigated	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1282	34	catheters	catheter	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1282	35	?	?	.
work_vvlzsj54cvf5de6ji6py6krqlm	1283	1	Results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1283	2	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1283	3	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1283	4	prospective	prospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1283	5	multicenter	multicenter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1283	6	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1283	7	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1284	1	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1284	2	Rhythm	Rhythm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1284	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1285	1	2014;11:791–798	2014;11:791–798	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1285	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1286	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1286	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1286	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1286	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1286	5	j.hrthm.2014.03.003	j.hrthm.2014.03.003	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1286	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1287	1	157	157	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1287	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1288	1	Konduru	Konduru	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	2	SV	SV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1288	4	Cheema	Cheema	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	5	AA	AA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1288	7	Jones	Jones	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	8	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1288	10	Li	Li	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	11	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1288	13	Ramza	Ramza	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	14	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1288	16	Wimmer	Wimmer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	17	AP	AP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1288	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1289	1	Differences	difference	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1289	2	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	3	intraprocedural	intraprocedural	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1289	4	acts	act	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1289	5	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	6	standardized	standardized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1289	7	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1289	8	dosing	dose	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1289	9	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	10	catheter	catheter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	11	ablation	ablation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	12	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	13	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1289	14	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	15	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	16	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1289	17	treated	treat	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	18	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	19	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1289	20	vs.	vs.	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	21	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1289	22	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	23	uninterrupted	uninterrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1289	24	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1289	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1290	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1290	2	Interv	Interv	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1290	3	Card	Card	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1290	4	Electrophysiol	Electrophysiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1290	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1291	1	2012;35:277–284	2012;35:277–284	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1291	2	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1291	3	discussion	discussion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1291	4	284	284	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1291	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1292	1	158	158	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1292	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1293	1	Cheng	Cheng	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	2	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	4	Nazarian	Nazarian	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	5	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	7	Brinker	Brinker	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	8	JA	JA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	10	Tompkins	Tompkins	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	11	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	13	Spragg	Spragg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	14	DD	DD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	16	Leng	Leng	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	17	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	19	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	20	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	22	Tandri	Tandri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	23	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	25	Sinha	Sinha	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	26	SK	SK	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	28	Marine	Marine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	29	JE	JE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	31	Calkins	Calkins	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	32	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	34	Tomaselli	Tomaselli	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	35	GF	GF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	37	Berger	Berger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	38	RD	RD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1293	40	Henrikson	Henrikson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	41	CA	CA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1293	42	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1294	1	Continuation	continuation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1294	2	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1294	3	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1294	4	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1294	5	pacemaker	pacemaker	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1294	6	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1294	7	implantable	implantable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1294	8	cardioverter	cardioverter	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1294	9	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1294	10	defibrillator	defibrillator	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1294	11	implantation	implantation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1294	12	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1294	13	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1294	14	randomized	randomized	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1294	15	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1294	16	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1294	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1295	1	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1295	2	Rhythm	Rhythm	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1295	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1296	1	2011;8:536–540	2011;8:536–540	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1296	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1297	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1297	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1297	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1297	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1297	5	j.hrthm.2010.12.016	j.hrthm.2010.12.016	RB
work_vvlzsj54cvf5de6ji6py6krqlm	1297	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1298	1	159	159	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1298	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1299	1	Birnie	Birnie	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	2	DH	DH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1299	4	Healey	Healey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	5	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1299	7	Wells	Wells	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	8	GA	GA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1299	10	Verma	Verma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	11	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1299	13	Tang	Tang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	14	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1299	16	Krahn	Krahn	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	17	AD	AD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1299	19	Simpson	Simpson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	20	CS	CS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1299	22	Ayala	Ayala	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	23	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1299	24	Paredes	Paredes	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	25	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	26	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1299	27	Coutu	Coutu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	28	B	B	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	29	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1299	30	Leiria	Leiria	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	31	TL	TL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	32	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1299	33	Essebag	Essebag	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	34	V	v	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1299	35	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1299	36	BRUISE	BRUISE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1299	37	CONTROL	control	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1299	38	Investigators	investigator	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1299	39	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1300	1	Pacemaker	pacemaker	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1300	2	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1300	3	defibrillator	defibrillator	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1300	4	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1300	5	without	without	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1300	6	interruption	interruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1300	7	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1300	8	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1300	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1301	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1301	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1301	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1301	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1301	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1302	1	2013;368:2084–2093	2013;368:2084–2093	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1302	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1303	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1303	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1303	3	10.1056	10.1056	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1303	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1303	5	NEJMoa1302946	nejmoa1302946	UH
work_vvlzsj54cvf5de6ji6py6krqlm	1303	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1304	1	160	160	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1304	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1305	1	Birnie	Birnie	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1305	2	DH	DH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1305	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1305	4	Healey	Healey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1305	5	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1305	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1305	7	Essebag	Essebag	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1305	8	V.	V.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1305	9	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1305	10	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1305	11	anticoagula-	anticoagula-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1305	12	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1305	13	around	around	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1305	14	pacemaker	pacemaker	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1305	15	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1305	16	defibrillator	defibrillator	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1305	17	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1305	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1306	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1306	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1307	1	2014;129:2062–2065	2014;129:2062–2065	ADD
work_vvlzsj54cvf5de6ji6py6krqlm	1307	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1308	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1308	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1308	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1308	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1308	5	CIRCULATIONAHA.113	CIRCULATIONAHA.113	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1308	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1309	1	006027	006027	NFP
work_vvlzsj54cvf5de6ji6py6krqlm	1309	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1310	1	161	161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1310	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1311	1	Nascimento	Nascimento	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	2	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1311	4	Birnie	Birnie	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	5	DH	DH	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1311	7	Healey	Healey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	8	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1311	10	Verma	Verma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	11	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1311	13	Joza	Joza	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	14	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1311	16	Bernier	Bernier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	17	ML	ML	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1311	19	Essebag	Essebag	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	20	V.	V.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1311	21	Managing	manage	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1311	22	novel	novel	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1311	23	oral	oral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1311	24	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1311	25	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1311	26	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1311	27	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1311	28	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1311	29	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1311	30	undergoing	undergo	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1311	31	device	device	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1311	32	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1311	33	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1311	34	Canadian	canadian	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1311	35	survey	survey	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1311	36	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1312	1	Can	Can	MD
work_vvlzsj54cvf5de6ji6py6krqlm	1312	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1312	3	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1312	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1313	1	2014;30:231–236	2014;30:231–236	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1313	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1314	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1314	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1314	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1314	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1314	5	j	j	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1314	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1315	1	cjca.2013.11.027	cjca.2013.11.027	FW
work_vvlzsj54cvf5de6ji6py6krqlm	1315	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1316	1	162	162	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1316	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1317	1	Jennings	Jennings	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	2	JM	JM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1317	4	Robichaux	Robichaux	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	5	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1317	7	McElderry	McElderry	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	8	HT	HT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1317	10	Plumb	Plumb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	11	VJ	VJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1317	13	Gunter	Gunter	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	14	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1317	16	Doppalapudi	Doppalapudi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	17	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1317	19	Osorio	Osorio	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	20	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1317	22	Yamada	Yamada	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	23	T	T	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1317	25	Kay	Kay	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	26	GN	GN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1317	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1318	1	Cardiovascular	Cardiovascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1318	2	implantable	implantable	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1318	3	electronic	electronic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1318	4	device	device	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1318	5	implantation	implantation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1318	6	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1318	7	uninterrupted	uninterrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1318	8	dabigatran	dabigatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1318	9	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1318	10	comparison	comparison	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1318	11	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1318	12	uninterrupted	uninterrupted	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1318	13	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1318	14	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1319	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1319	2	Cardiovasc	Cardiovasc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1319	3	Electrophysiol	Electrophysiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1319	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1320	1	2013;24:1125–1129	2013;24:1125–1129	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1320	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1321	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1321	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1321	3	10.1111	10.1111	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1321	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1321	5	jce.12214	jce.12214	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1321	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1322	1	163	163	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1322	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1323	1	Rowley	Rowley	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	2	CP	CP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1323	4	Bernard	Bernard	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	5	ML	ML	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1323	7	Brabham	Brabham	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	8	WW	WW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1323	10	Netzler	Netzler	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	11	PC	PC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1323	13	Sidney	Sidney	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	14	DS	DS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1323	16	Cuoco	Cuoco	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	17	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1323	19	Sturdivant	Sturdivant	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	20	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1323	22	Leman	Leman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	23	RB	RB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1323	25	Wharton	Wharton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	26	JM	JM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1323	28	Gold	Gold	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	29	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1323	31	Safety	Safety	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	32	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1323	33	continuous	continuous	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1323	34	anticoagulation	anticoagulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1323	35	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1323	36	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1323	37	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1323	38	implantation	implantation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1323	39	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1323	40	cardiac	cardiac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1323	41	rhythm	rhythm	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1323	42	devices	device	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1323	43	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1324	1	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1324	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1324	3	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1324	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1325	1	2013;111:1165–1168	2013;111:1165–1168	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1325	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1326	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1326	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1326	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1326	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1326	5	j.amjcard.2012.12.046	j.amjcard.2012.12.046	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1326	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1327	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1327	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1327	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	1327	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1327	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1327	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	1327	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1327	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1327	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1327	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1327	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1327	12	2021	2021	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1327	13	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1327	14	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1327	15	Patients	Patients	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1327	16	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1327	17	NOACs	NOACs	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1327	18	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1327	19	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1327	20	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1327	21	Care	Care	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1327	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1327	23	Periprocedural	Periprocedural	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1327	24	Setting	Setting	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1327	25	Circulation	Circulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1327	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1328	1	2017;135	2017;135	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1328	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1328	3	e604–e633	e604–e633	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1328	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1329	1	DOI	doi	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1329	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1329	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1329	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1329	5	CIR.0000000000000477	CIR.0000000000000477	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1329	6	March	March	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1329	7	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1329	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1329	9	2017	2017	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1329	10	e633	e633	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1329	11	CLINICAL	CLINICAL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1329	12	STATEM	statem	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1329	13	ENTS	ent	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1329	14	AND	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1329	15	GUIDELINES	GUIDELINES	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1329	16	164	164	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1329	17	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1330	1	Schulman	Schulman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	2	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1330	4	Carrier	Carrier	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	5	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1330	7	Lee	Lee	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	8	AY	AY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1330	10	Shivakumar	Shivakumar	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	11	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1330	13	Blostein	Blostein	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	14	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1330	16	Spencer	Spencer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	17	FA	FA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1330	19	Solymoss	Solymoss	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	20	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1330	22	Barty	Barty	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	23	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1330	25	Wang	Wang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	26	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1330	28	Heddle	Heddle	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	29	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1330	31	Douketis	Douketis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	32	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	33	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1330	34	Periop	Periop	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	35	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	36	Study	Study	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	37	Group	Group	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1330	38	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1331	1	Perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1331	2	management	management	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1331	3	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1331	4	dabi-	dabi-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1331	5	gatran	gatran	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1331	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1331	7	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1331	8	prospective	prospective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1331	9	cohort	cohort	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1331	10	study	study	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1331	11	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1332	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1332	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1333	1	2015;132:167	2015;132:167	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1333	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1333	3	173	173	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1333	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1333	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1333	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1333	7	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1333	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1333	9	CIRCULATIONAHA.115.015688	CIRCULATIONAHA.115.015688	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1333	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1334	1	165	165	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1334	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1335	1	Douketis	Douketis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	2	JD	JD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1335	4	Healey	Healey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	5	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1335	7	Brueckmann	Brueckmann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	8	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1335	10	Eikelboom	Eikelboom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	11	JW	JW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1335	13	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	14	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1335	16	Fraessdorf	Fraessdorf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	17	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1335	19	Noack	Noack	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	20	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1335	22	Oldgren	Oldgren	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	23	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1335	25	Reilly	Reilly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	26	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1335	28	Spyropoulos	Spyropoulos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	29	AC	AC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1335	31	Wallentin	Wallentin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	32	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1335	34	Connolly	Connolly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	35	SJ	SJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1335	36	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1336	1	Perioperative	perioperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1336	2	bridging	bridge	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1336	3	anticoagula-	anticoagula-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1336	4	tion	tion	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1336	5	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1336	6	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1336	7	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1336	8	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1336	9	interruption	interruption	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1336	10	among	among	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1336	11	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1336	12	who	who	WP
work_vvlzsj54cvf5de6ji6py6krqlm	1336	13	had	have	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	1336	14	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1336	15	elective	elective	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1336	16	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1336	17	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1336	18	procedure	procedure	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1336	19	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1336	20	substudy	substudy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1336	21	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1336	22	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1336	23	RE-	RE-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1336	24	LY	LY	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1336	25	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1336	26	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1337	1	Thromb	Thromb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1337	2	Haemost	Haemost	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1337	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1338	1	2015;113:625–632	2015;113:625–632	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1338	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1339	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1339	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1339	3	10.1160/	10.1160/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1339	4	TH14	TH14	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1339	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1339	6	04	04	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1339	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1339	8	0305	0305	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1339	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1340	1	166	166	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1340	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1341	1	Mega	Mega	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	2	JL	JL	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1341	4	Braunwald	Braunwald	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	5	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1341	7	Murphy	Murphy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	8	SA	SA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1341	10	Plotnikov	Plotnikov	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	11	AN	AN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1341	13	Burton	Burton	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	14	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1341	16	Kiss	Kiss	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	17	RG	RG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1341	19	Parkhomenko	Parkhomenko	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	20	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1341	22	Tendera	Tendera	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	23	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1341	25	Widimsky	Widimsky	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	26	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1341	28	Gibson	Gibson	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	29	CM	CM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1341	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1342	1	Rivaroxaban	rivaroxaban	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1342	2	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	3	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1342	4	stabilized	stabilize	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	1342	5	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	6	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1342	7	ST	ST	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1342	9	segment	segment	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	10	elevation	elevation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	11	myocardial	myocardial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1342	12	infarction	infarction	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	13	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1342	14	results	result	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1342	15	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1342	17	ATLAS	ATLAS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	18	ACS-2-TIMI-51	ACS-2-TIMI-51	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	19	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	20	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1342	21	Anti	Anti	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	22	-	-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	23	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	24	Therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	25	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	26	Lower	Lower	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	27	Cardiovascular	Cardiovascular	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	28	Events	event	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1342	29	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	30	Addition	addition	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	31	to	to	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	32	Standard	Standard	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	33	Therapy	Therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	34	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	35	Subjects	subject	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1342	36	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	37	Acute	Acute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	38	Coronary	Coronary	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	39	Syndrome-	Syndrome-	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	40	Thrombolysis	Thrombolysis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	41	In	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1342	42	Myocardial	Myocardial	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1342	43	Infarction-51	infarction-51	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1342	44	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1342	45	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1343	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1343	2	Am	Am	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1343	3	Coll	Coll	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1343	4	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1343	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1344	1	2013;61:1853–1859	2013;61:1853–1859	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1344	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1345	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1345	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1345	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1345	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1345	5	j.jacc.2013.01.066	j.jacc.2013.01.066	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1345	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1346	1	167	167	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1346	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1347	1	Eikelboom	Eikelboom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	2	JW	JW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	4	Connolly	Connolly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	5	SJ	SJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	7	Brueckmann	Brueckmann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	8	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	10	Granger	Granger	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	11	CB	CB	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	13	Kappetein	Kappetein	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	14	AP	AP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	16	Mack	Mack	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	17	MJ	MJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	19	Blatchford	Blatchford	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	20	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	22	Devenny	Devenny	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	23	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	25	Friedman	Friedman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	26	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	28	Guiver	Guiver	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	29	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	31	Harper	Harper	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	32	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	34	Khder	Khder	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	35	Y	Y	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	37	Lobmeyer	Lobmeyer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	38	MT	MT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	40	Maas	Maas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	41	H	H	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	43	Voigt	Voigt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	44	JU	JU	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	45	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	46	Simoons	Simoons	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	47	ML	ML	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	48	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1347	49	Van	Van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	50	de	de	FW
work_vvlzsj54cvf5de6ji6py6krqlm	1347	51	Werf	Werf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	52	F	F	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	53	;	;	:
work_vvlzsj54cvf5de6ji6py6krqlm	1347	54	RE	RE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	55	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1347	56	ALIGN	ALIGN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1347	57	Investigators	Investigators	NNPS
work_vvlzsj54cvf5de6ji6py6krqlm	1347	58	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1348	1	Dabigatran	Dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1348	2	versus	versus	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1348	3	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1348	4	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1348	5	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1348	6	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1348	7	mechanical	mechanical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1348	8	heart	heart	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1348	9	valves	valve	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1348	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1349	1	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1349	2	Engl	Engl	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1349	3	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1349	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1349	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1350	1	2013;369:1206–1214	2013;369:1206–1214	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1350	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1351	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1351	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1351	3	10.1056/	10.1056/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1351	4	NEJMoa1300615	nejmoa1300615	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1351	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1352	1	168	168	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1352	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1353	1	Terrovitis	Terrovitis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	2	JV	JV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1353	4	Ntalianis	Ntalianis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	5	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1353	7	Kapelios	Kapelios	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	8	CJ	CJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1353	10	Vakrou	Vakrou	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	11	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1353	13	Diakos	Diakos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	14	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1353	16	Katsaros	Katsaros	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	17	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1353	19	Tsamatsoulis	Tsamatsoulis	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	20	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1353	22	Kaldara	Kaldara	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	23	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1353	25	Charitos	Charitos	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	26	C	C	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1353	28	Nanas	Nanas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	29	JN	JN	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1353	30	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1354	1	Dabigatran	dabigatran	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1354	2	etexilate	etexilate	VBP
work_vvlzsj54cvf5de6ji6py6krqlm	1354	3	as	as	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1354	4	second	second	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1354	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1354	6	line	line	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1354	7	therapy	therapy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1354	8	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1354	9	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1354	10	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1354	11	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1354	12	left	left	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1354	13	ventricular	ventricular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1354	14	assist	assist	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1354	15	device	device	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1354	16	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1355	1	Hellenic	Hellenic	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1355	2	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1355	3	Cardiol	Cardiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1355	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1356	1	2015;56:20–25	2015;56:20–25	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1356	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1357	1	169	169	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1357	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1358	1	Abouchakra	Abouchakra	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1358	2	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1358	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1358	4	Khabbaz	Khabbaz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1358	5	Z	Z	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1358	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1358	7	Abouassi	Abouassi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1358	8	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1358	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1358	10	Badaoui	Badaoui	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1358	11	G.	G.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1358	12	Rivaroxaban	Rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1358	13	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1358	14	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1358	15	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1358	16	heparin	heparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1358	17	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1358	18	induced	induce	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1358	19	thrombocytopenia	thrombocytopenia	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1358	20	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1358	21	cardiac	cardiac	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1358	22	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1358	23	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1358	24	a	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1358	25	case	case	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1358	26	report	report	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1358	27	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1359	1	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1359	2	Thorac	Thorac	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1359	3	Cardiovasc	Cardiovasc	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1359	4	Surg	Surg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1359	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1360	1	2015;150	2015;150	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1360	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1360	3	e19	e19	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1360	4	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1360	5	e20	e20	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1360	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1361	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1361	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1361	3	10.1016	10.1016	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1361	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1361	5	j.jtcvs.2015.04.054	j.jtcvs.2015.04.054	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1361	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1362	1	170	170	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1362	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1363	1	Jones	Jones	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	2	WS	WS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1363	4	Hellkamp	Hellkamp	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	5	AS	AS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1363	7	Halperin	Halperin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	8	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1363	10	Piccini	Piccini	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	11	JP	JP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1363	13	Breithardt	Breithardt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	14	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1363	16	Singer	Singer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	17	DE	DE	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1363	19	Fox	Fox	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	20	KA	KA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1363	22	Hankey	Hankey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	23	GJ	GJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1363	25	Mahaffey	Mahaffey	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	26	KW	KW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1363	28	Califf	Califf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	29	RM	RM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1363	31	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	32	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	33	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1363	34	Efficacy	efficacy	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	35	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1363	36	safety	safety	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	38	rivaroxaban	rivaroxaban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	39	compared	compare	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	40	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	41	warfarin	warfarin	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	42	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	43	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1363	44	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	45	peripheral	peripheral	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1363	46	artery	artery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	47	disease	disease	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	48	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1363	49	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1363	50	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1363	51	valvular	valvular	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1363	52	atrial	atrial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1363	53	fibrillation	fibrillation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	54	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1363	55	insights	insight	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1363	56	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1363	57	ROCKET	ROCKET	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	58	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1363	59	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1364	1	Eur	Eur	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1364	2	Heart	Heart	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1364	3	J.	j.	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1365	1	2014;35:242	2014;35:242	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1365	2	–	–	:
work_vvlzsj54cvf5de6ji6py6krqlm	1365	3	249	249	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1365	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1365	5	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1365	6	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1365	7	10.1093	10.1093	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1365	8	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1365	9	eurheartj	eurheartj	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1365	10	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1365	11	eht492	eht492	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1365	12	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1366	1	171	171	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1366	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1367	1	Majeed	Majeed	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	2	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1367	4	Hwang	Hwang	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	5	HG	HG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1367	7	Connolly	Connolly	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	8	SJ	SJ	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1367	10	Eikelboom	Eikelboom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	11	JW	JW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1367	13	Ezekowitz	Ezekowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	14	MD	MD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1367	16	Wallentin	Wallentin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	17	L	L	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1367	19	Brueckmann	Brueckmann	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	20	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1367	22	Fraessdorf	Fraessdorf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	23	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1367	25	Yusuf	Yusuf	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	26	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1367	28	Schulman	Schulman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	29	S.	S.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	30	Management	Management	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	31	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1367	32	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1367	33	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1367	34	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1367	35	bleeding	bleeding	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1367	36	during	during	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1367	37	treatment	treatment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1367	38	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1367	39	dabigatran	dabigatran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	40	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1367	41	warfarin	warfarin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1367	42	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1368	1	Circulation	circulation	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1368	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1369	1	2013;128:2325–2332	2013;128:2325–2332	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1369	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1370	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1370	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1370	3	10.1161	10.1161	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1370	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1370	5	CIRCULATIONAHA.113.002332	CIRCULATIONAHA.113.002332	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1370	6	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1371	1	172	172	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1371	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1372	1	Paikin	Paikin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	2	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1372	4	Hirsh	Hirsh	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	5	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1372	7	Chan	Chan	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	8	NC	NC	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1372	10	Ginsberg	Ginsberg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	11	JS	JS	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1372	13	Weitz	Weitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	14	JI	JI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1372	16	Eikelboom	Eikelboom	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	17	JW	JW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1372	18	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1373	1	Timing	time	VBG
work_vvlzsj54cvf5de6ji6py6krqlm	1373	2	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1373	3	first	first	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1373	4	postoperative	postoperative	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1373	5	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1373	6	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1373	7	anticoagulants	anticoagulant	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1373	8	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1373	9	les-	les-	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1373	10	sons	son	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1373	11	learned	learn	VBN
work_vvlzsj54cvf5de6ji6py6krqlm	1373	12	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1373	13	clinical	clinical	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1373	14	trials	trial	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1373	15	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1374	1	Chest	chest	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1374	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1375	1	2015;148:587–595	2015;148:587–595	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1375	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1376	1	doi	doi	XX
work_vvlzsj54cvf5de6ji6py6krqlm	1376	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1376	3	10.1378	10.1378	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1376	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1376	5	chest.14	chest.14	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1376	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1376	7	2710	2710	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1376	8	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1377	1	173	173	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1377	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1378	1	Rosencher	Rosencher	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	2	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1378	4	Llau	Llau	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	5	JV	JV	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1378	7	Mueck	Mueck	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	8	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1378	10	Loewe	Loewe	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	11	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1378	13	Berkowitz	Berkowitz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	14	SD	SD	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1378	16	Homering	Homering	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	17	M.	M.	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	18	Incidence	Incidence	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1378	20	neuraxial	neuraxial	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1378	21	haematoma	haematoma	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	22	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1378	23	total	total	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1378	24	hip	hip	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1378	25	or	or	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1378	26	knee	knee	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1378	27	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1378	28	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1378	29	RECORD	record	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1378	30	programme	programme	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1378	31	(	(	-LRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1378	32	rivaroxaban	rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	33	vs.	vs.	FW
work_vvlzsj54cvf5de6ji6py6krqlm	1378	34	enoxaparin	enoxaparin	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1378	35	)	)	-RRB-
work_vvlzsj54cvf5de6ji6py6krqlm	1378	36	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1379	1	Acta	Acta	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1379	2	Anaesthesiol	Anaesthesiol	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1379	3	Scand	Scand	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1379	4	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1380	1	2013;57:565–572	2013;57:565–572	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1380	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1381	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1381	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1381	3	10.1111/	10.1111/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1381	4	aas.12069	aas.12069	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1381	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1382	1	174	174	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1382	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1383	1	Turpie	Turpie	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	2	AG	AG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1383	4	Haas	Haas	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	5	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1383	7	Kreutz	Kreutz	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	8	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1383	10	Mantovani	Mantovani	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	11	LG	LG	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1383	13	Pattanayak	Pattanayak	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	14	CW	CW	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1383	16	Holberg	Holberg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	17	G	G	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1383	19	Jamal	Jamal	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	20	W	W	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1383	22	Schmidt	Schmidt	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	23	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1383	25	van	van	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	26	Eickels	Eickels	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	27	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	28	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1383	29	Lassen	Lassen	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	30	MR	MR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	31	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1383	32	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1383	33	non	non	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1383	34	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1383	35	interventional	interventional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1383	36	comparison	comparison	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	37	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	38	rivaroxaban	rivaroxaban	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1383	39	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	40	standard	standard	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	41	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	42	care	care	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	43	for	for	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	44	thromboprophylaxis	thromboprophylaxi	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1383	45	after	after	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	46	major	major	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1383	47	orthopaedic	orthopaedic	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1383	48	surgery	surgery	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	49	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	50	17,701	17,701	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1383	51	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1383	52	with	with	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	53	propensity	propensity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	54	score	score	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	55	adjustment	adjustment	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1383	56	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1384	1	Thromb	Thromb	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1384	2	Haemost	Haemost	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1384	3	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1385	1	2014;111:94–102	2014;111:94–102	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1385	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1386	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1386	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1386	3	10.1160	10.1160	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1386	4	/	/	SYM
work_vvlzsj54cvf5de6ji6py6krqlm	1386	5	TH13	TH13	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1386	6	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1386	7	08	08	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1386	8	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1386	9	0666	0666	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1386	10	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1387	1	175	175	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1387	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1388	1	Narouze	Narouze	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	2	S	S	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1388	4	Benzon	Benzon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	5	HT	HT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1388	7	Provenzano	Provenzano	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	8	DA	DA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1388	10	Buvanendran	Buvanendran	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	11	A	A	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1388	13	De	De	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	14	Andres	Andres	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	15	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	16	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1388	17	Deer	Deer	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	18	TR	TR	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	19	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1388	20	Rauck	Rauck	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	21	R	R	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	22	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1388	23	Huntoon	Huntoon	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	24	MA	MA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1388	25	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1389	1	Interventional	interventional	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1389	2	spine	spine	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1389	3	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1389	4	pain	pain	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1389	5	procedures	procedure	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1389	6	in	in	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1389	7	patients	patient	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1389	8	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1389	9	antiplatelet	antiplatelet	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1389	10	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1389	11	anticoagulant	anticoagulant	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1389	12	medications	medication	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1389	13	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1389	14	guidelines	guideline	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1389	15	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1389	16	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1389	17	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	18	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	19	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1389	20	Regional	Regional	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	21	Anesthesia	Anesthesia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	22	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1389	23	Pain	Pain	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	24	Medicine	Medicine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1389	26	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1389	27	European	European	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	28	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	29	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1389	30	Regional	Regional	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	31	Anaesthesia	Anaesthesia	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	32	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1389	33	Pain	Pain	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	34	Therapy	Therapy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	35	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1389	36	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1389	37	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	38	Academy	Academy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	39	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1389	40	Pain	Pain	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	41	Medicine	Medicine	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	42	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1389	43	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1389	44	International	International	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	45	Neuromodulation	Neuromodulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	46	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	47	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1389	48	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1389	49	North	North	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	50	American	American	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	51	Neuromodulation	Neuromodulation	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	52	Society	Society	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	53	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1389	54	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1389	55	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1389	56	World	World	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	57	Institute	Institute	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	58	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1389	59	Pain	Pain	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1389	60	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1390	1	Reg	Reg	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1390	2	Anesth	Anesth	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1390	3	Pain	Pain	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1390	4	Med	Med	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1390	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1391	1	2015;40:182–212	2015;40:182–212	LS
work_vvlzsj54cvf5de6ji6py6krqlm	1391	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1392	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1392	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1392	3	10.1097/	10.1097/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1392	4	AAP.0000000000000223	aap.0000000000000223	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1392	5	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1393	1	176	176	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1393	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1394	1	Ruff	ruff	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1394	2	CT	CT	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	3	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	4	Giugliano	Giugliano	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	5	RP	RP	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	7	Braunwald	Braunwald	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	8	E	E	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	9	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	10	Morrow	Morrow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	11	DA	DA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	12	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	13	Murphy	Murphy	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	14	SA	SA	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	15	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	16	Kuder	Kuder	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	17	JF	JF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	18	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	19	Deenadayalu	Deenadayalu	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	20	N	N	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	21	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	22	Jarolim	Jarolim	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	23	P	P	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	24	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	25	Betcher	Betcher	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	26	J	J	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	27	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	28	Shi	Shi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	29	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	30	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	31	Brown	Brown	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	32	K	K	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	33	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	34	Patel	Patel	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	35	I	-PRON-	PRP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	36	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	37	Mercuri	Mercuri	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	38	M	M	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	39	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1394	40	Antman	Antman	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	41	EM	EM	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1394	42	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1395	1	Association	association	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1395	2	between	between	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1395	3	edoxa-	edoxa-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1395	4	ban	ban	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1395	5	dose	dose	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1395	6	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1395	7	concentration	concentration	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1395	8	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1395	9	anti	anti	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1395	10	-	-	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1395	11	factor	factor	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1395	12	Xa	Xa	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1395	13	activity	activity	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1395	14	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1395	15	and	and	CC
work_vvlzsj54cvf5de6ji6py6krqlm	1395	16	outcomes	outcome	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1395	17	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1395	18	an	an	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1395	19	analysis	analysis	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1395	20	of	of	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1395	21	data	datum	NNS
work_vvlzsj54cvf5de6ji6py6krqlm	1395	22	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1395	23	the	the	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1395	24	randomised	randomised	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1395	25	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1395	26	double	double	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1395	27	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1395	28	blind	blind	JJ
work_vvlzsj54cvf5de6ji6py6krqlm	1395	29	ENGAGE	engage	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1395	30	AF	AF	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1395	31	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1395	32	TIMI	TIMI	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1395	33	48	48	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1395	34	trial	trial	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1395	35	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1396	1	Lancet	Lancet	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1396	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1397	1	2015;385:2288–2295	2015;385:2288–2295	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1397	2	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1398	1	doi	doi	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1398	2	:	:	:
work_vvlzsj54cvf5de6ji6py6krqlm	1398	3	10.1016/	10.1016/	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1398	4	S0140	S0140	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1398	5	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1398	6	6736(14)61943	6736(14)61943	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1398	7	-	-	HYPH
work_vvlzsj54cvf5de6ji6py6krqlm	1398	8	7	7	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1398	9	.	.	.
work_vvlzsj54cvf5de6ji6py6krqlm	1399	1	D	D	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1399	2	ow	ow	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1399	3	nloaded	nloade	VBD
work_vvlzsj54cvf5de6ji6py6krqlm	1399	4	from	from	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1399	5	http://ahajournals.org	http://ahajournals.org	NNP
work_vvlzsj54cvf5de6ji6py6krqlm	1399	6	by	by	RB
work_vvlzsj54cvf5de6ji6py6krqlm	1399	7	on	on	IN
work_vvlzsj54cvf5de6ji6py6krqlm	1399	8	A	a	DT
work_vvlzsj54cvf5de6ji6py6krqlm	1399	9	pril	pril	NN
work_vvlzsj54cvf5de6ji6py6krqlm	1399	10	5	5	CD
work_vvlzsj54cvf5de6ji6py6krqlm	1399	11	,	,	,
work_vvlzsj54cvf5de6ji6py6krqlm	1399	12	2021	2021	CD